id	sid	tid	token	lemma	pos
dti-1330	1	1	matsuyama	matsuyama	PROPN
dti-1330	1	2	et	et	PROPN
dti-1330	1	3	al.indd	al.indd	PROPN
dti-1330	1	4	drug	drug	NOUN
dti-1330	1	5	target	target	NOUN
dti-1330	1	6	insights	insight	NOUN
dti-1330	1	7	2008:3	2008:3	NUM
dti-1330	1	8	137–151	137–151	NUM
dti-1330	1	9	137	137	NUM
dti-1330	1	10	review	review	NOUN
dti-1330	1	11	correspondence	correspondence	NOUN
dti-1330	1	12	:	:	PUNCT
dti-1330	1	13	rikio	rikio	PROPN
dti-1330	1	14	yoshimura	yoshimura	PROPN
dti-1330	1	15	,	,	PUNCT
dti-1330	1	16	m.d	m.d	PROPN
dti-1330	1	17	.	.	PROPN
dti-1330	1	18	,	,	PUNCT
dti-1330	1	19	ph.d	ph.d	PROPN
dti-1330	1	20	.	.	PROPN
dti-1330	1	21	,	,	PUNCT
dti-1330	1	22	department	department	NOUN
dti-1330	1	23	of	of	ADP
dti-1330	1	24	urology	urology	NOUN
dti-1330	1	25	,	,	PUNCT
dti-1330	1	26	osaka	osaka	PROPN
dti-1330	1	27	city	city	PROPN
dti-1330	1	28	university	university	PROPN
dti-1330	1	29	hospital	hospital	NOUN
dti-1330	1	30	,	,	PUNCT
dti-1330	1	31	1	1	NUM
dti-1330	1	32	-	-	SYM
dti-1330	1	33	4	4	NUM
dti-1330	1	34	-	-	SYM
dti-1330	1	35	3	3	NUM
dti-1330	1	36	asahi	asahi	NOUN
dti-1330	1	37	-	-	PUNCT
dti-1330	1	38	machi	machi	NOUN
dti-1330	1	39	,	,	PUNCT
dti-1330	1	40	abeno	abeno	PROPN
dti-1330	1	41	-	-	PUNCT
dti-1330	1	42	ku	ku	PROPN
dti-1330	1	43	,	,	PUNCT
dti-1330	1	44	osaka	osaka	PROPN
dti-1330	1	45	545	545	NUM
dti-1330	1	46	-	-	SYM
dti-1330	1	47	8585	8585	NUM
dti-1330	1	48	,	,	PUNCT
dti-1330	1	49	japan	japan	PROPN
dti-1330	1	50	.	.	PUNCT
dti-1330	2	1	tel	tel	ADP
dti-1330	2	2	:	:	PUNCT
dti-1330	2	3	81	81	NUM
dti-1330	2	4	-	-	PUNCT
dti-1330	2	5	6	6	NUM
dti-1330	2	6	-	-	PUNCT
dti-1330	2	7	6645	6645	NUM
dti-1330	2	8	-	-	SYM
dti-1330	2	9	3857	3857	NUM
dti-1330	2	10	;	;	PUNCT
dti-1330	2	11	fax	fax	NOUN
dti-1330	2	12	:	:	PUNCT
dti-1330	2	13	81	81	NUM
dti-1330	2	14	-	-	PUNCT
dti-1330	2	15	6	6	NUM
dti-1330	2	16	-	-	PUNCT
dti-1330	2	17	6647	6647	NUM
dti-1330	2	18	-	-	SYM
dti-1330	2	19	4426	4426	NUM
dti-1330	2	20	;	;	PUNCT
dti-1330	2	21	email	email	NOUN
dti-1330	2	22	:	:	PUNCT
dti-1330	2	23	jasmin@med.osaka-cu.ac.jp	jasmin@med.osaka-cu.ac.jp	PROPN
dti-1330	2	24	copyright	copyright	NOUN
dti-1330	2	25	in	in	ADP
dti-1330	2	26	this	this	DET
dti-1330	2	27	article	article	NOUN
dti-1330	2	28	,	,	PUNCT
dti-1330	2	29	its	its	PRON
dti-1330	2	30	metadata	metadata	NOUN
dti-1330	2	31	,	,	PUNCT
dti-1330	2	32	and	and	CCONJ
dti-1330	2	33	any	any	DET
dti-1330	2	34	supplementary	supplementary	ADJ
dti-1330	2	35	data	datum	NOUN
dti-1330	2	36	is	be	AUX
dti-1330	2	37	held	hold	VERB
dti-1330	2	38	by	by	ADP
dti-1330	2	39	its	its	PRON
dti-1330	2	40	author	author	NOUN
dti-1330	2	41	or	or	CCONJ
dti-1330	2	42	authors	author	NOUN
dti-1330	2	43	.	.	PUNCT
dti-1330	3	1	it	it	PRON
dti-1330	3	2	is	be	AUX
dti-1330	3	3	published	publish	VERB
dti-1330	3	4	under	under	ADP
dti-1330	3	5	the	the	DET
dti-1330	3	6	creative	creative	ADJ
dti-1330	3	7	commons	common	NOUN
dti-1330	3	8	attribution	attribution	NOUN
dti-1330	3	9	by	by	ADP
dti-1330	3	10	licence	licence	NOUN
dti-1330	3	11	.	.	PUNCT
dti-1330	4	1	for	for	SCONJ
dti-1330	4	2	further	further	ADJ
dti-1330	4	3	information	information	NOUN
dti-1330	4	4	go	go	VERB
dti-1330	4	5	to	to	ADP
dti-1330	4	6	:	:	PUNCT
dti-1330	4	7	http://creativecommons.org/licenses/by/3.0/.	http://creativecommons.org/licenses/by/3.0/.	VERB
dti-1330	4	8	the	the	DET
dti-1330	4	9	target	target	NOUN
dti-1330	4	10	of	of	ADP
dti-1330	4	11	5	5	NUM
dti-1330	4	12	-	-	PUNCT
dti-1330	4	13	lipoxygenase	lipoxygenase	NOUN
dti-1330	4	14	is	be	AUX
dti-1330	4	15	a	a	DET
dti-1330	4	16	novel	novel	ADJ
dti-1330	4	17	strategy	strategy	NOUN
dti-1330	4	18	over	over	ADP
dti-1330	4	19	human	human	ADJ
dti-1330	4	20	urological	urological	ADJ
dti-1330	4	21	tumors	tumor	NOUN
dti-1330	4	22	than	than	ADP
dti-1330	4	23	the	the	DET
dti-1330	4	24	target	target	NOUN
dti-1330	4	25	of	of	ADP
dti-1330	4	26	cyclooxygenase-2	cyclooxygenase-2	NUM
dti-1330	4	27	masahide	masahide	ADP
dti-1330	4	28	matsuyama	matsuyama	PROPN
dti-1330	4	29	and	and	CCONJ
dti-1330	4	30	rikio	rikio	VERB
dti-1330	4	31	yoshimura	yoshimura	PROPN
dti-1330	4	32	department	department	PROPN
dti-1330	4	33	of	of	ADP
dti-1330	4	34	urology	urology	NOUN
dti-1330	4	35	,	,	PUNCT
dti-1330	4	36	osaka	osaka	PROPN
dti-1330	4	37	city	city	PROPN
dti-1330	4	38	university	university	PROPN
dti-1330	4	39	graduate	graduate	NOUN
dti-1330	4	40	school	school	NOUN
dti-1330	4	41	of	of	ADP
dti-1330	4	42	medicine	medicine	NOUN
dti-1330	4	43	,	,	PUNCT
dti-1330	4	44	add	add	VERB
dti-1330	4	45	:	:	PUNCT
dti-1330	4	46	1	1	NUM
dti-1330	4	47	-	-	SYM
dti-1330	4	48	4	4	NUM
dti-1330	4	49	-	-	SYM
dti-1330	4	50	3	3	NUM
dti-1330	4	51	asahi	asahi	NOUN
dti-1330	4	52	-	-	PUNCT
dti-1330	4	53	machi	machi	NOUN
dti-1330	4	54	,	,	PUNCT
dti-1330	4	55	abeno	abeno	PROPN
dti-1330	4	56	-	-	PUNCT
dti-1330	4	57	ku	ku	PROPN
dti-1330	4	58	,	,	PUNCT
dti-1330	4	59	osaka	osaka	PROPN
dti-1330	4	60	,	,	PUNCT
dti-1330	4	61	545	545	NUM
dti-1330	4	62	-	-	SYM
dti-1330	4	63	8585	8585	NUM
dti-1330	4	64	,	,	PUNCT
dti-1330	4	65	japan	japan	PROPN
dti-1330	4	66	.	.	PUNCT
dti-1330	5	1	abstract	abstract	PROPN
dti-1330	5	2	:	:	PUNCT
dti-1330	5	3	the	the	DET
dti-1330	5	4	metabolism	metabolism	NOUN
dti-1330	5	5	of	of	ADP
dti-1330	5	6	arachidonic	arachidonic	ADJ
dti-1330	5	7	acid	acid	NOUN
dti-1330	5	8	by	by	ADP
dti-1330	5	9	either	either	CCONJ
dti-1330	5	10	the	the	DET
dti-1330	5	11	cyclooxygenase	cyclooxygenase	NOUN
dti-1330	5	12	(	(	PUNCT
dti-1330	5	13	cox	cox	PROPN
dti-1330	5	14	)	)	PUNCT
dti-1330	5	15	or	or	CCONJ
dti-1330	5	16	lipoxygenase	lipoxygenase	NOUN
dti-1330	5	17	(	(	PUNCT
dti-1330	5	18	lox	lox	NOUN
dti-1330	5	19	)	)	PUNCT
dti-1330	5	20	pathway	pathway	NOUN
dti-1330	5	21	generates	generate	VERB
dti-1330	5	22	eicosanoids	eicosanoid	NOUN
dti-1330	5	23	,	,	PUNCT
dti-1330	5	24	which	which	PRON
dti-1330	5	25	have	have	AUX
dti-1330	5	26	been	be	AUX
dti-1330	5	27	implicated	implicate	VERB
dti-1330	5	28	in	in	ADP
dti-1330	5	29	the	the	DET
dti-1330	5	30	pathogenesis	pathogenesis	NOUN
dti-1330	5	31	of	of	ADP
dti-1330	5	32	a	a	DET
dti-1330	5	33	variety	variety	NOUN
dti-1330	5	34	of	of	ADP
dti-1330	5	35	human	human	ADJ
dti-1330	5	36	diseases	disease	NOUN
dti-1330	5	37	,	,	PUNCT
dti-1330	5	38	including	include	VERB
dti-1330	5	39	cancer	cancer	NOUN
dti-1330	5	40	.	.	PUNCT
dti-1330	6	1	it	it	PRON
dti-1330	6	2	is	be	AUX
dti-1330	6	3	now	now	ADV
dti-1330	6	4	considered	consider	VERB
dti-1330	6	5	that	that	SCONJ
dti-1330	6	6	they	they	PRON
dti-1330	6	7	play	play	VERB
dti-1330	6	8	important	important	ADJ
dti-1330	6	9	roles	role	NOUN
dti-1330	6	10	in	in	ADP
dti-1330	6	11	tumor	tumor	NOUN
dti-1330	6	12	promotion	promotion	NOUN
dti-1330	6	13	,	,	PUNCT
dti-1330	6	14	progression	progression	NOUN
dti-1330	6	15	,	,	PUNCT
dti-1330	6	16	and	and	CCONJ
dti-1330	6	17	metastasis	metastasis	NOUN
dti-1330	6	18	,	,	PUNCT
dti-1330	6	19	also	also	ADV
dti-1330	6	20	,	,	PUNCT
dti-1330	6	21	the	the	DET
dti-1330	6	22	involvement	involvement	NOUN
dti-1330	6	23	of	of	ADP
dti-1330	6	24	cox	cox	PROPN
dti-1330	6	25	and	and	CCONJ
dti-1330	6	26	lox	lox	NOUN
dti-1330	6	27	expression	expression	NOUN
dti-1330	6	28	and	and	CCONJ
dti-1330	6	29	function	function	NOUN
dti-1330	6	30	in	in	ADP
dti-1330	6	31	tumor	tumor	NOUN
dti-1330	6	32	growth	growth	NOUN
dti-1330	6	33	and	and	CCONJ
dti-1330	6	34	metastasis	metastasis	NOUN
dti-1330	6	35	has	have	AUX
dti-1330	6	36	been	be	AUX
dti-1330	6	37	reported	report	VERB
dti-1330	6	38	in	in	ADP
dti-1330	6	39	human	human	ADJ
dti-1330	6	40	tumor	tumor	NOUN
dti-1330	6	41	cell	cell	NOUN
dti-1330	6	42	lines	line	NOUN
dti-1330	6	43	.	.	PUNCT
dti-1330	7	1	in	in	ADP
dti-1330	7	2	this	this	DET
dti-1330	7	3	study	study	NOUN
dti-1330	7	4	,	,	PUNCT
dti-1330	7	5	we	we	PRON
dti-1330	7	6	examined	examine	VERB
dti-1330	7	7	the	the	DET
dti-1330	7	8	expression	expression	NOUN
dti-1330	7	9	of	of	ADP
dti-1330	7	10	cox	cox	PROPN
dti-1330	7	11	and	and	CCONJ
dti-1330	7	12	lox	lox	PROPN
dti-1330	7	13	in	in	ADP
dti-1330	7	14	human	human	ADJ
dti-1330	7	15	urological	urological	ADJ
dti-1330	7	16	tumors	tumor	NOUN
dti-1330	7	17	(	(	PUNCT
dti-1330	7	18	renal	renal	ADJ
dti-1330	7	19	cell	cell	NOUN
dti-1330	7	20	carcinoma	carcinoma	NOUN
dti-1330	7	21	,	,	PUNCT
dti-1330	7	22	bladder	bladder	NOUN
dti-1330	7	23	tumor	tumor	NOUN
dti-1330	7	24	,	,	PUNCT
dti-1330	7	25	prostate	prostate	NOUN
dti-1330	7	26	cancer	cancer	NOUN
dti-1330	7	27	,	,	PUNCT
dti-1330	7	28	testicular	testicular	ADJ
dti-1330	7	29	cancer	cancer	NOUN
dti-1330	7	30	)	)	PUNCT
dti-1330	7	31	by	by	ADP
dti-1330	7	32	immunohistochemistry	immunohistochemistry	NOUN
dti-1330	7	33	and	and	CCONJ
dti-1330	7	34	rt	rt	NOUN
dti-1330	7	35	-	-	PUNCT
dti-1330	7	36	pcr	pcr	NOUN
dti-1330	7	37	,	,	PUNCT
dti-1330	7	38	and	and	CCONJ
dti-1330	7	39	we	we	PRON
dti-1330	7	40	also	also	ADV
dti-1330	7	41	examined	examine	VERB
dti-1330	7	42	the	the	DET
dti-1330	7	43	effects	effect	NOUN
dti-1330	7	44	of	of	ADP
dti-1330	7	45	cox	cox	PROPN
dti-1330	7	46	and	and	CCONJ
dti-1330	7	47	lox	lox	PROPN
dti-1330	7	48	(	(	PUNCT
dti-1330	7	49	5and	5and	NUM
dti-1330	7	50	12	12	NUM
dti-1330	7	51	-	-	PUNCT
dti-1330	7	52	lox	lox	NOUN
dti-1330	7	53	)	)	PUNCT
dti-1330	7	54	inhibitors	inhibitor	NOUN
dti-1330	7	55	in	in	ADP
dti-1330	7	56	those	those	DET
dti-1330	7	57	cells	cell	NOUN
dti-1330	7	58	by	by	ADP
dti-1330	7	59	mtt	mtt	PROPN
dti-1330	7	60	assay	assay	VERB
dti-1330	7	61	,	,	PUNCT
dti-1330	7	62	hoechest	hoech	ADJ
dti-1330	7	63	staining	staining	ADJ
dti-1330	7	64	,	,	PUNCT
dti-1330	7	65	and	and	CCONJ
dti-1330	7	66	fl	fl	INTJ
dti-1330	7	67	ow	ow	PROPN
dti-1330	7	68	cytometry	cytometry	PROPN
dti-1330	7	69	.	.	PUNCT
dti-1330	8	1	cox-2	cox-2	ADJ
dti-1330	8	2	,	,	PUNCT
dti-1330	8	3	5	5	NUM
dti-1330	8	4	-	-	PUNCT
dti-1330	8	5	lox	lox	NOUN
dti-1330	8	6	and	and	CCONJ
dti-1330	8	7	12	12	NUM
dti-1330	8	8	-	-	PUNCT
dti-1330	8	9	lox	lox	NOUN
dti-1330	8	10	expressions	expression	NOUN
dti-1330	8	11	were	be	AUX
dti-1330	8	12	signifi	signifi	NOUN
dti-1330	8	13	cantly	cantly	ADV
dti-1330	8	14	more	more	ADV
dti-1330	8	15	extensive	extensive	ADJ
dti-1330	8	16	and	and	CCONJ
dti-1330	8	17	intense	intense	ADJ
dti-1330	8	18	in	in	ADP
dti-1330	8	19	malignant	malignant	ADJ
dti-1330	8	20	tissues	tissue	NOUN
dti-1330	8	21	than	than	ADP
dti-1330	8	22	in	in	ADP
dti-1330	8	23	normal	normal	ADJ
dti-1330	8	24	tissues	tissue	NOUN
dti-1330	8	25	.	.	PUNCT
dti-1330	9	1	furthermore	furthermore	ADV
dti-1330	9	2	,	,	PUNCT
dti-1330	9	3	5	5	NUM
dti-1330	9	4	-	-	PUNCT
dti-1330	9	5	lox	lox	NOUN
dti-1330	9	6	inhibitor	inhibitor	NOUN
dti-1330	9	7	induced	induce	VERB
dti-1330	9	8	the	the	DET
dti-1330	9	9	reduction	reduction	NOUN
dti-1330	9	10	of	of	ADP
dti-1330	9	11	malignant	malignant	ADJ
dti-1330	9	12	cell	cell	NOUN
dti-1330	9	13	viability	viability	NOUN
dti-1330	9	14	through	through	ADP
dti-1330	9	15	early	early	ADJ
dti-1330	9	16	apoptosis	apoptosis	NOUN
dti-1330	9	17	.	.	PUNCT
dti-1330	10	1	these	these	DET
dti-1330	10	2	results	result	NOUN
dti-1330	10	3	demonstrated	demonstrate	VERB
dti-1330	10	4	cox-2	cox-2	NOUN
dti-1330	10	5	and	and	CCONJ
dti-1330	10	6	lox	lox	NOUN
dti-1330	10	7	were	be	AUX
dti-1330	10	8	induced	induce	VERB
dti-1330	10	9	in	in	ADP
dti-1330	10	10	urological	urological	ADJ
dti-1330	10	11	tumors	tumor	NOUN
dti-1330	10	12	,	,	PUNCT
dti-1330	10	13	and	and	CCONJ
dti-1330	10	14	5	5	NUM
dti-1330	10	15	-	-	PUNCT
dti-1330	10	16	lox	lox	NOUN
dti-1330	10	17	inhibitor	inhibitor	NOUN
dti-1330	10	18	may	may	AUX
dti-1330	10	19	mediate	mediate	VERB
dti-1330	10	20	potent	potent	ADJ
dti-1330	10	21	antiproliferative	antiproliferative	ADJ
dti-1330	10	22	effects	effect	NOUN
dti-1330	10	23	against	against	ADP
dti-1330	10	24	urological	urological	ADJ
dti-1330	10	25	tumors	tumor	NOUN
dti-1330	10	26	cells	cell	NOUN
dti-1330	10	27	.	.	PUNCT
dti-1330	11	1	thus	thus	ADV
dti-1330	11	2	,	,	PUNCT
dti-1330	11	3	5	5	NUM
dti-1330	11	4	-	-	PUNCT
dti-1330	11	5	lox	lox	NOUN
dti-1330	11	6	may	may	AUX
dti-1330	11	7	become	become	VERB
dti-1330	11	8	a	a	DET
dti-1330	11	9	new	new	ADJ
dti-1330	11	10	target	target	NOUN
dti-1330	11	11	in	in	ADP
dti-1330	11	12	the	the	DET
dti-1330	11	13	treatment	treatment	NOUN
dti-1330	11	14	of	of	ADP
dti-1330	11	15	urological	urological	ADJ
dti-1330	11	16	tumors	tumor	NOUN
dti-1330	11	17	.	.	PUNCT
dti-1330	12	1	keywords	keyword	NOUN
dti-1330	12	2	:	:	PUNCT
dti-1330	12	3	cyclooxygenase-2	cyclooxygenase-2	NUM
dti-1330	12	4	,	,	PUNCT
dti-1330	12	5	5	5	NUM
dti-1330	12	6	-	-	PUNCT
dti-1330	12	7	lipoxygenase	lipoxygenase	NOUN
dti-1330	12	8	,	,	PUNCT
dti-1330	12	9	12	12	NUM
dti-1330	12	10	-	-	PUNCT
dti-1330	12	11	lipoxygenase	lipoxygenase	NOUN
dti-1330	12	12	,	,	PUNCT
dti-1330	12	13	renal	renal	ADJ
dti-1330	12	14	cell	cell	NOUN
dti-1330	12	15	carcinoma	carcinoma	NOUN
dti-1330	12	16	,	,	PUNCT
dti-1330	12	17	bladder	bladder	NOUN
dti-1330	12	18	tumor	tumor	NOUN
dti-1330	12	19	,	,	PUNCT
dti-1330	12	20	prostate	prostate	NOUN
dti-1330	12	21	cancer	cancer	NOUN
dti-1330	12	22	,	,	PUNCT
dti-1330	12	23	testicular	testicular	ADJ
dti-1330	12	24	cancer	cancer	NOUN
dti-1330	12	25	introduction	introduction	NOUN
dti-1330	12	26	angiogenetic	angiogenetic	ADJ
dti-1330	12	27	factors	factor	NOUN
dti-1330	12	28	play	play	VERB
dti-1330	12	29	important	important	ADJ
dti-1330	12	30	roles	role	NOUN
dti-1330	12	31	in	in	ADP
dti-1330	12	32	urological	urological	ADJ
dti-1330	12	33	tumors	tumor	NOUN
dti-1330	12	34	as	as	ADV
dti-1330	12	35	well	well	ADV
dti-1330	12	36	as	as	ADP
dti-1330	12	37	in	in	ADP
dti-1330	12	38	other	other	ADJ
dti-1330	12	39	cancers	cancer	NOUN
dti-1330	12	40	.	.	PUNCT
dti-1330	13	1	in	in	ADP
dti-1330	13	2	recent	recent	ADJ
dti-1330	13	3	years	year	NOUN
dti-1330	13	4	,	,	PUNCT
dti-1330	13	5	the	the	DET
dti-1330	13	6	expression	expression	NOUN
dti-1330	13	7	of	of	ADP
dti-1330	13	8	angiogenic	angiogenic	ADJ
dti-1330	13	9	factors	factor	NOUN
dti-1330	13	10	in	in	ADP
dti-1330	13	11	solid	solid	ADJ
dti-1330	13	12	human	human	ADJ
dti-1330	13	13	tumors	tumor	NOUN
dti-1330	13	14	has	have	AUX
dti-1330	13	15	been	be	AUX
dti-1330	13	16	widely	widely	ADV
dti-1330	13	17	reported	report	VERB
dti-1330	13	18	[	[	X
dti-1330	13	19	1	1	NUM
dti-1330	13	20	]	]	PUNCT
dti-1330	13	21	.	.	PUNCT
dti-1330	14	1	growth	growth	NOUN
dti-1330	14	2	factors	factor	NOUN
dti-1330	14	3	secreted	secrete	VERB
dti-1330	14	4	by	by	ADP
dti-1330	14	5	tumor	tumor	NOUN
dti-1330	14	6	cells	cell	NOUN
dti-1330	14	7	such	such	ADJ
dti-1330	14	8	as	as	ADP
dti-1330	14	9	fi	fi	NOUN
dti-1330	14	10	broblast	broblast	ADJ
dti-1330	14	11	growth	growth	NOUN
dti-1330	14	12	factor	factor	NOUN
dti-1330	14	13	,	,	PUNCT
dti-1330	14	14	and	and	CCONJ
dti-1330	14	15	transforming	transform	VERB
dti-1330	14	16	growth	growth	NOUN
dti-1330	14	17	factor	factor	NOUN
dti-1330	14	18	,	,	PUNCT
dti-1330	14	19	have	have	AUX
dti-1330	14	20	increased	increase	VERB
dti-1330	14	21	neovascularization	neovascularization	NOUN
dti-1330	14	22	in	in	ADP
dti-1330	14	23	vivo	vivo	NOUN
dti-1330	14	24	and	and	CCONJ
dti-1330	14	25	in	in	ADP
dti-1330	14	26	vitro	vitro	X
dti-1330	14	27	[	[	X
dti-1330	14	28	2	2	NUM
dti-1330	14	29	]	]	PUNCT
dti-1330	14	30	.	.	PUNCT
dti-1330	15	1	the	the	DET
dti-1330	15	2	metabolism	metabolism	NOUN
dti-1330	15	3	of	of	ADP
dti-1330	15	4	arachidonic	arachidonic	ADJ
dti-1330	15	5	acid	acid	NOUN
dti-1330	15	6	(	(	PUNCT
dti-1330	15	7	aa	aa	NOUN
dti-1330	15	8	)	)	PUNCT
dti-1330	15	9	by	by	ADP
dti-1330	15	10	either	either	CCONJ
dti-1330	15	11	the	the	DET
dti-1330	15	12	cyclooxygenase	cyclooxygenase	NOUN
dti-1330	15	13	(	(	PUNCT
dti-1330	15	14	cox	cox	PROPN
dti-1330	15	15	)	)	PUNCT
dti-1330	15	16	pathway	pathway	NOUN
dti-1330	15	17	or	or	CCONJ
dti-1330	15	18	the	the	DET
dti-1330	15	19	lipoxygenase	lipoxygenase	NOUN
dti-1330	15	20	(	(	PUNCT
dti-1330	15	21	lox	lox	NOUN
dti-1330	15	22	)	)	PUNCT
dti-1330	15	23	pathway	pathway	NOUN
dti-1330	15	24	generates	generate	VERB
dti-1330	15	25	eicosanoids	eicosanoid	NOUN
dti-1330	15	26	,	,	PUNCT
dti-1330	15	27	have	have	AUX
dti-1330	15	28	been	be	AUX
dti-1330	15	29	implicated	implicate	VERB
dti-1330	15	30	in	in	ADP
dti-1330	15	31	the	the	DET
dti-1330	15	32	pathogenesis	pathogenesis	NOUN
dti-1330	15	33	of	of	ADP
dti-1330	15	34	a	a	DET
dti-1330	15	35	variety	variety	NOUN
dti-1330	15	36	of	of	ADP
dti-1330	15	37	human	human	ADJ
dti-1330	15	38	diseases	disease	NOUN
dti-1330	15	39	,	,	PUNCT
dti-1330	15	40	including	include	VERB
dti-1330	15	41	cancer	cancer	NOUN
dti-1330	15	42	,	,	PUNCT
dti-1330	15	43	and	and	CCONJ
dti-1330	15	44	are	be	AUX
dti-1330	15	45	considered	consider	VERB
dti-1330	15	46	important	important	ADJ
dti-1330	15	47	in	in	ADP
dti-1330	15	48	tumor	tumor	NOUN
dti-1330	15	49	promotion	promotion	NOUN
dti-1330	15	50	,	,	PUNCT
dti-1330	15	51	progression	progression	NOUN
dti-1330	15	52	,	,	PUNCT
dti-1330	15	53	and	and	CCONJ
dti-1330	15	54	metastasis	metastasis	NOUN
dti-1330	15	55	.	.	PUNCT
dti-1330	16	1	cox	cox	PROPN
dti-1330	16	2	is	be	AUX
dti-1330	16	3	the	the	DET
dti-1330	16	4	fi	fi	NOUN
dti-1330	16	5	rst	rst	ADJ
dti-1330	16	6	enzyme	enzyme	NOUN
dti-1330	16	7	in	in	ADP
dti-1330	16	8	the	the	DET
dti-1330	16	9	pathway	pathway	NOUN
dti-1330	16	10	for	for	ADP
dti-1330	16	11	producing	produce	VERB
dti-1330	16	12	prostaglandin	prostaglandin	NOUN
dti-1330	16	13	(	(	PUNCT
dti-1330	16	14	pg	pg	NOUN
dti-1330	16	15	)	)	PUNCT
dti-1330	16	16	and	and	CCONJ
dti-1330	16	17	thromboxane	thromboxane	NOUN
dti-1330	16	18	(	(	PUNCT
dti-1330	16	19	tx	tx	PROPN
dti-1330	16	20	)	)	PUNCT
dti-1330	16	21	from	from	ADP
dti-1330	16	22	arachidonic	arachidonic	ADJ
dti-1330	16	23	acid	acid	NOUN
dti-1330	16	24	,	,	PUNCT
dti-1330	16	25	and	and	CCONJ
dti-1330	16	26	can	can	AUX
dti-1330	16	27	occur	occur	VERB
dti-1330	16	28	as	as	ADP
dti-1330	16	29	three	three	NUM
dti-1330	16	30	isoforms	isoform	NOUN
dti-1330	16	31	,	,	PUNCT
dti-1330	16	32	cox-1	cox-1	NOUN
dti-1330	16	33	,	,	PUNCT
dti-1330	16	34	cox-2	cox-2	ADV
dti-1330	16	35	and	and	CCONJ
dti-1330	16	36	cox-3	cox-3	NOUN
dti-1330	16	37	.	.	PUNCT
dti-1330	17	1	the	the	DET
dti-1330	17	2	enzymes	enzyme	NOUN
dti-1330	17	3	of	of	ADP
dti-1330	17	4	both	both	PRON
dti-1330	17	5	cox-1	cox-1	PUNCT
dti-1330	17	6	and	and	CCONJ
dti-1330	17	7	cox-2	cox-2	NUM
dti-1330	17	8	are	be	AUX
dti-1330	17	9	transformed	transform	VERB
dti-1330	17	10	from	from	ADP
dti-1330	17	11	the	the	DET
dti-1330	17	12	cell	cell	NOUN
dti-1330	17	13	membrane	membrane	NOUN
dti-1330	17	14	phospholipid	phospholipid	NOUN
dti-1330	17	15	to	to	ADP
dti-1330	17	16	arachidonic	arachidonic	ADJ
dti-1330	17	17	acid	acid	NOUN
dti-1330	17	18	by	by	ADP
dti-1330	17	19	the	the	DET
dti-1330	17	20	phospholipasea2	phospholipasea2	PROPN
dti-1330	17	21	,	,	PUNCT
dti-1330	17	22	and	and	CCONJ
dti-1330	17	23	then	then	ADV
dti-1330	17	24	transform	transform	VERB
dti-1330	17	25	arachidonic	arachidonic	ADJ
dti-1330	17	26	acid	acid	NOUN
dti-1330	17	27	to	to	PART
dti-1330	17	28	pgh2	pgh2	PROPN
dti-1330	17	29	through	through	ADP
dti-1330	17	30	pgg2	pgg2	PROPN
dti-1330	17	31	(	(	PUNCT
dti-1330	17	32	fig	fig	NOUN
dti-1330	17	33	.	.	PUNCT
dti-1330	18	1	1	1	NUM
dti-1330	18	2	)	)	PUNCT
dti-1330	18	3	.	.	PUNCT
dti-1330	19	1	cox-1	cox-1	PUNCT
dti-1330	19	2	occurs	occur	VERB
dti-1330	19	3	in	in	ADP
dti-1330	19	4	tissues	tissue	NOUN
dti-1330	19	5	and	and	CCONJ
dti-1330	19	6	cells	cell	NOUN
dti-1330	19	7	and	and	CCONJ
dti-1330	19	8	works	work	VERB
dti-1330	19	9	to	to	PART
dti-1330	19	10	protect	protect	VERB
dti-1330	19	11	the	the	DET
dti-1330	19	12	cell	cell	NOUN
dti-1330	19	13	.	.	PUNCT
dti-1330	20	1	cox-2	cox-2	PRON
dti-1330	20	2	express	express	VERB
dti-1330	20	3	momentarily	momentarily	ADV
dti-1330	20	4	and	and	CCONJ
dti-1330	20	5	strongly	strongly	ADV
dti-1330	20	6	in	in	ADP
dti-1330	20	7	response	response	NOUN
dti-1330	20	8	to	to	ADP
dti-1330	20	9	growth	growth	NOUN
dti-1330	20	10	factors	factor	NOUN
dti-1330	20	11	and	and	CCONJ
dti-1330	20	12	some	some	DET
dti-1330	20	13	endotoxins	endotoxin	NOUN
dti-1330	20	14	.	.	PUNCT
dti-1330	21	1	it	it	PRON
dti-1330	21	2	is	be	AUX
dti-1330	21	3	involved	involve	VERB
dti-1330	21	4	with	with	ADP
dti-1330	21	5	infl	infl	PROPN
dti-1330	21	6	ammation	ammation	PROPN
dti-1330	21	7	,	,	PUNCT
dti-1330	21	8	cell	cell	NOUN
dti-1330	21	9	proliferation	proliferation	NOUN
dti-1330	21	10	and	and	CCONJ
dti-1330	21	11	differentiation	differentiation	NOUN
dti-1330	21	12	[	[	X
dti-1330	21	13	3	3	NUM
dti-1330	21	14	]	]	PUNCT
dti-1330	21	15	.	.	PUNCT
dti-1330	22	1	cox-2	cox-2	NOUN
dti-1330	22	2	has	have	AUX
dti-1330	22	3	also	also	ADV
dti-1330	22	4	been	be	AUX
dti-1330	22	5	shown	show	VERB
dti-1330	22	6	to	to	PART
dti-1330	22	7	play	play	VERB
dti-1330	22	8	an	an	DET
dti-1330	22	9	important	important	ADJ
dti-1330	22	10	role	role	NOUN
dti-1330	22	11	in	in	ADP
dti-1330	22	12	carcinogenesis	carcinogenesis	NOUN
dti-1330	22	13	.	.	PUNCT
dti-1330	23	1	although	although	SCONJ
dti-1330	23	2	the	the	DET
dti-1330	23	3	existence	existence	NOUN
dti-1330	23	4	of	of	ADP
dti-1330	23	5	cox-3	cox-3	PUNCT
dti-1330	23	6	has	have	AUX
dti-1330	23	7	recently	recently	ADV
dti-1330	23	8	been	be	AUX
dti-1330	23	9	reported	report	VERB
dti-1330	23	10	,	,	PUNCT
dti-1330	23	11	it	it	PRON
dti-1330	23	12	continues	continue	VERB
dti-1330	23	13	to	to	PART
dti-1330	23	14	be	be	AUX
dti-1330	23	15	argued	argue	VERB
dti-1330	23	16	[	[	X
dti-1330	23	17	4	4	NUM
dti-1330	23	18	]	]	PUNCT
dti-1330	23	19	.	.	PUNCT
dti-1330	24	1	lox	lox	PROPN
dti-1330	24	2	is	be	AUX
dti-1330	24	3	the	the	DET
dti-1330	24	4	fi	fi	NOUN
dti-1330	24	5	rst	rst	ADJ
dti-1330	24	6	enzyme	enzyme	NOUN
dti-1330	24	7	in	in	ADP
dti-1330	24	8	the	the	DET
dti-1330	24	9	pathway	pathway	NOUN
dti-1330	24	10	for	for	ADP
dti-1330	24	11	producing	produce	VERB
dti-1330	24	12	leukotrienes	leukotriene	NOUN
dti-1330	24	13	(	(	PUNCT
dti-1330	24	14	lt	lt	NOUN
dti-1330	24	15	)	)	PUNCT
dti-1330	24	16	from	from	ADP
dti-1330	24	17	arachidonic	arachidonic	ADJ
dti-1330	24	18	acid	acid	NOUN
dti-1330	24	19	.	.	PUNCT
dti-1330	25	1	isoenzymes	isoenzyme	NOUN
dti-1330	25	2	of	of	ADP
dti-1330	25	3	lox	lox	NOUN
dti-1330	25	4	include	include	VERB
dti-1330	25	5	5	5	NUM
dti-1330	25	6	-	-	PUNCT
dti-1330	25	7	lox	lox	NOUN
dti-1330	25	8	,	,	PUNCT
dti-1330	25	9	12	12	NUM
dti-1330	25	10	-	-	PUNCT
dti-1330	25	11	lox	lox	NOUN
dti-1330	25	12	and	and	CCONJ
dti-1330	25	13	two	two	NUM
dti-1330	25	14	15	15	NUM
dti-1330	25	15	-	-	PUNCT
dti-1330	25	16	lox	lox	NOUN
dti-1330	25	17	isoforms	isoform	NOUN
dti-1330	25	18	(	(	PUNCT
dti-1330	25	19	15	15	NUM
dti-1330	25	20	-	-	PUNCT
dti-1330	25	21	lox-1	lox-1	NOUN
dti-1330	25	22	,	,	PUNCT
dti-1330	25	23	15	15	NUM
dti-1330	25	24	-	-	PUNCT
dti-1330	25	25	lox-2	lox-2	NOUN
dti-1330	25	26	)	)	PUNCT
dti-1330	25	27	.	.	PUNCT
dti-1330	26	1	these	these	DET
dti-1330	26	2	catalyze	catalyze	NOUN
dti-1330	26	3	the	the	DET
dti-1330	26	4	biosynthesis	biosynthesis	NOUN
dti-1330	26	5	of	of	ADP
dti-1330	26	6	biologically	biologically	ADV
dti-1330	26	7	active	active	ADJ
dti-1330	26	8	compounds	compound	NOUN
dti-1330	26	9	such	such	ADJ
dti-1330	26	10	as	as	ADP
dti-1330	26	11	lts	lt	NOUN
dti-1330	26	12	and	and	CCONJ
dti-1330	26	13	hydroxyeicosatetraenoic	hydroxyeicosatetraenoic	ADJ
dti-1330	26	14	acids	acid	NOUN
dti-1330	26	15	(	(	PUNCT
dti-1330	26	16	hetes	hete	NOUN
dti-1330	26	17	)	)	PUNCT
dti-1330	27	1	[	[	X
dti-1330	27	2	5	5	NUM
dti-1330	27	3	,	,	PUNCT
dti-1330	27	4	6	6	NUM
dti-1330	27	5	]	]	PUNCT
dti-1330	27	6	.	.	PUNCT
dti-1330	28	1	5	5	NUM
dti-1330	28	2	-	-	PUNCT
dti-1330	28	3	lox	lox	NOUN
dti-1330	28	4	catalyzes	catalyze	VERB
dti-1330	28	5	the	the	DET
dti-1330	28	6	fi	fi	NOUN
dti-1330	28	7	rst	rst	ADJ
dti-1330	28	8	step	step	NOUN
dti-1330	28	9	in	in	ADP
dti-1330	28	10	oxygenation	oxygenation	NOUN
dti-1330	28	11	of	of	ADP
dti-1330	28	12	arachidonic	arachidonic	ADJ
dti-1330	28	13	acid	acid	NOUN
dti-1330	28	14	to	to	PART
dti-1330	28	15	produce	produce	VERB
dti-1330	28	16	5	5	NUM
dti-1330	28	17	-	-	PUNCT
dti-1330	28	18	hydroperoxyeicosatetraenoic	hydroperoxyeicosatetraenoic	ADJ
dti-1330	28	19	acid	acid	NOUN
dti-1330	28	20	(	(	PUNCT
dti-1330	28	21	5	5	NUM
dti-1330	28	22	-	-	PUNCT
dti-1330	28	23	hpete	hpete	NOUN
dti-1330	28	24	)	)	PUNCT
dti-1330	28	25	,	,	PUNCT
dti-1330	28	26	and	and	CCONJ
dti-1330	28	27	the	the	DET
dti-1330	28	28	subsequent	subsequent	ADJ
dti-1330	28	29	metabolism	metabolism	NOUN
dti-1330	28	30	of	of	ADP
dti-1330	28	31	5	5	NUM
dti-1330	28	32	-	-	PUNCT
dti-1330	28	33	hpete	hpete	NOUN
dti-1330	28	34	to	to	ADP
dti-1330	28	35	5	5	NUM
dti-1330	28	36	-	-	PUNCT
dti-1330	28	37	hete	hete	NOUN
dti-1330	28	38	and	and	CCONJ
dti-1330	28	39	lts	lts	PROPN
dti-1330	28	40	(	(	PUNCT
dti-1330	28	41	fig	fig	NOUN
dti-1330	28	42	.	.	PUNCT
dti-1330	28	43	1	1	NUM
dti-1330	28	44	)	)	PUNCT
dti-1330	28	45	.	.	PUNCT
dti-1330	29	1	lts	lts	PROPN
dti-1330	29	2	belong	belong	VERB
dti-1330	29	3	to	to	ADP
dti-1330	29	4	an	an	DET
dti-1330	29	5	important	important	ADJ
dti-1330	29	6	group	group	NOUN
dti-1330	29	7	of	of	ADP
dti-1330	29	8	pro	pro	ADJ
dti-1330	29	9	-	-	ADJ
dti-1330	29	10	infl	infl	ADJ
dti-1330	29	11	ammatory	ammatory	NOUN
dti-1330	29	12	mediators	mediator	NOUN
dti-1330	29	13	that	that	PRON
dti-1330	29	14	are	be	AUX
dti-1330	29	15	synthesized	synthesize	VERB
dti-1330	29	16	from	from	ADP
dti-1330	29	17	arachidonic	arachidonic	ADJ
dti-1330	29	18	acid	acid	NOUN
dti-1330	29	19	via	via	ADP
dti-1330	29	20	the	the	DET
dti-1330	29	21	5	5	NUM
dti-1330	29	22	-	-	PUNCT
dti-1330	29	23	lox	lox	NOUN
dti-1330	29	24	pathway	pathway	NOUN
dti-1330	29	25	.	.	PUNCT
dti-1330	30	1	the	the	DET
dti-1330	30	2	activity	activity	NOUN
dti-1330	30	3	of	of	ADP
dti-1330	30	4	5	5	NUM
dti-1330	30	5	-	-	PUNCT
dti-1330	30	6	lox	lox	NOUN
dti-1330	30	7	leads	lead	VERB
dti-1330	30	8	to	to	ADP
dti-1330	30	9	the	the	DET
dti-1330	30	10	formation	formation	NOUN
dti-1330	30	11	of	of	ADP
dti-1330	30	12	unstable	unstable	ADJ
dti-1330	30	13	lta4	lta4	NOUN
dti-1330	30	14	,	,	PUNCT
dti-1330	30	15	which	which	PRON
dti-1330	30	16	can	can	AUX
dti-1330	30	17	be	be	AUX
dti-1330	30	18	converted	convert	VERB
dti-1330	30	19	into	into	ADP
dti-1330	30	20	either	either	CCONJ
dti-1330	30	21	ltb4	ltb4	PROPN
dti-1330	30	22	,	,	PUNCT
dti-1330	30	23	or	or	CCONJ
dti-1330	30	24	cysteinyl	cysteinyl	ADJ
dti-1330	30	25	lts	lts	PROPN
dti-1330	30	26	(	(	PUNCT
dti-1330	30	27	ltc4	ltc4	PROPN
dti-1330	30	28	,	,	PUNCT
dti-1330	30	29	ltd4	ltd4	PROPN
dti-1330	30	30	and	and	CCONJ
dti-1330	30	31	lte4	lte4	PROPN
dti-1330	30	32	)	)	PUNCT
dti-1330	31	1	[	[	X
dti-1330	31	2	7	7	NUM
dti-1330	31	3	]	]	PUNCT
dti-1330	31	4	.	.	PUNCT
dti-1330	32	1	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
dti-1330	32	2	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
dti-1330	32	3	138	138	NUM
dti-1330	32	4	matsuyama	matsuyama	PROPN
dti-1330	32	5	and	and	CCONJ
dti-1330	32	6	yoshimura	yoshimura	PROPN
dti-1330	32	7	drug	drug	NOUN
dti-1330	32	8	target	target	NOUN
dti-1330	32	9	insights	insight	NOUN
dti-1330	32	10	2008:3	2008:3	NUM
dti-1330	32	11	the	the	DET
dti-1330	32	12	12	12	NUM
dti-1330	32	13	-	-	PUNCT
dti-1330	32	14	lox	lox	NOUN
dti-1330	32	15	,	,	PUNCT
dti-1330	32	16	includes	include	VERB
dti-1330	32	17	platelet	platelet	NOUN
dti-1330	32	18	12	12	NUM
dti-1330	32	19	-	-	PUNCT
dti-1330	32	20	lox	lox	NOUN
dti-1330	32	21	,	,	PUNCT
dti-1330	32	22	and	and	CCONJ
dti-1330	32	23	leukocyte	leukocyte	NOUN
dti-1330	32	24	12	12	NUM
dti-1330	32	25	-	-	PUNCT
dti-1330	32	26	lox	lox	NOUN
dti-1330	32	27	that	that	PRON
dti-1330	32	28	oxygenate	oxygenate	VERB
dti-1330	32	29	arachidonic	arachidonic	ADJ
dti-1330	32	30	acid	acid	NOUN
dti-1330	32	31	at	at	ADP
dti-1330	32	32	position	position	NOUN
dti-1330	32	33	c-12	c-12	NOUN
dti-1330	32	34	to	to	PART
dti-1330	32	35	produce	produce	VERB
dti-1330	32	36	12	12	NUM
dti-1330	32	37	-	-	PUNCT
dti-1330	32	38	hydroperoxyeicosatetraenoic	hydroperoxyeicosatetraenoic	ADJ
dti-1330	32	39	acid	acid	NOUN
dti-1330	32	40	and	and	CCONJ
dti-1330	32	41	then	then	ADV
dti-1330	32	42	12	12	NUM
dti-1330	32	43	-	-	PUNCT
dti-1330	32	44	hete	hete	NOUN
dti-1330	32	45	[	[	X
dti-1330	32	46	8	8	NUM
dti-1330	32	47	]	]	PUNCT
dti-1330	32	48	.	.	PUNCT
dti-1330	33	1	whereas	whereas	SCONJ
dti-1330	33	2	5	5	NUM
dti-1330	33	3	-	-	PUNCT
dti-1330	33	4	lox	lox	NOUN
dti-1330	33	5	,	,	PUNCT
dti-1330	33	6	12	12	NUM
dti-1330	33	7	-	-	PUNCT
dti-1330	33	8	lox	lox	NOUN
dti-1330	33	9	and	and	CCONJ
dti-1330	33	10	15	15	NUM
dti-1330	33	11	-	-	PUNCT
dti-1330	33	12	lox-1	lox-1	NOUN
dti-1330	33	13	,	,	PUNCT
dti-1330	33	14	have	have	AUX
dti-1330	33	15	procarcinogenic	procarcinogenic	ADJ
dti-1330	33	16	roles	role	NOUN
dti-1330	33	17	,	,	PUNCT
dti-1330	33	18	15	15	NUM
dti-1330	33	19	-	-	PUNCT
dti-1330	33	20	lox-2	lox-2	NOUN
dti-1330	33	21	appears	appear	VERB
dti-1330	33	22	to	to	PART
dti-1330	33	23	have	have	VERB
dti-1330	33	24	an	an	DET
dti-1330	33	25	anti	anti	ADJ
dti-1330	33	26	-	-	ADJ
dti-1330	33	27	carcinogenic	carcinogenic	ADJ
dti-1330	33	28	roles	role	NOUN
dti-1330	33	29	.	.	PUNCT
dti-1330	34	1	our	our	PRON
dti-1330	34	2	research	research	NOUN
dti-1330	34	3	focuses	focus	VERB
dti-1330	34	4	on	on	ADP
dti-1330	34	5	the	the	DET
dti-1330	34	6	relationship	relationship	NOUN
dti-1330	34	7	between	between	ADP
dti-1330	34	8	cox-2	cox-2	NOUN
dti-1330	34	9	and	and	CCONJ
dti-1330	34	10	lox	lox	NOUN
dti-1330	34	11	(	(	PUNCT
dti-1330	34	12	5and	5and	NUM
dti-1330	34	13	12	12	NUM
dti-1330	34	14	-	-	PUNCT
dti-1330	34	15	lox	lox	NOUN
dti-1330	34	16	)	)	PUNCT
dti-1330	34	17	and	and	CCONJ
dti-1330	34	18	urological	urological	ADJ
dti-1330	34	19	tumors	tumor	NOUN
dti-1330	34	20	(	(	PUNCT
dti-1330	34	21	renal	renal	ADJ
dti-1330	34	22	cell	cell	NOUN
dti-1330	34	23	carcinoma	carcinoma	NOUN
dti-1330	34	24	,	,	PUNCT
dti-1330	34	25	bladder	bladder	NOUN
dti-1330	34	26	tumor	tumor	NOUN
dti-1330	34	27	,	,	PUNCT
dti-1330	34	28	prostate	prostate	NOUN
dti-1330	34	29	cancer	cancer	NOUN
dti-1330	34	30	and	and	CCONJ
dti-1330	34	31	testicular	testicular	ADJ
dti-1330	34	32	cancer	cancer	NOUN
dti-1330	34	33	)	)	PUNCT
dti-1330	34	34	and	and	CCONJ
dti-1330	34	35	on	on	ADP
dti-1330	34	36	the	the	DET
dti-1330	34	37	antitumor	antitumor	PROPN
dti-1330	34	38	effects	effect	NOUN
dti-1330	34	39	of	of	ADP
dti-1330	34	40	cox	cox	PROPN
dti-1330	34	41	and	and	CCONJ
dti-1330	34	42	lox	lox	NOUN
dti-1330	34	43	inhibitors	inhibitor	NOUN
dti-1330	34	44	.	.	PUNCT
dti-1330	35	1	methods	method	NOUN
dti-1330	35	2	tumor	tumor	NOUN
dti-1330	35	3	specimens	specimen	VERB
dti-1330	35	4	all	all	DET
dti-1330	35	5	tissue	tissue	NOUN
dti-1330	35	6	specimens	specimen	NOUN
dti-1330	35	7	were	be	AUX
dti-1330	35	8	obtained	obtain	VERB
dti-1330	35	9	from	from	ADP
dti-1330	35	10	osaka	osaka	PROPN
dti-1330	35	11	city	city	PROPN
dti-1330	35	12	university	university	PROPN
dti-1330	35	13	hospital	hospital	NOUN
dti-1330	35	14	.	.	PUNCT
dti-1330	36	1	tumor	tumor	NOUN
dti-1330	36	2	tissues	tissue	NOUN
dti-1330	36	3	,	,	PUNCT
dti-1330	36	4	nontumor	nontumor	NOUN
dti-1330	36	5	tissues	tissue	NOUN
dti-1330	36	6	,	,	PUNCT
dti-1330	36	7	vascular	vascular	ADJ
dti-1330	36	8	endothelium	endothelium	NOUN
dti-1330	36	9	,	,	PUNCT
dti-1330	36	10	and	and	CCONJ
dti-1330	36	11	interstitial	interstitial	ADJ
dti-1330	36	12	tissues	tissue	NOUN
dti-1330	36	13	from	from	ADP
dti-1330	36	14	the	the	DET
dti-1330	36	15	subjects	subject	NOUN
dti-1330	36	16	were	be	AUX
dti-1330	36	17	preserved	preserve	VERB
dti-1330	36	18	in	in	ADP
dti-1330	36	19	10	10	NUM
dti-1330	36	20	%	%	NOUN
dti-1330	36	21	formalin	formalin	NOUN
dti-1330	36	22	and	and	CCONJ
dti-1330	36	23	embedded	embed	VERB
dti-1330	36	24	in	in	ADP
dti-1330	36	25	paraffi	paraffi	PROPN
dti-1330	36	26	n	n	CCONJ
dti-1330	36	27	,	,	PUNCT
dti-1330	36	28	serially	serially	ADV
dti-1330	36	29	sectioned	section	VERB
dti-1330	36	30	onto	onto	ADP
dti-1330	36	31	microscope	microscope	NOUN
dti-1330	36	32	slides	slide	NOUN
dti-1330	36	33	at	at	ADP
dti-1330	36	34	a	a	DET
dti-1330	36	35	thickness	thickness	NOUN
dti-1330	36	36	of	of	ADP
dti-1330	36	37	4	4	NUM
dti-1330	36	38	μm	μm	NOUN
dti-1330	36	39	.	.	PUNCT
dti-1330	37	1	a	a	DET
dti-1330	37	2	)	)	PUNCT
dti-1330	37	3	cox	cox	PROPN
dti-1330	37	4	renal	renal	ADJ
dti-1330	37	5	cell	cell	NOUN
dti-1330	37	6	carcinoma	carcinoma	NOUN
dti-1330	37	7	(	(	PUNCT
dti-1330	37	8	rcc	rcc	PROPN
dti-1330	37	9	)	)	PUNCT
dti-1330	37	10	specimens	specimen	NOUN
dti-1330	37	11	specimens	specimen	NOUN
dti-1330	37	12	were	be	AUX
dti-1330	37	13	obtained	obtain	VERB
dti-1330	37	14	from	from	ADP
dti-1330	37	15	108	108	NUM
dti-1330	37	16	patients	patient	NOUN
dti-1330	37	17	with	with	ADP
dti-1330	37	18	rcc	rcc	PROPN
dti-1330	37	19	and	and	CCONJ
dti-1330	37	20	20	20	NUM
dti-1330	37	21	patients	patient	NOUN
dti-1330	37	22	with	with	ADP
dti-1330	37	23	normal	normal	ADJ
dti-1330	37	24	kidney	kidney	NOUN
dti-1330	37	25	(	(	PUNCT
dti-1330	37	26	nk	nk	NOUN
dti-1330	37	27	)	)	PUNCT
dti-1330	37	28	tissues	tissue	NOUN
dti-1330	37	29	who	who	PRON
dti-1330	37	30	underwent	undergo	VERB
dti-1330	37	31	total	total	ADJ
dti-1330	37	32	nephroureterectomy	nephroureterectomy	NOUN
dti-1330	37	33	due	due	ADP
dti-1330	37	34	to	to	ADP
dti-1330	37	35	ureteral	ureteral	ADJ
dti-1330	37	36	cancer	cancer	NOUN
dti-1330	37	37	.	.	PUNCT
dti-1330	38	1	bladder	bladder	NOUN
dti-1330	38	2	tumor	tumor	NOUN
dti-1330	38	3	(	(	PUNCT
dti-1330	38	4	bt	bt	NOUN
dti-1330	38	5	)	)	PUNCT
dti-1330	38	6	specimens	specimen	NOUN
dti-1330	38	7	specimens	specimen	NOUN
dti-1330	38	8	were	be	AUX
dti-1330	38	9	obtained	obtain	VERB
dti-1330	38	10	from	from	ADP
dti-1330	38	11	118	118	NUM
dti-1330	38	12	patients	patient	NOUN
dti-1330	38	13	with	with	ADP
dti-1330	38	14	bt	bt	PROPN
dti-1330	38	15	(	(	PUNCT
dti-1330	38	16	including	include	VERB
dti-1330	38	17	68	68	NUM
dti-1330	38	18	who	who	PRON
dti-1330	38	19	underwent	undergo	VERB
dti-1330	38	20	total	total	ADJ
dti-1330	38	21	cystectomy	cystectomy	NOUN
dti-1330	38	22	and	and	CCONJ
dti-1330	38	23	50	50	NUM
dti-1330	38	24	who	who	PRON
dti-1330	38	25	underwent	undergo	VERB
dti-1330	38	26	transureteral	transureteral	ADJ
dti-1330	38	27	resection	resection	NOUN
dti-1330	38	28	of	of	ADP
dti-1330	38	29	arachidonic	arachidonic	ADJ
dti-1330	38	30	acid	acid	NOUN
dti-1330	38	31	5	5	NUM
dti-1330	38	32	-	-	PUNCT
dti-1330	38	33	lox	lox	NOUN
dti-1330	38	34	15	15	NUM
dti-1330	38	35	-	-	PUNCT
dti-1330	38	36	lox-1	lox-1	NUM
dti-1330	38	37	15	15	NUM
dti-1330	38	38	-	-	PUNCT
dti-1330	38	39	lox-2	lox-2	NOUN
dti-1330	38	40	12	12	NUM
dti-1330	38	41	-	-	PUNCT
dti-1330	38	42	lox	lox	NOUN
dti-1330	38	43	12	12	NUM
dti-1330	38	44	-	-	PUNCT
dti-1330	38	45	hete	hete	NOUN
dti-1330	38	46	5	5	NUM
dti-1330	38	47	-	-	PUNCT
dti-1330	38	48	hete	hete	NOUN
dti-1330	38	49	15	15	NUM
dti-1330	38	50	-	-	PUNCT
dti-1330	38	51	hete	hete	NOUN
dti-1330	38	52	lta4	lta4	NOUN
dti-1330	38	53	ltc4	ltc4	PROPN
dti-1330	38	54	ltb4	ltb4	PROPN
dti-1330	38	55	pgg2	pgg2	PROPN
dti-1330	38	56	pgh2	pgh2	PROPN
dti-1330	38	57	pgf2	pgf2	PROPN
dti-1330	38	58	pge2	pge2	VERB
dti-1330	38	59	pgd2	pgd2	PROPN
dti-1330	38	60	pgj2	pgj2	PROPN
dti-1330	38	61	txa2	txa2	PROPN
dti-1330	38	62	pgi2	pgi2	PROPN
dti-1330	38	63	ltd4	ltd4	PROPN
dti-1330	38	64	lte4	lte4	PROPN
dti-1330	38	65	membrane	membrane	PROPN
dti-1330	38	66	phospholipida2	phospholipida2	PROPN
dti-1330	38	67	phospholipasea2	phospholipasea2	NOUN
dti-1330	38	68	cox-2	cox-2	NUM
dti-1330	38	69	cox-1	cox-1	VERB
dti-1330	38	70	figure	figure	NOUN
dti-1330	38	71	1	1	NUM
dti-1330	38	72	.	.	PUNCT
dti-1330	38	73	map	map	NOUN
dti-1330	38	74	of	of	ADP
dti-1330	38	75	arachidonic	arachidonic	ADJ
dti-1330	38	76	acid	acid	NOUN
dti-1330	38	77	(	(	PUNCT
dti-1330	38	78	aa	aa	NOUN
dti-1330	38	79	)	)	PUNCT
dti-1330	38	80	cascade	cascade	NOUN
dti-1330	38	81	.	.	PUNCT
dti-1330	39	1	cyclooxygenase	cyclooxygenase	NOUN
dti-1330	39	2	(	(	PUNCT
dti-1330	39	3	cox	cox	PROPN
dti-1330	39	4	)	)	PUNCT
dti-1330	39	5	is	be	AUX
dti-1330	39	6	the	the	DET
dti-1330	39	7	fi	fi	NOUN
dti-1330	39	8	rst	rst	ADJ
dti-1330	39	9	enzyme	enzyme	NOUN
dti-1330	39	10	in	in	ADP
dti-1330	39	11	the	the	DET
dti-1330	39	12	pathway	pathway	NOUN
dti-1330	39	13	for	for	ADP
dti-1330	39	14	producing	produce	VERB
dti-1330	39	15	prostaglandin	prostaglandin	NOUN
dti-1330	39	16	(	(	PUNCT
dti-1330	39	17	pg	pg	NOUN
dti-1330	39	18	)	)	PUNCT
dti-1330	39	19	and	and	CCONJ
dti-1330	39	20	thromboxane	thromboxane	NOUN
dti-1330	39	21	(	(	PUNCT
dti-1330	39	22	tx	tx	PROPN
dti-1330	39	23	)	)	PUNCT
dti-1330	39	24	from	from	ADP
dti-1330	39	25	aa	aa	PROPN
dti-1330	39	26	,	,	PUNCT
dti-1330	39	27	and	and	CCONJ
dti-1330	39	28	there	there	PRON
dti-1330	39	29	are	be	VERB
dti-1330	39	30	two	two	NUM
dti-1330	39	31	isoforms	isoform	NOUN
dti-1330	39	32	,	,	PUNCT
dti-1330	39	33	cox-1	cox-1	PUNCT
dti-1330	39	34	and	and	CCONJ
dti-1330	39	35	cox-2	cox-2	NOUN
dti-1330	39	36	.	.	PUNCT
dti-1330	40	1	the	the	DET
dti-1330	40	2	enzymes	enzyme	NOUN
dti-1330	40	3	of	of	ADP
dti-1330	40	4	both	both	PRON
dti-1330	40	5	cox-1	cox-1	PUNCT
dti-1330	40	6	and	and	CCONJ
dti-1330	40	7	cox-2	cox-2	NUM
dti-1330	40	8	are	be	AUX
dti-1330	40	9	transformed	transform	VERB
dti-1330	40	10	from	from	ADP
dti-1330	40	11	the	the	DET
dti-1330	40	12	cell	cell	NOUN
dti-1330	40	13	membrane	membrane	NOUN
dti-1330	40	14	phospholipid	phospholipid	NOUN
dti-1330	40	15	to	to	ADP
dti-1330	40	16	aa	aa	VERB
dti-1330	40	17	by	by	ADP
dti-1330	40	18	the	the	DET
dti-1330	40	19	phospholipase	phospholipase	NOUN
dti-1330	40	20	a2	a2	PROPN
dti-1330	40	21	,	,	PUNCT
dti-1330	40	22	and	and	CCONJ
dti-1330	40	23	then	then	ADV
dti-1330	40	24	transform	transform	VERB
dti-1330	40	25	aa	aa	NOUN
dti-1330	40	26	to	to	ADP
dti-1330	40	27	pgh2	pgh2	PROPN
dti-1330	40	28	through	through	ADP
dti-1330	40	29	pgg2	pgg2	PROPN
dti-1330	40	30	.	.	PUNCT
dti-1330	41	1	lipoxygenase	lipoxygenase	NOUN
dti-1330	41	2	(	(	PUNCT
dti-1330	41	3	lox	lox	NOUN
dti-1330	41	4	)	)	PUNCT
dti-1330	41	5	is	be	AUX
dti-1330	41	6	an	an	DET
dti-1330	41	7	initial	initial	ADJ
dti-1330	41	8	enzyme	enzyme	NOUN
dti-1330	41	9	in	in	ADP
dti-1330	41	10	the	the	DET
dti-1330	41	11	pathway	pathway	NOUN
dti-1330	41	12	for	for	ADP
dti-1330	41	13	producing	produce	VERB
dti-1330	41	14	leukotrien	leukotrien	NOUN
dti-1330	41	15	(	(	PUNCT
dti-1330	41	16	lt	lt	NOUN
dti-1330	41	17	)	)	PUNCT
dti-1330	41	18	from	from	ADP
dti-1330	41	19	aa	aa	NOUN
dti-1330	41	20	and	and	CCONJ
dti-1330	41	21	there	there	PRON
dti-1330	41	22	are	be	VERB
dti-1330	41	23	5-	5-	PROPN
dti-1330	41	24	,	,	PUNCT
dti-1330	41	25	12	12	NUM
dti-1330	41	26	-	-	PUNCT
dti-1330	41	27	lox	lox	NOUN
dti-1330	41	28	and	and	CCONJ
dti-1330	41	29	two	two	NUM
dti-1330	41	30	isoenzymes	isoenzyme	NOUN
dti-1330	41	31	of	of	ADP
dti-1330	41	32	15	15	NUM
dti-1330	41	33	-	-	PUNCT
dti-1330	41	34	lox	lox	NOUN
dti-1330	41	35	(	(	PUNCT
dti-1330	41	36	15	15	NUM
dti-1330	41	37	-	-	PUNCT
dti-1330	41	38	lox-1	lox-1	NOUN
dti-1330	41	39	,	,	PUNCT
dti-1330	41	40	15	15	NUM
dti-1330	41	41	-	-	PUNCT
dti-1330	41	42	lox-2	lox-2	NOUN
dti-1330	41	43	)	)	PUNCT
dti-1330	41	44	as	as	ADP
dti-1330	41	45	isoforms	isoform	NOUN
dti-1330	41	46	catalyzing	catalyze	VERB
dti-1330	41	47	the	the	DET
dti-1330	41	48	biosynthesis	biosynthesis	NOUN
dti-1330	41	49	of	of	ADP
dti-1330	41	50	biologically	biologically	ADV
dti-1330	41	51	active	active	ADJ
dti-1330	41	52	compounds	compound	NOUN
dti-1330	41	53	such	such	ADJ
dti-1330	41	54	as	as	ADP
dti-1330	41	55	lts	lt	NOUN
dti-1330	41	56	and	and	CCONJ
dti-1330	41	57	hydroxyeicosatetraenoic	hydroxyeicosatetraenoic	ADJ
dti-1330	41	58	acids	acid	NOUN
dti-1330	41	59	(	(	PUNCT
dti-1330	41	60	hetes	hete	NOUN
dti-1330	41	61	)	)	PUNCT
dti-1330	41	62	.	.	PUNCT
dti-1330	42	1	139	139	NUM
dti-1330	42	2	5	5	NUM
dti-1330	42	3	-	-	NOUN
dti-1330	42	4	lipoxygenase	lipoxygenase	NOUN
dti-1330	42	5	in	in	ADP
dti-1330	42	6	urological	urological	ADJ
dti-1330	42	7	tumor	tumor	NOUN
dti-1330	42	8	drug	drug	NOUN
dti-1330	42	9	target	target	NOUN
dti-1330	42	10	insights	insight	NOUN
dti-1330	42	11	2008:3	2008:3	NUM
dti-1330	42	12	bladder	bladder	NOUN
dti-1330	42	13	tumor	tumor	NOUN
dti-1330	42	14	)	)	PUNCT
dti-1330	42	15	and	and	CCONJ
dti-1330	42	16	10	10	NUM
dti-1330	42	17	patients	patient	NOUN
dti-1330	42	18	with	with	ADP
dti-1330	42	19	chronic	chronic	ADJ
dti-1330	42	20	cystitis	cystitis	NOUN
dti-1330	42	21	(	(	PUNCT
dti-1330	42	22	cc	cc	NOUN
dti-1330	42	23	)	)	PUNCT
dti-1330	42	24	and	and	CCONJ
dti-1330	42	25	8	8	NUM
dti-1330	42	26	with	with	ADP
dti-1330	42	27	normal	normal	ADJ
dti-1330	42	28	bladder	bladder	NOUN
dti-1330	42	29	tissues	tissue	NOUN
dti-1330	42	30	(	(	PUNCT
dti-1330	42	31	nb	nb	INTJ
dti-1330	42	32	)	)	PUNCT
dti-1330	42	33	who	who	PRON
dti-1330	42	34	underwent	undergo	VERB
dti-1330	42	35	total	total	NOUN
dti-1330	42	36	prostatectomy	prostatectomy	ADV
dti-1330	42	37	because	because	SCONJ
dti-1330	42	38	of	of	ADP
dti-1330	42	39	prostate	prostate	NOUN
dti-1330	42	40	cancer	cancer	NOUN
dti-1330	42	41	.	.	PUNCT
dti-1330	43	1	prostate	prostate	NOUN
dti-1330	43	2	cancer	cancer	NOUN
dti-1330	43	3	(	(	PUNCT
dti-1330	43	4	pc	pc	NOUN
dti-1330	43	5	)	)	PUNCT
dti-1330	43	6	specimens	specimen	NOUN
dti-1330	43	7	specimens	specimen	NOUN
dti-1330	43	8	were	be	AUX
dti-1330	43	9	obtained	obtain	VERB
dti-1330	43	10	from	from	ADP
dti-1330	43	11	28	28	NUM
dti-1330	43	12	patients	patient	NOUN
dti-1330	43	13	with	with	ADP
dti-1330	43	14	pc	pc	NOUN
dti-1330	43	15	,	,	PUNCT
dti-1330	43	16	8	8	NUM
dti-1330	43	17	patients	patient	NOUN
dti-1330	43	18	with	with	ADP
dti-1330	43	19	benign	benign	ADJ
dti-1330	43	20	prostatic	prostatic	ADJ
dti-1330	43	21	hyperplasia	hyperplasia	NOUN
dti-1330	43	22	(	(	PUNCT
dti-1330	43	23	bph	bph	NOUN
dti-1330	43	24	)	)	PUNCT
dti-1330	43	25	,	,	PUNCT
dti-1330	43	26	1	1	NUM
dti-1330	43	27	patient	patient	NOUN
dti-1330	43	28	with	with	ADP
dti-1330	43	29	prostatic	prostatic	ADJ
dti-1330	43	30	intraepithelial	intraepithelial	ADJ
dti-1330	43	31	neoplasia	neoplasia	NOUN
dti-1330	43	32	(	(	PUNCT
dti-1330	43	33	pin	pin	NOUN
dti-1330	43	34	)	)	PUNCT
dti-1330	43	35	who	who	PRON
dti-1330	43	36	underwent	undergo	VERB
dti-1330	43	37	total	total	NOUN
dti-1330	43	38	prostatectomy	prostatectomy	NOUN
dti-1330	43	39	or	or	CCONJ
dti-1330	43	40	subcapsular	subcapsular	ADJ
dti-1330	43	41	prostatectomy	prostatectomy	NOUN
dti-1330	43	42	,	,	PUNCT
dti-1330	43	43	and	and	CCONJ
dti-1330	43	44	8	8	NUM
dti-1330	43	45	patients	patient	NOUN
dti-1330	43	46	with	with	ADP
dti-1330	43	47	normal	normal	ADJ
dti-1330	43	48	prostate	prostate	NOUN
dti-1330	43	49	(	(	PUNCT
dti-1330	43	50	np	np	INTJ
dti-1330	43	51	)	)	PUNCT
dti-1330	43	52	tissues	tissue	NOUN
dti-1330	43	53	who	who	PRON
dti-1330	43	54	underwent	undergo	VERB
dti-1330	43	55	total	total	ADJ
dti-1330	43	56	cystectomy	cystectomy	NOUN
dti-1330	43	57	because	because	SCONJ
dti-1330	43	58	of	of	ADP
dti-1330	43	59	bladder	bladder	NOUN
dti-1330	43	60	tumor	tumor	NOUN
dti-1330	43	61	.	.	PUNCT
dti-1330	44	1	testicular	testicular	ADJ
dti-1330	44	2	cancer	cancer	NOUN
dti-1330	44	3	(	(	PUNCT
dti-1330	44	4	tc	tc	NOUN
dti-1330	44	5	)	)	PUNCT
dti-1330	44	6	specimens	specimen	NOUN
dti-1330	44	7	specimens	specimen	NOUN
dti-1330	44	8	were	be	AUX
dti-1330	44	9	obtained	obtain	VERB
dti-1330	44	10	from	from	ADP
dti-1330	44	11	72	72	NUM
dti-1330	44	12	patients	patient	NOUN
dti-1330	44	13	with	with	ADP
dti-1330	44	14	tc	tc	ADP
dti-1330	44	15	,	,	PUNCT
dti-1330	44	16	20	20	NUM
dti-1330	44	17	patients	patient	NOUN
dti-1330	44	18	with	with	ADP
dti-1330	44	19	normal	normal	ADJ
dti-1330	44	20	testis	testis	NOUN
dti-1330	44	21	(	(	PUNCT
dti-1330	44	22	nt	nt	NOUN
dti-1330	44	23	)	)	PUNCT
dti-1330	44	24	tissues	tissue	NOUN
dti-1330	44	25	who	who	PRON
dti-1330	44	26	underwent	undergo	VERB
dti-1330	44	27	orchiectomy	orchiectomy	NOUN
dti-1330	44	28	for	for	ADP
dti-1330	44	29	prostate	prostate	NOUN
dti-1330	44	30	cancer	cancer	NOUN
dti-1330	44	31	.	.	PUNCT
dti-1330	45	1	b	b	X
dti-1330	45	2	)	)	PUNCT
dti-1330	45	3	lox	lox	PROPN
dti-1330	45	4	rcc	rcc	PROPN
dti-1330	45	5	specimens	specimens	PROPN
dti-1330	45	6	specimens	specimen	NOUN
dti-1330	45	7	were	be	AUX
dti-1330	45	8	obtained	obtain	VERB
dti-1330	45	9	from	from	ADP
dti-1330	45	10	50	50	NUM
dti-1330	45	11	patients	patient	NOUN
dti-1330	45	12	with	with	ADP
dti-1330	45	13	rcc	rcc	PROPN
dti-1330	45	14	and	and	CCONJ
dti-1330	45	15	10	10	NUM
dti-1330	45	16	patients	patient	NOUN
dti-1330	45	17	with	with	ADP
dti-1330	45	18	nk	nk	PROPN
dti-1330	45	19	tissues	tissue	NOUN
dti-1330	45	20	.	.	PUNCT
dti-1330	46	1	bt	bt	NOUN
dti-1330	46	2	specimens	specimen	NOUN
dti-1330	46	3	specimens	specimen	NOUN
dti-1330	46	4	were	be	AUX
dti-1330	46	5	obtained	obtain	VERB
dti-1330	46	6	from	from	ADP
dti-1330	46	7	170	170	NUM
dti-1330	46	8	patients	patient	NOUN
dti-1330	46	9	with	with	ADP
dti-1330	46	10	bt	bt	PROPN
dti-1330	46	11	(	(	PUNCT
dti-1330	46	12	87	87	NUM
dti-1330	46	13	total	total	ADJ
dti-1330	46	14	cystectomy	cystectomy	NOUN
dti-1330	46	15	and	and	CCONJ
dti-1330	46	16	83	83	NUM
dti-1330	46	17	transureteral	transureteral	ADJ
dti-1330	46	18	resection	resection	NOUN
dti-1330	46	19	)	)	PUNCT
dti-1330	46	20	and	and	CCONJ
dti-1330	46	21	20	20	NUM
dti-1330	46	22	patients	patient	NOUN
dti-1330	46	23	with	with	ADP
dti-1330	46	24	cc	cc	NOUN
dti-1330	46	25	and	and	CCONJ
dti-1330	46	26	20	20	NUM
dti-1330	46	27	patients	patient	NOUN
dti-1330	46	28	with	with	ADP
dti-1330	46	29	nb	nb	PROPN
dti-1330	46	30	tissues	tissue	NOUN
dti-1330	46	31	.	.	PUNCT
dti-1330	47	1	pc	pc	NOUN
dti-1330	47	2	specimens	specimen	NOUN
dti-1330	47	3	specimens	specimen	NOUN
dti-1330	47	4	were	be	AUX
dti-1330	47	5	obtained	obtain	VERB
dti-1330	47	6	from	from	ADP
dti-1330	47	7	174	174	NUM
dti-1330	47	8	patients	patient	NOUN
dti-1330	47	9	with	with	ADP
dti-1330	47	10	pc	pc	NOUN
dti-1330	47	11	,	,	PUNCT
dti-1330	47	12	20	20	NUM
dti-1330	47	13	patients	patient	NOUN
dti-1330	47	14	with	with	ADP
dti-1330	47	15	bph	bph	NOUN
dti-1330	47	16	,	,	PUNCT
dti-1330	47	17	20	20	NUM
dti-1330	47	18	patients	patient	NOUN
dti-1330	47	19	with	with	ADP
dti-1330	47	20	pin	pin	NOUN
dti-1330	47	21	,	,	PUNCT
dti-1330	47	22	and	and	CCONJ
dti-1330	47	23	8	8	NUM
dti-1330	47	24	patients	patient	NOUN
dti-1330	47	25	with	with	ADP
dti-1330	47	26	np	np	NOUN
dti-1330	47	27	tissues	tissue	NOUN
dti-1330	47	28	.	.	PUNCT
dti-1330	48	1	tc	tc	NUM
dti-1330	48	2	specimens	specimen	NOUN
dti-1330	48	3	specimens	specimen	NOUN
dti-1330	48	4	were	be	AUX
dti-1330	48	5	obtained	obtain	VERB
dti-1330	48	6	from	from	ADP
dti-1330	48	7	72	72	NUM
dti-1330	48	8	patients	patient	NOUN
dti-1330	48	9	with	with	ADP
dti-1330	48	10	tc	tc	ADP
dti-1330	48	11	,	,	PUNCT
dti-1330	48	12	20	20	NUM
dti-1330	48	13	patients	patient	NOUN
dti-1330	48	14	with	with	ADP
dti-1330	48	15	nt	nt	ADP
dti-1330	48	16	tissues	tissue	NOUN
dti-1330	48	17	.	.	PUNCT
dti-1330	49	1	immunohistochemical	immunohistochemical	ADJ
dti-1330	49	2	staining	staining	ADJ
dti-1330	49	3	immunohistochemical	immunohistochemical	ADJ
dti-1330	49	4	staining	staining	NOUN
dti-1330	49	5	was	be	AUX
dti-1330	49	6	performed	perform	VERB
dti-1330	49	7	with	with	ADP
dti-1330	49	8	a	a	DET
dti-1330	49	9	vectastain	vectastain	NOUN
dti-1330	49	10	(	(	PUNCT
dti-1330	49	11	vector	vector	NOUN
dti-1330	49	12	laboratories	laboratory	NOUN
dti-1330	49	13	,	,	PUNCT
dti-1330	49	14	burlingame	burlingame	PROPN
dti-1330	49	15	,	,	PUNCT
dti-1330	49	16	california	california	PROPN
dti-1330	49	17	)	)	PUNCT
dti-1330	49	18	avidin	avidin	NOUN
dti-1330	49	19	-	-	PUNCT
dti-1330	49	20	biotin	biotin	NOUN
dti-1330	49	21	preoxidase	preoxidase	NOUN
dti-1330	49	22	complex	complex	PROPN
dti-1330	49	23	kit	kit	NOUN
dti-1330	49	24	,	,	PUNCT
dti-1330	49	25	as	as	SCONJ
dti-1330	49	26	previously	previously	ADV
dti-1330	49	27	described	describe	VERB
dti-1330	49	28	[	[	PUNCT
dti-1330	49	29	9	9	NUM
dti-1330	49	30	]	]	PUNCT
dti-1330	49	31	.	.	PUNCT
dti-1330	50	1	primary	primary	ADJ
dti-1330	50	2	antibodies	antibody	NOUN
dti-1330	50	3	against	against	ADP
dti-1330	50	4	rabbit	rabbit	NOUN
dti-1330	50	5	cox-1	cox-1	PUNCT
dti-1330	50	6	(	(	PUNCT
dti-1330	50	7	dhhilhvavdv	dhhilhvavdv	PROPN
dti-1330	50	8	)	)	PUNCT
dti-1330	50	9	(	(	PUNCT
dti-1330	50	10	1:100	1:100	NUM
dti-1330	50	11	dilution	dilution	NOUN
dti-1330	50	12	in	in	ADP
dti-1330	50	13	pbs	pbs	PROPN
dti-1330	50	14	)	)	PUNCT
dti-1330	50	15	,	,	PUNCT
dti-1330	50	16	rabbit	rabbit	NOUN
dti-1330	50	17	cox-2	cox-2	NOUN
dti-1330	50	18	(	(	PUNCT
dti-1330	50	19	lddinptvllker	lddinptvllker	NOUN
dti-1330	50	20	)	)	PUNCT
dti-1330	50	21	(	(	PUNCT
dti-1330	50	22	1:100	1:100	NUM
dti-1330	50	23	dilution	dilution	NOUN
dti-1330	50	24	in	in	ADP
dti-1330	50	25	pbs	pbs	PROPN
dti-1330	50	26	)	)	PUNCT
dti-1330	50	27	,	,	PUNCT
dti-1330	50	28	rabbit	rabbit	NOUN
dti-1330	50	29	5	5	NUM
dti-1330	50	30	-	-	PUNCT
dti-1330	50	31	lox	lox	NOUN
dti-1330	50	32	(	(	PUNCT
dti-1330	50	33	cayman	cayman	NOUN
dti-1330	50	34	chemical	chemical	PROPN
dti-1330	50	35	,	,	PUNCT
dti-1330	50	36	ann	ann	PROPN
dti-1330	50	37	arbor	arbor	PROPN
dti-1330	50	38	,	,	PUNCT
dti-1330	50	39	michigan	michigan	PROPN
dti-1330	50	40	)	)	PUNCT
dti-1330	50	41	(	(	PUNCT
dti-1330	50	42	1:100	1:100	NUM
dti-1330	50	43	dilution	dilution	NOUN
dti-1330	50	44	in	in	ADP
dti-1330	50	45	pbs	pbs	PROPN
dti-1330	50	46	)	)	PUNCT
dti-1330	50	47	,	,	PUNCT
dti-1330	50	48	rabbit	rabbit	NOUN
dti-1330	50	49	12	12	NUM
dti-1330	50	50	-	-	PUNCT
dti-1330	50	51	lox	lox	NOUN
dti-1330	50	52	(	(	PUNCT
dti-1330	50	53	oxford	oxford	PROPN
dti-1330	50	54	biomedical	biomedical	ADJ
dti-1330	50	55	research	research	NOUN
dti-1330	50	56	,	,	PUNCT
dti-1330	50	57	oxford	oxford	PROPN
dti-1330	50	58	,	,	PUNCT
dti-1330	50	59	michigan	michigan	PROPN
dti-1330	50	60	)	)	PUNCT
dti-1330	50	61	(	(	PUNCT
dti-1330	50	62	1:100	1:100	NUM
dti-1330	50	63	dilution	dilution	NOUN
dti-1330	50	64	in	in	ADP
dti-1330	50	65	pbs	pbs	PROPN
dti-1330	50	66	)	)	PUNCT
dti-1330	50	67	and	and	CCONJ
dti-1330	50	68	control	control	PROPN
dti-1330	50	69	pbs	pbs	PROPN
dti-1330	50	70	were	be	AUX
dti-1330	50	71	used	use	VERB
dti-1330	50	72	.	.	PUNCT
dti-1330	51	1	immunohistochemical	immunohistochemical	ADJ
dti-1330	51	2	analysis	analysis	NOUN
dti-1330	51	3	staining	stain	VERB
dti-1330	51	4	was	be	AUX
dti-1330	51	5	classifi	classifi	PROPN
dti-1330	51	6	ed	ed	NOUN
dti-1330	51	7	into	into	ADP
dti-1330	51	8	5	5	NUM
dti-1330	51	9	grades	grade	NOUN
dti-1330	51	10	from	from	ADP
dti-1330	51	11	0	0	NUM
dti-1330	51	12	to	to	ADP
dti-1330	51	13	4	4	NUM
dti-1330	51	14	according	accord	VERB
dti-1330	51	15	to	to	ADP
dti-1330	51	16	staining	stain	VERB
dti-1330	51	17	intensity	intensity	NOUN
dti-1330	51	18	and	and	CCONJ
dti-1330	51	19	number	number	NOUN
dti-1330	51	20	of	of	ADP
dti-1330	51	21	positive	positive	ADJ
dti-1330	51	22	cells	cell	NOUN
dti-1330	51	23	by	by	ADP
dti-1330	51	24	two	two	NUM
dti-1330	51	25	blind	blind	ADJ
dti-1330	51	26	observers	observer	NOUN
dti-1330	51	27	on	on	ADP
dti-1330	51	28	two	two	NUM
dti-1330	51	29	separate	separate	ADJ
dti-1330	51	30	occasions	occasion	NOUN
dti-1330	51	31	using	use	VERB
dti-1330	51	32	coded	code	VERB
dti-1330	51	33	slides	slide	NOUN
dti-1330	51	34	.	.	PUNCT
dti-1330	52	1	an	an	DET
dti-1330	52	2	average	average	ADJ
dti-1330	52	3	score	score	NOUN
dti-1330	52	4	was	be	AUX
dti-1330	52	5	calculated	calculate	VERB
dti-1330	52	6	.	.	PUNCT
dti-1330	53	1	a	a	DET
dti-1330	53	2	4	4	NUM
dti-1330	53	3	grade	grade	NOUN
dti-1330	53	4	indicated	indicate	VERB
dti-1330	53	5	that	that	SCONJ
dti-1330	53	6	all	all	DET
dti-1330	53	7	staining	stain	VERB
dti-1330	53	8	was	be	AUX
dti-1330	53	9	maximally	maximally	ADV
dti-1330	53	10	intense	intense	ADJ
dti-1330	53	11	throughout	throughout	ADP
dti-1330	53	12	the	the	DET
dti-1330	53	13	specimen	speciman	NOUN
dti-1330	53	14	,	,	PUNCT
dti-1330	53	15	while	while	SCONJ
dti-1330	53	16	0	0	NUM
dti-1330	53	17	indicated	indicate	VERB
dti-1330	53	18	that	that	SCONJ
dti-1330	53	19	staining	stain	VERB
dti-1330	53	20	was	be	AUX
dti-1330	53	21	absent	absent	ADJ
dti-1330	53	22	throughout	throughout	ADP
dti-1330	53	23	the	the	DET
dti-1330	53	24	specimen	speciman	NOUN
dti-1330	53	25	.	.	PUNCT
dti-1330	54	1	micro	micro	ADJ
dti-1330	54	2	-	-	ADJ
dti-1330	54	3	anatomical	anatomical	ADJ
dti-1330	54	4	staining	stain	VERB
dti-1330	54	5	sites	site	NOUN
dti-1330	54	6	were	be	AUX
dti-1330	54	7	also	also	ADV
dti-1330	54	8	recorded	record	VERB
dti-1330	54	9	.	.	PUNCT
dti-1330	55	1	this	this	DET
dti-1330	55	2	method	method	NOUN
dti-1330	55	3	was	be	AUX
dti-1330	55	4	perfomed	perfome	VERB
dti-1330	55	5	as	as	SCONJ
dti-1330	55	6	previously	previously	ADV
dti-1330	55	7	described	describe	VERB
dti-1330	55	8	[	[	PUNCT
dti-1330	55	9	9	9	NUM
dti-1330	55	10	]	]	PUNCT
dti-1330	55	11	.	.	PUNCT
dti-1330	56	1	all	all	DET
dti-1330	56	2	results	result	NOUN
dti-1330	56	3	are	be	AUX
dti-1330	56	4	presented	present	VERB
dti-1330	56	5	as	as	ADP
dti-1330	56	6	the	the	DET
dti-1330	56	7	mean	mean	ADJ
dti-1330	56	8	±	±	PROPN
dti-1330	56	9	sd	sd	NOUN
dti-1330	56	10	.	.	PUNCT
dti-1330	57	1	data	datum	NOUN
dti-1330	57	2	analysis	analysis	NOUN
dti-1330	57	3	were	be	AUX
dti-1330	57	4	performed	perform	VERB
dti-1330	57	5	using	use	VERB
dti-1330	57	6	anova	anova	PROPN
dti-1330	58	1	[	[	X
dti-1330	58	2	10	10	NUM
dti-1330	58	3	]	]	PUNCT
dti-1330	58	4	.	.	PUNCT
dti-1330	59	1	pt	pt	X
dti-1330	59	2	-	-	ADJ
dti-1330	59	3	pcr	pcr	NOUN
dti-1330	59	4	concerning	concern	VERB
dti-1330	59	5	cox	cox	PROPN
dti-1330	60	1	,	,	PUNCT
dti-1330	60	2	total	total	ADJ
dti-1330	60	3	rna	rna	NOUN
dti-1330	60	4	was	be	AUX
dti-1330	60	5	extracted	extract	VERB
dti-1330	60	6	from	from	ADP
dti-1330	60	7	rcc	rcc	PROPN
dti-1330	60	8	,	,	PUNCT
dti-1330	60	9	bt	bt	NOUN
dti-1330	60	10	,	,	PUNCT
dti-1330	60	11	pc	pc	NOUN
dti-1330	60	12	and	and	CCONJ
dti-1330	60	13	tc	tc	NOUN
dti-1330	60	14	tissues	tissue	NOUN
dti-1330	60	15	.	.	PUNCT
dti-1330	61	1	concerning	concern	VERB
dti-1330	61	2	lox	lox	NOUN
dti-1330	61	3	,	,	PUNCT
dti-1330	61	4	total	total	ADJ
dti-1330	61	5	rna	rna	NOUN
dti-1330	61	6	was	be	AUX
dti-1330	61	7	extracted	extract	VERB
dti-1330	61	8	from	from	ADP
dti-1330	61	9	rcc	rcc	PROPN
dti-1330	61	10	tissues	tissue	NOUN
dti-1330	61	11	,	,	PUNCT
dti-1330	61	12	bt	bt	NOUN
dti-1330	61	13	and	and	CCONJ
dti-1330	61	14	pc	pc	NOUN
dti-1330	61	15	cell	cell	NOUN
dti-1330	61	16	lines	line	NOUN
dti-1330	61	17	by	by	ADP
dti-1330	61	18	the	the	DET
dti-1330	61	19	acid	acid	PROPN
dti-1330	61	20	guanidium	guanidium	NOUN
dti-1330	61	21	thiocyanatephenol	thiocyanatephenol	ADJ
dti-1330	61	22	-	-	PUNCT
dti-1330	61	23	chloroform	chloroform	NOUN
dti-1330	61	24	method	method	NOUN
dti-1330	61	25	[	[	X
dti-1330	61	26	11	11	NUM
dti-1330	61	27	]	]	PUNCT
dti-1330	61	28	.	.	PUNCT
dti-1330	62	1	a	a	DET
dti-1330	62	2	)	)	PUNCT
dti-1330	62	3	cox	cox	PROPN
dti-1330	62	4	for	for	ADP
dti-1330	62	5	polymerase	polymerase	NOUN
dti-1330	62	6	chain	chain	NOUN
dti-1330	62	7	reaction	reaction	NOUN
dti-1330	62	8	(	(	PUNCT
dti-1330	62	9	pcr	pcr	NOUN
dti-1330	62	10	)	)	PUNCT
dti-1330	62	11	analysis	analysis	NOUN
dti-1330	62	12	of	of	ADP
dti-1330	62	13	rna	rna	NOUN
dti-1330	62	14	,	,	PUNCT
dti-1330	62	15	complementary	complementary	ADJ
dti-1330	62	16	dna	dna	PROPN
dti-1330	62	17	(	(	PUNCT
dti-1330	62	18	cdna	cdna	PROPN
dti-1330	62	19	)	)	PUNCT
dti-1330	62	20	was	be	AUX
dti-1330	62	21	made	make	VERB
dti-1330	62	22	by	by	ADP
dti-1330	62	23	reverse	reverse	NOUN
dti-1330	62	24	-	-	PUNCT
dti-1330	62	25	transcription	transcription	NOUN
dti-1330	62	26	of	of	ADP
dti-1330	62	27	2	2	NUM
dti-1330	62	28	μg	μg	NOUN
dti-1330	62	29	of	of	ADP
dti-1330	62	30	each	each	DET
dti-1330	62	31	rna	rna	NOUN
dti-1330	62	32	sample	sample	NOUN
dti-1330	62	33	using	use	VERB
dti-1330	62	34	super	super	ADJ
dti-1330	62	35	script	script	NOUN
dti-1330	62	36	preamplifi	preamplifi	NOUN
dti-1330	62	37	cation	cation	NOUN
dti-1330	62	38	system	system	NOUN
dti-1330	62	39	for	for	ADP
dti-1330	62	40	fi	fi	NOUN
dti-1330	62	41	rst	rst	VERB
dti-1330	62	42	-	-	PUNCT
dti-1330	62	43	strand	strand	ADJ
dti-1330	62	44	cdna	cdna	PROPN
dti-1330	62	45	synthesis	synthesis	NOUN
dti-1330	62	46	(	(	PUNCT
dti-1330	62	47	gibco	gibco	NOUN
dti-1330	62	48	brl	brl	PROPN
dti-1330	62	49	,	,	PUNCT
dti-1330	62	50	md	md	PROPN
dti-1330	62	51	,	,	PUNCT
dti-1330	62	52	u.s.a	u.s.a	PROPN
dti-1330	62	53	.	.	PUNCT
dti-1330	62	54	)	)	PUNCT
dti-1330	62	55	.	.	PUNCT
dti-1330	63	1	pcr	pcr	ADJ
dti-1330	63	2	reactions	reaction	NOUN
dti-1330	63	3	were	be	AUX
dti-1330	63	4	performed	perform	VERB
dti-1330	63	5	with	with	ADP
dti-1330	63	6	3	3	NUM
dti-1330	63	7	μl	μl	ADP
dti-1330	63	8	of	of	ADP
dti-1330	63	9	each	each	DET
dti-1330	63	10	cdna	cdna	PROPN
dti-1330	63	11	,	,	PUNCT
dti-1330	63	12	3	3	NUM
dti-1330	63	13	μl	μl	ADP
dti-1330	63	14	of	of	ADP
dti-1330	63	15	each	each	DET
dti-1330	63	16	sense	sense	NOUN
dti-1330	63	17	and	and	CCONJ
dti-1330	63	18	antisense	antisense	NOUN
dti-1330	63	19	primers	primer	NOUN
dti-1330	63	20	(	(	PUNCT
dti-1330	63	21	20	20	NUM
dti-1330	63	22	μm	μm	NUM
dti-1330	63	23	)	)	PUNCT
dti-1330	63	24	,	,	PUNCT
dti-1330	63	25	and	and	CCONJ
dti-1330	63	26	1	1	NUM
dti-1330	63	27	unit	unit	NOUN
dti-1330	63	28	of	of	ADP
dti-1330	63	29	taq	taq	PROPN
dti-1330	63	30	polymerase	polymerase	NOUN
dti-1330	63	31	(	(	PUNCT
dti-1330	63	32	nippon	nippon	PROPN
dti-1330	63	33	gene	gene	NOUN
dti-1330	63	34	,	,	PUNCT
dti-1330	63	35	toyama	toyama	PROPN
dti-1330	63	36	,	,	PUNCT
dti-1330	63	37	japan	japan	PROPN
dti-1330	63	38	)	)	PUNCT
dti-1330	63	39	.	.	PUNCT
dti-1330	64	1	35	35	NUM
dti-1330	64	2	cycles	cycle	NOUN
dti-1330	64	3	of	of	ADP
dti-1330	64	4	denaturation	denaturation	NOUN
dti-1330	64	5	,	,	PUNCT
dti-1330	64	6	annealing	annealing	NOUN
dti-1330	64	7	,	,	PUNCT
dti-1330	64	8	and	and	CCONJ
dti-1330	64	9	extension	extension	NOUN
dti-1330	64	10	(	(	PUNCT
dti-1330	64	11	94ºc	94ºc	ADJ
dti-1330	64	12	for	for	ADP
dti-1330	64	13	45	45	NUM
dti-1330	64	14	sec	sec	PROPN
dti-1330	64	15	,	,	PUNCT
dti-1330	64	16	54	54	NUM
dti-1330	64	17	ºc	ºc	NOUN
dti-1330	64	18	for	for	ADP
dti-1330	64	19	45	45	NUM
dti-1330	64	20	sec	sec	PROPN
dti-1330	64	21	,	,	PUNCT
dti-1330	64	22	and	and	CCONJ
dti-1330	64	23	72	72	NUM
dti-1330	64	24	ºc	ºc	NOUN
dti-1330	64	25	for	for	ADP
dti-1330	64	26	2	2	NUM
dti-1330	64	27	min	min	NOUN
dti-1330	64	28	)	)	PUNCT
dti-1330	64	29	were	be	AUX
dti-1330	64	30	performed	perform	VERB
dti-1330	64	31	on	on	ADP
dti-1330	64	32	automatic	automatic	ADJ
dti-1330	64	33	heat	heat	NOUN
dti-1330	64	34	-	-	PUNCT
dti-1330	64	35	block	block	NOUN
dti-1330	64	36	(	(	PUNCT
dti-1330	64	37	model	model	NOUN
dti-1330	64	38	pj2000	pj2000	PROPN
dti-1330	64	39	dna	dna	PROPN
dti-1330	64	40	thermal	thermal	ADJ
dti-1330	64	41	cycler	cycler	PROPN
dti-1330	64	42	,	,	PUNCT
dti-1330	64	43	perkin	perkin	PROPN
dti-1330	64	44	elmer	elmer	PROPN
dti-1330	64	45	,	,	PUNCT
dti-1330	64	46	nj	nj	PROPN
dti-1330	64	47	,	,	PUNCT
dti-1330	64	48	u.s.a	u.s.a	PROPN
dti-1330	64	49	.	.	PUNCT
dti-1330	64	50	)	)	PUNCT
dti-1330	64	51	.	.	PUNCT
dti-1330	65	1	the	the	DET
dti-1330	65	2	primers	primer	NOUN
dti-1330	65	3	used	use	VERB
dti-1330	65	4	were	be	AUX
dti-1330	65	5	:	:	PUNCT
dti-1330	65	6	human	human	ADJ
dti-1330	65	7	cox-1	cox-1	VERB
dti-1330	65	8	sense	sense	NOUN
dti-1330	65	9	(	(	PUNCT
dti-1330	65	10	5’-tgccc	5’-tgccc	NUM
dti-1330	65	11	agctcctggcccgccgctt-3	agctcctggcccgccgctt-3	NUM
dti-1330	65	12	’	'	PUNCT
dti-1330	65	13	)	)	PUNCT
dti-1330	65	14	and	and	CCONJ
dti-1330	65	15	antisense	antisense	NOUN
dti-1330	65	16	(	(	PUNCT
dti-1330	65	17	5’-gtgcatcaacacaggcgcctctt	5’-gtgcatcaacacaggcgcctctt	NUM
dti-1330	65	18	c-3	c-3	NOUN
dti-1330	65	19	’	'	PUNCT
dti-1330	65	20	)	)	PUNCT
dti-1330	65	21	;	;	PUNCT
dti-1330	65	22	human	human	ADJ
dti-1330	65	23	cox-2	cox-2	ADJ
dti-1330	65	24	sense	sense	NOUN
dti-1330	65	25	(	(	PUNCT
dti-1330	65	26	5’-ttcaaatgagattgtgggaaaattgct-3	5’-ttcaaatgagattgtgggaaaattgct-3	NOUN
dti-1330	65	27	’	'	PUNCT
dti-1330	65	28	)	)	PUNCT
dti-1330	65	29	and	and	CCONJ
dti-1330	65	30	antisense	antisense	NOUN
dti-1330	65	31	(	(	PUNCT
dti-1330	65	32	5’-agatcatctctgcctgagtatctt-3	5’-agatcatctctgcctgagtatctt-3	NUM
dti-1330	65	33	’	'	PUNCT
dti-1330	65	34	)	)	PUNCT
dti-1330	65	35	;	;	PUNCT
dti-1330	65	36	140	140	NUM
dti-1330	65	37	matsuyama	matsuyama	NOUN
dti-1330	65	38	and	and	CCONJ
dti-1330	65	39	yoshimura	yoshimura	VERB
dti-1330	65	40	drug	drug	NOUN
dti-1330	65	41	target	target	NOUN
dti-1330	65	42	insights	insight	NOUN
dti-1330	65	43	2008:3	2008:3	NUM
dti-1330	65	44	human	human	ADJ
dti-1330	65	45	g	g	PROPN
dti-1330	65	46	lyce	lyce	PROPN
dti-1330	65	47	ra	ra	PROPN
dti-1330	65	48	ldehyde	ldehyde	NOUN
dti-1330	65	49	3	3	NUM
dti-1330	65	50	-phospha	-phospha	NOUN
dti-1330	65	51	te	te	X
dti-1330	65	52	dehydrogenase	dehydrogenase	NOUN
dti-1330	65	53	(	(	PUNCT
dti-1330	65	54	g3pdh	g3pdh	NOUN
dti-1330	65	55	)	)	PUNCT
dti-1330	65	56	sense	sense	NOUN
dti-1330	65	57	(	(	PUNCT
dti-1330	65	58	5’-ccacccatggcaaattccatggca-3	5’-ccacccatggcaaattccatggca-3	NUM
dti-1330	65	59	’	'	PUNCT
dti-1330	65	60	)	)	PUNCT
dti-1330	65	61	and	and	CCONJ
dti-1330	65	62	antisense	antisense	NOUN
dti-1330	65	63	(	(	PUNCT
dti-1330	65	64	5’-tctagagggcaggtcaggtccacc-3	5’-tctagagggcaggtcaggtccacc-3	NUM
dti-1330	65	65	’	'	PUNCT
dti-1330	65	66	)	)	PUNCT
dti-1330	65	67	.	.	PUNCT
dti-1330	66	1	b	b	X
dti-1330	66	2	)	)	PUNCT
dti-1330	66	3	lox	lox	NOUN
dti-1330	66	4	after	after	ADP
dti-1330	66	5	the	the	DET
dti-1330	66	6	rt	rt	PROPN
dti-1330	66	7	reaction	reaction	NOUN
dti-1330	66	8	,	,	PUNCT
dti-1330	66	9	nested	nest	VERB
dti-1330	66	10	pcr	pcr	PROPN
dti-1330	66	11	was	be	AUX
dti-1330	66	12	used	use	VERB
dti-1330	66	13	to	to	PART
dti-1330	66	14	examine	examine	VERB
dti-1330	66	15	5and	5and	NUM
dti-1330	66	16	12	12	NUM
dti-1330	66	17	-	-	PUNCT
dti-1330	66	18	lox	lox	NOUN
dti-1330	66	19	mrna	mrna	NOUN
dti-1330	66	20	expression	expression	NOUN
dti-1330	66	21	.	.	PUNCT
dti-1330	67	1	for	for	ADP
dti-1330	67	2	5and	5and	NUM
dti-1330	67	3	12	12	NUM
dti-1330	67	4	-	-	PUNCT
dti-1330	67	5	lox	lox	NOUN
dti-1330	67	6	,	,	PUNCT
dti-1330	67	7	the	the	DET
dti-1330	67	8	fi	fi	NOUN
dti-1330	67	9	rst	rst	NOUN
dti-1330	67	10	run	run	NOUN
dti-1330	67	11	pcr	pcr	PROPN
dti-1330	67	12	profi	profi	PROPN
dti-1330	67	13	le	le	PROPN
dti-1330	67	14	was	be	AUX
dti-1330	67	15	94	94	NUM
dti-1330	67	16	ºc	ºc	NUM
dti-1330	67	17	,	,	PUNCT
dti-1330	67	18	15s	15s	NUM
dti-1330	67	19	to	to	ADP
dti-1330	67	20	denature	denature	NOUN
dti-1330	67	21	;	;	PUNCT
dti-1330	67	22	61	61	NUM
dti-1330	67	23	ºc	ºc	NOUN
dti-1330	67	24	,	,	PUNCT
dti-1330	67	25	30s	30	NOUN
dti-1330	67	26	for	for	ADP
dti-1330	67	27	annealing	annealing	NOUN
dti-1330	67	28	and	and	CCONJ
dti-1330	67	29	extension	extension	NOUN
dti-1330	67	30	for	for	ADP
dti-1330	67	31	30	30	NUM
dti-1330	67	32	cycles	cycle	NOUN
dti-1330	67	33	with	with	ADP
dti-1330	67	34	upstream	upstream	ADJ
dti-1330	67	35	(	(	PUNCT
dti-1330	67	36	5’cttcccgtgctaccgctg-3	5’cttcccgtgctaccgctg-3	NUM
dti-1330	67	37	’	'	PUNCT
dti-1330	67	38	)	)	PUNCT
dti-1330	67	39	and	and	CCONJ
dti-1330	67	40	downstream	downstream	ADJ
dti-1330	67	41	(	(	PUNCT
dti-1330	67	42	5’-tggggttggcaccattgag-3	5’-tggggttggcaccattgag-3	NUM
dti-1330	67	43	’	'	PUNCT
dti-1330	67	44	)	)	PUNCT
dti-1330	67	45	primers	primer	NOUN
dti-1330	67	46	.	.	PUNCT
dti-1330	68	1	5	5	NUM
dti-1330	68	2	μl	μl	NOUN
dti-1330	68	3	of	of	ADP
dti-1330	68	4	fi	fi	NOUN
dti-1330	68	5	rst	rst	PROPN
dti-1330	68	6	run	run	VERB
dti-1330	68	7	pcr	pcr	NOUN
dti-1330	68	8	product	product	NOUN
dti-1330	68	9	was	be	AUX
dti-1330	68	10	used	use	VERB
dti-1330	68	11	for	for	ADP
dti-1330	68	12	the	the	DET
dti-1330	68	13	nested	nested	ADJ
dti-1330	68	14	pcr	pcr	NOUN
dti-1330	68	15	with	with	ADP
dti-1330	68	16	the	the	DET
dti-1330	68	17	profi	profi	PROPN
dti-1330	68	18	le	le	PROPN
dti-1330	68	19	of	of	ADP
dti-1330	68	20	94	94	NUM
dti-1330	68	21	ºc	ºc	NUM
dti-1330	68	22	,	,	PUNCT
dti-1330	68	23	15s	15s	NUM
dti-1330	68	24	to	to	ADP
dti-1330	68	25	denature	denature	NOUN
dti-1330	68	26	;	;	PUNCT
dti-1330	68	27	61	61	NUM
dti-1330	68	28	ºc	ºc	NOUN
dti-1330	68	29	,	,	PUNCT
dti-1330	68	30	30s	30	NOUN
dti-1330	68	31	for	for	ADP
dti-1330	68	32	annealing	annealing	NOUN
dti-1330	68	33	and	and	CCONJ
dti-1330	68	34	extension	extension	NOUN
dti-1330	68	35	for	for	ADP
dti-1330	68	36	25	25	NUM
dti-1330	68	37	cycles	cycle	NOUN
dti-1330	68	38	with	with	ADP
dti-1330	68	39	nested	nested	ADJ
dti-1330	68	40	primers	primer	NOUN
dti-1330	68	41	(	(	PUNCT
dti-1330	68	42	upstream	upstream	ADJ
dti-1330	68	43	5’-ccaggagacaatgctttggaca-3	5’-ccaggagacaatgctttggaca-3	NUM
dti-1330	68	44	’	'	PUNCT
dti-1330	68	45	;	;	PUNCT
dti-1330	68	46	downstream	downstream	ADJ
dti-1330	68	47	5’-gaacaactcatcatcctgccag-3	5’-gaacaactcatcatcctgccag-3	NUM
dti-1330	68	48	’	'	PUNCT
dti-1330	68	49	)	)	PUNCT
dti-1330	68	50	.	.	PUNCT
dti-1330	69	1	reagents	reagent	NOUN
dti-1330	69	2	and	and	CCONJ
dti-1330	69	3	materials	material	NOUN
dti-1330	69	4	rpmi	rpmi	NOUN
dti-1330	69	5	1640	1640	NUM
dti-1330	69	6	was	be	AUX
dti-1330	69	7	purchased	purchase	VERB
dti-1330	69	8	from	from	ADP
dti-1330	69	9	nissui	nissui	PROPN
dti-1330	69	10	pharmaceutical	pharmaceutical	NOUN
dti-1330	69	11	company	company	NOUN
dti-1330	69	12	(	(	PUNCT
dti-1330	69	13	tokyo	tokyo	PROPN
dti-1330	69	14	,	,	PUNCT
dti-1330	69	15	japan	japan	PROPN
dti-1330	69	16	)	)	PUNCT
dti-1330	69	17	,	,	PUNCT
dti-1330	69	18	fetal	fetal	ADJ
dti-1330	69	19	bovine	bovine	NOUN
dti-1330	69	20	serum	serum	NOUN
dti-1330	69	21	(	(	PUNCT
dti-1330	69	22	fbs	fbs	PROPN
dti-1330	69	23	)	)	PUNCT
dti-1330	69	24	and	and	CCONJ
dti-1330	69	25	penicillin	penicillin	PROPN
dti-1330	69	26	-	-	PUNCT
dti-1330	69	27	streptomycin	streptomycin	NOUN
dti-1330	69	28	mixture	mixture	NOUN
dti-1330	69	29	from	from	ADP
dti-1330	69	30	biowhitteker	biowhitteker	PROPN
dti-1330	69	31	(	(	PUNCT
dti-1330	69	32	walkerville	walkerville	NOUN
dti-1330	69	33	,	,	PUNCT
dti-1330	69	34	md	md	PROPN
dti-1330	69	35	)	)	PUNCT
dti-1330	69	36	,	,	PUNCT
dti-1330	69	37	and	and	CCONJ
dti-1330	69	38	trypsin/	trypsin/	NUM
dti-1330	69	39	edta	edta	NOUN
dti-1330	69	40	from	from	ADP
dti-1330	69	41	gibco	gibco	PROPN
dti-1330	69	42	brl	brl	PROPN
dti-1330	69	43	(	(	PUNCT
dti-1330	69	44	rockville	rockville	PROPN
dti-1330	69	45	,	,	PUNCT
dti-1330	69	46	md	md	PROPN
dti-1330	69	47	)	)	PUNCT
dti-1330	69	48	.	.	PUNCT
dti-1330	70	1	ibupurofen	ibupurofen	PROPN
dti-1330	70	2	,	,	PUNCT
dti-1330	70	3	piroxicam	piroxicam	ADJ
dti-1330	70	4	,	,	PUNCT
dti-1330	70	5	meloxicam	meloxicam	NOUN
dti-1330	70	6	,	,	PUNCT
dti-1330	70	7	and	and	CCONJ
dti-1330	70	8	nimesulide	nimesulide	ADV
dti-1330	70	9	were	be	AUX
dti-1330	70	10	obtained	obtain	VERB
dti-1330	70	11	from	from	ADP
dti-1330	70	12	biomol	biomol	NOUN
dti-1330	70	13	research	research	NOUN
dti-1330	70	14	laboratories	laboratories	PROPN
dti-1330	70	15	inc	inc	PROPN
dti-1330	70	16	(	(	PUNCT
dti-1330	70	17	u.s.a	u.s.a	PROPN
dti-1330	70	18	.	.	PUNCT
dti-1330	70	19	)	)	PUNCT
dti-1330	70	20	,	,	PUNCT
dti-1330	70	21	naproxen	naproxen	PROPN
dti-1330	70	22	was	be	AUX
dti-1330	70	23	obtained	obtain	VERB
dti-1330	70	24	from	from	ADP
dti-1330	70	25	cayman	cayman	PROPN
dti-1330	70	26	chemical	chemical	PROPN
dti-1330	70	27	company	company	PROPN
dti-1330	70	28	(	(	PUNCT
dti-1330	70	29	st	st	PROPN
dti-1330	70	30	.	.	PROPN
dti-1330	70	31	louis	louis	PROPN
dti-1330	70	32	,	,	PUNCT
dti-1330	70	33	u.s.a	u.s.a	NOUN
dti-1330	70	34	.	.	PUNCT
dti-1330	70	35	)	)	PUNCT
dti-1330	70	36	,	,	PUNCT
dti-1330	70	37	indomethacin	indomethacin	NOUN
dti-1330	70	38	and	and	CCONJ
dti-1330	70	39	ns	ns	NUM
dti-1330	70	40	398	398	NUM
dti-1330	70	41	were	be	AUX
dti-1330	70	42	obtained	obtain	VERB
dti-1330	70	43	from	from	ADP
dti-1330	70	44	wako	wako	PROPN
dti-1330	70	45	pure	pure	PROPN
dti-1330	70	46	chemical	chemical	PROPN
dti-1330	70	47	industries	industries	PROPN
dti-1330	70	48	ltd	ltd	PROPN
dti-1330	70	49	(	(	PUNCT
dti-1330	70	50	osaka	osaka	PROPN
dti-1330	70	51	,	,	PUNCT
dti-1330	70	52	japan	japan	PROPN
dti-1330	70	53	)	)	PUNCT
dti-1330	70	54	,	,	PUNCT
dti-1330	70	55	and	and	CCONJ
dti-1330	70	56	etodolac	etodolac	NOUN
dti-1330	70	57	was	be	AUX
dti-1330	70	58	obtained	obtain	VERB
dti-1330	70	59	from	from	ADP
dti-1330	70	60	nippon	nippon	PROPN
dti-1330	70	61	shinyaku	shinyaku	PROPN
dti-1330	70	62	co.	co.	PROPN
dti-1330	70	63	ltd	ltd	PROPN
dti-1330	70	64	(	(	PUNCT
dti-1330	70	65	kyoto	kyoto	PROPN
dti-1330	70	66	,	,	PUNCT
dti-1330	70	67	japan	japan	PROPN
dti-1330	70	68	)	)	PUNCT
dti-1330	70	69	.	.	PUNCT
dti-1330	71	1	ibupurofen	ibupurofen	PROPN
dti-1330	71	2	,	,	PUNCT
dti-1330	71	3	piroxicam	piroxicam	ADJ
dti-1330	71	4	,	,	PUNCT
dti-1330	71	5	meloxicam	meloxicam	NOUN
dti-1330	71	6	,	,	PUNCT
dti-1330	71	7	nimesulide	nimesulide	PROPN
dti-1330	71	8	naproxen	naproxen	PROPN
dti-1330	71	9	,	,	PUNCT
dti-1330	71	10	indomethacin	indomethacin	NOUN
dti-1330	71	11	,	,	PUNCT
dti-1330	71	12	ns	ns	NUM
dti-1330	71	13	398	398	NUM
dti-1330	71	14	,	,	PUNCT
dti-1330	71	15	and	and	CCONJ
dti-1330	71	16	etodolac	etodolac	NOUN
dti-1330	71	17	were	be	AUX
dti-1330	71	18	all	all	PRON
dti-1330	71	19	cox	cox	PROPN
dti-1330	71	20	inhibitors	inhibitor	NOUN
dti-1330	71	21	.	.	PUNCT
dti-1330	72	1	5	5	NUM
dti-1330	72	2	-	-	PUNCT
dti-1330	72	3	lox	lox	NOUN
dti-1330	72	4	inhibitor	inhibitor	NOUN
dti-1330	72	5	(	(	PUNCT
dti-1330	72	6	caffeic	caffeic	VERB
dti-1330	72	7	acid	acid	NOUN
dti-1330	72	8	)	)	PUNCT
dti-1330	72	9	and	and	CCONJ
dti-1330	72	10	12	12	NUM
dti-1330	72	11	-	-	PUNCT
dti-1330	72	12	lox	lox	NOUN
dti-1330	72	13	inhibitor	inhibitor	NOUN
dti-1330	72	14	(	(	PUNCT
dti-1330	72	15	baicalein	baicalein	PROPN
dti-1330	72	16	)	)	PUNCT
dti-1330	72	17	were	be	AUX
dti-1330	72	18	obtained	obtain	VERB
dti-1330	72	19	from	from	ADP
dti-1330	72	20	biomol	biomol	NOUN
dti-1330	72	21	.	.	PUNCT
dti-1330	73	1	research	research	PROPN
dti-1330	73	2	laboratories	laboratories	PROPN
dti-1330	73	3	inc	inc	PROPN
dti-1330	73	4	,	,	PUNCT
dti-1330	73	5	u.s.a	u.s.a	PROPN
dti-1330	73	6	.	.	PROPN
dti-1330	73	7	nonspecifi	nonspecifi	PROPN
dti-1330	73	8	c	c	PROPN
dti-1330	73	9	lox	lox	PROPN
dti-1330	73	10	inhibitor	inhibitor	PROPN
dti-1330	73	11	(	(	PUNCT
dti-1330	73	12	ndga	ndga	ADV
dti-1330	73	13	)	)	PUNCT
dti-1330	73	14	was	be	AUX
dti-1330	73	15	obtained	obtain	VERB
dti-1330	73	16	from	from	ADP
dti-1330	73	17	cayman	cayman	PROPN
dti-1330	73	18	chemical	chemical	PROPN
dti-1330	73	19	,	,	PUNCT
dti-1330	73	20	u.s.a	u.s.a	PROPN
dti-1330	73	21	.	.	PUNCT
dti-1330	74	1	all	all	DET
dti-1330	74	2	data	datum	NOUN
dti-1330	74	3	characteristics	characteristic	NOUN
dti-1330	74	4	of	of	ADP
dti-1330	74	5	these	these	DET
dti-1330	74	6	inhibitors	inhibitor	NOUN
dti-1330	74	7	were	be	AUX
dti-1330	74	8	published	publish	VERB
dti-1330	74	9	in	in	ADP
dti-1330	74	10	their	their	PRON
dti-1330	74	11	product	product	NOUN
dti-1330	74	12	information	information	NOUN
dti-1330	74	13	.	.	PUNCT
dti-1330	75	1	cell	cell	NOUN
dti-1330	75	2	cultures	culture	VERB
dti-1330	75	3	the	the	DET
dti-1330	75	4	human	human	PROPN
dti-1330	75	5	rcc	rcc	PROPN
dti-1330	75	6	cell	cell	NOUN
dti-1330	75	7	line	line	NOUN
dti-1330	75	8	(	(	PUNCT
dti-1330	75	9	caki-1	caki-1	NOUN
dti-1330	75	10	)	)	PUNCT
dti-1330	75	11	and	and	CCONJ
dti-1330	75	12	normal	normal	ADJ
dti-1330	75	13	prostate	prostate	NOUN
dti-1330	75	14	stromal	stromal	ADJ
dti-1330	75	15	cell	cell	NOUN
dti-1330	75	16	were	be	AUX
dti-1330	75	17	provided	provide	VERB
dti-1330	75	18	by	by	ADP
dti-1330	75	19	dr	dr	PROPN
dti-1330	75	20	.	.	PROPN
dti-1330	75	21	shinichi	shinichi	PROPN
dti-1330	75	22	ikemoto	ikemoto	PROPN
dti-1330	75	23	(	(	PUNCT
dti-1330	75	24	dept	dept	PROPN
dti-1330	75	25	.	.	PROPN
dti-1330	75	26	of	of	ADP
dti-1330	75	27	urology	urology	NOUN
dti-1330	75	28	,	,	PUNCT
dti-1330	75	29	osaka	osaka	PROPN
dti-1330	75	30	city	city	PROPN
dti-1330	75	31	university	university	PROPN
dti-1330	75	32	school	school	NOUN
dti-1330	75	33	of	of	ADP
dti-1330	75	34	medicine	medicine	NOUN
dti-1330	75	35	,	,	PUNCT
dti-1330	75	36	osaka	osaka	PROPN
dti-1330	75	37	,	,	PUNCT
dti-1330	75	38	japan	japan	PROPN
dti-1330	75	39	)	)	PUNCT
dti-1330	75	40	.	.	PUNCT
dti-1330	76	1	the	the	DET
dti-1330	76	2	human	human	PROPN
dti-1330	76	3	bt	bt	PROPN
dti-1330	76	4	cell	cell	NOUN
dti-1330	76	5	line	line	NOUN
dti-1330	76	6	(	(	PUNCT
dti-1330	76	7	t24	t24	NOUN
dti-1330	76	8	)	)	PUNCT
dti-1330	76	9	,	,	PUNCT
dti-1330	76	10	pc	pc	NOUN
dti-1330	76	11	cell	cell	NOUN
dti-1330	76	12	lines	line	NOUN
dti-1330	76	13	(	(	PUNCT
dti-1330	76	14	pc3	pc3	ADJ
dti-1330	76	15	,	,	PUNCT
dti-1330	76	16	du-145	du-145	PROPN
dti-1330	76	17	)	)	PUNCT
dti-1330	76	18	,	,	PUNCT
dti-1330	76	19	tc	tc	NUM
dti-1330	76	20	cell	cell	NOUN
dti-1330	76	21	line	line	NOUN
dti-1330	76	22	(	(	PUNCT
dti-1330	76	23	nec-8	nec-8	NUM
dti-1330	76	24	)	)	PUNCT
dti-1330	76	25	and	and	CCONJ
dti-1330	76	26	normal	normal	ADJ
dti-1330	76	27	proximal	proximal	ADJ
dti-1330	76	28	tubular	tubular	ADJ
dti-1330	76	29	endothelial	endothelial	ADJ
dti-1330	76	30	cell	cell	NOUN
dti-1330	76	31	(	(	PUNCT
dti-1330	76	32	prtec	prtec	NOUN
dti-1330	76	33	)	)	PUNCT
dti-1330	76	34	were	be	AUX
dti-1330	76	35	obtained	obtain	VERB
dti-1330	76	36	from	from	ADP
dti-1330	76	37	health	health	NOUN
dti-1330	76	38	science	science	PROPN
dti-1330	76	39	research	research	PROPN
dti-1330	76	40	resources	resource	NOUN
dti-1330	76	41	bank	bank	PROPN
dti-1330	76	42	(	(	PUNCT
dti-1330	76	43	osaka	osaka	PROPN
dti-1330	76	44	,	,	PUNCT
dti-1330	76	45	japan	japan	PROPN
dti-1330	76	46	)	)	PUNCT
dti-1330	76	47	.	.	PUNCT
dti-1330	77	1	normal	normal	ADJ
dti-1330	77	2	bladder	bladder	NOUN
dti-1330	77	3	cell	cell	NOUN
dti-1330	77	4	line	line	NOUN
dti-1330	77	5	was	be	AUX
dti-1330	77	6	obtained	obtain	VERB
dti-1330	77	7	from	from	ADP
dti-1330	77	8	the	the	DET
dti-1330	77	9	patients	patient	NOUN
dti-1330	77	10	with	with	ADP
dti-1330	77	11	normal	normal	ADJ
dti-1330	77	12	bladder	bladder	NOUN
dti-1330	77	13	tissues	tissue	NOUN
dti-1330	77	14	who	who	PRON
dti-1330	77	15	underwent	undergo	VERB
dti-1330	77	16	total	total	NOUN
dti-1330	77	17	prostatectomy	prostatectomy	ADV
dti-1330	77	18	due	due	ADJ
dti-1330	77	19	to	to	ADP
dti-1330	77	20	prostate	prostate	NOUN
dti-1330	77	21	cancer	cancer	NOUN
dti-1330	77	22	.	.	PUNCT
dti-1330	78	1	cells	cell	NOUN
dti-1330	78	2	were	be	AUX
dti-1330	78	3	grown	grow	VERB
dti-1330	78	4	in	in	ADP
dti-1330	78	5	culture	culture	NOUN
dti-1330	78	6	flask	flask	NOUN
dti-1330	78	7	(	(	PUNCT
dti-1330	78	8	nunc	nunc	PROPN
dti-1330	78	9	,	,	PUNCT
dti-1330	78	10	roskilde	roskilde	NOUN
dti-1330	78	11	,	,	PUNCT
dti-1330	78	12	denmark	denmark	NOUN
dti-1330	78	13	)	)	PUNCT
dti-1330	78	14	in	in	ADP
dti-1330	78	15	rpmi	rpmi	NOUN
dti-1330	78	16	1640	1640	NUM
dti-1330	78	17	supplemented	supplement	VERB
dti-1330	78	18	with	with	ADP
dti-1330	78	19	10	10	NUM
dti-1330	78	20	%	%	NOUN
dti-1330	78	21	fbs	fbs	PROPN
dti-1330	78	22	,	,	PUNCT
dti-1330	78	23	100	100	NUM
dti-1330	78	24	u	u	NOUN
dti-1330	78	25	/	/	SYM
dti-1330	78	26	ml	ml	NOUN
dti-1330	78	27	of	of	ADP
dti-1330	78	28	penicillin	penicillin	NOUN
dti-1330	78	29	and	and	CCONJ
dti-1330	78	30	100	100	NUM
dti-1330	78	31	μg/	μg/	NOUN
dti-1330	78	32	ml	ml	NOUN
dti-1330	78	33	of	of	ADP
dti-1330	78	34	streptomycin	streptomycin	PROPN
dti-1330	78	35	in	in	ADP
dti-1330	78	36	a	a	DET
dti-1330	78	37	humidifi	humidifi	NOUN
dti-1330	78	38	ed	ed	NOUN
dti-1330	78	39	5	5	NUM
dti-1330	78	40	%	%	NOUN
dti-1330	78	41	co2	co2	NOUN
dti-1330	78	42	atmosphere	atmosphere	NOUN
dti-1330	78	43	at	at	ADP
dti-1330	78	44	37	37	NUM
dti-1330	78	45	ºc	ºc	NOUN
dti-1330	78	46	.	.	PUNCT
dti-1330	79	1	the	the	DET
dti-1330	79	2	media	medium	NOUN
dti-1330	79	3	were	be	AUX
dti-1330	79	4	changed	change	VERB
dti-1330	79	5	every	every	DET
dti-1330	79	6	3	3	NUM
dti-1330	79	7	days	day	NOUN
dti-1330	79	8	and	and	CCONJ
dti-1330	79	9	the	the	DET
dti-1330	79	10	cells	cell	NOUN
dti-1330	79	11	were	be	AUX
dti-1330	79	12	separated	separate	VERB
dti-1330	79	13	via	via	ADP
dti-1330	79	14	trypsinization	trypsinization	NOUN
dti-1330	79	15	,	,	PUNCT
dti-1330	79	16	using	use	VERB
dti-1330	79	17	trypsin	trypsin	NOUN
dti-1330	79	18	/	/	SYM
dti-1330	79	19	edta	edta	NOUN
dti-1330	79	20	when	when	SCONJ
dti-1330	79	21	they	they	PRON
dti-1330	79	22	reached	reach	VERB
dti-1330	79	23	subconfl	subconfl	NOUN
dti-1330	79	24	uence	uence	NOUN
dti-1330	79	25	.	.	PUNCT
dti-1330	80	1	cell	cell	NOUN
dti-1330	80	2	proliferative	proliferative	ADJ
dti-1330	80	3	studies	study	NOUN
dti-1330	80	4	approximately	approximately	ADV
dti-1330	80	5	1.0	1.0	NUM
dti-1330	80	6	×	×	NOUN
dti-1330	80	7	104	104	NUM
dti-1330	80	8	cells	cell	NOUN
dti-1330	80	9	placed	place	VERB
dti-1330	80	10	onto	onto	ADP
dti-1330	80	11	8	8	NUM
dti-1330	80	12	×	×	NOUN
dti-1330	80	13	8	8	NUM
dti-1330	80	14	mm	mm	NOUN
dti-1330	80	15	diameter	diameter	NOUN
dti-1330	80	16	multichamber	multichamber	NOUN
dti-1330	80	17	slides	slide	VERB
dti-1330	80	18	(	(	PUNCT
dti-1330	80	19	nunc	nunc	PROPN
dti-1330	80	20	,	,	PUNCT
dti-1330	80	21	copenhagen	copenhagen	PROPN
dti-1330	80	22	,	,	PUNCT
dti-1330	80	23	denmark	denmark	PROPN
dti-1330	80	24	)	)	PUNCT
dti-1330	80	25	were	be	AUX
dti-1330	80	26	treated	treat	VERB
dti-1330	80	27	with	with	ADP
dti-1330	80	28	cox	cox	PROPN
dti-1330	80	29	and	and	CCONJ
dti-1330	80	30	lox	lox	NOUN
dti-1330	80	31	inhibitors	inhibitor	NOUN
dti-1330	80	32	(	(	PUNCT
dti-1330	80	33	10–80	10–80	NUM
dti-1330	80	34	μm	μm	NOUN
dti-1330	80	35	)	)	PUNCT
dti-1330	80	36	dissolved	dissolve	VERB
dti-1330	80	37	in	in	ADP
dti-1330	80	38	ethanol	ethanol	NOUN
dti-1330	80	39	.	.	PUNCT
dti-1330	81	1	the	the	DET
dti-1330	81	2	fi	fi	NOUN
dti-1330	81	3	nal	nal	ADJ
dti-1330	81	4	concentration	concentration	NOUN
dti-1330	81	5	of	of	ADP
dti-1330	81	6	ethanol	ethanol	NOUN
dti-1330	81	7	was	be	AUX
dti-1330	81	8	�	�	NOUN
dti-1330	81	9	0.05	0.05	NUM
dti-1330	81	10	%	%	NOUN
dti-1330	81	11	.	.	PUNCT
dti-1330	82	1	cell	cell	NOUN
dti-1330	82	2	viability	viability	NOUN
dti-1330	82	3	was	be	AUX
dti-1330	82	4	measured	measure	VERB
dti-1330	82	5	after	after	ADP
dti-1330	82	6	48	48	NUM
dti-1330	82	7	hours	hour	NOUN
dti-1330	82	8	by	by	ADP
dti-1330	82	9	a	a	DET
dti-1330	82	10	microplate	microplate	NOUN
dti-1330	82	11	reader	reader	NOUN
dti-1330	82	12	using	use	VERB
dti-1330	82	13	a	a	DET
dti-1330	82	14	modifi	modifi	NOUN
dti-1330	82	15	ed	ed	NOUN
dti-1330	82	16	3-[4	3-[4	NUM
dti-1330	82	17	,	,	PUNCT
dti-1330	82	18	5	5	NUM
dti-1330	82	19	-	-	PUNCT
dti-1330	82	20	dimethylthiazol-2	dimethylthiazol-2	NUM
dti-1330	82	21	-	-	PUNCT
dti-1330	82	22	thiazolyl]-2	thiazolyl]-2	ADJ
dti-1330	82	23	,	,	PUNCT
dti-1330	82	24	5diphenyltetrazolium	5diphenyltetrazolium	NUM
dti-1330	82	25	bromide	bromide	NOUN
dti-1330	82	26	(	(	PUNCT
dti-1330	82	27	mtt	mtt	NOUN
dti-1330	82	28	)	)	PUNCT
dti-1330	82	29	assay	assay	PROPN
dti-1330	82	30	(	(	PUNCT
dti-1330	82	31	wst-1	wst-1	NUM
dti-1330	82	32	assay	assay	VERB
dti-1330	82	33	;	;	PUNCT
dti-1330	82	34	dojindo	dojindo	PROPN
dti-1330	82	35	,	,	PUNCT
dti-1330	82	36	kumamoto	kumamoto	PROPN
dti-1330	82	37	,	,	PUNCT
dti-1330	82	38	japan	japan	PROPN
dti-1330	82	39	)	)	PUNCT
dti-1330	82	40	and	and	CCONJ
dti-1330	82	41	presented	present	VERB
dti-1330	82	42	as	as	ADP
dti-1330	82	43	the	the	DET
dti-1330	82	44	percentage	percentage	NOUN
dti-1330	82	45	of	of	ADP
dti-1330	82	46	control	control	NOUN
dti-1330	82	47	-	-	PUNCT
dti-1330	82	48	culture	culture	NOUN
dti-1330	82	49	conditions	condition	NOUN
dti-1330	82	50	.	.	PUNCT
dti-1330	83	1	flow	flow	NOUN
dti-1330	83	2	cytometry	cytometry	NOUN
dti-1330	83	3	(	(	PUNCT
dti-1330	83	4	annexin	annexin	NOUN
dti-1330	83	5	v	v	PROPN
dti-1330	83	6	and	and	CCONJ
dti-1330	83	7	propidium	propidium	NOUN
dti-1330	83	8	iodide	iodide	NOUN
dti-1330	83	9	staining	stain	VERB
dti-1330	83	10	)	)	PUNCT
dti-1330	83	11	the	the	DET
dti-1330	83	12	effects	effect	NOUN
dti-1330	83	13	of	of	ADP
dti-1330	83	14	lox	lox	NOUN
dti-1330	83	15	inhibitors	inhibitor	NOUN
dti-1330	83	16	on	on	ADP
dti-1330	83	17	human	human	ADJ
dti-1330	83	18	urological	urological	ADJ
dti-1330	83	19	tumors	tumor	NOUN
dti-1330	83	20	cell	cell	NOUN
dti-1330	83	21	lines	line	NOUN
dti-1330	83	22	were	be	AUX
dti-1330	83	23	determined	determine	VERB
dti-1330	83	24	by	by	ADP
dti-1330	83	25	dual	dual	ADJ
dti-1330	83	26	staining	stain	VERB
dti-1330	83	27	with	with	ADP
dti-1330	83	28	annexin	annexin	NOUN
dti-1330	83	29	v	v	NOUN
dti-1330	83	30	-	-	PUNCT
dti-1330	83	31	fitc	fitc	NOUN
dti-1330	83	32	and	and	CCONJ
dti-1330	83	33	propidium	propidium	NOUN
dti-1330	83	34	iodide	iodide	NOUN
dti-1330	83	35	using	use	VERB
dti-1330	83	36	annexin	annexin	PROPN
dti-1330	83	37	v	v	NOUN
dti-1330	83	38	-	-	PUNCT
dti-1330	83	39	fitc	fitc	NOUN
dti-1330	83	40	apoptosis	apoptosis	NOUN
dti-1330	83	41	detection	detection	NOUN
dti-1330	83	42	kit	kit	NOUN
dti-1330	84	1	i	i	PRON
dti-1330	84	2	(	(	PUNCT
dti-1330	84	3	biosiences	biosiences	PROPN
dti-1330	84	4	pharmingen	pharmingen	PROPN
dti-1330	84	5	)	)	PUNCT
dti-1330	84	6	.	.	PUNCT
dti-1330	85	1	annexin	annexin	PROPN
dti-1330	85	2	v	v	PROPN
dti-1330	85	3	-	-	PUNCT
dti-1330	85	4	fitc	fitc	NOUN
dti-1330	85	5	and	and	CCONJ
dti-1330	85	6	propidium	propidium	NOUN
dti-1330	85	7	iodide	iodide	NOUN
dti-1330	85	8	(	(	PUNCT
dti-1330	85	9	pi	pi	NOUN
dti-1330	85	10	)	)	PUNCT
dti-1330	85	11	were	be	AUX
dti-1330	85	12	added	add	VERB
dti-1330	85	13	to	to	ADP
dti-1330	85	14	the	the	DET
dti-1330	85	15	cellular	cellular	ADJ
dti-1330	85	16	suspension	suspension	NOUN
dti-1330	85	17	as	as	ADP
dti-1330	85	18	in	in	ADP
dti-1330	85	19	the	the	DET
dti-1330	85	20	manufacturer	manufacturer	NOUN
dti-1330	85	21	’s	’s	PART
dti-1330	85	22	instruction	instruction	NOUN
dti-1330	85	23	,	,	PUNCT
dti-1330	85	24	and	and	CCONJ
dti-1330	85	25	sample	sample	NOUN
dti-1330	85	26	fl	fl	PRON
dti-1330	85	27	uorescence	uorescence	NOUN
dti-1330	85	28	of	of	ADP
dti-1330	85	29	1.0	1.0	NUM
dti-1330	85	30	×	×	NOUN
dti-1330	85	31	104	104	NUM
dti-1330	85	32	cells	cell	NOUN
dti-1330	85	33	was	be	AUX
dti-1330	85	34	analyzed	analyze	VERB
dti-1330	85	35	fl	fl	PRON
dti-1330	85	36	ow	ow	INTJ
dti-1330	85	37	cytometry	cytometry	PROPN
dti-1330	85	38	.	.	PUNCT
dti-1330	86	1	flow	flow	NOUN
dti-1330	86	2	cytometry	cytometry	PROPN
dti-1330	86	3	was	be	AUX
dti-1330	86	4	with	with	ADP
dti-1330	86	5	facscan	facscan	PROPN
dti-1330	86	6	(	(	PUNCT
dti-1330	86	7	becton	becton	PROPN
dti-1330	86	8	dickinson	dickinson	PROPN
dti-1330	86	9	,	,	PUNCT
dti-1330	86	10	germany	germany	PROPN
dti-1330	86	11	)	)	PUNCT
dti-1330	86	12	.	.	PUNCT
dti-1330	87	1	cell	cell	NOUN
dti-1330	87	2	which	which	PRON
dti-1330	87	3	were	be	AUX
dti-1330	87	4	annexin	annexin	NOUN
dti-1330	87	5	v	v	NOUN
dti-1330	87	6	-	-	PUNCT
dti-1330	87	7	fitc	fitc	NOUN
dti-1330	87	8	positive	positive	ADJ
dti-1330	87	9	and	and	CCONJ
dti-1330	87	10	pi	pi	NOUN
dti-1330	87	11	negative	negative	ADJ
dti-1330	87	12	were	be	AUX
dti-1330	87	13	identifi	identifi	PROPN
dti-1330	87	14	ed	ed	NOUN
dti-1330	87	15	as	as	ADP
dti-1330	87	16	early	early	ADJ
dti-1330	87	17	apoptosis	apoptosis	NOUN
dti-1330	87	18	.	.	PUNCT
dti-1330	88	1	cell	cell	NOUN
dti-1330	88	2	which	which	PRON
dti-1330	88	3	were	be	AUX
dti-1330	88	4	annexin	annexin	NOUN
dti-1330	88	5	v	v	NOUN
dti-1330	88	6	-	-	PUNCT
dti-1330	88	7	fitc	fitc	NOUN
dti-1330	88	8	positive	positive	ADJ
dti-1330	88	9	and	and	CCONJ
dti-1330	88	10	pi	pi	ADJ
dti-1330	88	11	positive	positive	ADJ
dti-1330	88	12	were	be	AUX
dti-1330	88	13	identified	identify	VERB
dti-1330	88	14	as	as	ADP
dti-1330	88	15	late	late	ADJ
dti-1330	88	16	apoptosis	apoptosis	NOUN
dti-1330	88	17	or	or	CCONJ
dti-1330	88	18	necrosis	necrosis	NOUN
dti-1330	88	19	.	.	PUNCT
dti-1330	89	1	flow	flow	NOUN
dti-1330	89	2	cytometry	cytometry	NOUN
dti-1330	89	3	(	(	PUNCT
dti-1330	89	4	identifi	identifi	PROPN
dti-1330	89	5	cation	cation	NOUN
dti-1330	89	6	of	of	ADP
dti-1330	89	7	dna	dna	PROPN
dti-1330	89	8	fragmentation	fragmentation	NOUN
dti-1330	89	9	)	)	PUNCT
dti-1330	89	10	the	the	DET
dti-1330	89	11	assay	assay	NOUN
dti-1330	89	12	was	be	AUX
dti-1330	89	13	performed	perform	VERB
dti-1330	89	14	by	by	ADP
dti-1330	89	15	tdt	tdt	PROPN
dti-1330	89	16	-	-	PUNCT
dti-1330	89	17	mediated	mediate	VERB
dti-1330	89	18	dutp	dutp	NOUN
dti-1330	89	19	nick	nick	PROPN
dti-1330	89	20	end	end	PROPN
dti-1330	89	21	labelling	labelling	NOUN
dti-1330	89	22	(	(	PUNCT
dti-1330	89	23	tunel	tunel	NOUN
dti-1330	89	24	)	)	PUNCT
dti-1330	89	25	method	method	NOUN
dti-1330	89	26	using	use	VERB
dti-1330	89	27	141	141	NUM
dti-1330	89	28	5	5	NUM
dti-1330	89	29	-	-	NOUN
dti-1330	89	30	lipoxygenase	lipoxygenase	NOUN
dti-1330	89	31	in	in	ADP
dti-1330	89	32	urological	urological	ADJ
dti-1330	89	33	tumor	tumor	NOUN
dti-1330	89	34	drug	drug	NOUN
dti-1330	89	35	target	target	NOUN
dti-1330	89	36	insights	insight	VERB
dti-1330	89	37	2008:3	2008:3	NUM
dti-1330	89	38	apo	apo	NOUN
dti-1330	89	39	-	-	PUNCT
dti-1330	89	40	directtm	directtm	NOUN
dti-1330	89	41	kit	kit	NOUN
dti-1330	89	42	(	(	PUNCT
dti-1330	89	43	becton	becton	PROPN
dti-1330	89	44	dickinson	dickinson	PROPN
dti-1330	89	45	,	,	PUNCT
dti-1330	89	46	germany	germany	PROPN
dti-1330	89	47	)	)	PUNCT
dti-1330	89	48	.	.	PUNCT
dti-1330	90	1	following	follow	VERB
dti-1330	90	2	the	the	DET
dti-1330	90	3	experiments	experiment	NOUN
dti-1330	90	4	,	,	PUNCT
dti-1330	90	5	human	human	ADJ
dti-1330	90	6	urological	urological	ADJ
dti-1330	90	7	tumors	tumor	NOUN
dti-1330	90	8	cell	cell	NOUN
dti-1330	90	9	lines	line	NOUN
dti-1330	90	10	in	in	ADP
dti-1330	90	11	suspension	suspension	NOUN
dti-1330	90	12	(	(	PUNCT
dti-1330	90	13	1	1	NUM
dti-1330	90	14	×	×	NOUN
dti-1330	90	15	106	106	NUM
dti-1330	90	16	/	/	SYM
dti-1330	90	17	ml	ml	NOUN
dti-1330	90	18	)	)	PUNCT
dti-1330	90	19	were	be	AUX
dti-1330	90	20	fi	fi	NOUN
dti-1330	90	21	xed	xe	VERB
dti-1330	90	22	with	with	ADP
dti-1330	90	23	1	1	NUM
dti-1330	90	24	%	%	NOUN
dti-1330	90	25	pbs	pbs	PROPN
dti-1330	90	26	,	,	PUNCT
dti-1330	90	27	washed	wash	VERB
dti-1330	90	28	in	in	ADP
dti-1330	90	29	pbs	pbs	PROPN
dti-1330	90	30	,	,	PUNCT
dti-1330	90	31	and	and	CCONJ
dti-1330	90	32	suspended	suspend	VERB
dti-1330	90	33	in	in	ADP
dti-1330	90	34	70%(v	70%(v	PROPN
dti-1330	90	35	/	/	SYM
dti-1330	90	36	v	v	NOUN
dti-1330	90	37	)	)	PUNCT
dti-1330	90	38	ice	ice	NOUN
dti-1330	90	39	-	-	PUNCT
dti-1330	90	40	cold	cold	ADJ
dti-1330	90	41	ethanol	ethanol	NOUN
dti-1330	90	42	.	.	PUNCT
dti-1330	91	1	the	the	DET
dti-1330	91	2	cells	cell	NOUN
dti-1330	91	3	were	be	AUX
dti-1330	91	4	stored	store	VERB
dti-1330	91	5	in	in	ADP
dti-1330	91	6	ethanol	ethanol	NOUN
dti-1330	91	7	at	at	ADP
dti-1330	91	8	–	–	PUNCT
dti-1330	91	9	20	20	NUM
dti-1330	91	10	ºc	ºc	NOUN
dti-1330	91	11	until	until	ADP
dti-1330	91	12	use	use	NOUN
dti-1330	91	13	.	.	PUNCT
dti-1330	92	1	the	the	DET
dti-1330	92	2	positive	positive	ADJ
dti-1330	92	3	and	and	CCONJ
dti-1330	92	4	negative	negative	ADJ
dti-1330	92	5	controls	control	NOUN
dti-1330	92	6	and	and	CCONJ
dti-1330	92	7	the	the	DET
dti-1330	92	8	sample	sample	NOUN
dti-1330	92	9	were	be	AUX
dti-1330	92	10	stained	stain	VERB
dti-1330	92	11	with	with	ADP
dti-1330	92	12	fitc	fitc	NOUN
dti-1330	92	13	-	-	PUNCT
dti-1330	92	14	dutp	dutp	NOUN
dti-1330	92	15	by	by	ADP
dti-1330	92	16	incubation	incubation	NOUN
dti-1330	92	17	in	in	ADP
dti-1330	92	18	terminal	terminal	ADJ
dti-1330	92	19	deoxynucleotidyl	deoxynucleotidyl	NOUN
dti-1330	92	20	transferase	transferase	NOUN
dti-1330	92	21	buffer	buffer	NOUN
dti-1330	92	22	as	as	ADP
dti-1330	92	23	in	in	ADP
dti-1330	92	24	the	the	DET
dti-1330	92	25	manufacturer	manufacturer	NOUN
dti-1330	92	26	’s	’s	PART
dti-1330	92	27	instruction	instruction	NOUN
dti-1330	92	28	,	,	PUNCT
dti-1330	92	29	and	and	CCONJ
dti-1330	92	30	sample	sample	NOUN
dti-1330	92	31	fl	fl	PRON
dti-1330	92	32	uorescence	uorescence	NOUN
dti-1330	92	33	of	of	ADP
dti-1330	92	34	1	1	NUM
dti-1330	92	35	×	×	NOUN
dti-1330	92	36	104	104	NUM
dti-1330	92	37	cells	cell	NOUN
dti-1330	92	38	was	be	AUX
dti-1330	92	39	analyzed	analyze	VERB
dti-1330	92	40	by	by	ADP
dti-1330	92	41	fl	fl	INTJ
dti-1330	92	42	ow	ow	PROPN
dti-1330	92	43	cytometry	cytometry	PROPN
dti-1330	92	44	(	(	PUNCT
dti-1330	92	45	becton	becton	PROPN
dti-1330	92	46	dickinson	dickinson	PROPN
dti-1330	92	47	,	,	PUNCT
dti-1330	92	48	germany	germany	PROPN
dti-1330	92	49	)	)	PUNCT
dti-1330	92	50	.	.	PUNCT
dti-1330	93	1	results	result	NOUN
dti-1330	93	2	are	be	AUX
dti-1330	93	3	given	give	VERB
dti-1330	93	4	as	as	ADP
dti-1330	93	5	%	%	NOUN
dti-1330	93	6	of	of	ADP
dti-1330	93	7	tunel	tunel	ADJ
dti-1330	93	8	-	-	ADJ
dti-1330	93	9	positive	positive	ADJ
dti-1330	93	10	cells	cell	NOUN
dti-1330	93	11	.	.	PUNCT
dti-1330	94	1	detection	detection	NOUN
dti-1330	94	2	of	of	ADP
dti-1330	94	3	apoptosis	apoptosis	NOUN
dti-1330	94	4	by	by	ADP
dti-1330	94	5	hoechst	hoechst	ADJ
dti-1330	94	6	staining	stain	VERB
dti-1330	94	7	dna	dna	PROPN
dti-1330	94	8	chromatin	chromatin	NOUN
dti-1330	94	9	morphology	morphology	NOUN
dti-1330	94	10	was	be	AUX
dti-1330	94	11	assessed	assess	VERB
dti-1330	94	12	using	use	VERB
dti-1330	94	13	hoechst	hoechst	ADJ
dti-1330	94	14	staining	stain	VERB
dti-1330	94	15	.	.	PUNCT
dti-1330	95	1	human	human	ADJ
dti-1330	95	2	urological	urological	ADJ
dti-1330	95	3	tumors	tumor	NOUN
dti-1330	95	4	cell	cell	NOUN
dti-1330	95	5	(	(	PUNCT
dti-1330	95	6	5	5	NUM
dti-1330	95	7	×	×	NOUN
dti-1330	95	8	105	105	NUM
dti-1330	95	9	cells	cell	NOUN
dti-1330	95	10	)	)	PUNCT
dti-1330	95	11	were	be	AUX
dti-1330	95	12	incubated	incubate	VERB
dti-1330	95	13	with	with	ADP
dti-1330	95	14	50	50	NUM
dti-1330	95	15	μm	μm	NOUN
dti-1330	95	16	lox	lox	NOUN
dti-1330	95	17	inhibitor	inhibitor	NOUN
dti-1330	95	18	for	for	ADP
dti-1330	95	19	24	24	NUM
dti-1330	95	20	hour	hour	NOUN
dti-1330	95	21	.	.	PUNCT
dti-1330	96	1	cells	cell	NOUN
dti-1330	96	2	were	be	AUX
dti-1330	96	3	washed	wash	VERB
dti-1330	96	4	by	by	ADP
dti-1330	96	5	rpmi1640	rpmi1640	NOUN
dti-1330	96	6	and	and	CCONJ
dti-1330	96	7	labeled	label	VERB
dti-1330	96	8	with	with	ADP
dti-1330	96	9	8	8	NUM
dti-1330	96	10	mg	mg	NUM
dti-1330	96	11	/	/	SYM
dti-1330	96	12	ml	ml	NOUN
dti-1330	96	13	of	of	ADP
dti-1330	96	14	hoechest	hoech	ADJ
dti-1330	96	15	33342	33342	NUM
dti-1330	96	16	(	(	PUNCT
dti-1330	96	17	sigma	sigma	PROPN
dti-1330	96	18	-	-	PUNCT
dti-1330	96	19	aldrich	aldrich	PROPN
dti-1330	96	20	japan	japan	PROPN
dti-1330	96	21	k.k	k.k	PROPN
dti-1330	96	22	.	.	PROPN
dti-1330	96	23	tokyo	tokyo	PROPN
dti-1330	96	24	,	,	PUNCT
dti-1330	96	25	japan	japan	PROPN
dti-1330	96	26	)	)	PUNCT
dti-1330	96	27	for	for	ADP
dti-1330	96	28	10	10	NUM
dti-1330	96	29	min	min	NOUN
dti-1330	96	30	;	;	PUNCT
dti-1330	96	31	pi	pi	NOUN
dti-1330	96	32	(	(	PUNCT
dti-1330	96	33	sigma	sigma	PROPN
dti-1330	96	34	-	-	PUNCT
dti-1330	96	35	aldrich	aldrich	PROPN
dti-1330	96	36	japan	japan	PROPN
dti-1330	96	37	k.k	k.k	PROPN
dti-1330	96	38	.	.	PROPN
dti-1330	96	39	tokyo	tokyo	PROPN
dti-1330	96	40	,	,	PUNCT
dti-1330	96	41	japan	japan	PROPN
dti-1330	96	42	)	)	PUNCT
dti-1330	96	43	was	be	AUX
dti-1330	96	44	added	add	VERB
dti-1330	96	45	(	(	PUNCT
dti-1330	96	46	10mg	10mg	NOUN
dti-1330	96	47	/	/	SYM
dti-1330	96	48	ml	ml	ADP
dti-1330	96	49	fi	fi	NOUN
dti-1330	96	50	nal	nal	ADJ
dti-1330	96	51	concentration	concentration	NOUN
dti-1330	96	52	)	)	PUNCT
dti-1330	96	53	,	,	PUNCT
dti-1330	96	54	and	and	CCONJ
dti-1330	96	55	the	the	DET
dti-1330	96	56	cells	cell	NOUN
dti-1330	96	57	were	be	AUX
dti-1330	96	58	examined	examine	VERB
dti-1330	96	59	by	by	ADP
dti-1330	96	60	fl	fl	PROPN
dti-1330	96	61	uorescence	uorescence	NOUN
dti-1330	96	62	microscopy	microscopy	NOUN
dti-1330	96	63	.	.	PUNCT
dti-1330	97	1	results	result	VERB
dti-1330	97	2	expression	expression	NOUN
dti-1330	97	3	of	of	ADP
dti-1330	97	4	cox	cox	PROPN
dti-1330	97	5	and	and	CCONJ
dti-1330	97	6	lox	lox	PROPN
dti-1330	97	7	1	1	NUM
dti-1330	97	8	)	)	PUNCT
dti-1330	97	9	immunohistochemistry	immunohistochemistry	NOUN
dti-1330	97	10	a	a	NOUN
dti-1330	97	11	)	)	PUNCT
dti-1330	97	12	cox	cox	PROPN
dti-1330	97	13	rcc	rcc	PROPN
dti-1330	97	14	tissue	tissue	NOUN
dti-1330	97	15	sample	sample	NOUN
dti-1330	98	1	cox-2	cox-2	NOUN
dti-1330	98	2	expression	expression	NOUN
dti-1330	98	3	was	be	AUX
dti-1330	98	4	observed	observe	VERB
dti-1330	98	5	in	in	ADP
dti-1330	98	6	proximal	proximal	ADJ
dti-1330	98	7	and	and	CCONJ
dti-1330	98	8	distal	distal	ADJ
dti-1330	98	9	tubules	tubule	NOUN
dti-1330	98	10	of	of	ADP
dti-1330	98	11	nk	nk	PROPN
dti-1330	98	12	tissues	tissue	NOUN
dti-1330	98	13	.	.	PUNCT
dti-1330	99	1	however	however	ADV
dti-1330	99	2	,	,	PUNCT
dti-1330	99	3	in	in	ADP
dti-1330	99	4	epithelial	epithelial	ADJ
dti-1330	99	5	cells	cell	NOUN
dti-1330	99	6	,	,	PUNCT
dti-1330	99	7	blood	blood	NOUN
dti-1330	99	8	vessels	vessel	NOUN
dti-1330	99	9	and	and	CCONJ
dti-1330	99	10	stromal	stromal	ADJ
dti-1330	99	11	tissues	tissue	NOUN
dti-1330	99	12	,	,	PUNCT
dti-1330	99	13	while	while	SCONJ
dti-1330	99	14	cox-2	cox-2	ADV
dti-1330	99	15	was	be	AUX
dti-1330	99	16	not	not	PART
dti-1330	99	17	expressed	express	VERB
dti-1330	99	18	in	in	ADP
dti-1330	99	19	nk	nk	PROPN
dti-1330	99	20	tissues	tissue	NOUN
dti-1330	99	21	,	,	PUNCT
dti-1330	99	22	cox-2	cox-2	PRON
dti-1330	99	23	was	be	AUX
dti-1330	99	24	strongly	strongly	ADV
dti-1330	99	25	expressed	express	VERB
dti-1330	99	26	in	in	ADP
dti-1330	99	27	all	all	DET
dti-1330	99	28	rcc	rcc	PROPN
dti-1330	99	29	tissues	tissue	NOUN
dti-1330	99	30	.	.	PUNCT
dti-1330	100	1	bt	bt	NOUN
dti-1330	100	2	tissue	tissue	NOUN
dti-1330	100	3	sample	sample	NOUN
dti-1330	100	4	cox-1	cox-1	PUNCT
dti-1330	100	5	was	be	AUX
dti-1330	100	6	weakly	weakly	ADV
dti-1330	100	7	expressed	express	VERB
dti-1330	100	8	in	in	ADP
dti-1330	100	9	cc	cc	NOUN
dti-1330	100	10	tissues	tissue	NOUN
dti-1330	100	11	but	but	CCONJ
dti-1330	100	12	no	no	DET
dti-1330	100	13	expression	expression	NOUN
dti-1330	100	14	was	be	AUX
dti-1330	100	15	found	find	VERB
dti-1330	100	16	in	in	ADP
dti-1330	100	17	any	any	DET
dti-1330	100	18	bt	bt	NOUN
dti-1330	100	19	tissues	tissue	NOUN
dti-1330	100	20	.	.	PUNCT
dti-1330	101	1	on	on	ADP
dti-1330	101	2	the	the	DET
dti-1330	101	3	other	other	ADJ
dti-1330	101	4	hand	hand	NOUN
dti-1330	101	5	,	,	PUNCT
dti-1330	101	6	cox-2	cox-2	PRON
dti-1330	101	7	was	be	AUX
dti-1330	101	8	strongly	strongly	ADV
dti-1330	101	9	expressed	express	VERB
dti-1330	101	10	in	in	ADP
dti-1330	101	11	all	all	DET
dti-1330	101	12	bt	bt	NOUN
dti-1330	101	13	tissues	tissue	NOUN
dti-1330	101	14	with	with	ADP
dti-1330	101	15	an	an	DET
dti-1330	101	16	intense	intense	ADJ
dti-1330	101	17	expression	expression	NOUN
dti-1330	101	18	in	in	ADP
dti-1330	101	19	high	high	ADJ
dti-1330	101	20	-	-	PUNCT
dti-1330	101	21	grade	grade	NOUN
dti-1330	101	22	bt	bt	NOUN
dti-1330	101	23	group	group	NOUN
dti-1330	101	24	.	.	PUNCT
dti-1330	102	1	neither	neither	CCONJ
dti-1330	102	2	cox-1	cox-1	PUNCT
dti-1330	102	3	nor	nor	CCONJ
dti-1330	102	4	cox-2	cox-2	NUM
dti-1330	102	5	were	be	AUX
dti-1330	102	6	expressed	express	VERB
dti-1330	102	7	in	in	ADP
dti-1330	102	8	nb	nb	PROPN
dti-1330	102	9	tissues	tissue	NOUN
dti-1330	102	10	.	.	PUNCT
dti-1330	103	1	pc	pc	NOUN
dti-1330	103	2	tissue	tissue	NOUN
dti-1330	103	3	sample	sample	NOUN
dti-1330	103	4	the	the	DET
dti-1330	103	5	expression	expression	NOUN
dti-1330	103	6	of	of	ADP
dti-1330	103	7	cox-1	cox-1	PUNCT
dti-1330	103	8	was	be	AUX
dti-1330	103	9	very	very	ADV
dti-1330	103	10	weak	weak	ADJ
dti-1330	103	11	in	in	ADP
dti-1330	103	12	pc	pc	NOUN
dti-1330	103	13	,	,	PUNCT
dti-1330	103	14	pin	pin	NOUN
dti-1330	103	15	,	,	PUNCT
dti-1330	103	16	bph	bph	NOUN
dti-1330	103	17	and	and	CCONJ
dti-1330	103	18	np	np	ADJ
dti-1330	103	19	tissues	tissue	NOUN
dti-1330	103	20	.	.	PUNCT
dti-1330	104	1	however	however	ADV
dti-1330	104	2	,	,	PUNCT
dti-1330	104	3	cox-2	cox-2	PRON
dti-1330	104	4	was	be	AUX
dti-1330	104	5	strongly	strongly	ADV
dti-1330	104	6	expressed	express	VERB
dti-1330	104	7	in	in	ADP
dti-1330	104	8	all	all	DET
dti-1330	104	9	pc	pc	NOUN
dti-1330	104	10	tissues	tissue	NOUN
dti-1330	104	11	,	,	PUNCT
dti-1330	104	12	although	although	SCONJ
dti-1330	104	13	very	very	ADV
dti-1330	104	14	weak	weak	ADJ
dti-1330	104	15	expression	expression	NOUN
dti-1330	104	16	of	of	ADP
dti-1330	104	17	cox-2	cox-2	NUM
dti-1330	104	18	was	be	AUX
dti-1330	104	19	found	find	VERB
dti-1330	104	20	in	in	ADP
dti-1330	104	21	pin	pin	NOUN
dti-1330	104	22	,	,	PUNCT
dti-1330	104	23	bph	bph	NOUN
dti-1330	104	24	and	and	CCONJ
dti-1330	104	25	np	np	ADJ
dti-1330	104	26	tissues	tissue	NOUN
dti-1330	104	27	.	.	PUNCT
dti-1330	105	1	tc	tc	NUM
dti-1330	105	2	tissue	tissue	NOUN
dti-1330	105	3	sample	sample	NOUN
dti-1330	105	4	cox-1	cox-1	PUNCT
dti-1330	105	5	and	and	CCONJ
dti-1330	105	6	cox-2	cox-2	NUM
dti-1330	105	7	were	be	AUX
dti-1330	105	8	strongly	strongly	ADV
dti-1330	105	9	expressed	express	VERB
dti-1330	105	10	in	in	ADP
dti-1330	105	11	all	all	DET
dti-1330	105	12	tc	tc	NOUN
dti-1330	105	13	group	group	NOUN
dti-1330	105	14	tissues	tissue	NOUN
dti-1330	105	15	,	,	PUNCT
dti-1330	105	16	although	although	SCONJ
dti-1330	105	17	very	very	ADV
dti-1330	105	18	weak	weak	ADJ
dti-1330	105	19	expression	expression	NOUN
dti-1330	105	20	of	of	ADP
dti-1330	105	21	cox-1	cox-1	PUNCT
dti-1330	105	22	and	and	CCONJ
dti-1330	105	23	cox-2	cox-2	NUM
dti-1330	105	24	were	be	AUX
dti-1330	105	25	found	find	VERB
dti-1330	105	26	in	in	ADP
dti-1330	105	27	nt	nt	ADP
dti-1330	105	28	tissues	tissue	NOUN
dti-1330	105	29	.	.	PUNCT
dti-1330	106	1	b	b	X
dti-1330	106	2	)	)	PUNCT
dti-1330	106	3	lox	lox	PROPN
dti-1330	106	4	rcc	rcc	PROPN
dti-1330	106	5	tissue	tissue	NOUN
dti-1330	106	6	sample	sample	NOUN
dti-1330	106	7	5and	5and	NUM
dti-1330	106	8	12	12	NUM
dti-1330	106	9	-	-	PUNCT
dti-1330	106	10	lox	lox	NOUN
dti-1330	106	11	were	be	AUX
dti-1330	106	12	strongly	strongly	ADV
dti-1330	106	13	expressed	express	VERB
dti-1330	106	14	in	in	ADP
dti-1330	106	15	all	all	DET
dti-1330	106	16	grades	grade	NOUN
dti-1330	106	17	rcc	rcc	PROPN
dti-1330	106	18	tissues	tissue	NOUN
dti-1330	106	19	(	(	PUNCT
dti-1330	106	20	a	a	X
dti-1330	106	21	:	:	PUNCT
dti-1330	106	22	rcc	rcc	PROPN
dti-1330	106	23	-g1	-g1	PROPN
dti-1330	106	24	,	,	PUNCT
dti-1330	106	25	b	b	X
dti-1330	106	26	:	:	PUNCT
dti-1330	106	27	rcc	rcc	PROPN
dti-1330	106	28	-g2	-g2	PROPN
dti-1330	106	29	,	,	PUNCT
dti-1330	106	30	c	c	X
dti-1330	106	31	:	:	PUNCT
dti-1330	106	32	rcc	rcc	PROPN
dti-1330	106	33	-g3	-g3	PROPN
dti-1330	106	34	)	)	PUNCT
dti-1330	106	35	and	and	CCONJ
dti-1330	106	36	other	other	ADJ
dti-1330	106	37	types	type	NOUN
dti-1330	106	38	of	of	ADP
dti-1330	106	39	rcc	rcc	PROPN
dti-1330	106	40	tissues	tissue	NOUN
dti-1330	106	41	(	(	PUNCT
dti-1330	106	42	d	d	X
dti-1330	106	43	:	:	PUNCT
dti-1330	106	44	rcc	rcc	PROPN
dti-1330	106	45	papillary	papillary	PROPN
dti-1330	106	46	cell	cell	NOUN
dti-1330	106	47	type	type	NOUN
dti-1330	106	48	,	,	PUNCT
dti-1330	106	49	e	e	NOUN
dti-1330	106	50	:	:	PUNCT
dti-1330	106	51	rcc	rcc	PROPN
dti-1330	106	52	chromphobe	chromphobe	PROPN
dti-1330	106	53	cell	cell	NOUN
dti-1330	106	54	type	type	NOUN
dti-1330	106	55	,	,	PUNCT
dti-1330	106	56	f	f	PROPN
dti-1330	106	57	:	:	PUNCT
dti-1330	106	58	rcc	rcc	PROPN
dti-1330	106	59	collecting	collect	VERB
dti-1330	106	60	duct	duct	NOUN
dti-1330	106	61	type	type	NOUN
dti-1330	106	62	)	)	PUNCT
dti-1330	106	63	although	although	SCONJ
dti-1330	106	64	very	very	ADV
dti-1330	106	65	weak	weak	ADJ
dti-1330	106	66	expressions	expression	NOUN
dti-1330	106	67	of	of	ADP
dti-1330	106	68	5and	5and	NUM
dti-1330	106	69	12	12	NUM
dti-1330	106	70	-	-	PUNCT
dti-1330	106	71	lox	lox	NOUN
dti-1330	106	72	were	be	AUX
dti-1330	106	73	found	find	VERB
dti-1330	106	74	in	in	ADP
dti-1330	106	75	nk	nk	PROPN
dti-1330	106	76	tissues	tissue	NOUN
dti-1330	106	77	(	(	PUNCT
dti-1330	106	78	g	g	NOUN
dti-1330	106	79	)	)	PUNCT
dti-1330	106	80	.	.	PUNCT
dti-1330	107	1	immunostaining	immunostaine	VERB
dti-1330	107	2	with	with	ADP
dti-1330	107	3	pbs	pbs	PROPN
dti-1330	107	4	was	be	AUX
dti-1330	107	5	negative	negative	ADJ
dti-1330	107	6	(	(	PUNCT
dti-1330	107	7	h	h	NOUN
dti-1330	107	8	)	)	PUNCT
dti-1330	107	9	(	(	PUNCT
dti-1330	107	10	fig	fig	NOUN
dti-1330	107	11	.	.	PUNCT
dti-1330	108	1	2	2	NUM
dti-1330	108	2	)	)	PUNCT
dti-1330	108	3	.	.	PUNCT
dti-1330	109	1	bt	bt	NOUN
dti-1330	109	2	tissue	tissue	NOUN
dti-1330	109	3	sample	sample	NOUN
dti-1330	109	4	5and	5and	NUM
dti-1330	109	5	12	12	NUM
dti-1330	109	6	-	-	PUNCT
dti-1330	109	7	lox	lox	NOUN
dti-1330	109	8	were	be	AUX
dti-1330	109	9	strongly	strongly	ADV
dti-1330	109	10	expressed	express	VERB
dti-1330	109	11	in	in	ADP
dti-1330	109	12	all	all	DET
dti-1330	109	13	grades	grade	NOUN
dti-1330	109	14	of	of	ADP
dti-1330	109	15	bt	bt	NOUN
dti-1330	109	16	tissues	tissue	NOUN
dti-1330	109	17	,	,	PUNCT
dti-1330	109	18	although	although	SCONJ
dti-1330	109	19	very	very	ADV
dti-1330	109	20	weak	weak	ADJ
dti-1330	109	21	expressions	expression	NOUN
dti-1330	109	22	of	of	ADP
dti-1330	109	23	5and	5and	NUM
dti-1330	109	24	12	12	NUM
dti-1330	109	25	-	-	PUNCT
dti-1330	109	26	lox	lox	NOUN
dti-1330	109	27	were	be	AUX
dti-1330	109	28	found	find	VERB
dti-1330	109	29	in	in	ADP
dti-1330	109	30	cc	cc	PROPN
dti-1330	109	31	and	and	CCONJ
dti-1330	109	32	nb	nb	PROPN
dti-1330	109	33	tissues	tissue	NOUN
dti-1330	109	34	.	.	PUNCT
dti-1330	110	1	pc	pc	NOUN
dti-1330	110	2	tissue	tissue	NOUN
dti-1330	110	3	sample	sample	NOUN
dti-1330	110	4	5and	5and	NUM
dti-1330	110	5	12	12	NUM
dti-1330	110	6	-	-	PUNCT
dti-1330	110	7	lox	lox	NOUN
dti-1330	110	8	were	be	AUX
dti-1330	110	9	strongly	strongly	ADV
dti-1330	110	10	expressed	express	VERB
dti-1330	110	11	in	in	ADP
dti-1330	110	12	all	all	DET
dti-1330	110	13	grades	grade	NOUN
dti-1330	110	14	of	of	ADP
dti-1330	110	15	pc	pc	NOUN
dti-1330	110	16	and	and	CCONJ
dti-1330	110	17	pin	pin	NOUN
dti-1330	110	18	tissues	tissue	NOUN
dti-1330	110	19	,	,	PUNCT
dti-1330	110	20	although	although	SCONJ
dti-1330	110	21	very	very	ADV
dti-1330	110	22	weak	weak	ADJ
dti-1330	110	23	expressions	expression	NOUN
dti-1330	110	24	of	of	ADP
dti-1330	110	25	5and	5and	NUM
dti-1330	110	26	12	12	NUM
dti-1330	110	27	-	-	PUNCT
dti-1330	110	28	lox	lox	NOUN
dti-1330	110	29	were	be	AUX
dti-1330	110	30	found	find	VERB
dti-1330	110	31	in	in	ADP
dti-1330	110	32	bph	bph	NOUN
dti-1330	110	33	and	and	CCONJ
dti-1330	110	34	np	np	ADJ
dti-1330	110	35	tissues	tissue	NOUN
dti-1330	110	36	.	.	PUNCT
dti-1330	111	1	tc	tc	NUM
dti-1330	111	2	tissue	tissue	NOUN
dti-1330	111	3	sample	sample	NOUN
dti-1330	111	4	5and	5and	NUM
dti-1330	111	5	12	12	NUM
dti-1330	111	6	-	-	PUNCT
dti-1330	111	7	lox	lox	NOUN
dti-1330	111	8	were	be	AUX
dti-1330	111	9	strongly	strongly	ADV
dti-1330	111	10	expressed	express	VERB
dti-1330	111	11	in	in	ADP
dti-1330	111	12	all	all	DET
dti-1330	111	13	tc	tc	NOUN
dti-1330	111	14	group	group	NOUN
dti-1330	111	15	tissues	tissue	NOUN
dti-1330	111	16	,	,	PUNCT
dti-1330	111	17	although	although	SCONJ
dti-1330	111	18	very	very	ADV
dti-1330	111	19	weak	weak	ADJ
dti-1330	111	20	expressions	expression	NOUN
dti-1330	111	21	of	of	ADP
dti-1330	111	22	5and	5and	NUM
dti-1330	111	23	12	12	NUM
dti-1330	111	24	-	-	PUNCT
dti-1330	111	25	lox	lox	NOUN
dti-1330	111	26	were	be	AUX
dti-1330	111	27	found	find	VERB
dti-1330	111	28	in	in	ADP
dti-1330	111	29	nt	nt	ADP
dti-1330	111	30	tissues	tissue	NOUN
dti-1330	111	31	.	.	PUNCT
dti-1330	112	1	statistical	statistical	ADJ
dti-1330	112	2	analysis	analysis	NOUN
dti-1330	112	3	of	of	ADP
dti-1330	112	4	immunohistochemistry	immunohistochemistry	NOUN
dti-1330	112	5	a	a	PROPN
dti-1330	112	6	)	)	PUNCT
dti-1330	112	7	cox	cox	PROPN
dti-1330	112	8	rcc	rcc	PROPN
dti-1330	112	9	tissue	tissue	NOUN
dti-1330	112	10	sample	sample	NOUN
dti-1330	112	11	we	we	PRON
dti-1330	112	12	classified	classify	VERB
dti-1330	112	13	3	3	NUM
dti-1330	112	14	categories	category	NOUN
dti-1330	112	15	(	(	PUNCT
dti-1330	112	16	epithelium	epithelium	NOUN
dti-1330	112	17	,	,	PUNCT
dti-1330	112	18	blood	blood	NOUN
dti-1330	112	19	vessel	vessel	NOUN
dti-1330	112	20	,	,	PUNCT
dti-1330	112	21	a	a	DET
dti-1330	112	22	small	small	ADJ
dti-1330	112	23	quantity	quantity	NOUN
dti-1330	112	24	of	of	ADP
dti-1330	112	25	stromal	stromal	ADJ
dti-1330	112	26	tissue	tissue	NOUN
dti-1330	112	27	)	)	PUNCT
dti-1330	112	28	in	in	ADP
dti-1330	112	29	142	142	NUM
dti-1330	112	30	matsuyama	matsuyama	NOUN
dti-1330	112	31	and	and	CCONJ
dti-1330	112	32	yoshimura	yoshimura	VERB
dti-1330	112	33	drug	drug	NOUN
dti-1330	112	34	target	target	NOUN
dti-1330	112	35	insights	insight	NOUN
dti-1330	112	36	2008:3	2008:3	NUM
dti-1330	112	37	a	a	DET
dti-1330	112	38	b	b	X
dti-1330	112	39	dc	dc	PROPN
dti-1330	112	40	cce	cce	PROPN
dti-1330	112	41	f	f	PROPN
dti-1330	112	42	g	g	PROPN
dti-1330	112	43	h	h	PROPN
dti-1330	112	44	figure	figure	NOUN
dti-1330	112	45	2	2	NUM
dti-1330	112	46	.	.	NOUN
dti-1330	112	47	5	5	NUM
dti-1330	112	48	-	-	NOUN
dti-1330	112	49	lipoxygenase	lipoxygenase	NOUN
dti-1330	112	50	(	(	PUNCT
dti-1330	112	51	lox	lox	NOUN
dti-1330	112	52	)	)	PUNCT
dti-1330	112	53	immunostaining	immunostaine	VERB
dti-1330	112	54	in	in	ADP
dti-1330	112	55	renal	renal	ADJ
dti-1330	112	56	cell	cell	NOUN
dti-1330	112	57	carcinoma	carcinoma	NOUN
dti-1330	112	58	(	(	PUNCT
dti-1330	112	59	rcc	rcc	PROPN
dti-1330	112	60	)	)	PUNCT
dti-1330	112	61	and	and	CCONJ
dti-1330	112	62	normal	normal	ADJ
dti-1330	112	63	kidney	kidney	NOUN
dti-1330	112	64	(	(	PUNCT
dti-1330	112	65	nk	nk	NOUN
dti-1330	112	66	)	)	PUNCT
dti-1330	112	67	tissues	tissue	NOUN
dti-1330	112	68	.	.	PUNCT
dti-1330	113	1	5	5	NUM
dti-1330	113	2	-	-	PUNCT
dti-1330	113	3	lox	lox	NOUN
dti-1330	113	4	was	be	AUX
dti-1330	113	5	strongly	strongly	ADV
dti-1330	113	6	expressed	express	VERB
dti-1330	113	7	in	in	ADP
dti-1330	113	8	all	all	DET
dti-1330	113	9	slides	slide	NOUN
dti-1330	113	10	from	from	ADP
dti-1330	113	11	cancer	cancer	NOUN
dti-1330	113	12	specimens	specimen	NOUN
dti-1330	113	13	,	,	PUNCT
dti-1330	113	14	clear	clear	ADJ
dti-1330	113	15	cell	cell	NOUN
dti-1330	113	16	rcc	rcc	PROPN
dti-1330	113	17	-g1	-g1	PROPN
dti-1330	113	18	,	,	PUNCT
dti-1330	113	19	-g2	-g2	PROPN
dti-1330	113	20	and	and	CCONJ
dti-1330	113	21	g3	g3	PROPN
dti-1330	113	22	(	(	PUNCT
dti-1330	113	23	a	a	DET
dti-1330	113	24	,	,	PUNCT
dti-1330	113	25	b	b	PROPN
dti-1330	113	26	and	and	CCONJ
dti-1330	113	27	c	c	NOUN
dti-1330	113	28	)	)	PUNCT
dti-1330	113	29	and	and	CCONJ
dti-1330	113	30	other	other	ADJ
dti-1330	113	31	types	type	NOUN
dti-1330	113	32	of	of	ADP
dti-1330	113	33	rcc	rcc	PROPN
dti-1330	113	34	tissues	tissue	NOUN
dti-1330	113	35	(	(	PUNCT
dti-1330	113	36	d	d	X
dti-1330	113	37	:	:	PUNCT
dti-1330	113	38	rcc	rcc	PROPN
dti-1330	113	39	papillary	papillary	PROPN
dti-1330	113	40	cell	cell	NOUN
dti-1330	113	41	type	type	NOUN
dti-1330	113	42	,	,	PUNCT
dti-1330	113	43	e	e	NOUN
dti-1330	113	44	:	:	PUNCT
dti-1330	113	45	rcc	rcc	PROPN
dti-1330	113	46	chromphobe	chromphobe	PROPN
dti-1330	113	47	cell	cell	NOUN
dti-1330	113	48	type	type	NOUN
dti-1330	113	49	,	,	PUNCT
dti-1330	113	50	f	f	PROPN
dti-1330	113	51	:	:	PUNCT
dti-1330	113	52	rcc	rcc	PROPN
dti-1330	113	53	collecting	collect	VERB
dti-1330	113	54	duct	duct	NOUN
dti-1330	113	55	type	type	NOUN
dti-1330	113	56	)	)	PUNCT
dti-1330	113	57	.	.	PUNCT
dti-1330	114	1	in	in	ADP
dti-1330	114	2	nk	nk	PROPN
dti-1330	114	3	tissues	tissue	NOUN
dti-1330	114	4	,	,	PUNCT
dti-1330	114	5	expression	expression	NOUN
dti-1330	114	6	of	of	ADP
dti-1330	114	7	5	5	NUM
dti-1330	114	8	-	-	PUNCT
dti-1330	114	9	lox	lox	NOUN
dti-1330	114	10	was	be	AUX
dti-1330	114	11	observed	observe	VERB
dti-1330	114	12	only	only	ADV
dti-1330	114	13	in	in	ADP
dti-1330	114	14	tubules	tubule	NOUN
dti-1330	114	15	and	and	CCONJ
dti-1330	114	16	was	be	AUX
dti-1330	114	17	not	not	PART
dti-1330	114	18	expressed	express	VERB
dti-1330	114	19	in	in	ADP
dti-1330	114	20	tissues	tissue	NOUN
dti-1330	114	21	from	from	ADP
dti-1330	114	22	nk	nk	PROPN
dti-1330	114	23	in	in	ADP
dti-1330	114	24	epithelial	epithelial	ADJ
dti-1330	114	25	cells	cell	NOUN
dti-1330	114	26	,	,	PUNCT
dti-1330	114	27	blood	blood	NOUN
dti-1330	114	28	vessels	vessel	NOUN
dti-1330	114	29	or	or	CCONJ
dti-1330	114	30	stromal	stromal	ADJ
dti-1330	114	31	tissues	tissue	NOUN
dti-1330	114	32	(	(	PUNCT
dti-1330	114	33	g	g	NOUN
dti-1330	114	34	)	)	PUNCT
dti-1330	114	35	.	.	PUNCT
dti-1330	115	1	immunostaining	immunostaine	VERB
dti-1330	115	2	with	with	ADP
dti-1330	115	3	pbs	pbs	PROPN
dti-1330	115	4	was	be	AUX
dti-1330	115	5	negative	negative	ADJ
dti-1330	115	6	(	(	PUNCT
dti-1330	115	7	h	h	NOUN
dti-1330	115	8	)	)	PUNCT
dti-1330	115	9	.	.	PUNCT
dti-1330	116	1	143	143	NUM
dti-1330	116	2	5	5	NUM
dti-1330	116	3	-	-	NOUN
dti-1330	116	4	lipoxygenase	lipoxygenase	NOUN
dti-1330	116	5	in	in	ADP
dti-1330	116	6	urological	urological	ADJ
dti-1330	116	7	tumor	tumor	NOUN
dti-1330	116	8	drug	drug	NOUN
dti-1330	116	9	target	target	NOUN
dti-1330	116	10	insights	insight	NOUN
dti-1330	116	11	2008:3	2008:3	NUM
dti-1330	116	12	rcc	rcc	PROPN
dti-1330	116	13	tissues	tissue	NOUN
dti-1330	116	14	,	,	PUNCT
dti-1330	116	15	and	and	CCONJ
dti-1330	116	16	examined	examine	VERB
dti-1330	116	17	them	they	PRON
dti-1330	116	18	for	for	ADP
dti-1330	116	19	intensity	intensity	NOUN
dti-1330	116	20	of	of	ADP
dti-1330	116	21	cox-2	cox-2	NOUN
dti-1330	116	22	immunostaining	immunostaining	NOUN
dti-1330	116	23	.	.	PUNCT
dti-1330	117	1	cox-2	cox-2	ADJ
dti-1330	117	2	expression	expression	NOUN
dti-1330	117	3	score	score	NOUN
dti-1330	117	4	was	be	AUX
dti-1330	117	5	signifi	signifi	NOUN
dti-1330	117	6	cantly	cantly	ADV
dti-1330	117	7	more	more	ADV
dti-1330	117	8	extensive	extensive	ADJ
dti-1330	117	9	and	and	CCONJ
dti-1330	117	10	intense	intense	ADJ
dti-1330	117	11	in	in	ADP
dti-1330	117	12	all	all	DET
dti-1330	117	13	categories	category	NOUN
dti-1330	117	14	of	of	ADP
dti-1330	117	15	rcc	rcc	PROPN
dti-1330	117	16	tissues	tissue	NOUN
dti-1330	117	17	than	than	ADP
dti-1330	117	18	nk	nk	PROPN
dti-1330	117	19	tissues	tissue	NOUN
dti-1330	117	20	.	.	PUNCT
dti-1330	118	1	cox-2	cox-2	NOUN
dti-1330	118	2	expression	expression	NOUN
dti-1330	118	3	score	score	NOUN
dti-1330	118	4	was	be	AUX
dti-1330	118	5	higher	high	ADJ
dti-1330	118	6	in	in	ADP
dti-1330	118	7	g1	g1	PROPN
dti-1330	118	8	cancer	cancer	NOUN
dti-1330	118	9	than	than	ADP
dti-1330	118	10	in	in	ADP
dti-1330	118	11	g3	g3	NOUN
dti-1330	118	12	cancer	cancer	NOUN
dti-1330	118	13	.	.	PUNCT
dti-1330	119	1	however	however	ADV
dti-1330	119	2	,	,	PUNCT
dti-1330	119	3	no	no	DET
dti-1330	119	4	difference	difference	NOUN
dti-1330	119	5	was	be	AUX
dti-1330	119	6	seen	see	VERB
dti-1330	119	7	in	in	ADP
dti-1330	119	8	all	all	DET
dti-1330	119	9	categories	category	NOUN
dti-1330	119	10	among	among	ADP
dti-1330	119	11	grades	grade	NOUN
dti-1330	119	12	.	.	PUNCT
dti-1330	120	1	another	another	DET
dti-1330	120	2	comparison	comparison	NOUN
dti-1330	120	3	between	between	ADP
dti-1330	120	4	stages	stage	NOUN
dti-1330	120	5	,	,	PUNCT
dti-1330	120	6	the	the	DET
dti-1330	120	7	expression	expression	NOUN
dti-1330	120	8	score	score	NOUN
dti-1330	120	9	was	be	AUX
dti-1330	120	10	higher	high	ADJ
dti-1330	120	11	in	in	ADP
dti-1330	120	12	early	early	ADJ
dti-1330	120	13	stage	stage	NOUN
dti-1330	120	14	cancer	cancer	NOUN
dti-1330	120	15	pt1	pt1	PROPN
dti-1330	120	16	than	than	ADP
dti-1330	120	17	in	in	ADP
dti-1330	120	18	advanced	advanced	ADJ
dti-1330	120	19	cancer	cancer	NOUN
dti-1330	120	20	(	(	PUNCT
dti-1330	120	21	pt2	pt2	NOUN
dti-1330	120	22	or	or	CCONJ
dti-1330	120	23	above	above	ADV
dti-1330	120	24	)	)	PUNCT
dti-1330	120	25	.	.	PUNCT
dti-1330	121	1	however	however	ADV
dti-1330	121	2	,	,	PUNCT
dti-1330	121	3	this	this	DET
dti-1330	121	4	comparison	comparison	NOUN
dti-1330	121	5	among	among	ADP
dti-1330	121	6	stages	stage	NOUN
dti-1330	121	7	also	also	ADV
dti-1330	121	8	shows	show	VERB
dti-1330	121	9	no	no	DET
dti-1330	121	10	signifi	signifi	NOUN
dti-1330	121	11	ca	can	AUX
dti-1330	121	12	nt	not	PART
dti-1330	121	13	difference	difference	VERB
dti-1330	121	14	among	among	ADP
dti-1330	121	15	the	the	DET
dti-1330	121	16	categories	category	NOUN
dti-1330	121	17	.	.	PUNCT
dti-1330	122	1	bt	bt	NOUN
dti-1330	122	2	tissue	tissue	NOUN
dti-1330	122	3	sample	sample	NOUN
dti-1330	122	4	we	we	PRON
dti-1330	122	5	classified	classify	VERB
dti-1330	122	6	3	3	NUM
dti-1330	122	7	categories	category	NOUN
dti-1330	122	8	(	(	PUNCT
dti-1330	122	9	epithelium	epithelium	NOUN
dti-1330	122	10	,	,	PUNCT
dti-1330	122	11	blood	blood	NOUN
dti-1330	122	12	vessel	vessel	NOUN
dti-1330	122	13	,	,	PUNCT
dti-1330	122	14	stromal	stromal	ADJ
dti-1330	122	15	tissue	tissue	NOUN
dti-1330	122	16	)	)	PUNCT
dti-1330	122	17	in	in	ADP
dti-1330	122	18	bt	bt	NOUN
dti-1330	122	19	tissues	tissue	NOUN
dti-1330	122	20	,	,	PUNCT
dti-1330	122	21	and	and	CCONJ
dti-1330	122	22	examined	examine	VERB
dti-1330	122	23	them	they	PRON
dti-1330	122	24	for	for	ADP
dti-1330	122	25	intensity	intensity	NOUN
dti-1330	122	26	of	of	ADP
dti-1330	122	27	cox-1	cox-1	PUNCT
dti-1330	122	28	and	and	CCONJ
dti-1330	122	29	cox-2	cox-2	ADV
dti-1330	122	30	immunostaining	immunostaining	NOUN
dti-1330	122	31	.	.	PUNCT
dti-1330	123	1	cox-2	cox-2	ADJ
dti-1330	123	2	expression	expression	NOUN
dti-1330	123	3	score	score	NOUN
dti-1330	123	4	was	be	AUX
dti-1330	123	5	signifi	signifi	NOUN
dti-1330	123	6	cantly	cantly	ADV
dti-1330	123	7	more	more	ADV
dti-1330	123	8	extensive	extensive	ADJ
dti-1330	123	9	and	and	CCONJ
dti-1330	123	10	intense	intense	ADJ
dti-1330	123	11	in	in	ADP
dti-1330	123	12	epithelial	epithelial	ADJ
dti-1330	123	13	cells	cell	NOUN
dti-1330	123	14	of	of	ADP
dti-1330	123	15	bt	bt	NOUN
dti-1330	123	16	and	and	CCONJ
dti-1330	123	17	cc	cc	NOUN
dti-1330	123	18	than	than	SCONJ
dti-1330	123	19	in	in	ADP
dti-1330	123	20	epithelial	epithelial	ADJ
dti-1330	123	21	cells	cell	NOUN
dti-1330	123	22	of	of	ADP
dti-1330	123	23	nb	nb	PROPN
dti-1330	123	24	.	.	PROPN
dti-1330	123	25	cox-2	cox-2	ADJ
dti-1330	123	26	expression	expression	NOUN
dti-1330	123	27	score	score	NOUN
dti-1330	123	28	was	be	AUX
dti-1330	123	29	higher	high	ADJ
dti-1330	123	30	in	in	ADP
dti-1330	123	31	g3	g3	PROPN
dti-1330	123	32	cancer	cancer	NOUN
dti-1330	123	33	than	than	ADP
dti-1330	123	34	in	in	ADP
dti-1330	123	35	g1	g1	PROPN
dti-1330	123	36	cancer	cancer	NOUN
dti-1330	123	37	.	.	PUNCT
dti-1330	124	1	moreover	moreover	ADV
dti-1330	124	2	,	,	PUNCT
dti-1330	124	3	the	the	DET
dti-1330	124	4	expression	expression	NOUN
dti-1330	124	5	score	score	NOUN
dti-1330	124	6	was	be	AUX
dti-1330	124	7	higher	high	ADJ
dti-1330	124	8	in	in	ADP
dti-1330	124	9	advanced	advanced	ADJ
dti-1330	124	10	cancer	cancer	NOUN
dti-1330	124	11	(	(	PUNCT
dti-1330	124	12	pt2	pt2	NOUN
dti-1330	124	13	or	or	CCONJ
dti-1330	124	14	above	above	ADV
dti-1330	124	15	)	)	PUNCT
dti-1330	124	16	than	than	ADP
dti-1330	124	17	in	in	ADP
dti-1330	124	18	early	early	ADJ
dti-1330	124	19	stage	stage	NOUN
dti-1330	124	20	cancer	cancer	NOUN
dti-1330	124	21	(	(	PUNCT
dti-1330	124	22	pt1	pt1	NOUN
dti-1330	124	23	or	or	CCONJ
dti-1330	124	24	below	below	ADV
dti-1330	124	25	)	)	PUNCT
dti-1330	124	26	.	.	PUNCT
dti-1330	125	1	on	on	ADP
dti-1330	125	2	the	the	DET
dti-1330	125	3	other	other	ADJ
dti-1330	125	4	hand	hand	NOUN
dti-1330	125	5	,	,	PUNCT
dti-1330	125	6	no	no	DET
dti-1330	125	7	difference	difference	NOUN
dti-1330	125	8	was	be	AUX
dti-1330	125	9	seen	see	VERB
dti-1330	125	10	in	in	ADP
dti-1330	125	11	blood	blood	NOUN
dti-1330	125	12	vessels	vessel	NOUN
dti-1330	125	13	and	and	CCONJ
dti-1330	125	14	stromal	stromal	ADJ
dti-1330	125	15	tissues	tissue	NOUN
dti-1330	125	16	between	between	ADP
dti-1330	125	17	nb	nb	NOUN
dti-1330	125	18	and	and	CCONJ
dti-1330	125	19	bt	bt	NOUN
dti-1330	125	20	tissues	tissue	NOUN
dti-1330	125	21	.	.	PUNCT
dti-1330	126	1	pc	pc	NOUN
dti-1330	126	2	tissue	tissue	NOUN
dti-1330	126	3	sample	sample	NOUN
dti-1330	126	4	we	we	PRON
dti-1330	126	5	classified	classify	VERB
dti-1330	126	6	3	3	NUM
dti-1330	126	7	categories	category	NOUN
dti-1330	126	8	(	(	PUNCT
dti-1330	126	9	epithelium	epithelium	NOUN
dti-1330	126	10	,	,	PUNCT
dti-1330	126	11	blood	blood	NOUN
dti-1330	126	12	vessel	vessel	NOUN
dti-1330	126	13	,	,	PUNCT
dti-1330	126	14	stromal	stromal	ADJ
dti-1330	126	15	tissue	tissue	NOUN
dti-1330	126	16	)	)	PUNCT
dti-1330	126	17	in	in	ADP
dti-1330	126	18	pc	pc	NOUN
dti-1330	126	19	tissues	tissue	NOUN
dti-1330	126	20	,	,	PUNCT
dti-1330	126	21	and	and	CCONJ
dti-1330	126	22	examined	examine	VERB
dti-1330	126	23	them	they	PRON
dti-1330	126	24	for	for	ADP
dti-1330	126	25	intensity	intensity	NOUN
dti-1330	126	26	of	of	ADP
dti-1330	126	27	cox-1	cox-1	PUNCT
dti-1330	126	28	and	and	CCONJ
dti-1330	126	29	cox-2	cox-2	ADV
dti-1330	126	30	immunostaining	immunostaining	NOUN
dti-1330	126	31	.	.	PUNCT
dti-1330	127	1	cox-2	cox-2	ADJ
dti-1330	127	2	expression	expression	NOUN
dti-1330	127	3	score	score	NOUN
dti-1330	127	4	was	be	AUX
dti-1330	127	5	signifi	signifi	NOUN
dti-1330	127	6	cantly	cantly	ADV
dti-1330	127	7	more	more	ADV
dti-1330	127	8	extensive	extensive	ADJ
dti-1330	127	9	and	and	CCONJ
dti-1330	127	10	intense	intense	ADJ
dti-1330	127	11	in	in	ADP
dti-1330	127	12	epithelial	epithelial	ADJ
dti-1330	127	13	cells	cell	NOUN
dti-1330	127	14	of	of	ADP
dti-1330	127	15	all	all	DET
dti-1330	127	16	grades	grade	NOUN
dti-1330	127	17	pc	pc	NOUN
dti-1330	127	18	tissues	tissue	NOUN
dti-1330	127	19	than	than	ADP
dti-1330	127	20	in	in	ADP
dti-1330	127	21	bph	bph	NOUN
dti-1330	127	22	and	and	CCONJ
dti-1330	127	23	pin	pin	NOUN
dti-1330	127	24	tissues	tissue	NOUN
dti-1330	127	25	.	.	PUNCT
dti-1330	128	1	on	on	ADP
dti-1330	128	2	the	the	DET
dti-1330	128	3	other	other	ADJ
dti-1330	128	4	hand	hand	NOUN
dti-1330	128	5	,	,	PUNCT
dti-1330	128	6	cox-2	cox-2	DET
dti-1330	128	7	expression	expression	NOUN
dti-1330	128	8	score	score	NOUN
dti-1330	128	9	was	be	AUX
dti-1330	128	10	high	high	ADJ
dti-1330	128	11	in	in	ADP
dti-1330	128	12	the	the	DET
dti-1330	128	13	blood	blood	NOUN
dti-1330	128	14	vessels	vessel	NOUN
dti-1330	128	15	,	,	PUNCT
dti-1330	128	16	and	and	CCONJ
dti-1330	128	17	the	the	DET
dti-1330	128	18	stromal	stromal	ADJ
dti-1330	128	19	tissues	tissue	NOUN
dti-1330	128	20	of	of	ADP
dti-1330	128	21	pc	pc	NOUN
dti-1330	128	22	in	in	ADP
dti-1330	128	23	the	the	DET
dti-1330	128	24	study	study	NOUN
dti-1330	128	25	groups	group	NOUN
dti-1330	128	26	with	with	ADP
dti-1330	128	27	no	no	DET
dti-1330	128	28	signifi	signifi	NOUN
dti-1330	128	29	ca	can	AUX
dti-1330	128	30	nt	not	PART
dti-1330	128	31	difference	difference	VERB
dti-1330	128	32	between	between	ADP
dti-1330	128	33	grades	grade	NOUN
dti-1330	128	34	.	.	PUNCT
dti-1330	129	1	however	however	ADV
dti-1330	129	2	,	,	PUNCT
dti-1330	129	3	cox-2	cox-2	ADJ
dti-1330	129	4	expression	expression	NOUN
dti-1330	129	5	score	score	NOUN
dti-1330	129	6	in	in	ADP
dti-1330	129	7	the	the	DET
dti-1330	129	8	blood	blood	NOUN
dti-1330	129	9	vessels	vessel	NOUN
dti-1330	129	10	and	and	CCONJ
dti-1330	129	11	stromal	stromal	ADJ
dti-1330	129	12	tissues	tissue	NOUN
dti-1330	129	13	from	from	ADP
dti-1330	129	14	bph	bph	NOUN
dti-1330	129	15	,	,	PUNCT
dti-1330	129	16	pin	pin	NOUN
dti-1330	129	17	and	and	CCONJ
dti-1330	129	18	np	np	INTJ
dti-1330	129	19	were	be	AUX
dti-1330	129	20	at	at	ADP
dti-1330	129	21	basic	basic	ADJ
dti-1330	129	22	level	level	NOUN
dti-1330	129	23	.	.	PUNCT
dti-1330	130	1	tc	tc	NUM
dti-1330	130	2	tissue	tissue	NOUN
dti-1330	130	3	sample	sample	NOUN
dti-1330	130	4	we	we	PRON
dti-1330	130	5	classified	classify	VERB
dti-1330	130	6	2	2	NUM
dti-1330	130	7	categories	category	NOUN
dti-1330	130	8	(	(	PUNCT
dti-1330	130	9	epithelium	epithelium	NOUN
dti-1330	130	10	,	,	PUNCT
dti-1330	130	11	blood	blood	NOUN
dti-1330	130	12	vessel	vessel	NOUN
dti-1330	130	13	)	)	PUNCT
dti-1330	130	14	in	in	ADP
dti-1330	130	15	tc	tc	NUM
dti-1330	130	16	tissues	tissue	NOUN
dti-1330	130	17	,	,	PUNCT
dti-1330	130	18	and	and	CCONJ
dti-1330	130	19	examined	examine	VERB
dti-1330	130	20	them	they	PRON
dti-1330	130	21	for	for	ADP
dti-1330	130	22	intensity	intensity	NOUN
dti-1330	130	23	of	of	ADP
dti-1330	130	24	cox-1	cox-1	PUNCT
dti-1330	130	25	and	and	CCONJ
dti-1330	130	26	cox-2	cox-2	ADV
dti-1330	130	27	immunostaining	immunostaining	NOUN
dti-1330	130	28	.	.	PUNCT
dti-1330	131	1	cox-1	cox-1	PUNCT
dti-1330	131	2	expression	expression	NOUN
dti-1330	131	3	score	score	NOUN
dti-1330	131	4	was	be	AUX
dti-1330	131	5	signifi	signifi	NOUN
dti-1330	131	6	cantly	cantly	ADV
dti-1330	131	7	more	more	ADV
dti-1330	131	8	extensive	extensive	ADJ
dti-1330	131	9	and	and	CCONJ
dti-1330	131	10	intense	intense	ADJ
dti-1330	131	11	in	in	ADP
dti-1330	131	12	all	all	DET
dti-1330	131	13	categories	category	NOUN
dti-1330	131	14	of	of	ADP
dti-1330	131	15	tc	tc	NOUN
dti-1330	131	16	tissues	tissue	NOUN
dti-1330	131	17	than	than	ADP
dti-1330	131	18	in	in	ADP
dti-1330	131	19	nt	nt	DET
dti-1330	131	20	tissues	tissue	NOUN
dti-1330	131	21	.	.	PUNCT
dti-1330	132	1	cox-2	cox-2	NOUN
dti-1330	132	2	expression	expression	NOUN
dti-1330	132	3	score	score	NOUN
dti-1330	132	4	was	be	AUX
dti-1330	132	5	also	also	ADV
dti-1330	132	6	signifi	signifi	VERB
dti-1330	132	7	cantly	cantly	ADV
dti-1330	132	8	more	more	ADV
dti-1330	132	9	extensive	extensive	ADJ
dti-1330	132	10	and	and	CCONJ
dti-1330	132	11	intense	intense	ADJ
dti-1330	132	12	in	in	ADP
dti-1330	132	13	all	all	DET
dti-1330	132	14	categories	category	NOUN
dti-1330	132	15	of	of	ADP
dti-1330	132	16	tc	tc	NUM
dti-1330	132	17	tissues	tissue	NOUN
dti-1330	132	18	in	in	ADP
dti-1330	132	19	the	the	DET
dti-1330	132	20	studied	study	VERB
dti-1330	132	21	groups	group	NOUN
dti-1330	132	22	than	than	ADP
dti-1330	132	23	in	in	ADP
dti-1330	132	24	nt	nt	DET
dti-1330	132	25	tissues	tissue	NOUN
dti-1330	132	26	.	.	PUNCT
dti-1330	133	1	however	however	ADV
dti-1330	133	2	,	,	PUNCT
dti-1330	133	3	there	there	PRON
dti-1330	133	4	were	be	VERB
dti-1330	133	5	no	no	DET
dti-1330	133	6	signifi	signifi	NOUN
dti-1330	133	7	ca	can	AUX
dti-1330	133	8	nt	not	PART
dti-1330	133	9	differences	difference	NOUN
dti-1330	133	10	among	among	ADP
dti-1330	133	11	the	the	DET
dti-1330	133	12	five	five	NUM
dti-1330	133	13	histopathological	histopathological	ADJ
dti-1330	133	14	groups	group	NOUN
dti-1330	133	15	in	in	ADP
dti-1330	133	16	all	all	DET
dti-1330	133	17	categories	category	NOUN
dti-1330	133	18	.	.	PUNCT
dti-1330	134	1	b	b	X
dti-1330	134	2	)	)	PUNCT
dti-1330	134	3	lox	lox	PROPN
dti-1330	134	4	rcc	rcc	PROPN
dti-1330	134	5	tissue	tissue	NOUN
dti-1330	134	6	sample	sample	NOUN
dti-1330	134	7	we	we	PRON
dti-1330	134	8	classifi	classifi	VERB
dti-1330	135	1	ed	ed	NOUN
dti-1330	135	2	3	3	NUM
dti-1330	135	3	categories	category	NOUN
dti-1330	135	4	(	(	PUNCT
dti-1330	135	5	epithelium	epithelium	NOUN
dti-1330	135	6	,	,	PUNCT
dti-1330	135	7	blood	blood	NOUN
dti-1330	135	8	vessel	vessel	NOUN
dti-1330	135	9	,	,	PUNCT
dti-1330	135	10	a	a	DET
dti-1330	135	11	small	small	ADJ
dti-1330	135	12	quantity	quantity	NOUN
dti-1330	135	13	of	of	ADP
dti-1330	135	14	stromal	stromal	ADJ
dti-1330	135	15	tissue	tissue	NOUN
dti-1330	135	16	)	)	PUNCT
dti-1330	135	17	in	in	ADP
dti-1330	135	18	rcc	rcc	PROPN
dti-1330	135	19	tissues	tissue	NOUN
dti-1330	135	20	,	,	PUNCT
dti-1330	135	21	and	and	CCONJ
dti-1330	135	22	examined	examine	VERB
dti-1330	135	23	them	they	PRON
dti-1330	135	24	for	for	ADP
dti-1330	135	25	intensity	intensity	NOUN
dti-1330	135	26	of	of	ADP
dti-1330	135	27	5and	5and	NUM
dti-1330	135	28	12	12	NUM
dti-1330	135	29	-	-	PUNCT
dti-1330	135	30	lox	lox	NOUN
dti-1330	135	31	immunostaining	immunostaining	NOUN
dti-1330	135	32	.	.	PUNCT
dti-1330	136	1	5and	5and	NUM
dti-1330	136	2	12	12	NUM
dti-1330	136	3	-	-	PUNCT
dti-1330	136	4	lox	lox	NOUN
dti-1330	136	5	expression	expression	NOUN
dti-1330	136	6	scores	score	NOUN
dti-1330	136	7	were	be	AUX
dti-1330	136	8	signifi	signifi	NOUN
dti-1330	136	9	cantly	cantly	ADV
dti-1330	136	10	more	more	ADV
dti-1330	136	11	extensive	extensive	ADJ
dti-1330	136	12	and	and	CCONJ
dti-1330	136	13	intense	intense	ADJ
dti-1330	136	14	in	in	ADP
dti-1330	136	15	all	all	DET
dti-1330	136	16	categories	category	NOUN
dti-1330	136	17	of	of	ADP
dti-1330	136	18	rcc	rcc	PROPN
dti-1330	136	19	tissues	tissue	NOUN
dti-1330	136	20	than	than	ADP
dti-1330	136	21	nk	nk	PROPN
dti-1330	136	22	tissues	tissue	NOUN
dti-1330	136	23	.	.	PUNCT
dti-1330	137	1	only	only	ADV
dti-1330	137	2	in	in	ADP
dti-1330	137	3	epithelium	epithelium	NOUN
dti-1330	137	4	,	,	PUNCT
dti-1330	137	5	5and	5and	NUM
dti-1330	137	6	12	12	NUM
dti-1330	137	7	-	-	PUNCT
dti-1330	137	8	lox	lox	NOUN
dti-1330	137	9	expression	expression	NOUN
dti-1330	137	10	scores	score	NOUN
dti-1330	137	11	were	be	AUX
dti-1330	137	12	higher	high	ADJ
dti-1330	137	13	in	in	ADP
dti-1330	137	14	g1	g1	PROPN
dti-1330	137	15	cancer	cancer	NOUN
dti-1330	137	16	than	than	ADP
dti-1330	137	17	in	in	ADP
dti-1330	137	18	g3	g3	NOUN
dti-1330	137	19	cancer	cancer	NOUN
dti-1330	137	20	.	.	PUNCT
dti-1330	138	1	however	however	ADV
dti-1330	138	2	,	,	PUNCT
dti-1330	138	3	no	no	DET
dti-1330	138	4	differences	difference	NOUN
dti-1330	138	5	were	be	AUX
dti-1330	138	6	seen	see	VERB
dti-1330	138	7	in	in	ADP
dti-1330	138	8	blood	blood	NOUN
dti-1330	138	9	vessels	vessel	NOUN
dti-1330	138	10	and	and	CCONJ
dti-1330	138	11	stromal	stromal	ADJ
dti-1330	138	12	tissues	tissue	NOUN
dti-1330	138	13	among	among	ADP
dti-1330	138	14	the	the	DET
dti-1330	138	15	three	three	NUM
dti-1330	138	16	grades	grade	NOUN
dti-1330	138	17	.	.	PUNCT
dti-1330	139	1	bt	bt	NOUN
dti-1330	139	2	tissue	tissue	NOUN
dti-1330	139	3	sample	sample	NOUN
dti-1330	139	4	we	we	PRON
dti-1330	139	5	classifi	classifi	VERB
dti-1330	140	1	ed	ed	NOUN
dti-1330	140	2	3	3	NUM
dti-1330	140	3	categories	category	NOUN
dti-1330	140	4	(	(	PUNCT
dti-1330	140	5	epithelium	epithelium	NOUN
dti-1330	140	6	,	,	PUNCT
dti-1330	140	7	blood	blood	NOUN
dti-1330	140	8	vessel	vessel	NOUN
dti-1330	140	9	,	,	PUNCT
dti-1330	140	10	stromal	stromal	ADJ
dti-1330	140	11	tissue	tissue	NOUN
dti-1330	140	12	)	)	PUNCT
dti-1330	140	13	in	in	ADP
dti-1330	140	14	bt	bt	NOUN
dti-1330	140	15	tissues	tissue	NOUN
dti-1330	140	16	,	,	PUNCT
dti-1330	140	17	and	and	CCONJ
dti-1330	140	18	examined	examine	VERB
dti-1330	140	19	them	they	PRON
dti-1330	140	20	for	for	ADP
dti-1330	140	21	intensity	intensity	NOUN
dti-1330	140	22	of	of	ADP
dti-1330	140	23	5and	5and	NUM
dti-1330	140	24	12	12	NUM
dti-1330	140	25	-	-	PUNCT
dti-1330	140	26	lox	lox	NOUN
dti-1330	140	27	immunostaining	immunostaining	NOUN
dti-1330	140	28	.	.	PUNCT
dti-1330	141	1	5and	5and	NUM
dti-1330	141	2	12	12	NUM
dti-1330	141	3	-	-	PUNCT
dti-1330	141	4	lox	lox	NOUN
dti-1330	141	5	expression	expression	NOUN
dti-1330	141	6	scores	score	NOUN
dti-1330	141	7	were	be	AUX
dti-1330	141	8	signifi	signifi	NOUN
dti-1330	141	9	cantly	cantly	ADV
dti-1330	141	10	more	more	ADV
dti-1330	141	11	extensive	extensive	ADJ
dti-1330	141	12	and	and	CCONJ
dti-1330	141	13	intense	intense	ADJ
dti-1330	141	14	in	in	ADP
dti-1330	141	15	bt	bt	NOUN
dti-1330	141	16	tissues	tissue	NOUN
dti-1330	141	17	than	than	ADP
dti-1330	141	18	in	in	ADP
dti-1330	141	19	cc	cc	PROPN
dti-1330	141	20	and	and	CCONJ
dti-1330	141	21	nb	nb	INTJ
dti-1330	141	22	.	.	PUNCT
dti-1330	142	1	a	a	DET
dti-1330	142	2	signifi	signifi	NOUN
dti-1330	142	3	ca	can	AUX
dti-1330	142	4	nt	not	PART
dti-1330	142	5	difference	difference	NOUN
dti-1330	142	6	was	be	AUX
dti-1330	142	7	seen	see	VERB
dti-1330	142	8	only	only	ADV
dti-1330	142	9	in	in	ADP
dti-1330	142	10	epithelium	epithelium	NOUN
dti-1330	142	11	,	,	PUNCT
dti-1330	142	12	showing	show	VERB
dti-1330	142	13	that	that	SCONJ
dti-1330	142	14	staining	stain	VERB
dti-1330	142	15	was	be	AUX
dti-1330	142	16	intensifi	intensifi	NOUN
dti-1330	142	17	ed	ed	NOUN
dti-1330	142	18	as	as	SCONJ
dti-1330	142	19	the	the	DET
dti-1330	142	20	grade	grade	NOUN
dti-1330	142	21	increased	increase	VERB
dti-1330	142	22	.	.	PUNCT
dti-1330	143	1	no	no	DET
dti-1330	143	2	difference	difference	NOUN
dti-1330	143	3	was	be	AUX
dti-1330	143	4	seen	see	VERB
dti-1330	143	5	in	in	ADP
dti-1330	143	6	blood	blood	NOUN
dti-1330	143	7	vessels	vessel	NOUN
dti-1330	143	8	and	and	CCONJ
dti-1330	143	9	stromal	stromal	ADJ
dti-1330	143	10	tissues	tissue	NOUN
dti-1330	143	11	between	between	ADP
dti-1330	143	12	grades	grade	NOUN
dti-1330	143	13	.	.	PUNCT
dti-1330	144	1	comparison	comparison	NOUN
dti-1330	144	2	of	of	ADP
dti-1330	144	3	early	early	ADJ
dti-1330	144	4	and	and	CCONJ
dti-1330	144	5	advanced	advanced	ADJ
dti-1330	144	6	stages	stage	NOUN
dti-1330	144	7	shows	show	VERB
dti-1330	144	8	a	a	DET
dti-1330	144	9	signifi	signifi	NOUN
dti-1330	144	10	ca	can	AUX
dti-1330	144	11	nt	not	PART
dti-1330	144	12	difference	difference	VERB
dti-1330	144	13	only	only	ADV
dti-1330	144	14	in	in	ADP
dti-1330	144	15	epithelium	epithelium	NOUN
dti-1330	144	16	.	.	PUNCT
dti-1330	145	1	no	no	DET
dti-1330	145	2	difference	difference	NOUN
dti-1330	145	3	was	be	AUX
dti-1330	145	4	seen	see	VERB
dti-1330	145	5	in	in	ADP
dti-1330	145	6	blood	blood	NOUN
dti-1330	145	7	vessels	vessel	NOUN
dti-1330	145	8	and	and	CCONJ
dti-1330	145	9	stromal	stromal	ADJ
dti-1330	145	10	tissues	tissue	NOUN
dti-1330	145	11	between	between	ADP
dti-1330	145	12	early	early	ADJ
dti-1330	145	13	stage	stage	NOUN
dti-1330	145	14	(	(	PUNCT
dti-1330	145	15	pt1	pt1	NOUN
dti-1330	145	16	or	or	CCONJ
dti-1330	145	17	below	below	ADV
dti-1330	145	18	)	)	PUNCT
dti-1330	145	19	and	and	CCONJ
dti-1330	145	20	advanced	advanced	ADJ
dti-1330	145	21	cancer	cancer	NOUN
dti-1330	145	22	(	(	PUNCT
dti-1330	145	23	pt2	pt2	NOUN
dti-1330	145	24	or	or	CCONJ
dti-1330	145	25	above	above	ADV
dti-1330	145	26	)	)	PUNCT
dti-1330	145	27	.	.	PUNCT
dti-1330	146	1	pc	pc	NOUN
dti-1330	146	2	tissue	tissue	NOUN
dti-1330	146	3	sample	sample	NOUN
dti-1330	146	4	we	we	PRON
dti-1330	146	5	classifi	classifi	VERB
dti-1330	147	1	ed	ed	NOUN
dti-1330	147	2	3	3	NUM
dti-1330	147	3	categories	category	NOUN
dti-1330	147	4	(	(	PUNCT
dti-1330	147	5	epithelium	epithelium	NOUN
dti-1330	147	6	,	,	PUNCT
dti-1330	147	7	blood	blood	NOUN
dti-1330	147	8	vessel	vessel	NOUN
dti-1330	147	9	,	,	PUNCT
dti-1330	147	10	stromal	stromal	ADJ
dti-1330	147	11	tissue	tissue	NOUN
dti-1330	147	12	)	)	PUNCT
dti-1330	147	13	in	in	ADP
dti-1330	147	14	pc	pc	NOUN
dti-1330	147	15	tissues	tissue	NOUN
dti-1330	147	16	,	,	PUNCT
dti-1330	147	17	and	and	CCONJ
dti-1330	147	18	examined	examine	VERB
dti-1330	147	19	them	they	PRON
dti-1330	147	20	for	for	ADP
dti-1330	147	21	intensity	intensity	NOUN
dti-1330	147	22	of	of	ADP
dti-1330	147	23	5and	5and	NUM
dti-1330	147	24	12	12	NUM
dti-1330	147	25	-	-	PUNCT
dti-1330	147	26	lox	lox	NOUN
dti-1330	147	27	immunostaining	immunostaining	NOUN
dti-1330	147	28	.	.	PUNCT
dti-1330	148	1	5and	5and	NUM
dti-1330	148	2	12	12	NUM
dti-1330	148	3	-	-	PUNCT
dti-1330	148	4	lox	lox	NOUN
dti-1330	148	5	expression	expression	NOUN
dti-1330	148	6	scores	score	NOUN
dti-1330	148	7	were	be	AUX
dti-1330	148	8	signifi	signifi	NOUN
dti-1330	148	9	cantly	cantly	ADV
dti-1330	148	10	more	more	ADV
dti-1330	148	11	extensive	extensive	ADJ
dti-1330	148	12	and	and	CCONJ
dti-1330	148	13	intense	intense	ADJ
dti-1330	148	14	in	in	ADP
dti-1330	148	15	pc	pc	NOUN
dti-1330	148	16	and	and	CCONJ
dti-1330	148	17	pin	pin	NOUN
dti-1330	148	18	tissues	tissue	NOUN
dti-1330	148	19	than	than	ADP
dti-1330	148	20	bph	bph	NOUN
dti-1330	148	21	and	and	CCONJ
dti-1330	148	22	np	np	ADJ
dti-1330	148	23	tissues	tissue	NOUN
dti-1330	148	24	in	in	ADP
dti-1330	148	25	all	all	DET
dti-1330	148	26	categories	category	NOUN
dti-1330	148	27	.	.	PUNCT
dti-1330	149	1	there	there	PRON
dti-1330	149	2	was	be	VERB
dti-1330	149	3	no	no	DET
dti-1330	149	4	significant	significant	ADJ
dti-1330	149	5	difference	difference	NOUN
dti-1330	149	6	between	between	ADP
dti-1330	149	7	grades	grade	NOUN
dti-1330	149	8	.	.	PUNCT
dti-1330	150	1	144	144	NUM
dti-1330	150	2	matsuyama	matsuyama	PROPN
dti-1330	150	3	and	and	CCONJ
dti-1330	150	4	yoshimura	yoshimura	PROPN
dti-1330	150	5	drug	drug	NOUN
dti-1330	150	6	target	target	NOUN
dti-1330	150	7	insights	insight	VERB
dti-1330	150	8	2008:3	2008:3	NUM
dti-1330	150	9	tc	tc	NUM
dti-1330	150	10	tissue	tissue	NOUN
dti-1330	150	11	sample	sample	NOUN
dti-1330	150	12	we	we	PRON
dti-1330	150	13	classified	classify	VERB
dti-1330	150	14	2	2	NUM
dti-1330	150	15	categories	category	NOUN
dti-1330	150	16	(	(	PUNCT
dti-1330	150	17	epithelium	epithelium	NOUN
dti-1330	150	18	,	,	PUNCT
dti-1330	150	19	blood	blood	NOUN
dti-1330	150	20	vessel	vessel	NOUN
dti-1330	150	21	)	)	PUNCT
dti-1330	150	22	in	in	ADP
dti-1330	150	23	tc	tc	NUM
dti-1330	150	24	tissues	tissue	NOUN
dti-1330	150	25	,	,	PUNCT
dti-1330	150	26	and	and	CCONJ
dti-1330	150	27	examined	examine	VERB
dti-1330	150	28	them	they	PRON
dti-1330	150	29	for	for	ADP
dti-1330	150	30	intensity	intensity	NOUN
dti-1330	150	31	of	of	ADP
dti-1330	150	32	5and	5and	NUM
dti-1330	150	33	12	12	NUM
dti-1330	150	34	-	-	PUNCT
dti-1330	150	35	lox	lox	NOUN
dti-1330	150	36	immunostaining	immunostaining	NOUN
dti-1330	150	37	.	.	PUNCT
dti-1330	151	1	5and	5and	NUM
dti-1330	151	2	12	12	NUM
dti-1330	151	3	-	-	PUNCT
dti-1330	151	4	lox	lox	NOUN
dti-1330	151	5	expression	expression	NOUN
dti-1330	151	6	scores	score	NOUN
dti-1330	151	7	were	be	AUX
dti-1330	151	8	signifi	signifi	NOUN
dti-1330	151	9	cantly	cantly	ADV
dti-1330	151	10	more	more	ADV
dti-1330	151	11	extensive	extensive	ADJ
dti-1330	151	12	and	and	CCONJ
dti-1330	151	13	intense	intense	ADJ
dti-1330	151	14	in	in	ADP
dti-1330	151	15	all	all	DET
dti-1330	151	16	tc	tc	NOUN
dti-1330	151	17	groups	group	NOUN
dti-1330	151	18	than	than	ADP
dti-1330	151	19	nt	not	PART
dti-1330	151	20	tissues	tissue	NOUN
dti-1330	151	21	in	in	ADP
dti-1330	151	22	all	all	DET
dti-1330	151	23	categories	category	NOUN
dti-1330	151	24	.	.	PUNCT
dti-1330	152	1	however	however	ADV
dti-1330	152	2	,	,	PUNCT
dti-1330	152	3	there	there	PRON
dti-1330	152	4	were	be	VERB
dti-1330	152	5	no	no	DET
dti-1330	152	6	signifi	signifi	NOUN
dti-1330	152	7	ca	can	AUX
dti-1330	152	8	nt	not	PART
dti-1330	152	9	differences	difference	NOUN
dti-1330	152	10	among	among	ADP
dti-1330	152	11	the	the	DET
dti-1330	152	12	fi	fi	NOUN
dti-1330	152	13	ve	ve	ADP
dti-1330	152	14	histopathological	histopathological	ADJ
dti-1330	152	15	groups	group	NOUN
dti-1330	152	16	in	in	ADP
dti-1330	152	17	all	all	DET
dti-1330	152	18	categories	category	NOUN
dti-1330	152	19	(	(	PUNCT
dti-1330	152	20	table	table	NOUN
dti-1330	152	21	1	1	NUM
dti-1330	152	22	)	)	PUNCT
dti-1330	152	23	.	.	PUNCT
dti-1330	153	1	rt	rt	NOUN
dti-1330	153	2	-	-	PUNCT
dti-1330	153	3	pcr	pcr	PROPN
dti-1330	153	4	a	a	NOUN
dti-1330	153	5	)	)	PUNCT
dti-1330	153	6	cox	cox	PROPN
dti-1330	153	7	rcc	rcc	PROPN
dti-1330	153	8	tissue	tissue	NOUN
dti-1330	153	9	we	we	PRON
dti-1330	153	10	detected	detect	VERB
dti-1330	153	11	a	a	DET
dti-1330	153	12	specifi	specifi	PROPN
dti-1330	153	13	c	c	PROPN
dti-1330	153	14	band	band	NOUN
dti-1330	153	15	of	of	ADP
dti-1330	153	16	cox-2	cox-2	VERB
dti-1330	153	17	mrna	mrna	PROPN
dti-1330	153	18	band	band	NOUN
dti-1330	153	19	in	in	ADP
dti-1330	153	20	rcc	rcc	PROPN
dti-1330	153	21	,	,	PUNCT
dti-1330	153	22	whereas	whereas	SCONJ
dti-1330	153	23	sample	sample	NOUN
dti-1330	153	24	of	of	ADP
dti-1330	153	25	from	from	ADP
dti-1330	153	26	nk	nk	PROPN
dti-1330	153	27	displayed	display	VERB
dti-1330	153	28	no	no	DET
dti-1330	153	29	band	band	NOUN
dti-1330	153	30	of	of	ADP
dti-1330	153	31	cox-2	cox-2	NOUN
dti-1330	153	32	mrna	mrna	PROPN
dti-1330	153	33	.	.	PUNCT
dti-1330	154	1	bt	bt	PROPN
dti-1330	154	2	tissue	tissue	NOUN
dti-1330	154	3	we	we	PRON
dti-1330	154	4	detected	detect	VERB
dti-1330	154	5	specifi	specifi	PROPN
dti-1330	154	6	c	c	PROPN
dti-1330	154	7	band	band	NOUN
dti-1330	154	8	of	of	ADP
dti-1330	154	9	cox-1	cox-1	PUNCT
dti-1330	154	10	mrna	mrna	PROPN
dti-1330	154	11	in	in	ADP
dti-1330	154	12	all	all	DET
dti-1330	154	13	samples	sample	NOUN
dti-1330	154	14	(	(	PUNCT
dti-1330	154	15	bt	bt	NOUN
dti-1330	154	16	,	,	PUNCT
dti-1330	154	17	cc	cc	NOUN
dti-1330	154	18	and	and	CCONJ
dti-1330	154	19	nb	nb	PROPN
dti-1330	154	20	)	)	PUNCT
dti-1330	154	21	.	.	PUNCT
dti-1330	155	1	however	however	ADV
dti-1330	155	2	,	,	PUNCT
dti-1330	155	3	we	we	PRON
dti-1330	155	4	detected	detect	VERB
dti-1330	155	5	specifi	specifi	PROPN
dti-1330	155	6	c	c	PROPN
dti-1330	155	7	band	band	NOUN
dti-1330	155	8	of	of	ADP
dti-1330	155	9	cox-2	cox-2	NOUN
dti-1330	155	10	in	in	ADP
dti-1330	155	11	bt	bt	NOUN
dti-1330	155	12	,	,	PUNCT
dti-1330	155	13	while	while	SCONJ
dti-1330	155	14	a	a	DET
dti-1330	155	15	weak	weak	ADJ
dti-1330	155	16	band	band	NOUN
dti-1330	155	17	was	be	AUX
dti-1330	155	18	displayed	display	VERB
dti-1330	155	19	in	in	ADP
dti-1330	155	20	cc	cc	PROPN
dti-1330	155	21	and	and	CCONJ
dti-1330	155	22	no	no	DET
dti-1330	155	23	clear	clear	ADJ
dti-1330	155	24	band	band	NOUN
dti-1330	155	25	was	be	AUX
dti-1330	155	26	displayed	display	VERB
dti-1330	155	27	in	in	ADP
dti-1330	155	28	nb	nb	PROPN
dti-1330	155	29	.	.	PUNCT
dti-1330	155	30	pc	pc	NOUN
dti-1330	155	31	tissue	tissue	NOUN
dti-1330	155	32	we	we	PRON
dti-1330	155	33	detected	detect	VERB
dti-1330	155	34	a	a	DET
dti-1330	155	35	specifi	specifi	PROPN
dti-1330	155	36	c	c	PROPN
dti-1330	155	37	band	band	NOUN
dti-1330	155	38	of	of	ADP
dti-1330	155	39	cox-1	cox-1	PUNCT
dti-1330	155	40	mrna	mrna	PROPN
dti-1330	155	41	in	in	ADP
dti-1330	155	42	all	all	DET
dti-1330	155	43	samples	sample	NOUN
dti-1330	155	44	(	(	PUNCT
dti-1330	155	45	pc	pc	NOUN
dti-1330	155	46	,	,	PUNCT
dti-1330	155	47	bph	bph	NOUN
dti-1330	155	48	and	and	CCONJ
dti-1330	155	49	np	np	NOUN
dti-1330	155	50	)	)	PUNCT
dti-1330	155	51	.	.	PUNCT
dti-1330	156	1	however	however	ADV
dti-1330	156	2	,	,	PUNCT
dti-1330	156	3	we	we	PRON
dti-1330	156	4	detected	detect	VERB
dti-1330	156	5	a	a	DET
dti-1330	156	6	specifi	specifi	PROPN
dti-1330	156	7	c	c	PROPN
dti-1330	156	8	band	band	NOUN
dti-1330	156	9	of	of	ADP
dti-1330	156	10	cox-2	cox-2	NUM
dti-1330	156	11	was	be	AUX
dti-1330	156	12	detected	detect	VERB
dti-1330	156	13	in	in	ADP
dti-1330	156	14	pc	pc	NOUN
dti-1330	156	15	,	,	PUNCT
dti-1330	156	16	while	while	SCONJ
dti-1330	156	17	a	a	DET
dti-1330	156	18	weak	weak	ADJ
dti-1330	156	19	band	band	NOUN
dti-1330	156	20	was	be	AUX
dti-1330	156	21	displayed	display	VERB
dti-1330	156	22	in	in	ADP
dti-1330	156	23	bph	bph	NOUN
dti-1330	156	24	and	and	CCONJ
dti-1330	156	25	no	no	DET
dti-1330	156	26	clear	clear	ADJ
dti-1330	156	27	band	band	NOUN
dti-1330	156	28	was	be	AUX
dti-1330	156	29	displayed	display	VERB
dti-1330	156	30	in	in	ADP
dti-1330	156	31	np	np	PROPN
dti-1330	156	32	.	.	PROPN
dti-1330	156	33	tc	tc	NOUN
dti-1330	156	34	tissue	tissue	NOUN
dti-1330	156	35	we	we	PRON
dti-1330	156	36	detected	detect	VERB
dti-1330	156	37	a	a	DET
dti-1330	156	38	specifi	specifi	PROPN
dti-1330	156	39	c	c	PROPN
dti-1330	156	40	band	band	NOUN
dti-1330	156	41	of	of	ADP
dti-1330	156	42	cox-1	cox-1	PUNCT
dti-1330	156	43	and	and	CCONJ
dti-1330	156	44	cox2	cox2	PROPN
dti-1330	156	45	mrna	mrna	PROPN
dti-1330	156	46	all	all	DET
dti-1330	156	47	tc	tc	NUM
dti-1330	156	48	groups	group	NOUN
dti-1330	156	49	.	.	PUNCT
dti-1330	157	1	b	b	X
dti-1330	157	2	)	)	PUNCT
dti-1330	157	3	lox	lox	PROPN
dti-1330	157	4	rcc	rcc	PROPN
dti-1330	157	5	tissue	tissue	NOUN
dti-1330	157	6	we	we	PRON
dti-1330	157	7	detected	detect	VERB
dti-1330	157	8	a	a	DET
dti-1330	157	9	specifi	specifi	PROPN
dti-1330	157	10	c	c	PROPN
dti-1330	157	11	band	band	NOUN
dti-1330	157	12	of	of	ADP
dti-1330	157	13	5and	5and	NUM
dti-1330	157	14	12	12	NUM
dti-1330	157	15	-	-	PUNCT
dti-1330	157	16	lox	lox	NOUN
dti-1330	157	17	mrna	mrna	PROPN
dti-1330	157	18	in	in	ADP
dti-1330	157	19	rcc	rcc	PROPN
dti-1330	157	20	,	,	PUNCT
dti-1330	157	21	whereas	whereas	SCONJ
dti-1330	157	22	the	the	DET
dti-1330	157	23	sample	sample	NOUN
dti-1330	157	24	of	of	ADP
dti-1330	157	25	from	from	ADP
dti-1330	157	26	nk	nk	PROPN
dti-1330	157	27	displayed	display	VERB
dti-1330	157	28	no	no	DET
dti-1330	157	29	band	band	NOUN
dti-1330	157	30	of	of	ADP
dti-1330	157	31	—	—	PUNCT
dti-1330	157	32	and	and	CCONJ
dti-1330	157	33	12	12	NUM
dti-1330	157	34	-	-	PUNCT
dti-1330	157	35	lox	lox	NOUN
dti-1330	157	36	mrna	mrna	PROPN
dti-1330	157	37	.	.	PUNCT
dti-1330	158	1	bt	bt	PROPN
dti-1330	158	2	cell	cell	NOUN
dti-1330	158	3	line	line	NOUN
dti-1330	158	4	we	we	PRON
dti-1330	158	5	detected	detect	VERB
dti-1330	158	6	a	a	DET
dti-1330	158	7	specifi	specifi	PROPN
dti-1330	158	8	c	c	PROPN
dti-1330	158	9	band	band	NOUN
dti-1330	158	10	of	of	ADP
dti-1330	158	11	5and	5and	NUM
dti-1330	158	12	12	12	NUM
dti-1330	158	13	-	-	PUNCT
dti-1330	158	14	lox	lox	NOUN
dti-1330	158	15	mrna	mrna	PROPN
dti-1330	158	16	(	(	PUNCT
dti-1330	158	17	a	a	DET
dti-1330	158	18	:	:	PUNCT
dti-1330	158	19	5	5	NUM
dti-1330	158	20	-	-	PUNCT
dti-1330	158	21	lox	lox	NOUN
dti-1330	158	22	,	,	PUNCT
dti-1330	158	23	b	b	NOUN
dti-1330	158	24	:	:	PUNCT
dti-1330	158	25	12	12	NUM
dti-1330	158	26	-	-	PUNCT
dti-1330	158	27	lox	lox	NOUN
dti-1330	158	28	,	,	PUNCT
dti-1330	158	29	lane	lane	NOUN
dti-1330	158	30	2	2	NUM
dti-1330	158	31	)	)	PUNCT
dti-1330	158	32	in	in	ADP
dti-1330	158	33	bt	bt	PROPN
dti-1330	158	34	cell	cell	NOUN
dti-1330	158	35	line	line	NOUN
dti-1330	158	36	,	,	PUNCT
dti-1330	158	37	whereas	whereas	SCONJ
dti-1330	158	38	the	the	DET
dti-1330	158	39	sample	sample	NOUN
dti-1330	158	40	of	of	ADP
dti-1330	158	41	from	from	ADP
dti-1330	158	42	nb	nb	PROPN
dti-1330	158	43	cells	cell	NOUN
dti-1330	158	44	displayed	display	VERB
dti-1330	158	45	no	no	DET
dti-1330	158	46	band	band	NOUN
dti-1330	158	47	of	of	ADP
dti-1330	158	48	—	—	PUNCT
dti-1330	158	49	and	and	CCONJ
dti-1330	158	50	12	12	NUM
dti-1330	158	51	-	-	PUNCT
dti-1330	158	52	lox	lox	NOUN
dti-1330	158	53	mrna	mrna	PROPN
dti-1330	158	54	(	(	PUNCT
dti-1330	158	55	a	a	DET
dti-1330	158	56	:	:	PUNCT
dti-1330	158	57	5	5	NUM
dti-1330	158	58	-	-	PUNCT
dti-1330	158	59	lox	lox	NOUN
dti-1330	158	60	,	,	PUNCT
dti-1330	158	61	b	b	NOUN
dti-1330	158	62	:	:	PUNCT
dti-1330	158	63	12	12	NUM
dti-1330	158	64	-	-	PUNCT
dti-1330	158	65	lox	lox	NOUN
dti-1330	158	66	,	,	PUNCT
dti-1330	158	67	lane	lane	NOUN
dti-1330	158	68	1	1	NUM
dti-1330	158	69	)	)	PUNCT
dti-1330	158	70	(	(	PUNCT
dti-1330	158	71	fig	fig	NOUN
dti-1330	158	72	.	.	PUNCT
dti-1330	159	1	3	3	NUM
dti-1330	159	2	)	)	PUNCT
dti-1330	159	3	.	.	PUNCT
dti-1330	160	1	pc	pc	NOUN
dti-1330	160	2	cell	cell	NOUN
dti-1330	160	3	line	line	NOUN
dti-1330	160	4	we	we	PRON
dti-1330	160	5	detected	detect	VERB
dti-1330	160	6	a	a	DET
dti-1330	160	7	specifi	specifi	PROPN
dti-1330	160	8	c	c	PROPN
dti-1330	160	9	band	band	NOUN
dti-1330	160	10	of	of	ADP
dti-1330	160	11	5and	5and	NUM
dti-1330	160	12	12	12	NUM
dti-1330	160	13	-	-	PUNCT
dti-1330	160	14	lox	lox	NOUN
dti-1330	160	15	mrna	mrna	NOUN
dti-1330	160	16	in	in	ADP
dti-1330	160	17	pc	pc	NOUN
dti-1330	160	18	cell	cell	NOUN
dti-1330	160	19	line	line	NOUN
dti-1330	160	20	,	,	PUNCT
dti-1330	160	21	whereas	whereas	SCONJ
dti-1330	160	22	a	a	DET
dti-1330	160	23	sample	sample	NOUN
dti-1330	160	24	of	of	ADP
dti-1330	160	25	from	from	ADP
dti-1330	160	26	np	np	NOUN
dti-1330	160	27	cells	cell	NOUN
dti-1330	160	28	displayed	display	VERB
dti-1330	160	29	no	no	DET
dti-1330	160	30	band	band	NOUN
dti-1330	160	31	of	of	ADP
dti-1330	160	32	—	—	PUNCT
dti-1330	160	33	and	and	CCONJ
dti-1330	160	34	12	12	NUM
dti-1330	160	35	-	-	PUNCT
dti-1330	160	36	lox	lox	NOUN
dti-1330	160	37	mrna	mrna	PROPN
dti-1330	160	38	.	.	PROPN
dti-1330	161	1	2	2	NUM
dti-1330	161	2	)	)	PUNCT
dti-1330	161	3	effect	effect	NOUN
dti-1330	161	4	of	of	ADP
dti-1330	161	5	cox	cox	PROPN
dti-1330	161	6	and	and	CCONJ
dti-1330	161	7	lox	lox	NOUN
dti-1330	161	8	inhibitors	inhibitor	NOUN
dti-1330	161	9	mtt	mtt	X
dti-1330	161	10	assay	assay	VERB
dti-1330	161	11	a	a	DET
dti-1330	161	12	)	)	PUNCT
dti-1330	161	13	cox	cox	PROPN
dti-1330	161	14	rcc	rcc	PROPN
dti-1330	161	15	cell	cell	NOUN
dti-1330	161	16	line	line	NOUN
dti-1330	161	17	all	all	DET
dti-1330	161	18	cox	cox	PROPN
dti-1330	161	19	inhibitors	inhibitor	NOUN
dti-1330	161	20	were	be	AUX
dti-1330	161	21	unable	unable	ADJ
dti-1330	161	22	to	to	PART
dti-1330	161	23	induce	induce	VERB
dti-1330	161	24	a	a	DET
dti-1330	161	25	reduction	reduction	NOUN
dti-1330	161	26	of	of	ADP
dti-1330	161	27	cell	cell	NOUN
dti-1330	161	28	viability	viability	NOUN
dti-1330	161	29	with	with	ADP
dti-1330	161	30	the	the	DET
dti-1330	161	31	half	half	ADJ
dti-1330	161	32	-	-	PUNCT
dti-1330	161	33	maximal	maximal	ADJ
dti-1330	161	34	concentration	concentration	NOUN
dti-1330	161	35	of	of	ADP
dti-1330	161	36	growth	growth	NOUN
dti-1330	161	37	inhibition	inhibition	NOUN
dti-1330	161	38	of	of	ADP
dti-1330	161	39	rcc	rcc	PROPN
dti-1330	161	40	cells	cell	NOUN
dti-1330	161	41	in	in	ADP
dti-1330	161	42	the	the	DET
dti-1330	161	43	range	range	NOUN
dti-1330	161	44	of	of	ADP
dti-1330	161	45	10–80	10–80	NUM
dti-1330	161	46	μm	μm	NUM
dti-1330	161	47	and	and	CCONJ
dti-1330	161	48	were	be	AUX
dti-1330	161	49	unable	unable	ADJ
dti-1330	161	50	to	to	PART
dti-1330	161	51	stop	stop	VERB
dti-1330	161	52	the	the	DET
dti-1330	161	53	growth	growth	NOUN
dti-1330	161	54	of	of	ADP
dti-1330	161	55	rcc	rcc	PROPN
dti-1330	161	56	cells	cell	NOUN
dti-1330	161	57	.	.	PUNCT
dti-1330	162	1	all	all	DET
dti-1330	162	2	cox	cox	PROPN
dti-1330	162	3	inhibitors	inhibitor	NOUN
dti-1330	162	4	had	have	VERB
dti-1330	162	5	no	no	DET
dti-1330	162	6	effect	effect	NOUN
dti-1330	162	7	on	on	ADP
dti-1330	162	8	normal	normal	ADJ
dti-1330	162	9	proximal	proximal	ADJ
dti-1330	162	10	tubular	tubular	ADJ
dti-1330	162	11	endothelial	endothelial	ADJ
dti-1330	162	12	cells	cell	NOUN
dti-1330	162	13	(	(	PUNCT
dti-1330	162	14	prtec	prtec	ADJ
dti-1330	162	15	)	)	PUNCT
dti-1330	162	16	proliferation	proliferation	NOUN
dti-1330	162	17	.	.	PUNCT
dti-1330	163	1	bt	bt	NOUN
dti-1330	163	2	cell	cell	NOUN
dti-1330	163	3	line	line	NOUN
dti-1330	163	4	similar	similar	ADJ
dti-1330	163	5	to	to	ADP
dti-1330	163	6	rcc	rcc	PROPN
dti-1330	163	7	cells	cell	NOUN
dti-1330	163	8	,	,	PUNCT
dti-1330	163	9	cox	cox	PROPN
dti-1330	163	10	inhibitors	inhibitor	NOUN
dti-1330	163	11	could	could	AUX
dti-1330	163	12	not	not	PART
dti-1330	163	13	induce	induce	VERB
dti-1330	163	14	a	a	DET
dti-1330	163	15	reduction	reduction	NOUN
dti-1330	163	16	of	of	ADP
dti-1330	163	17	cell	cell	NOUN
dti-1330	163	18	viability	viability	NOUN
dti-1330	163	19	with	with	ADP
dti-1330	163	20	the	the	DET
dti-1330	163	21	halfmaximal	halfmaximal	ADJ
dti-1330	163	22	concentration	concentration	NOUN
dti-1330	163	23	of	of	ADP
dti-1330	163	24	growth	growth	NOUN
dti-1330	163	25	inhibition	inhibition	NOUN
dti-1330	163	26	of	of	ADP
dti-1330	163	27	bt	bt	NOUN
dti-1330	163	28	cells	cell	NOUN
dti-1330	163	29	in	in	ADP
dti-1330	163	30	the	the	DET
dti-1330	163	31	range	range	NOUN
dti-1330	163	32	of	of	ADP
dti-1330	163	33	10–80	10–80	NUM
dti-1330	163	34	μm	μm	NUM
dti-1330	163	35	and	and	CCONJ
dti-1330	163	36	could	could	AUX
dti-1330	163	37	not	not	PART
dti-1330	163	38	stop	stop	VERB
dti-1330	163	39	the	the	DET
dti-1330	163	40	growth	growth	NOUN
dti-1330	163	41	of	of	ADP
dti-1330	163	42	bt	bt	NOUN
dti-1330	163	43	cells	cell	NOUN
dti-1330	163	44	.	.	PUNCT
dti-1330	164	1	cox	cox	PROPN
dti-1330	164	2	inhibitors	inhibitor	NOUN
dti-1330	164	3	had	have	VERB
dti-1330	164	4	no	no	DET
dti-1330	164	5	effect	effect	NOUN
dti-1330	164	6	on	on	ADP
dti-1330	164	7	normal	normal	ADJ
dti-1330	164	8	bladder	bladder	NOUN
dti-1330	164	9	cells	cell	NOUN
dti-1330	164	10	proliferation	proliferation	NOUN
dti-1330	164	11	.	.	PUNCT
dti-1330	165	1	pc	pc	NOUN
dti-1330	165	2	cell	cell	NOUN
dti-1330	165	3	line	line	NOUN
dti-1330	165	4	similar	similar	ADJ
dti-1330	165	5	to	to	ADP
dti-1330	165	6	rcc	rcc	PROPN
dti-1330	165	7	and	and	CCONJ
dti-1330	165	8	bt	bt	NOUN
dti-1330	165	9	cells	cell	NOUN
dti-1330	165	10	,	,	PUNCT
dti-1330	165	11	none	none	NOUN
dti-1330	165	12	of	of	ADP
dti-1330	165	13	the	the	DET
dti-1330	165	14	cox	cox	PROPN
dti-1330	165	15	inhibitors	inhibitor	NOUN
dti-1330	165	16	could	could	AUX
dti-1330	165	17	induce	induce	VERB
dti-1330	165	18	a	a	DET
dti-1330	165	19	reduction	reduction	NOUN
dti-1330	165	20	of	of	ADP
dti-1330	165	21	cell	cell	NOUN
dti-1330	165	22	viability	viability	NOUN
dti-1330	165	23	with	with	ADP
dti-1330	165	24	the	the	DET
dti-1330	165	25	half	half	ADJ
dti-1330	165	26	-	-	PUNCT
dti-1330	165	27	maximal	maximal	ADJ
dti-1330	165	28	concentration	concentration	NOUN
dti-1330	165	29	of	of	ADP
dti-1330	165	30	growth	growth	NOUN
dti-1330	165	31	inhibition	inhibition	NOUN
dti-1330	165	32	of	of	ADP
dti-1330	165	33	pc	pc	NOUN
dti-1330	165	34	cells	cell	NOUN
dti-1330	165	35	in	in	ADP
dti-1330	165	36	the	the	DET
dti-1330	165	37	range	range	NOUN
dti-1330	165	38	of	of	ADP
dti-1330	165	39	10–80	10–80	NUM
dti-1330	165	40	μm	μm	NOUN
dti-1330	165	41	,	,	PUNCT
dti-1330	165	42	neither	neither	CCONJ
dti-1330	165	43	could	could	AUX
dti-1330	165	44	they	they	PRON
dti-1330	165	45	stop	stop	VERB
dti-1330	165	46	the	the	DET
dti-1330	165	47	growth	growth	NOUN
dti-1330	165	48	of	of	ADP
dti-1330	165	49	pc	pc	NOUN
dti-1330	165	50	cells	cell	NOUN
dti-1330	165	51	.	.	PUNCT
dti-1330	166	1	cox	cox	PROPN
dti-1330	166	2	inhibitors	inhibitor	NOUN
dti-1330	166	3	had	have	VERB
dti-1330	166	4	no	no	DET
dti-1330	166	5	effect	effect	NOUN
dti-1330	166	6	on	on	ADP
dti-1330	166	7	normal	normal	ADJ
dti-1330	166	8	prostate	prostate	NOUN
dti-1330	166	9	stromal	stromal	ADJ
dti-1330	166	10	cells	cell	NOUN
dti-1330	166	11	proliferation	proliferation	NOUN
dti-1330	166	12	(	(	PUNCT
dti-1330	166	13	table	table	NOUN
dti-1330	166	14	2	2	NUM
dti-1330	166	15	)	)	PUNCT
dti-1330	166	16	.	.	PUNCT
dti-1330	167	1	tc	tc	NOUN
dti-1330	167	2	cell	cell	NOUN
dti-1330	167	3	line	line	NOUN
dti-1330	167	4	regarding	regard	VERB
dti-1330	167	5	rcc	rcc	PROPN
dti-1330	167	6	,	,	PUNCT
dti-1330	167	7	bt	bt	NOUN
dti-1330	167	8	and	and	CCONJ
dti-1330	167	9	pc	pc	NOUN
dti-1330	167	10	cells	cell	NOUN
dti-1330	167	11	,	,	PUNCT
dti-1330	167	12	some	some	DET
dti-1330	167	13	forms	form	NOUN
dti-1330	167	14	of	of	ADP
dti-1330	167	15	cox	cox	PROPN
dti-1330	167	16	inhibitors	inhibitor	NOUN
dti-1330	167	17	induced	induce	VERB
dti-1330	167	18	a	a	DET
dti-1330	167	19	slight	slight	ADJ
dti-1330	167	20	reduction	reduction	NOUN
dti-1330	167	21	of	of	ADP
dti-1330	167	22	tc	tc	NOUN
dti-1330	167	23	cells	cell	NOUN
dti-1330	167	24	growth	growth	NOUN
dti-1330	167	25	in	in	ADP
dti-1330	167	26	80	80	NUM
dti-1330	167	27	μm	μm	NUM
dti-1330	167	28	,	,	PUNCT
dti-1330	167	29	but	but	CCONJ
dti-1330	167	30	we	we	PRON
dti-1330	167	31	were	be	AUX
dti-1330	167	32	unable	unable	ADJ
dti-1330	167	33	to	to	PART
dti-1330	167	34	detect	detect	VERB
dti-1330	167	35	the	the	DET
dti-1330	167	36	induction	induction	NOUN
dti-1330	167	37	of	of	ADP
dti-1330	167	38	tc	tc	NOUN
dti-1330	167	39	cells	cell	NOUN
dti-1330	167	40	apoptosis	apoptosis	NOUN
dti-1330	167	41	in	in	ADP
dti-1330	167	42	80	80	NUM
dti-1330	167	43	μm	μm	NOUN
dti-1330	167	44	cox	cox	PROPN
dti-1330	167	45	inhibitors	inhibitor	NOUN
dti-1330	167	46	.	.	PUNCT
dti-1330	168	1	145	145	NUM
dti-1330	168	2	5	5	NUM
dti-1330	168	3	-	-	NOUN
dti-1330	168	4	lipoxygenase	lipoxygenase	NOUN
dti-1330	168	5	in	in	ADP
dti-1330	168	6	urological	urological	ADJ
dti-1330	168	7	tumor	tumor	NOUN
dti-1330	168	8	drug	drug	NOUN
dti-1330	168	9	target	target	NOUN
dti-1330	168	10	insights	insight	VERB
dti-1330	168	11	2008:3	2008:3	NUM
dti-1330	168	12	a	a	X
dti-1330	168	13	)	)	PUNCT
dti-1330	168	14	lox	lox	PROPN
dti-1330	168	15	rcc	rcc	PROPN
dti-1330	168	16	cell	cell	PROPN
dti-1330	168	17	line	line	NOUN
dti-1330	168	18	lox	lox	NOUN
dti-1330	168	19	inhibitors	inhibitor	NOUN
dti-1330	168	20	induced	induce	VERB
dti-1330	168	21	a	a	DET
dti-1330	168	22	reduction	reduction	NOUN
dti-1330	168	23	of	of	ADP
dti-1330	168	24	cell	cell	NOUN
dti-1330	168	25	viability	viability	NOUN
dti-1330	168	26	with	with	ADP
dti-1330	168	27	the	the	DET
dti-1330	168	28	half	half	ADJ
dti-1330	168	29	-	-	PUNCT
dti-1330	168	30	maximal	maximal	ADJ
dti-1330	168	31	concentration	concentration	NOUN
dti-1330	168	32	of	of	ADP
dti-1330	168	33	growth	growth	NOUN
dti-1330	168	34	inhibition	inhibition	NOUN
dti-1330	168	35	of	of	ADP
dti-1330	168	36	rcc	rcc	PROPN
dti-1330	168	37	cells	cell	NOUN
dti-1330	168	38	in	in	ADP
dti-1330	168	39	the	the	DET
dti-1330	168	40	range	range	NOUN
dti-1330	168	41	of	of	ADP
dti-1330	168	42	10–80	10–80	NUM
dti-1330	168	43	μm	μm	NOUN
dti-1330	168	44	.	.	PUNCT
dti-1330	169	1	although	although	SCONJ
dti-1330	169	2	the	the	DET
dti-1330	169	3	effect	effect	NOUN
dti-1330	169	4	of	of	ADP
dti-1330	169	5	non	non	ADJ
dti-1330	169	6	-	-	ADJ
dti-1330	169	7	specifi	specifi	ADJ
dti-1330	169	8	c	c	PROPN
dti-1330	169	9	lox	lox	PROPN
dti-1330	169	10	inhibitor	inhibitor	PROPN
dti-1330	169	11	was	be	AUX
dti-1330	169	12	strongest	strong	ADJ
dti-1330	169	13	,	,	PUNCT
dti-1330	169	14	the	the	DET
dti-1330	169	15	effect	effect	NOUN
dti-1330	169	16	of	of	ADP
dti-1330	169	17	5	5	NUM
dti-1330	169	18	-	-	PUNCT
dti-1330	169	19	lox	lox	NOUN
dti-1330	169	20	inhibitor	inhibitor	NOUN
dti-1330	169	21	was	be	AUX
dti-1330	169	22	stronger	strong	ADJ
dti-1330	169	23	than	than	ADP
dti-1330	169	24	that	that	PRON
dti-1330	169	25	of	of	ADP
dti-1330	169	26	12	12	NUM
dti-1330	169	27	-	-	PUNCT
dti-1330	169	28	lox	lox	NOUN
dti-1330	169	29	inhibitor	inhibitor	NOUN
dti-1330	169	30	.	.	PUNCT
dti-1330	170	1	no	no	DET
dti-1330	170	2	lox	lox	NOUN
dti-1330	170	3	inhibitors	inhibitor	NOUN
dti-1330	170	4	had	have	VERB
dti-1330	170	5	any	any	DET
dti-1330	170	6	effect	effect	NOUN
dti-1330	170	7	on	on	ADP
dti-1330	170	8	normal	normal	ADJ
dti-1330	170	9	proximal	proximal	ADJ
dti-1330	170	10	tubular	tubular	ADJ
dti-1330	170	11	endothelial	endothelial	ADJ
dti-1330	170	12	cells	cell	NOUN
dti-1330	170	13	(	(	PUNCT
dti-1330	170	14	prtec	prtec	ADJ
dti-1330	170	15	)	)	PUNCT
dti-1330	170	16	proliferation	proliferation	NOUN
dti-1330	170	17	.	.	PUNCT
dti-1330	171	1	bt	bt	NOUN
dti-1330	171	2	cell	cell	NOUN
dti-1330	171	3	line	line	NOUN
dti-1330	171	4	similar	similar	ADJ
dti-1330	171	5	to	to	ADP
dti-1330	171	6	rcc	rcc	PROPN
dti-1330	171	7	cells	cell	NOUN
dti-1330	171	8	,	,	PUNCT
dti-1330	171	9	lox	lox	NOUN
dti-1330	171	10	inhibitors	inhibitor	NOUN
dti-1330	171	11	induced	induce	VERB
dti-1330	171	12	a	a	DET
dti-1330	171	13	reduction	reduction	NOUN
dti-1330	171	14	of	of	ADP
dti-1330	171	15	cell	cell	NOUN
dti-1330	171	16	viability	viability	NOUN
dti-1330	171	17	with	with	ADP
dti-1330	171	18	the	the	DET
dti-1330	171	19	half	half	ADJ
dti-1330	171	20	-	-	PUNCT
dti-1330	171	21	maximal	maximal	ADJ
dti-1330	171	22	concentration	concentration	NOUN
dti-1330	171	23	of	of	ADP
dti-1330	171	24	growth	growth	NOUN
dti-1330	171	25	inhibition	inhibition	NOUN
dti-1330	171	26	of	of	ADP
dti-1330	171	27	bt	bt	NOUN
dti-1330	171	28	cells	cell	NOUN
dti-1330	171	29	in	in	ADP
dti-1330	171	30	table	table	NOUN
dti-1330	171	31	1	1	NUM
dti-1330	171	32	.	.	PUNCT
dti-1330	171	33	effects	effect	NOUN
dti-1330	171	34	of	of	ADP
dti-1330	171	35	cox	cox	PROPN
dti-1330	171	36	and	and	CCONJ
dti-1330	171	37	lox	lox	NOUN
dti-1330	171	38	inhibitors	inhibitor	NOUN
dti-1330	171	39	in	in	ADP
dti-1330	171	40	viabity	viabity	NOUN
dti-1330	171	41	of	of	ADP
dti-1330	171	42	human	human	ADJ
dti-1330	171	43	prostate	prostate	NOUN
dti-1330	171	44	cancer	cancer	NOUN
dti-1330	171	45	and	and	CCONJ
dti-1330	171	46	normal	normal	ADJ
dti-1330	171	47	prostate	prostate	NOUN
dti-1330	171	48	stromal	stromal	ADJ
dti-1330	171	49	cells	cell	NOUN
dti-1330	171	50	.	.	PUNCT
dti-1330	172	1	%	%	NOUN
dti-1330	172	2	of	of	ADP
dti-1330	172	3	control	control	NOUN
dti-1330	172	4	culture	culture	NOUN
dti-1330	172	5	10	10	NUM
dti-1330	172	6	μm	μm	NUM
dti-1330	172	7	20	20	NUM
dti-1330	172	8	μm	μm	NUM
dti-1330	172	9	40	40	NUM
dti-1330	172	10	μm	μm	NUM
dti-1330	172	11	80	80	NUM
dti-1330	172	12	μm	μm	NOUN
dti-1330	172	13	du-145	du-145	NOUN
dti-1330	172	14	cox	cox	NOUN
dti-1330	172	15	inhibitors	inhibitor	NOUN
dti-1330	172	16	ibupurofen	ibupurofen	VERB
dti-1330	172	17	96.4	96.4	NUM
dti-1330	172	18	%	%	NOUN
dti-1330	172	19	107.5	107.5	NUM
dti-1330	172	20	%	%	NOUN
dti-1330	172	21	94.8	94.8	NUM
dti-1330	172	22	%	%	NOUN
dti-1330	172	23	96.7	96.7	NUM
dti-1330	172	24	%	%	NOUN
dti-1330	172	25	piroxicam	piroxicam	ADJ
dti-1330	172	26	127.5	127.5	NUM
dti-1330	172	27	%	%	NOUN
dti-1330	172	28	126.9	126.9	NUM
dti-1330	172	29	%	%	NOUN
dti-1330	172	30	93.0	93.0	NUM
dti-1330	172	31	%	%	NOUN
dti-1330	172	32	94.7	94.7	NUM
dti-1330	172	33	%	%	NOUN
dti-1330	172	34	meloxicam	meloxicam	NOUN
dti-1330	172	35	114.6	114.6	NUM
dti-1330	172	36	%	%	NOUN
dti-1330	172	37	110.2	110.2	NUM
dti-1330	172	38	%	%	NOUN
dti-1330	172	39	108.3	108.3	NUM
dti-1330	172	40	%	%	NOUN
dti-1330	172	41	97.6	97.6	NUM
dti-1330	172	42	%	%	NOUN
dti-1330	172	43	nimesulide	nimesulide	ADP
dti-1330	172	44	110.1	110.1	NUM
dti-1330	172	45	%	%	NOUN
dti-1330	172	46	99.1	99.1	NUM
dti-1330	172	47	%	%	NOUN
dti-1330	172	48	99.8	99.8	NUM
dti-1330	172	49	%	%	NOUN
dti-1330	172	50	105.9	105.9	NUM
dti-1330	172	51	%	%	NOUN
dti-1330	172	52	naproxen	naproxen	NOUN
dti-1330	172	53	121.6	121.6	NUM
dti-1330	172	54	%	%	NOUN
dti-1330	172	55	114.2	114.2	NUM
dti-1330	172	56	%	%	NOUN
dti-1330	172	57	106.5	106.5	NUM
dti-1330	172	58	%	%	NOUN
dti-1330	172	59	85.4	85.4	NUM
dti-1330	172	60	%	%	NOUN
dti-1330	172	61	indomethacin	indomethacin	VERB
dti-1330	172	62	120.6	120.6	NUM
dti-1330	172	63	%	%	NOUN
dti-1330	172	64	117.8	117.8	NUM
dti-1330	172	65	%	%	NOUN
dti-1330	172	66	114.5	114.5	NUM
dti-1330	172	67	%	%	NOUN
dti-1330	172	68	97.9	97.9	NUM
dti-1330	172	69	%	%	NOUN
dti-1330	172	70	ns398	ns398	PROPN
dti-1330	173	1	91.5	91.5	NUM
dti-1330	173	2	%	%	NOUN
dti-1330	173	3	80.7	80.7	NUM
dti-1330	173	4	%	%	NOUN
dti-1330	173	5	81.9	81.9	NUM
dti-1330	173	6	%	%	NOUN
dti-1330	173	7	61.3	61.3	NUM
dti-1330	173	8	%	%	NOUN
dti-1330	173	9	etodolac	etodolac	NOUN
dti-1330	173	10	105.1.%	105.1.%	NOUN
dti-1330	173	11	106.7	106.7	NUM
dti-1330	173	12	%	%	NOUN
dti-1330	173	13	104.4	104.4	NUM
dti-1330	173	14	%	%	NOUN
dti-1330	173	15	95.1	95.1	NUM
dti-1330	173	16	%	%	NOUN
dti-1330	173	17	lox	lox	NOUN
dti-1330	173	18	inhibitors	inhibitor	NOUN
dti-1330	173	19	baicalein	baicalein	VERB
dti-1330	173	20	102.4	102.4	NUM
dti-1330	173	21	%	%	NOUN
dti-1330	173	22	99.1	99.1	NUM
dti-1330	173	23	%	%	NOUN
dti-1330	173	24	85.3	85.3	NUM
dti-1330	173	25	%	%	NOUN
dti-1330	173	26	63.5	63.5	NUM
dti-1330	173	27	%	%	NOUN
dti-1330	173	28	caffeic	caffeic	NOUN
dti-1330	173	29	acid	acid	NOUN
dti-1330	173	30	80.7	80.7	NUM
dti-1330	173	31	%	%	NOUN
dti-1330	173	32	69.2	69.2	NUM
dti-1330	173	33	%	%	NOUN
dti-1330	173	34	22.2	22.2	NUM
dti-1330	173	35	%	%	NOUN
dti-1330	173	36	8.1	8.1	NUM
dti-1330	173	37	%	%	NOUN
dti-1330	173	38	ndga	ndga	ADV
dti-1330	173	39	67.7	67.7	NUM
dti-1330	173	40	%	%	NOUN
dti-1330	173	41	42.3	42.3	NUM
dti-1330	173	42	%	%	NOUN
dti-1330	173	43	9.9	9.9	NUM
dti-1330	173	44	%	%	NOUN
dti-1330	173	45	5.2	5.2	NUM
dti-1330	173	46	%	%	NOUN
dti-1330	173	47	pc3	pc3	PROPN
dti-1330	173	48	cox	cox	PROPN
dti-1330	173	49	inhibitors	inhibitor	NOUN
dti-1330	173	50	ibupurofen	ibupurofen	VERB
dti-1330	173	51	90.0	90.0	NUM
dti-1330	173	52	%	%	NOUN
dti-1330	173	53	86.2	86.2	NUM
dti-1330	173	54	%	%	NOUN
dti-1330	173	55	75.3	75.3	NUM
dti-1330	173	56	%	%	NOUN
dti-1330	173	57	62.9	62.9	NUM
dti-1330	173	58	%	%	NOUN
dti-1330	173	59	piroxicam	piroxicam	NOUN
dti-1330	173	60	93.6	93.6	NUM
dti-1330	173	61	%	%	NOUN
dti-1330	173	62	87.4	87.4	NUM
dti-1330	173	63	%	%	NOUN
dti-1330	173	64	78.2	78.2	NUM
dti-1330	173	65	%	%	NOUN
dti-1330	173	66	64.3	64.3	NUM
dti-1330	173	67	%	%	NOUN
dti-1330	173	68	meloxicam	meloxicam	NOUN
dti-1330	173	69	98.1	98.1	NUM
dti-1330	173	70	%	%	NOUN
dti-1330	173	71	97.9	97.9	NUM
dti-1330	173	72	%	%	NOUN
dti-1330	173	73	89.3	89.3	NUM
dti-1330	173	74	%	%	NOUN
dti-1330	173	75	67.4	67.4	NUM
dti-1330	173	76	%	%	NOUN
dti-1330	173	77	nimesulide	nimesulide	ADP
dti-1330	173	78	83.1	83.1	NUM
dti-1330	173	79	%	%	NOUN
dti-1330	173	80	91.5	91.5	NUM
dti-1330	173	81	%	%	NOUN
dti-1330	173	82	78.1	78.1	NUM
dti-1330	173	83	%	%	NOUN
dti-1330	173	84	94.1	94.1	NUM
dti-1330	173	85	%	%	NOUN
dti-1330	173	86	naproxen	naproxen	NOUN
dti-1330	173	87	87.4	87.4	NUM
dti-1330	173	88	%	%	NOUN
dti-1330	173	89	90.7	90.7	NUM
dti-1330	173	90	%	%	NOUN
dti-1330	173	91	94.7	94.7	NUM
dti-1330	173	92	%	%	NOUN
dti-1330	173	93	105.8	105.8	NUM
dti-1330	173	94	%	%	NOUN
dti-1330	173	95	indomethacin	indomethacin	VERB
dti-1330	173	96	95.1	95.1	NUM
dti-1330	173	97	%	%	NOUN
dti-1330	173	98	96.8	96.8	NUM
dti-1330	173	99	%	%	NOUN
dti-1330	173	100	86.6	86.6	NUM
dti-1330	173	101	%	%	NOUN
dti-1330	173	102	65.9	65.9	NUM
dti-1330	173	103	%	%	NOUN
dti-1330	173	104	ns398	ns398	PROPN
dti-1330	173	105	88.9	88.9	NUM
dti-1330	173	106	%	%	NOUN
dti-1330	173	107	77.5	77.5	NUM
dti-1330	173	108	%	%	NOUN
dti-1330	173	109	67.1	67.1	NUM
dti-1330	173	110	%	%	NOUN
dti-1330	173	111	58.1	58.1	NUM
dti-1330	173	112	%	%	NOUN
dti-1330	173	113	etodolac	etodolac	NOUN
dti-1330	173	114	93.6	93.6	NUM
dti-1330	173	115	%	%	NOUN
dti-1330	173	116	88.3	88.3	NUM
dti-1330	173	117	%	%	NOUN
dti-1330	173	118	89.1	89.1	NUM
dti-1330	173	119	%	%	NOUN
dti-1330	173	120	77.5	77.5	NUM
dti-1330	173	121	%	%	NOUN
dti-1330	173	122	lox	lox	NOUN
dti-1330	173	123	inhibitors	inhibitor	NOUN
dti-1330	173	124	baicalein	baicalein	VERB
dti-1330	173	125	117.8	117.8	NUM
dti-1330	173	126	%	%	NOUN
dti-1330	173	127	100.2	100.2	NUM
dti-1330	173	128	%	%	NOUN
dti-1330	173	129	103.8	103.8	NUM
dti-1330	173	130	%	%	NOUN
dti-1330	173	131	76.5	76.5	NUM
dti-1330	173	132	%	%	NOUN
dti-1330	173	133	caffeic	caffeic	NOUN
dti-1330	173	134	acid	acid	NOUN
dti-1330	173	135	112.5	112.5	NUM
dti-1330	173	136	%	%	NOUN
dti-1330	173	137	96.7	96.7	NUM
dti-1330	173	138	%	%	NOUN
dti-1330	173	139	78.8	78.8	NUM
dti-1330	173	140	%	%	NOUN
dti-1330	173	141	45.3	45.3	NUM
dti-1330	173	142	%	%	NOUN
dti-1330	173	143	ndga	ndga	ADV
dti-1330	173	144	113.0	113.0	NUM
dti-1330	173	145	%	%	NOUN
dti-1330	173	146	101.7	101.7	NUM
dti-1330	173	147	%	%	NOUN
dti-1330	173	148	51.1	51.1	NUM
dti-1330	173	149	%	%	NOUN
dti-1330	173	150	18.5	18.5	NUM
dti-1330	173	151	%	%	NOUN
dti-1330	173	152	normal	normal	ADJ
dti-1330	173	153	prostate	prostate	NOUN
dti-1330	173	154	stromal	stromal	ADJ
dti-1330	173	155	cell	cell	NOUN
dti-1330	173	156	cox	cox	PROPN
dti-1330	173	157	inhibitors	inhibitor	NOUN
dti-1330	173	158	ibupurofen	ibupurofen	VERB
dti-1330	173	159	97.6	97.6	NUM
dti-1330	173	160	%	%	NOUN
dti-1330	173	161	95.6	95.6	NUM
dti-1330	173	162	%	%	NOUN
dti-1330	173	163	92.3	92.3	NUM
dti-1330	173	164	%	%	NOUN
dti-1330	173	165	81.7	81.7	NUM
dti-1330	173	166	%	%	NOUN
dti-1330	173	167	piroxicam	piroxicam	NOUN
dti-1330	173	168	99.5	99.5	NUM
dti-1330	173	169	%	%	NOUN
dti-1330	173	170	105.1	105.1	NUM
dti-1330	173	171	%	%	NOUN
dti-1330	173	172	98.3	98.3	NUM
dti-1330	173	173	%	%	NOUN
dti-1330	173	174	108.1	108.1	NUM
dti-1330	173	175	%	%	NOUN
dti-1330	173	176	meloxicam	meloxicam	NOUN
dti-1330	173	177	115.3	115.3	NUM
dti-1330	173	178	%	%	NOUN
dti-1330	173	179	97.0	97.0	NUM
dti-1330	173	180	%	%	NOUN
dti-1330	173	181	103.6	103.6	NUM
dti-1330	173	182	%	%	NOUN
dti-1330	173	183	108.7	108.7	NUM
dti-1330	173	184	%	%	NOUN
dti-1330	173	185	nimesulide	nimesulide	ADV
dti-1330	173	186	96.1	96.1	NUM
dti-1330	173	187	%	%	NOUN
dti-1330	173	188	95.1	95.1	NUM
dti-1330	173	189	%	%	NOUN
dti-1330	173	190	99.6	99.6	NUM
dti-1330	173	191	%	%	NOUN
dti-1330	173	192	103.3	103.3	NUM
dti-1330	173	193	%	%	NOUN
dti-1330	173	194	naproxen	naproxen	NOUN
dti-1330	173	195	95.2	95.2	NUM
dti-1330	173	196	%	%	NOUN
dti-1330	173	197	94.9	94.9	NUM
dti-1330	173	198	%	%	NOUN
dti-1330	173	199	94.6	94.6	NUM
dti-1330	173	200	%	%	NOUN
dti-1330	173	201	107.7	107.7	NUM
dti-1330	173	202	%	%	NOUN
dti-1330	173	203	indomethacin	indomethacin	VERB
dti-1330	173	204	98.4	98.4	NUM
dti-1330	173	205	%	%	NOUN
dti-1330	173	206	116.5	116.5	NUM
dti-1330	173	207	%	%	NOUN
dti-1330	173	208	118.1	118.1	NUM
dti-1330	173	209	%	%	NOUN
dti-1330	173	210	113.4	113.4	NUM
dti-1330	173	211	%	%	NOUN
dti-1330	173	212	ns398	ns398	PROPN
dti-1330	173	213	106.0	106.0	NUM
dti-1330	173	214	%	%	NOUN
dti-1330	173	215	92.1	92.1	NUM
dti-1330	173	216	%	%	NOUN
dti-1330	173	217	90.5	90.5	NUM
dti-1330	173	218	%	%	NOUN
dti-1330	173	219	90.3	90.3	NUM
dti-1330	173	220	%	%	NOUN
dti-1330	173	221	etodolac	etodolac	NOUN
dti-1330	173	222	101.0	101.0	NUM
dti-1330	173	223	%	%	NOUN
dti-1330	173	224	104.1	104.1	NUM
dti-1330	173	225	%	%	NOUN
dti-1330	173	226	104.8	104.8	NUM
dti-1330	173	227	%	%	NOUN
dti-1330	173	228	98.6	98.6	NUM
dti-1330	173	229	%	%	NOUN
dti-1330	173	230	lox	lox	NOUN
dti-1330	173	231	inhibitors	inhibitor	NOUN
dti-1330	173	232	baicalein	baicalein	VERB
dti-1330	173	233	97.2	97.2	NUM
dti-1330	173	234	%	%	NOUN
dti-1330	173	235	84.8	84.8	NUM
dti-1330	173	236	%	%	NOUN
dti-1330	173	237	87.0	87.0	NUM
dti-1330	173	238	%	%	NOUN
dti-1330	173	239	81.6	81.6	NUM
dti-1330	173	240	%	%	NOUN
dti-1330	173	241	caffeic	caffeic	NOUN
dti-1330	173	242	acid	acid	NOUN
dti-1330	173	243	89.7	89.7	NUM
dti-1330	173	244	%	%	NOUN
dti-1330	173	245	80.1	80.1	NUM
dti-1330	173	246	%	%	NOUN
dti-1330	173	247	81.8	81.8	NUM
dti-1330	173	248	%	%	NOUN
dti-1330	173	249	84.1	84.1	NUM
dti-1330	173	250	%	%	NOUN
dti-1330	173	251	ndga	ndga	ADV
dti-1330	173	252	107.3	107.3	NUM
dti-1330	173	253	%	%	NOUN
dti-1330	173	254	86.9	86.9	NUM
dti-1330	173	255	%	%	NOUN
dti-1330	173	256	88.6	88.6	NUM
dti-1330	173	257	%	%	NOUN
dti-1330	173	258	80.7	80.7	NUM
dti-1330	173	259	%	%	NOUN
dti-1330	173	260	the	the	DET
dti-1330	173	261	dose	dose	NOUN
dti-1330	173	262	-	-	PUNCT
dti-1330	173	263	response	response	NOUN
dti-1330	173	264	analysis	analysis	NOUN
dti-1330	173	265	of	of	ADP
dti-1330	173	266	viability	viability	NOUN
dti-1330	173	267	in	in	ADP
dti-1330	173	268	human	human	ADJ
dti-1330	173	269	prostate	prostate	NOUN
dti-1330	173	270	cancer	cancer	NOUN
dti-1330	173	271	and	and	CCONJ
dti-1330	173	272	normal	normal	ADJ
dti-1330	173	273	prostate	prostate	NOUN
dti-1330	173	274	stromal	stromal	ADJ
dti-1330	173	275	cells	cell	NOUN
dti-1330	173	276	treated	treat	VERB
dti-1330	173	277	with	with	ADP
dti-1330	173	278	cox	cox	PROPN
dti-1330	173	279	and	and	CCONJ
dti-1330	173	280	lox	lox	NOUN
dti-1330	173	281	inhibitors	inhibitor	NOUN
dti-1330	173	282	(	(	PUNCT
dti-1330	173	283	10	10	NUM
dti-1330	173	284	-	-	SYM
dti-1330	173	285	80	80	NUM
dti-1330	173	286	μm	μm	NUM
dti-1330	173	287	,	,	PUNCT
dti-1330	173	288	48	48	NUM
dti-1330	173	289	hr	hr	NOUN
dti-1330	173	290	)	)	PUNCT
dti-1330	173	291	was	be	AUX
dti-1330	173	292	measured	measure	VERB
dti-1330	173	293	by	by	ADP
dti-1330	173	294	the	the	DET
dti-1330	173	295	mtt	mtt	NOUN
dti-1330	173	296	assay	assay	VERB
dti-1330	173	297	and	and	CCONJ
dti-1330	173	298	expressed	express	VERB
dti-1330	173	299	as%	as%	NOUN
dti-1330	173	300	of	of	ADP
dti-1330	173	301	control	control	NOUN
dti-1330	173	302	culture	culture	NOUN
dti-1330	173	303	conditions	condition	NOUN
dti-1330	173	304	.	.	PUNCT
dti-1330	174	1	146	146	NUM
dti-1330	174	2	matsuyama	matsuyama	PROPN
dti-1330	174	3	and	and	CCONJ
dti-1330	174	4	yoshimura	yoshimura	VERB
dti-1330	174	5	drug	drug	NOUN
dti-1330	174	6	target	target	NOUN
dti-1330	174	7	insights	insight	NOUN
dti-1330	174	8	2008:3	2008:3	NUM
dti-1330	174	9	the	the	DET
dti-1330	174	10	range	range	NOUN
dti-1330	174	11	of	of	ADP
dti-1330	174	12	10–80	10–80	NUM
dti-1330	174	13	μm	μm	NOUN
dti-1330	174	14	.	.	PUNCT
dti-1330	175	1	although	although	SCONJ
dti-1330	175	2	the	the	DET
dti-1330	175	3	effect	effect	NOUN
dti-1330	175	4	of	of	ADP
dti-1330	175	5	non	non	ADJ
dti-1330	175	6	-	-	ADJ
dti-1330	175	7	specifi	specifi	ADJ
dti-1330	175	8	c	c	PROPN
dti-1330	175	9	lox	lox	PROPN
dti-1330	175	10	inhibitor	inhibitor	PROPN
dti-1330	175	11	was	be	AUX
dti-1330	175	12	strongest	strong	ADJ
dti-1330	175	13	,	,	PUNCT
dti-1330	175	14	the	the	DET
dti-1330	175	15	effect	effect	NOUN
dti-1330	175	16	of	of	ADP
dti-1330	175	17	5	5	NUM
dti-1330	175	18	-	-	PUNCT
dti-1330	175	19	lox	lox	NOUN
dti-1330	175	20	inhibitor	inhibitor	NOUN
dti-1330	175	21	was	be	AUX
dti-1330	175	22	stronger	strong	ADJ
dti-1330	175	23	than	than	ADP
dti-1330	175	24	that	that	PRON
dti-1330	175	25	of	of	ADP
dti-1330	175	26	12	12	NUM
dti-1330	175	27	-	-	PUNCT
dti-1330	175	28	lox	lox	NOUN
dti-1330	175	29	inhibitor	inhibitor	NOUN
dti-1330	175	30	.	.	PUNCT
dti-1330	176	1	no	no	DET
dti-1330	176	2	lox	lox	NOUN
dti-1330	176	3	inhibitors	inhibitor	NOUN
dti-1330	176	4	had	have	VERB
dti-1330	176	5	any	any	DET
dti-1330	176	6	effect	effect	NOUN
dti-1330	176	7	on	on	ADP
dti-1330	176	8	normal	normal	ADJ
dti-1330	176	9	bladder	bladder	NOUN
dti-1330	176	10	cells	cell	NOUN
dti-1330	176	11	proliferation	proliferation	NOUN
dti-1330	176	12	.	.	PUNCT
dti-1330	177	1	pc	pc	NOUN
dti-1330	177	2	cell	cell	NOUN
dti-1330	177	3	line	line	NOUN
dti-1330	177	4	similar	similar	ADJ
dti-1330	177	5	to	to	ADP
dti-1330	177	6	rcc	rcc	PROPN
dti-1330	177	7	and	and	CCONJ
dti-1330	177	8	bt	bt	NOUN
dti-1330	177	9	cells	cell	NOUN
dti-1330	177	10	,	,	PUNCT
dti-1330	177	11	lox	lox	NOUN
dti-1330	177	12	inhibitors	inhibitor	NOUN
dti-1330	177	13	induced	induce	VERB
dti-1330	177	14	a	a	DET
dti-1330	177	15	reduction	reduction	NOUN
dti-1330	177	16	of	of	ADP
dti-1330	177	17	cell	cell	NOUN
dti-1330	177	18	viability	viability	NOUN
dti-1330	177	19	with	with	ADP
dti-1330	177	20	the	the	DET
dti-1330	177	21	half	half	ADJ
dti-1330	177	22	-	-	PUNCT
dti-1330	177	23	maximal	maximal	ADJ
dti-1330	177	24	concentration	concentration	NOUN
dti-1330	177	25	of	of	ADP
dti-1330	177	26	growth	growth	NOUN
dti-1330	177	27	inhibition	inhibition	NOUN
dti-1330	177	28	of	of	ADP
dti-1330	177	29	pc	pc	NOUN
dti-1330	177	30	cells	cell	NOUN
dti-1330	177	31	in	in	ADP
dti-1330	177	32	the	the	DET
dti-1330	177	33	range	range	NOUN
dti-1330	177	34	of	of	ADP
dti-1330	177	35	10–80	10–80	NUM
dti-1330	177	36	μm	μm	NOUN
dti-1330	177	37	.	.	PUNCT
dti-1330	178	1	although	although	SCONJ
dti-1330	178	2	the	the	DET
dti-1330	178	3	effect	effect	NOUN
dti-1330	178	4	of	of	ADP
dti-1330	178	5	nonspecifi	nonspecifi	NOUN
dti-1330	178	6	c	c	PROPN
dti-1330	178	7	lox	lox	PROPN
dti-1330	178	8	inhibitor	inhibitor	PROPN
dti-1330	178	9	was	be	AUX
dti-1330	178	10	strongest	strong	ADJ
dti-1330	178	11	,	,	PUNCT
dti-1330	178	12	the	the	DET
dti-1330	178	13	effect	effect	NOUN
dti-1330	178	14	of	of	ADP
dti-1330	178	15	5	5	NUM
dti-1330	178	16	-	-	PUNCT
dti-1330	178	17	lox	lox	NOUN
dti-1330	178	18	inhibitor	inhibitor	NOUN
dti-1330	178	19	was	be	AUX
dti-1330	178	20	stronger	strong	ADJ
dti-1330	178	21	than	than	ADP
dti-1330	178	22	that	that	PRON
dti-1330	178	23	of	of	ADP
dti-1330	178	24	12	12	NUM
dti-1330	178	25	-	-	PUNCT
dti-1330	178	26	lox	lox	NOUN
dti-1330	178	27	inhibitor	inhibitor	NOUN
dti-1330	178	28	.	.	PUNCT
dti-1330	179	1	no	no	DET
dti-1330	179	2	lox	lox	NOUN
dti-1330	179	3	inhibitors	inhibitor	NOUN
dti-1330	179	4	had	have	VERB
dti-1330	179	5	any	any	DET
dti-1330	179	6	effect	effect	NOUN
dti-1330	179	7	on	on	ADP
dti-1330	179	8	normal	normal	ADJ
dti-1330	179	9	prostate	prostate	NOUN
dti-1330	179	10	stromal	stromal	ADJ
dti-1330	179	11	cells	cell	NOUN
dti-1330	179	12	proliferation	proliferation	NOUN
dti-1330	179	13	(	(	PUNCT
dti-1330	179	14	table	table	NOUN
dti-1330	179	15	2	2	NUM
dti-1330	179	16	)	)	PUNCT
dti-1330	179	17	.	.	PUNCT
dti-1330	180	1	tc	tc	NOUN
dti-1330	180	2	cell	cell	NOUN
dti-1330	180	3	line	line	NOUN
dti-1330	180	4	similar	similar	ADJ
dti-1330	180	5	to	to	ADP
dti-1330	180	6	rcc	rcc	PROPN
dti-1330	180	7	,	,	PUNCT
dti-1330	180	8	bt	bt	NOUN
dti-1330	180	9	and	and	CCONJ
dti-1330	180	10	pc	pc	NOUN
dti-1330	180	11	cells	cell	NOUN
dti-1330	180	12	,	,	PUNCT
dti-1330	180	13	lox	lox	NOUN
dti-1330	180	14	inhibitors	inhibitor	NOUN
dti-1330	180	15	induced	induce	VERB
dti-1330	180	16	a	a	DET
dti-1330	180	17	reduction	reduction	NOUN
dti-1330	180	18	of	of	ADP
dti-1330	180	19	cell	cell	NOUN
dti-1330	180	20	viability	viability	NOUN
dti-1330	180	21	with	with	ADP
dti-1330	180	22	the	the	DET
dti-1330	180	23	halfmaximal	halfmaximal	ADJ
dti-1330	180	24	concentration	concentration	NOUN
dti-1330	180	25	of	of	ADP
dti-1330	180	26	growth	growth	NOUN
dti-1330	180	27	inhibition	inhibition	NOUN
dti-1330	180	28	of	of	ADP
dti-1330	180	29	tc	tc	NOUN
dti-1330	180	30	cells	cell	NOUN
dti-1330	180	31	in	in	ADP
dti-1330	180	32	the	the	DET
dti-1330	180	33	range	range	NOUN
dti-1330	180	34	of	of	ADP
dti-1330	180	35	10–80	10–80	NUM
dti-1330	180	36	μm	μm	NOUN
dti-1330	180	37	.	.	PUNCT
dti-1330	181	1	although	although	SCONJ
dti-1330	181	2	the	the	DET
dti-1330	181	3	effect	effect	NOUN
dti-1330	181	4	of	of	ADP
dti-1330	181	5	non	non	ADJ
dti-1330	181	6	-	-	ADJ
dti-1330	181	7	specifi	specifi	ADJ
dti-1330	181	8	c	c	PROPN
dti-1330	181	9	lox	lox	PROPN
dti-1330	181	10	inhibitor	inhibitor	PROPN
dti-1330	181	11	was	be	AUX
dti-1330	181	12	strongest	strong	ADJ
dti-1330	181	13	,	,	PUNCT
dti-1330	181	14	the	the	DET
dti-1330	181	15	effect	effect	NOUN
dti-1330	181	16	of	of	ADP
dti-1330	181	17	5	5	NUM
dti-1330	181	18	-	-	PUNCT
dti-1330	181	19	lox	lox	NOUN
dti-1330	181	20	inhibitor	inhibitor	NOUN
dti-1330	181	21	was	be	AUX
dti-1330	181	22	stronger	strong	ADJ
dti-1330	181	23	than	than	ADP
dti-1330	181	24	that	that	PRON
dti-1330	181	25	of	of	ADP
dti-1330	181	26	12	12	NUM
dti-1330	181	27	-	-	PUNCT
dti-1330	181	28	lox	lox	NOUN
dti-1330	181	29	inhibitor	inhibitor	NOUN
dti-1330	181	30	.	.	PUNCT
dti-1330	182	1	3	3	X
dti-1330	182	2	)	)	PUNCT
dti-1330	182	3	apoptosis	apoptosis	NOUN
dti-1330	182	4	effect	effect	NOUN
dti-1330	182	5	of	of	ADP
dti-1330	182	6	lox	lox	PROPN
dti-1330	182	7	inhibitor	inhibitor	PROPN
dti-1330	182	8	a	a	PRON
dti-1330	182	9	)	)	PUNCT
dti-1330	182	10	flow	flow	NOUN
dti-1330	182	11	cytometry	cytometry	PROPN
dti-1330	182	12	rcc	rcc	PROPN
dti-1330	182	13	cell	cell	PROPN
dti-1330	182	14	line	line	PROPN
dti-1330	182	15	rcc	rcc	PROPN
dti-1330	182	16	cells	cell	NOUN
dti-1330	182	17	treated	treat	VERB
dti-1330	182	18	with	with	ADP
dti-1330	182	19	100	100	NUM
dti-1330	182	20	μm	μm	NUM
dti-1330	182	21	5	5	NUM
dti-1330	182	22	-	-	PUNCT
dti-1330	182	23	lox	lox	NOUN
dti-1330	182	24	inhibitor	inhibitor	NOUN
dti-1330	182	25	could	could	AUX
dti-1330	182	26	induce	induce	VERB
dti-1330	182	27	early	early	ADJ
dti-1330	182	28	apoptosis	apoptosis	NOUN
dti-1330	182	29	,	,	PUNCT
dti-1330	182	30	not	not	PART
dti-1330	182	31	late	late	ADJ
dti-1330	182	32	apoptosis	apoptosis	NOUN
dti-1330	182	33	or	or	CCONJ
dti-1330	182	34	necrosis	necrosis	NOUN
dti-1330	182	35	and	and	CCONJ
dti-1330	182	36	dna	dna	NOUN
dti-1330	182	37	fragmentation	fragmentation	NOUN
dti-1330	182	38	.	.	PUNCT
dti-1330	183	1	however	however	ADV
dti-1330	183	2	,	,	PUNCT
dti-1330	183	3	treated	treat	VERB
dti-1330	183	4	with	with	ADP
dti-1330	183	5	100	100	NUM
dti-1330	183	6	μm	μm	NUM
dti-1330	183	7	5	5	NUM
dti-1330	183	8	-	-	PUNCT
dti-1330	183	9	lox	lox	NOUN
dti-1330	183	10	inhibitor	inhibitor	NOUN
dti-1330	183	11	did	do	AUX
dti-1330	183	12	not	not	PART
dti-1330	183	13	induce	induce	VERB
dti-1330	183	14	apoptosis	apoptosis	NOUN
dti-1330	183	15	in	in	ADP
dti-1330	183	16	normal	normal	ADJ
dti-1330	183	17	proximal	proximal	ADJ
dti-1330	183	18	tubular	tubular	ADJ
dti-1330	183	19	endothelial	endothelial	NOUN
dti-1330	183	20	cellss	cellss	PROPN
dti-1330	183	21	(	(	PUNCT
dti-1330	183	22	prtec	prtec	NOUN
dti-1330	183	23	)	)	PUNCT
dti-1330	183	24	.	.	PUNCT
dti-1330	184	1	diagram	diagram	NOUN
dti-1330	184	2	of	of	ADP
dti-1330	184	3	fitcannexin	fitcannexin	PROPN
dti-1330	184	4	v	v	PROPN
dti-1330	184	5	/	/	SYM
dti-1330	184	6	pi	pi	NOUN
dti-1330	184	7	fl	fl	INTJ
dti-1330	184	8	ow	ow	INTJ
dti-1330	184	9	cytometry	cytometry	PROPN
dti-1330	184	10	(	(	PUNCT
dti-1330	184	11	fig	fig	NOUN
dti-1330	184	12	.	.	PUNCT
dti-1330	184	13	4	4	NUM
dti-1330	184	14	)	)	PUNCT
dti-1330	184	15	and	and	CCONJ
dti-1330	184	16	typical	typical	ADJ
dti-1330	184	17	fl	fl	PRON
dti-1330	184	18	ow	ow	INTJ
dti-1330	184	19	cytometry	cytometry	NOUN
dti-1330	184	20	analysis	analysis	NOUN
dti-1330	184	21	histogram	histogram	NOUN
dti-1330	184	22	are	be	AUX
dti-1330	184	23	presented	present	VERB
dti-1330	184	24	(	(	PUNCT
dti-1330	184	25	fig	fig	NOUN
dti-1330	184	26	.	.	PUNCT
dti-1330	185	1	5	5	NUM
dti-1330	185	2	)	)	PUNCT
dti-1330	185	3	.	.	PUNCT
dti-1330	186	1	bt	bt	NOUN
dti-1330	186	2	cell	cell	NOUN
dti-1330	186	3	line	line	NOUN
dti-1330	186	4	similar	similar	ADJ
dti-1330	186	5	to	to	ADP
dti-1330	186	6	rcc	rcc	PROPN
dti-1330	186	7	cells	cell	NOUN
dti-1330	186	8	,	,	PUNCT
dti-1330	186	9	bt	bt	PROPN
dti-1330	186	10	cells	cell	NOUN
dti-1330	186	11	treated	treat	VERB
dti-1330	186	12	with	with	ADP
dti-1330	186	13	100	100	NUM
dti-1330	186	14	μm	μm	NUM
dti-1330	186	15	5	5	NUM
dti-1330	186	16	-	-	PUNCT
dti-1330	186	17	lox	lox	NOUN
dti-1330	186	18	inhibitor	inhibitor	NOUN
dti-1330	186	19	could	could	AUX
dti-1330	186	20	induce	induce	VERB
dti-1330	186	21	early	early	ADJ
dti-1330	186	22	apoptosis	apoptosis	NOUN
dti-1330	186	23	,	,	PUNCT
dti-1330	186	24	not	not	PART
dti-1330	186	25	late	late	ADJ
dti-1330	186	26	apoptosis	apoptosis	NOUN
dti-1330	186	27	or	or	CCONJ
dti-1330	186	28	necrosis	necrosis	NOUN
dti-1330	186	29	and	and	CCONJ
dti-1330	186	30	dna	dna	NOUN
dti-1330	186	31	fragmentation	fragmentation	NOUN
dti-1330	186	32	.	.	PUNCT
dti-1330	187	1	figure	figure	NOUN
dti-1330	187	2	3	3	NUM
dti-1330	187	3	.	.	PUNCT
dti-1330	187	4	rt	rt	ADJ
dti-1330	187	5	-	-	PUNCT
dti-1330	187	6	pcr	pcr	NOUN
dti-1330	187	7	analysis	analysis	NOUN
dti-1330	187	8	of	of	ADP
dti-1330	187	9	5and	5and	NUM
dti-1330	187	10	12	12	NUM
dti-1330	187	11	-	-	PUNCT
dti-1330	187	12	lipoxygenase	lipoxygenase	NOUN
dti-1330	187	13	(	(	PUNCT
dti-1330	187	14	lox	lox	NOUN
dti-1330	187	15	)	)	PUNCT
dti-1330	187	16	in	in	ADP
dti-1330	187	17	bladder	bladder	NOUN
dti-1330	187	18	tumor	tumor	NOUN
dti-1330	187	19	(	(	PUNCT
dti-1330	187	20	bt	bt	NOUN
dti-1330	187	21	)	)	PUNCT
dti-1330	187	22	cell	cell	NOUN
dti-1330	187	23	line	line	NOUN
dti-1330	187	24	and	and	CCONJ
dti-1330	187	25	normal	normal	ADJ
dti-1330	187	26	bladder	bladder	NOUN
dti-1330	187	27	(	(	PUNCT
dti-1330	187	28	nb	nb	NOUN
dti-1330	187	29	)	)	PUNCT
dti-1330	187	30	cell	cell	NOUN
dti-1330	187	31	line	line	NOUN
dti-1330	187	32	.	.	PUNCT
dti-1330	188	1	using	use	VERB
dti-1330	188	2	specifi	specifi	PROPN
dti-1330	188	3	c	c	PROPN
dti-1330	188	4	primers	primer	NOUN
dti-1330	188	5	for	for	ADP
dti-1330	188	6	5and	5and	NUM
dti-1330	188	7	12	12	NUM
dti-1330	188	8	-	-	PUNCT
dti-1330	188	9	lox	lox	NOUN
dti-1330	188	10	,	,	PUNCT
dti-1330	188	11	the	the	DET
dti-1330	188	12	amplifi	amplifi	NOUN
dti-1330	188	13	cation	cation	NOUN
dti-1330	188	14	predicted	predict	VERB
dti-1330	188	15	fragments	fragment	NOUN
dti-1330	188	16	of	of	ADP
dti-1330	188	17	337	337	NUM
dti-1330	188	18	bp	bp	NOUN
dti-1330	188	19	for	for	ADP
dti-1330	188	20	5	5	NUM
dti-1330	188	21	-	-	PUNCT
dti-1330	188	22	lox	lox	NOUN
dti-1330	188	23	and	and	CCONJ
dti-1330	188	24	345	345	NUM
dti-1330	188	25	bp	bp	NOUN
dti-1330	188	26	for	for	ADP
dti-1330	188	27	12	12	NUM
dti-1330	188	28	-	-	PUNCT
dti-1330	188	29	lox	lox	NOUN
dti-1330	188	30	in	in	ADP
dti-1330	188	31	length	length	NOUN
dti-1330	188	32	.	.	PUNCT
dti-1330	189	1	a	a	DET
dti-1330	189	2	;	;	PUNCT
dti-1330	189	3	5	5	NUM
dti-1330	189	4	-	-	PUNCT
dti-1330	189	5	lox	lox	NOUN
dti-1330	189	6	,	,	PUNCT
dti-1330	189	7	b	b	NOUN
dti-1330	189	8	;	;	PUNCT
dti-1330	189	9	12	12	NUM
dti-1330	189	10	-	-	PUNCT
dti-1330	189	11	lox	lox	PROPN
dti-1330	189	12	.	.	PUNCT
dti-1330	189	13	lane	lane	PROPN
dti-1330	189	14	1	1	NUM
dti-1330	189	15	;	;	PUNCT
dti-1330	189	16	nb	nb	NOUN
dti-1330	189	17	cells	cell	NOUN
dti-1330	189	18	,	,	PUNCT
dti-1330	189	19	lane	lane	NOUN
dti-1330	189	20	2	2	NUM
dti-1330	189	21	;	;	PUNCT
dti-1330	189	22	bt	bt	NOUN
dti-1330	189	23	cells	cell	NOUN
dti-1330	189	24	.	.	PUNCT
dti-1330	190	1	bt	bt	NOUN
dti-1330	190	2	cells	cell	NOUN
dti-1330	190	3	expressed	express	VERB
dti-1330	190	4	signifi	signifi	NOUN
dti-1330	190	5	ca	can	AUX
dti-1330	190	6	nt	not	PART
dti-1330	190	7	5and	5and	NOUN
dti-1330	190	8	12	12	NUM
dti-1330	190	9	-	-	PUNCT
dti-1330	190	10	lox	lox	NOUN
dti-1330	190	11	mrna	mrna	PROPN
dti-1330	190	12	bands	band	NOUN
dti-1330	190	13	while	while	SCONJ
dti-1330	190	14	nb	nb	PROPN
dti-1330	190	15	cells	cell	NOUN
dti-1330	190	16	expressed	express	VERB
dti-1330	190	17	no	no	DET
dti-1330	190	18	5and	5and	NUM
dti-1330	190	19	12	12	NUM
dti-1330	190	20	-	-	PUNCT
dti-1330	190	21	lox	lox	NOUN
dti-1330	190	22	mrna	mrna	PROPN
dti-1330	190	23	bands	bands	PROPN
dti-1330	190	24	.	.	PUNCT
dti-1330	191	1	table	table	NOUN
dti-1330	191	2	2	2	NUM
dti-1330	191	3	.	.	PUNCT
dti-1330	192	1	statistical	statistical	ADJ
dti-1330	192	2	analysis	analysis	NOUN
dti-1330	192	3	of	of	ADP
dti-1330	192	4	5and	5and	NUM
dti-1330	192	5	12	12	NUM
dti-1330	192	6	-	-	PUNCT
dti-1330	192	7	lox	lox	NOUN
dti-1330	192	8	immunostaining	immunostaining	NOUN
dti-1330	192	9	.	.	PUNCT
dti-1330	193	1	av	av	PROPN
dti-1330	193	2	.	.	PUNCT
dti-1330	193	3	±	±	PROPN
dti-1330	193	4	sd	sd	ADP
dti-1330	193	5	tumor	tumor	NOUN
dti-1330	193	6	type	type	NOUN
dti-1330	193	7	epithelium	epithelium	NOUN
dti-1330	193	8	blood	blood	NOUN
dti-1330	193	9	vessel	vessel	NOUN
dti-1330	193	10	5	5	NUM
dti-1330	193	11	-	-	PUNCT
dti-1330	193	12	lox	lox	NOUN
dti-1330	193	13	immunostaining	immunostaine	VERB
dti-1330	193	14	seminoma	seminoma	NOUN
dti-1330	193	15	2.3	2.3	NUM
dti-1330	193	16	±	±	NUM
dti-1330	193	17	0.8	0.8	NUM
dti-1330	193	18	*	*	SYM
dti-1330	193	19	1.9	1.9	NUM
dti-1330	193	20	±	±	NUM
dti-1330	193	21	0.7	0.7	NUM
dti-1330	193	22	*	*	NOUN
dti-1330	193	23	embryonal	embryonal	ADJ
dti-1330	193	24	carcinoma	carcinoma	NOUN
dti-1330	193	25	2.8	2.8	NUM
dti-1330	193	26	±	±	NUM
dti-1330	193	27	0.8	0.8	NUM
dti-1330	193	28	*	*	SYM
dti-1330	193	29	2.3	2.3	NUM
dti-1330	193	30	±	±	NUM
dti-1330	193	31	0.7	0.7	NUM
dti-1330	193	32	*	*	NUM
dti-1330	193	33	yolk	yolk	NOUN
dti-1330	193	34	sac	sac	NOUN
dti-1330	193	35	tumor	tumor	NOUN
dti-1330	193	36	1.6	1.6	NUM
dti-1330	193	37	±	±	NUM
dti-1330	193	38	0.6	0.6	NUM
dti-1330	193	39	*	*	SYM
dti-1330	193	40	1.4	1.4	NUM
dti-1330	193	41	±	±	NUM
dti-1330	193	42	0.6	0.6	NUM
dti-1330	193	43	*	*	PUNCT
dti-1330	193	44	choriocarcinoma	choriocarcinoma	VERB
dti-1330	193	45	2.4	2.4	NUM
dti-1330	193	46	±	±	NUM
dti-1330	193	47	0.6	0.6	NUM
dti-1330	193	48	*	*	SYM
dti-1330	193	49	1.9	1.9	NUM
dti-1330	193	50	±	±	NUM
dti-1330	193	51	0.5	0.5	NUM
dti-1330	193	52	*	*	NOUN
dti-1330	193	53	teratoma	teratoma	NOUN
dti-1330	193	54	2.5	2.5	NUM
dti-1330	193	55	±	±	NUM
dti-1330	193	56	0.7	0.7	NUM
dti-1330	193	57	*	*	SYM
dti-1330	193	58	2.0	2.0	NUM
dti-1330	193	59	±	±	NUM
dti-1330	193	60	0.6	0.6	NUM
dti-1330	193	61	*	*	NOUN
dti-1330	193	62	normal	normal	ADJ
dti-1330	193	63	testis	testis	NOUN
dti-1330	193	64	0.9	0.9	NUM
dti-1330	193	65	±	±	NUM
dti-1330	193	66	0.5	0.5	NUM
dti-1330	193	67	0.7	0.7	NUM
dti-1330	193	68	±	±	NUM
dti-1330	193	69	0.5	0.5	NUM
dti-1330	193	70	12	12	NUM
dti-1330	193	71	-	-	PUNCT
dti-1330	193	72	lox	lox	NOUN
dti-1330	193	73	immunostaining	immunostaine	VERB
dti-1330	193	74	seminoma	seminoma	NOUN
dti-1330	193	75	2.0	2.0	NUM
dti-1330	193	76	±	±	NUM
dti-1330	193	77	0.8	0.8	NUM
dti-1330	193	78	*	*	SYM
dti-1330	193	79	1.6	1.6	NUM
dti-1330	193	80	±	±	NUM
dti-1330	193	81	0.8	0.8	NUM
dti-1330	193	82	*	*	PUNCT
dti-1330	193	83	embryonal	embryonal	ADJ
dti-1330	193	84	carcinoma	carcinoma	NOUN
dti-1330	193	85	2.4	2.4	NUM
dti-1330	193	86	±	±	NUM
dti-1330	193	87	0.6	0.6	NUM
dti-1330	193	88	*	*	SYM
dti-1330	193	89	1.9	1.9	NUM
dti-1330	193	90	±	±	NUM
dti-1330	193	91	0.9	0.9	NUM
dti-1330	193	92	*	*	PUNCT
dti-1330	193	93	yolk	yolk	NOUN
dti-1330	193	94	sac	sac	NOUN
dti-1330	193	95	tumor	tumor	NOUN
dti-1330	193	96	1.3	1.3	NUM
dti-1330	193	97	±	±	NUM
dti-1330	193	98	0.5	0.5	NUM
dti-1330	193	99	*	*	PROPN
dti-1330	193	100	1.2	1.2	NUM
dti-1330	193	101	±	±	NUM
dti-1330	193	102	0.6	0.6	NUM
dti-1330	193	103	*	*	PUNCT
dti-1330	193	104	choriocarcinoma	choriocarcinoma	VERB
dti-1330	193	105	2.1	2.1	NUM
dti-1330	193	106	±	±	NUM
dti-1330	193	107	0.7	0.7	NUM
dti-1330	193	108	*	*	SYM
dti-1330	193	109	1.7	1.7	NUM
dti-1330	193	110	±	±	NUM
dti-1330	193	111	0.5	0.5	NUM
dti-1330	193	112	*	*	NOUN
dti-1330	193	113	teratoma	teratoma	NOUN
dti-1330	193	114	2.3	2.3	NUM
dti-1330	193	115	±	±	NOUN
dti-1330	193	116	0.8	0.8	NUM
dti-1330	193	117	*	*	SYM
dti-1330	193	118	1.9	1.9	NUM
dti-1330	193	119	±	±	NUM
dti-1330	193	120	0.7	0.7	NUM
dti-1330	193	121	*	*	NOUN
dti-1330	193	122	normal	normal	ADJ
dti-1330	193	123	testis	testis	NOUN
dti-1330	193	124	0.9	0.9	NUM
dti-1330	193	125	±	±	NUM
dti-1330	193	126	0.5	0.5	NUM
dti-1330	193	127	0.6	0.6	NUM
dti-1330	193	128	±	±	NUM
dti-1330	193	129	0.4	0.4	NUM
dti-1330	193	130	note	note	NOUN
dti-1330	193	131	:	:	PUNCT
dti-1330	193	132	graded	grade	VERB
dti-1330	193	133	0	0	NUM
dti-1330	193	134	to	to	ADP
dti-1330	193	135	4	4	NUM
dti-1330	193	136	on	on	ADP
dti-1330	193	137	the	the	DET
dti-1330	193	138	coded	code	VERB
dti-1330	193	139	sections	section	NOUN
dti-1330	193	140	by	by	ADP
dti-1330	193	141	two	two	NUM
dti-1330	193	142	observers	observer	NOUN
dti-1330	193	143	in	in	ADP
dti-1330	193	144	a	a	DET
dti-1330	193	145	blinded	blinded	ADJ
dti-1330	193	146	manner	manner	NOUN
dti-1330	193	147	.	.	PUNCT
dti-1330	193	148	0	0	NUM
dti-1330	193	149	,	,	PUNCT
dti-1330	193	150	no	no	DET
dti-1330	193	151	staining	staining	NOUN
dti-1330	193	152	;	;	PUNCT
dti-1330	193	153	4	4	NUM
dti-1330	193	154	,	,	PUNCT
dti-1330	193	155	maximum	maximum	ADJ
dti-1330	193	156	intensity	intensity	NOUN
dti-1330	193	157	.	.	PUNCT
dti-1330	194	1	statistical	statistical	ADJ
dti-1330	194	2	analysis	analysis	NOUN
dti-1330	194	3	was	be	AUX
dti-1330	194	4	performed	perform	VERB
dti-1330	194	5	using	use	VERB
dti-1330	194	6	the	the	DET
dti-1330	194	7	analysis	analysis	NOUN
dti-1330	194	8	of	of	ADP
dti-1330	194	9	variance	variance	NOUN
dti-1330	194	10	(	(	PUNCT
dti-1330	194	11	p	p	NOUN
dti-1330	194	12	value	value	NOUN
dti-1330	194	13	;	;	PUNCT
dti-1330	194	14	anova	anova	PROPN
dti-1330	194	15	)	)	PUNCT
dti-1330	194	16	.	.	PUNCT
dti-1330	195	1	5	5	NUM
dti-1330	195	2	-	-	PUNCT
dti-1330	195	3	and	and	CCONJ
dti-1330	195	4	12	12	NUM
dti-1330	195	5	-	-	PUNCT
dti-1330	195	6	lox	lox	NOUN
dti-1330	195	7	immunostaining	immunostaining	NOUN
dti-1330	195	8	were	be	AUX
dti-1330	195	9	more	more	ADV
dti-1330	195	10	intense	intense	ADJ
dti-1330	195	11	and	and	CCONJ
dti-1330	195	12	diffuse	diffuse	NOUN
dti-1330	195	13	in	in	ADP
dti-1330	195	14	testicular	testicular	ADJ
dti-1330	195	15	tumor	tumor	NOUN
dti-1330	195	16	tissues	tissue	NOUN
dti-1330	195	17	than	than	ADP
dti-1330	195	18	in	in	ADP
dti-1330	195	19	the	the	DET
dti-1330	195	20	normal	normal	ADJ
dti-1330	195	21	testicular	testicular	ADJ
dti-1330	195	22	tissues	tissue	NOUN
dti-1330	195	23	.	.	PUNCT
dti-1330	196	1	p	p	PROPN
dti-1330	196	2	�	�	PROPN
dti-1330	196	3	0.001	0.001	NUM
dti-1330	196	4	.	.	PUNCT
dti-1330	197	1	a	a	DET
dti-1330	197	2	b	b	NUM
dti-1330	197	3	147	147	NUM
dti-1330	197	4	5	5	NUM
dti-1330	197	5	-	-	NOUN
dti-1330	197	6	lipoxygenase	lipoxygenase	NOUN
dti-1330	197	7	in	in	ADP
dti-1330	197	8	urological	urological	ADJ
dti-1330	197	9	tumor	tumor	NOUN
dti-1330	197	10	drug	drug	NOUN
dti-1330	197	11	target	target	NOUN
dti-1330	197	12	insights	insight	NOUN
dti-1330	197	13	2008:3	2008:3	NUM
dti-1330	197	14	pc	pc	NOUN
dti-1330	197	15	cell	cell	NOUN
dti-1330	197	16	line	line	NOUN
dti-1330	197	17	similar	similar	ADJ
dti-1330	197	18	to	to	ADP
dti-1330	197	19	rcc	rcc	PROPN
dti-1330	197	20	and	and	CCONJ
dti-1330	197	21	bt	bt	NOUN
dti-1330	197	22	cells	cell	NOUN
dti-1330	197	23	,	,	PUNCT
dti-1330	197	24	pc	pc	NOUN
dti-1330	197	25	cells	cell	NOUN
dti-1330	197	26	treated	treat	VERB
dti-1330	197	27	with	with	ADP
dti-1330	197	28	100	100	NUM
dti-1330	197	29	μm	μm	NUM
dti-1330	197	30	5	5	NUM
dti-1330	197	31	-	-	PUNCT
dti-1330	197	32	lox	lox	NOUN
dti-1330	197	33	inhibitor	inhibitor	NOUN
dti-1330	197	34	could	could	AUX
dti-1330	197	35	induce	induce	VERB
dti-1330	197	36	early	early	ADJ
dti-1330	197	37	apoptosis	apoptosis	NOUN
dti-1330	197	38	,	,	PUNCT
dti-1330	197	39	not	not	PART
dti-1330	197	40	late	late	ADJ
dti-1330	197	41	apoptosis	apoptosis	NOUN
dti-1330	197	42	or	or	CCONJ
dti-1330	197	43	necrosis	necrosis	NOUN
dti-1330	197	44	and	and	CCONJ
dti-1330	197	45	dna	dna	NOUN
dti-1330	197	46	fragmentation	fragmentation	NOUN
dti-1330	197	47	.	.	PUNCT
dti-1330	198	1	tc	tc	NOUN
dti-1330	198	2	cell	cell	NOUN
dti-1330	198	3	line	line	NOUN
dti-1330	198	4	similar	similar	ADJ
dti-1330	198	5	to	to	ADP
dti-1330	198	6	rcc	rcc	PROPN
dti-1330	198	7	,	,	PUNCT
dti-1330	198	8	bt	bt	NOUN
dti-1330	198	9	and	and	CCONJ
dti-1330	198	10	pc	pc	NOUN
dti-1330	198	11	cells	cell	NOUN
dti-1330	198	12	,	,	PUNCT
dti-1330	198	13	tc	tc	NUM
dti-1330	198	14	cells	cell	NOUN
dti-1330	198	15	treated	treat	VERB
dti-1330	198	16	with	with	ADP
dti-1330	198	17	100	100	NUM
dti-1330	198	18	μm	μm	NUM
dti-1330	198	19	5	5	NUM
dti-1330	198	20	-	-	PUNCT
dti-1330	198	21	lox	lox	NOUN
dti-1330	198	22	inhibitor	inhibitor	NOUN
dti-1330	198	23	could	could	AUX
dti-1330	198	24	induce	induce	VERB
dti-1330	198	25	early	early	ADJ
dti-1330	198	26	apoptosis	apoptosis	NOUN
dti-1330	198	27	,	,	PUNCT
dti-1330	198	28	not	not	PART
dti-1330	198	29	late	late	ADJ
dti-1330	198	30	apoptosis	apoptosis	NOUN
dti-1330	198	31	or	or	CCONJ
dti-1330	198	32	necrosis	necrosis	NOUN
dti-1330	198	33	and	and	CCONJ
dti-1330	198	34	dna	dna	NOUN
dti-1330	198	35	fragmentation	fragmentation	NOUN
dti-1330	198	36	.	.	PUNCT
dti-1330	199	1	2	2	X
dti-1330	199	2	)	)	PUNCT
dti-1330	199	3	hoechest	hoech	ADJ
dti-1330	199	4	staining	stain	VERB
dti-1330	199	5	rcc	rcc	PROPN
dti-1330	199	6	cell	cell	NOUN
dti-1330	199	7	line	line	NOUN
dti-1330	199	8	rcc	rcc	PROPN
dti-1330	199	9	cells	cell	NOUN
dti-1330	199	10	treated	treat	VERB
dti-1330	199	11	with	with	ADP
dti-1330	199	12	50	50	NUM
dti-1330	199	13	μm	μm	NUM
dti-1330	199	14	5	5	NUM
dti-1330	199	15	-	-	PUNCT
dti-1330	199	16	lox	lox	NOUN
dti-1330	199	17	inhibitors	inhibitor	NOUN
dti-1330	199	18	caffeic	caffeic	VERB
dti-1330	199	19	acid	acid	PROPN
dti-1330	199	20	,	,	PUNCT
dti-1330	199	21	and	and	CCONJ
dti-1330	199	22	non	non	ADJ
dti-1330	199	23	-	-	ADJ
dti-1330	199	24	specifi	specifi	ADJ
dti-1330	199	25	c	c	PROPN
dti-1330	199	26	lox	lox	PROPN
dti-1330	199	27	inhibitor	inhibitor	PROPN
dti-1330	199	28	ndga	ndga	ADV
dti-1330	199	29	showed	show	VERB
dti-1330	199	30	chromatin	chromatin	NOUN
dti-1330	199	31	condensation	condensation	NOUN
dti-1330	199	32	,	,	PUNCT
dti-1330	199	33	cellular	cellular	ADJ
dti-1330	199	34	shrinkage	shrinkage	NOUN
dti-1330	199	35	,	,	PUNCT
dti-1330	199	36	small	small	ADJ
dti-1330	199	37	membrane	membrane	NOUN
dti-1330	199	38	-	-	PUNCT
dti-1330	199	39	bound	bind	VERB
dti-1330	199	40	bodies	body	NOUN
dti-1330	199	41	(	(	PUNCT
dti-1330	199	42	apoptotic	apoptotic	ADJ
dti-1330	199	43	bodies	body	NOUN
dti-1330	199	44	)	)	PUNCT
dti-1330	199	45	,	,	PUNCT
dti-1330	199	46	and	and	CCONJ
dti-1330	199	47	cytoplasmic	cytoplasmic	ADJ
dti-1330	199	48	condensation	condensation	NOUN
dti-1330	199	49	.	.	PUNCT
dti-1330	200	1	cells	cell	NOUN
dti-1330	200	2	with	with	ADP
dti-1330	200	3	12	12	NUM
dti-1330	200	4	-	-	PUNCT
dti-1330	200	5	lox	lox	NOUN
dti-1330	200	6	inhibitor	inhibitor	PROPN
dti-1330	200	7	baicalein	baicalein	PROPN
dti-1330	200	8	showed	show	VERB
dti-1330	200	9	the	the	DET
dti-1330	200	10	same	same	ADJ
dti-1330	200	11	apoptotic	apoptotic	ADJ
dti-1330	200	12	changes	change	NOUN
dti-1330	200	13	slightly	slightly	ADV
dti-1330	200	14	.	.	PUNCT
dti-1330	201	1	in	in	ADP
dti-1330	201	2	contrast	contrast	NOUN
dti-1330	201	3	,	,	PUNCT
dti-1330	201	4	untreated	untreated	ADJ
dti-1330	201	5	cells	cell	NOUN
dti-1330	201	6	maintained	maintain	VERB
dti-1330	201	7	normal	normal	ADJ
dti-1330	201	8	chromatin	chromatin	NOUN
dti-1330	201	9	patterns	pattern	NOUN
dti-1330	201	10	and	and	CCONJ
dti-1330	201	11	cell	cell	NOUN
dti-1330	201	12	size	size	NOUN
dti-1330	201	13	.	.	PUNCT
dti-1330	202	1	caki-1	caki-1	PROPN
dti-1330	202	2	prtec	prtec	VERB
dti-1330	202	3	a	a	DET
dti-1330	202	4	nn	nn	X
dti-1330	202	5	ex	ex	X
dti-1330	202	6	in	in	ADP
dti-1330	202	7	-v	-v	PRON
dti-1330	203	1	-f	-f	INTJ
dti-1330	203	2	it	it	PRON
dti-1330	203	3	c	c	VERB
dti-1330	203	4	a	a	PRON
dti-1330	203	5	nn	nn	X
dti-1330	203	6	ex	ex	X
dti-1330	203	7	in	in	ADP
dti-1330	203	8	-v	-v	PRON
dti-1330	204	1	-f	-f	INTJ
dti-1330	204	2	it	it	PRON
dti-1330	204	3	c	c	VERB
dti-1330	204	4	a	a	PRON
dti-1330	204	5	nn	nn	X
dti-1330	204	6	ex	ex	X
dti-1330	204	7	in	in	ADP
dti-1330	204	8	-v	-v	PRON
dti-1330	205	1	-f	-f	INTJ
dti-1330	205	2	it	it	PRON
dti-1330	205	3	c	c	VERB
dti-1330	205	4	a	a	PRON
dti-1330	205	5	nn	nn	X
dti-1330	205	6	ex	ex	X
dti-1330	205	7	in	in	ADP
dti-1330	205	8	-v	-v	PRON
dti-1330	206	1	-f	-f	NUM
dti-1330	206	2	it	it	PRON
dti-1330	206	3	c	c	VERB
dti-1330	207	1	99.5	99.5	NUM
dti-1330	207	2	%	%	NOUN
dti-1330	207	3	74.2	74.2	NUM
dti-1330	207	4	%	%	NOUN
dti-1330	207	5	25.8	25.8	NUM
dti-1330	207	6	%	%	NOUN
dti-1330	207	7	control	control	PROPN
dti-1330	207	8	control	control	PROPN
dti-1330	207	9	100μm	100μm	PROPN
dti-1330	207	10	5	5	NUM
dti-1330	207	11	-	-	PUNCT
dti-1330	207	12	lox	lox	NOUN
dti-1330	207	13	inhibitor	inhibitor	NOUN
dti-1330	207	14	100μm	100μm	PROPN
dti-1330	207	15	5	5	NUM
dti-1330	207	16	-	-	PUNCT
dti-1330	207	17	lox	lox	NOUN
dti-1330	207	18	inhibitor	inhibitor	NOUN
dti-1330	207	19	99.6	99.6	NUM
dti-1330	207	20	%	%	NOUN
dti-1330	207	21	95.9	95.9	NUM
dti-1330	207	22	%	%	NOUN
dti-1330	207	23	pi	pi	NOUN
dti-1330	207	24	pi	pi	PROPN
dti-1330	207	25	pi	pi	PROPN
dti-1330	207	26	pi	pi	PROPN
dti-1330	207	27	4.1	4.1	NUM
dti-1330	207	28	%	%	NOUN
dti-1330	207	29	0.4	0.4	NUM
dti-1330	207	30	%	%	NOUN
dti-1330	207	31	0.5	0.5	NUM
dti-1330	207	32	%	%	NOUN
dti-1330	207	33	figure	figure	NOUN
dti-1330	207	34	4	4	NUM
dti-1330	207	35	.	.	PUNCT
dti-1330	207	36	effects	effect	NOUN
dti-1330	207	37	of	of	ADP
dti-1330	207	38	5	5	NUM
dti-1330	207	39	-	-	PUNCT
dti-1330	207	40	lipoxygenase	lipoxygenase	NOUN
dti-1330	207	41	(	(	PUNCT
dti-1330	207	42	lox	lox	NOUN
dti-1330	207	43	)	)	PUNCT
dti-1330	207	44	inhibitor	inhibitor	NOUN
dti-1330	207	45	on	on	ADP
dti-1330	207	46	early	early	ADJ
dti-1330	207	47	and	and	CCONJ
dti-1330	207	48	late	late	ADJ
dti-1330	207	49	apoptosis	apoptosis	NOUN
dti-1330	207	50	as	as	SCONJ
dti-1330	207	51	shown	show	VERB
dti-1330	207	52	by	by	ADP
dti-1330	207	53	fl	fl	INTJ
dti-1330	207	54	ow	ow	INTJ
dti-1330	207	55	cytometry	cytometry	PROPN
dti-1330	207	56	on	on	ADP
dti-1330	207	57	human	human	ADJ
dti-1330	207	58	renal	renal	ADJ
dti-1330	207	59	cell	cell	NOUN
dti-1330	207	60	carcinoma	carcinoma	NOUN
dti-1330	207	61	(	(	PUNCT
dti-1330	207	62	rcc	rcc	PROPN
dti-1330	207	63	)	)	PUNCT
dti-1330	207	64	cells	cell	NOUN
dti-1330	207	65	.	.	PUNCT
dti-1330	208	1	treatment	treatment	NOUN
dti-1330	208	2	with	with	ADP
dti-1330	208	3	100	100	NUM
dti-1330	208	4	μm	μm	NUM
dti-1330	208	5	5	5	NUM
dti-1330	208	6	-	-	PUNCT
dti-1330	208	7	lox	lox	NOUN
dti-1330	208	8	inhibitor	inhibitor	NOUN
dti-1330	208	9	induced	induce	VERB
dti-1330	208	10	early	early	ADJ
dti-1330	208	11	apoptosis	apoptosis	NOUN
dti-1330	208	12	in	in	ADP
dti-1330	208	13	most	most	ADJ
dti-1330	208	14	of	of	ADP
dti-1330	208	15	the	the	DET
dti-1330	208	16	total	total	ADJ
dti-1330	208	17	percentage	percentage	NOUN
dti-1330	208	18	of	of	ADP
dti-1330	208	19	rcc	rcc	PROPN
dti-1330	208	20	cells	cell	NOUN
dti-1330	208	21	.	.	PUNCT
dti-1330	209	1	however	however	ADV
dti-1330	209	2	,	,	PUNCT
dti-1330	209	3	treatment	treatment	NOUN
dti-1330	209	4	with	with	ADP
dti-1330	209	5	100μm	100μm	ADJ
dti-1330	209	6	5	5	NUM
dti-1330	209	7	-	-	PUNCT
dti-1330	209	8	lox	lox	NOUN
dti-1330	209	9	inhibitor	inhibitor	NOUN
dti-1330	209	10	did	do	AUX
dti-1330	209	11	not	not	PART
dti-1330	209	12	induce	induce	VERB
dti-1330	209	13	apoptosis	apoptosis	NOUN
dti-1330	209	14	in	in	ADP
dti-1330	209	15	normal	normal	ADJ
dti-1330	209	16	proximal	proximal	ADJ
dti-1330	209	17	tubular	tubular	ADJ
dti-1330	209	18	endothelial	endothelial	ADJ
dti-1330	209	19	cells	cell	NOUN
dti-1330	209	20	(	(	PUNCT
dti-1330	209	21	prtec	prtec	NOUN
dti-1330	209	22	)	)	PUNCT
dti-1330	209	23	.	.	PUNCT
dti-1330	210	1	the	the	DET
dti-1330	210	2	top	top	ADJ
dti-1330	210	3	left	left	ADJ
dti-1330	210	4	quadrants	quadrant	NOUN
dti-1330	210	5	represent	represent	VERB
dti-1330	210	6	early	early	ADJ
dti-1330	210	7	apoptosis	apoptosis	NOUN
dti-1330	210	8	(	(	PUNCT
dti-1330	210	9	annexin	annexin	NOUN
dti-1330	210	10	v	v	NOUN
dti-1330	210	11	-	-	PUNCT
dti-1330	210	12	fitc	fitc	NOUN
dti-1330	210	13	-	-	PUNCT
dti-1330	210	14	positive	positive	ADJ
dti-1330	210	15	cells	cell	NOUN
dti-1330	210	16	and	and	CCONJ
dti-1330	210	17	pi	pi	NOUN
dti-1330	210	18	-	-	PUNCT
dti-1330	210	19	negative	negative	ADJ
dti-1330	210	20	cells	cell	NOUN
dti-1330	210	21	)	)	PUNCT
dti-1330	210	22	.	.	PUNCT
dti-1330	211	1	the	the	DET
dti-1330	211	2	top	top	ADJ
dti-1330	211	3	right	right	ADJ
dti-1330	211	4	quadrants	quadrant	NOUN
dti-1330	211	5	represent	represent	VERB
dti-1330	211	6	late	late	ADJ
dti-1330	211	7	necrosis	necrosis	NOUN
dti-1330	211	8	and	and	CCONJ
dti-1330	211	9	necrosis	necrosis	NOUN
dti-1330	211	10	(	(	PUNCT
dti-1330	211	11	annexin	annexin	NOUN
dti-1330	211	12	v	v	NOUN
dti-1330	211	13	-	-	PUNCT
dti-1330	211	14	fitc	fitc	NOUN
dti-1330	211	15	-	-	PUNCT
dti-1330	211	16	positive	positive	ADJ
dti-1330	211	17	cells	cell	NOUN
dti-1330	211	18	and	and	CCONJ
dti-1330	211	19	pi	pi	NOUN
dti-1330	211	20	-	-	PUNCT
dti-1330	211	21	positive	positive	ADJ
dti-1330	211	22	cells	cell	NOUN
dti-1330	211	23	)	)	PUNCT
dti-1330	211	24	.	.	PUNCT
dti-1330	212	1	diagram	diagram	PROPN
dti-1330	212	2	of	of	ADP
dti-1330	212	3	fitc	fitc	PROPN
dti-1330	212	4	-	-	PUNCT
dti-1330	212	5	annexin	annexin	NOUN
dti-1330	212	6	v	v	NOUN
dti-1330	212	7	/	/	SYM
dti-1330	212	8	pi	pi	NOUN
dti-1330	212	9	fl	fl	INTJ
dti-1330	212	10	ow	ow	INTJ
dti-1330	212	11	cytometry	cytometry	PROPN
dti-1330	212	12	in	in	ADP
dti-1330	212	13	a	a	DET
dti-1330	212	14	representative	representative	ADJ
dti-1330	212	15	experiment	experiment	NOUN
dti-1330	212	16	are	be	AUX
dti-1330	212	17	presented	present	VERB
dti-1330	212	18	.	.	PUNCT
dti-1330	213	1	148	148	NUM
dti-1330	213	2	matsuyama	matsuyama	NOUN
dti-1330	213	3	and	and	CCONJ
dti-1330	213	4	yoshimura	yoshimura	VERB
dti-1330	213	5	drug	drug	NOUN
dti-1330	213	6	target	target	NOUN
dti-1330	213	7	insights	insight	NOUN
dti-1330	213	8	2008:3	2008:3	NUM
dti-1330	213	9	bt	bt	NOUN
dti-1330	213	10	cell	cell	NOUN
dti-1330	213	11	line	line	NOUN
dti-1330	213	12	similar	similar	ADJ
dti-1330	213	13	to	to	ADP
dti-1330	213	14	rcc	rcc	PROPN
dti-1330	213	15	cells	cell	NOUN
dti-1330	213	16	,	,	PUNCT
dti-1330	213	17	bt	bt	PROPN
dti-1330	213	18	cells	cell	NOUN
dti-1330	213	19	treated	treat	VERB
dti-1330	213	20	with	with	ADP
dti-1330	213	21	50	50	NUM
dti-1330	213	22	μm	μm	NUM
dti-1330	213	23	5	5	NUM
dti-1330	213	24	-	-	PUNCT
dti-1330	213	25	lox	lox	NOUN
dti-1330	213	26	inhibitors	inhibitor	NOUN
dti-1330	213	27	caffeic	caffeic	VERB
dti-1330	213	28	acid	acid	NOUN
dti-1330	213	29	(	(	PUNCT
dti-1330	213	30	b	b	NOUN
dti-1330	213	31	)	)	PUNCT
dti-1330	213	32	,	,	PUNCT
dti-1330	213	33	and	and	CCONJ
dti-1330	213	34	non	non	ADJ
dti-1330	213	35	-	-	ADJ
dti-1330	213	36	specifi	specifi	ADJ
dti-1330	213	37	c	c	PROPN
dti-1330	213	38	lox	lox	PROPN
dti-1330	213	39	inhibitor	inhibitor	PROPN
dti-1330	213	40	ndga	ndga	ADV
dti-1330	213	41	(	(	PUNCT
dti-1330	213	42	d	d	NOUN
dti-1330	213	43	)	)	PUNCT
dti-1330	213	44	showed	show	VERB
dti-1330	213	45	chromatin	chromatin	NOUN
dti-1330	213	46	condensation	condensation	NOUN
dti-1330	213	47	,	,	PUNCT
dti-1330	213	48	cellular	cellular	ADJ
dti-1330	213	49	shrinkage	shrinkage	NOUN
dti-1330	213	50	,	,	PUNCT
dti-1330	213	51	apoptotic	apoptotic	ADJ
dti-1330	213	52	bodies	body	NOUN
dti-1330	213	53	,	,	PUNCT
dti-1330	213	54	and	and	CCONJ
dti-1330	213	55	cytoplasmic	cytoplasmic	ADJ
dti-1330	213	56	condensation	condensation	NOUN
dti-1330	213	57	.	.	PUNCT
dti-1330	214	1	cells	cell	NOUN
dti-1330	214	2	with	with	ADP
dti-1330	214	3	12	12	NUM
dti-1330	214	4	-	-	PUNCT
dti-1330	214	5	lox	lox	NOUN
dti-1330	214	6	inhibitor	inhibitor	PROPN
dti-1330	214	7	baicalein	baicalein	PROPN
dti-1330	214	8	(	(	PUNCT
dti-1330	214	9	c	c	NOUN
dti-1330	214	10	)	)	PUNCT
dti-1330	214	11	showed	show	VERB
dti-1330	214	12	the	the	DET
dti-1330	214	13	same	same	ADJ
dti-1330	214	14	apoptotic	apoptotic	ADJ
dti-1330	214	15	changes	change	NOUN
dti-1330	214	16	slightly	slightly	ADV
dti-1330	214	17	.	.	PUNCT
dti-1330	215	1	in	in	ADP
dti-1330	215	2	contrast	contrast	NOUN
dti-1330	215	3	,	,	PUNCT
dti-1330	215	4	untreated	untreated	ADJ
dti-1330	215	5	cells	cell	NOUN
dti-1330	215	6	maintained	maintain	VERB
dti-1330	215	7	normal	normal	ADJ
dti-1330	215	8	chromatin	chromatin	NOUN
dti-1330	215	9	patterns	pattern	NOUN
dti-1330	215	10	and	and	CCONJ
dti-1330	215	11	cell	cell	NOUN
dti-1330	215	12	size	size	NOUN
dti-1330	215	13	(	(	PUNCT
dti-1330	215	14	a	a	NOUN
dti-1330	215	15	)	)	PUNCT
dti-1330	215	16	(	(	PUNCT
dti-1330	215	17	fig	fig	NOUN
dti-1330	215	18	.	.	PUNCT
dti-1330	216	1	6	6	NUM
dti-1330	216	2	)	)	PUNCT
dti-1330	216	3	.	.	PUNCT
dti-1330	217	1	pc	pc	NOUN
dti-1330	217	2	cell	cell	NOUN
dti-1330	217	3	line	line	NOUN
dti-1330	217	4	similar	similar	ADJ
dti-1330	217	5	to	to	ADP
dti-1330	217	6	rcc	rcc	PROPN
dti-1330	217	7	and	and	CCONJ
dti-1330	217	8	bt	bt	NOUN
dti-1330	217	9	cells	cell	NOUN
dti-1330	217	10	,	,	PUNCT
dti-1330	217	11	pc	pc	NOUN
dti-1330	217	12	cells	cell	NOUN
dti-1330	217	13	treated	treat	VERB
dti-1330	217	14	with	with	ADP
dti-1330	217	15	50	50	NUM
dti-1330	217	16	μm	μm	NUM
dti-1330	217	17	5	5	NUM
dti-1330	217	18	-	-	PUNCT
dti-1330	217	19	lox	lox	NOUN
dti-1330	217	20	inhibitors	inhibitor	NOUN
dti-1330	217	21	caffeic	caffeic	VERB
dti-1330	217	22	acid	acid	NOUN
dti-1330	217	23	,	,	PUNCT
dti-1330	217	24	and	and	CCONJ
dti-1330	217	25	nonspecifi	nonspecifi	PROPN
dti-1330	217	26	c	c	PROPN
dti-1330	217	27	lox	lox	PROPN
dti-1330	217	28	inhibitor	inhibitor	PROPN
dti-1330	217	29	ndga	ndga	ADV
dti-1330	217	30	showed	show	VERB
dti-1330	217	31	chromatin	chromatin	NOUN
dti-1330	217	32	condensation	condensation	NOUN
dti-1330	217	33	,	,	PUNCT
dti-1330	217	34	cellular	cellular	ADJ
dti-1330	217	35	shrinkage	shrinkage	NOUN
dti-1330	217	36	,	,	PUNCT
dti-1330	217	37	apoptotic	apoptotic	ADJ
dti-1330	217	38	bodies	body	NOUN
dti-1330	217	39	,	,	PUNCT
dti-1330	217	40	and	and	CCONJ
dti-1330	217	41	cytoplasmic	cytoplasmic	ADJ
dti-1330	217	42	condensation	condensation	NOUN
dti-1330	217	43	.	.	PUNCT
dti-1330	218	1	cells	cell	NOUN
dti-1330	218	2	with	with	ADP
dti-1330	218	3	12	12	NUM
dti-1330	218	4	-	-	PUNCT
dti-1330	218	5	lox	lox	NOUN
dti-1330	218	6	inhibitor	inhibitor	PROPN
dti-1330	218	7	baicalein	baicalein	PROPN
dti-1330	218	8	showed	show	VERB
dti-1330	218	9	the	the	DET
dti-1330	218	10	same	same	ADJ
dti-1330	218	11	apoptotic	apoptotic	ADJ
dti-1330	218	12	changes	change	NOUN
dti-1330	218	13	slightly	slightly	ADV
dti-1330	218	14	.	.	PUNCT
dti-1330	219	1	in	in	ADP
dti-1330	219	2	contrast	contrast	NOUN
dti-1330	219	3	,	,	PUNCT
dti-1330	219	4	untreated	untreated	ADJ
dti-1330	219	5	cells	cell	NOUN
dti-1330	219	6	maintained	maintain	VERB
dti-1330	219	7	normal	normal	ADJ
dti-1330	219	8	chromatin	chromatin	NOUN
dti-1330	219	9	patterns	pattern	NOUN
dti-1330	219	10	and	and	CCONJ
dti-1330	219	11	cell	cell	NOUN
dti-1330	219	12	size	size	NOUN
dti-1330	219	13	.	.	PUNCT
dti-1330	220	1	tc	tc	NOUN
dti-1330	220	2	cell	cell	NOUN
dti-1330	220	3	line	line	NOUN
dti-1330	220	4	similar	similar	ADJ
dti-1330	220	5	to	to	ADP
dti-1330	220	6	rcc	rcc	PROPN
dti-1330	220	7	,	,	PUNCT
dti-1330	220	8	bt	bt	NOUN
dti-1330	220	9	and	and	CCONJ
dti-1330	220	10	pc	pc	NOUN
dti-1330	220	11	cells	cell	NOUN
dti-1330	220	12	,	,	PUNCT
dti-1330	220	13	tc	tc	NUM
dti-1330	220	14	cells	cell	NOUN
dti-1330	220	15	treated	treat	VERB
dti-1330	220	16	with	with	ADP
dti-1330	220	17	50	50	NUM
dti-1330	220	18	μm	μm	NUM
dti-1330	220	19	5	5	NUM
dti-1330	220	20	-	-	PUNCT
dti-1330	220	21	lox	lox	NOUN
dti-1330	220	22	inhibitors	inhibitor	NOUN
dti-1330	220	23	caffeic	caffeic	VERB
dti-1330	220	24	acid	acid	PROPN
dti-1330	220	25	,	,	PUNCT
dti-1330	220	26	and	and	CCONJ
dti-1330	220	27	non	non	ADJ
dti-1330	220	28	-	-	ADJ
dti-1330	220	29	specific	specific	ADJ
dti-1330	220	30	lox	lox	NOUN
dti-1330	220	31	inhibitor	inhibitor	NOUN
dti-1330	220	32	ndga	ndga	ADV
dti-1330	220	33	showed	show	VERB
dti-1330	220	34	chromatin	chromatin	NOUN
dti-1330	220	35	condensation	condensation	NOUN
dti-1330	220	36	,	,	PUNCT
dti-1330	220	37	cellular	cellular	ADJ
dti-1330	220	38	shrinkage	shrinkage	NOUN
dti-1330	220	39	,	,	PUNCT
dti-1330	220	40	apoptotic	apoptotic	ADJ
dti-1330	220	41	bodies	body	NOUN
dti-1330	220	42	,	,	PUNCT
dti-1330	220	43	and	and	CCONJ
dti-1330	220	44	cytoplasmic	cytoplasmic	ADJ
dti-1330	220	45	condensation	condensation	NOUN
dti-1330	220	46	.	.	PUNCT
dti-1330	221	1	cells	cell	NOUN
dti-1330	221	2	with	with	ADP
dti-1330	221	3	12	12	NUM
dti-1330	221	4	-	-	PUNCT
dti-1330	221	5	lox	lox	NOUN
dti-1330	221	6	inhibitor	inhibitor	PROPN
dti-1330	221	7	baicalein	baicalein	PROPN
dti-1330	221	8	showed	show	VERB
dti-1330	221	9	the	the	DET
dti-1330	221	10	same	same	ADJ
dti-1330	221	11	apoptotic	apoptotic	ADJ
dti-1330	221	12	changes	change	NOUN
dti-1330	221	13	slightly	slightly	ADV
dti-1330	221	14	.	.	PUNCT
dti-1330	222	1	in	in	ADP
dti-1330	222	2	contrast	contrast	NOUN
dti-1330	222	3	,	,	PUNCT
dti-1330	222	4	untreated	untreated	ADJ
dti-1330	222	5	cells	cell	NOUN
dti-1330	222	6	maintained	maintain	VERB
dti-1330	222	7	normal	normal	ADJ
dti-1330	222	8	chromatin	chromatin	NOUN
dti-1330	222	9	patterns	pattern	NOUN
dti-1330	222	10	and	and	CCONJ
dti-1330	222	11	cell	cell	NOUN
dti-1330	222	12	size	size	NOUN
dti-1330	222	13	.	.	PUNCT
dti-1330	223	1	discussion	discussion	NOUN
dti-1330	223	2	with	with	ADP
dti-1330	223	3	recent	recent	ADJ
dti-1330	223	4	increases	increase	NOUN
dti-1330	223	5	in	in	ADP
dti-1330	223	6	routine	routine	ADJ
dti-1330	223	7	medical	medical	ADJ
dti-1330	223	8	check	check	NOUN
dti-1330	223	9	-	-	PUNCT
dti-1330	223	10	ups	up	NOUN
dti-1330	223	11	and	and	CCONJ
dti-1330	223	12	progress	progress	NOUN
dti-1330	223	13	in	in	ADP
dti-1330	223	14	diagnostic	diagnostic	ADJ
dti-1330	223	15	imaging	imaging	NOUN
dti-1330	223	16	techniques	technique	NOUN
dti-1330	223	17	,	,	PUNCT
dti-1330	223	18	the	the	DET
dti-1330	223	19	discoveries	discovery	NOUN
dti-1330	223	20	of	of	ADP
dti-1330	223	21	rcc	rcc	PROPN
dti-1330	223	22	have	have	AUX
dti-1330	223	23	risen	rise	VERB
dti-1330	223	24	.	.	PUNCT
dti-1330	224	1	the	the	DET
dti-1330	224	2	cause	cause	NOUN
dti-1330	224	3	of	of	ADP
dti-1330	224	4	rcc	rcc	PROPN
dti-1330	224	5	is	be	AUX
dti-1330	224	6	unknown	unknown	ADJ
dti-1330	224	7	.	.	PUNCT
dti-1330	225	1	rcc	rcc	PROPN
dti-1330	225	2	generally	generally	ADV
dti-1330	225	3	does	do	AUX
dti-1330	225	4	not	not	PART
dti-1330	225	5	respond	respond	VERB
dti-1330	225	6	well	well	ADV
dti-1330	225	7	to	to	PART
dti-1330	225	8	radiotherapy	radiotherapy	VERB
dti-1330	225	9	and	and	CCONJ
dti-1330	225	10	chemotherapy	chemotherapy	NOUN
dti-1330	225	11	compared	compare	VERB
dti-1330	225	12	to	to	ADP
dti-1330	225	13	many	many	ADJ
dti-1330	225	14	other	other	ADJ
dti-1330	225	15	types	type	NOUN
dti-1330	225	16	of	of	ADP
dti-1330	225	17	cancers	cancer	NOUN
dti-1330	225	18	,	,	PUNCT
dti-1330	225	19	and	and	CCONJ
dti-1330	225	20	anticancer	anticancer	NOUN
dti-1330	225	21	drugs	drug	NOUN
dti-1330	225	22	as	as	SCONJ
dti-1330	225	23	interleukin-2	interleukin-2	PRON
dti-1330	225	24	is	be	AUX
dti-1330	225	25	used	use	VERB
dti-1330	225	26	with	with	ADP
dti-1330	225	27	relative	relative	ADJ
dti-1330	225	28	success	success	NOUN
dti-1330	225	29	.	.	PUNCT
dti-1330	226	1	surgery	surgery	NOUN
dti-1330	226	2	is	be	AUX
dti-1330	226	3	currently	currently	ADV
dti-1330	226	4	the	the	DET
dti-1330	226	5	only	only	ADJ
dti-1330	226	6	therapeutic	therapeutic	ADJ
dti-1330	226	7	option	option	NOUN
dti-1330	226	8	.	.	PUNCT
dti-1330	227	1	hence	hence	ADV
dti-1330	227	2	,	,	PUNCT
dti-1330	227	3	new	new	ADJ
dti-1330	227	4	molecular	molecular	ADJ
dti-1330	227	5	targets	target	NOUN
dti-1330	227	6	are	be	AUX
dti-1330	227	7	needed	need	VERB
dti-1330	227	8	for	for	ADP
dti-1330	227	9	the	the	DET
dti-1330	227	10	treatment	treatment	NOUN
dti-1330	227	11	and	and	CCONJ
dti-1330	227	12	prevention	prevention	NOUN
dti-1330	227	13	of	of	ADP
dti-1330	227	14	rcc	rcc	PROPN
dti-1330	227	15	.	.	PUNCT
dti-1330	228	1	the	the	DET
dti-1330	228	2	natural	natural	ADJ
dti-1330	228	3	history	history	NOUN
dti-1330	228	4	of	of	ADP
dti-1330	228	5	bt	bt	PROPN
dti-1330	228	6	is	be	AUX
dti-1330	228	7	not	not	PART
dti-1330	228	8	well	well	ADV
dti-1330	228	9	understood	understand	VERB
dti-1330	228	10	,	,	PUNCT
dti-1330	228	11	but	but	CCONJ
dti-1330	228	12	exposure	exposure	NOUN
dti-1330	228	13	to	to	ADP
dti-1330	228	14	carcinogens	carcinogen	NOUN
dti-1330	228	15	,	,	PUNCT
dti-1330	228	16	including	include	VERB
dti-1330	228	17	aromatic	aromatic	ADJ
dti-1330	228	18	amines	amine	NOUN
dti-1330	228	19	,	,	PUNCT
dti-1330	228	20	is	be	AUX
dti-1330	228	21	considered	consider	VERB
dti-1330	228	22	a	a	DET
dti-1330	228	23	major	major	ADJ
dti-1330	228	24	risk	risk	NOUN
dti-1330	228	25	factors	factor	NOUN
dti-1330	228	26	for	for	ADP
dti-1330	228	27	the	the	DET
dti-1330	228	28	development	development	NOUN
dti-1330	228	29	of	of	ADP
dti-1330	228	30	bt	bt	PROPN
dti-1330	228	31	.	.	PUNCT
dti-1330	229	1	workers	worker	NOUN
dti-1330	229	2	exposed	expose	VERB
dti-1330	229	3	to	to	ADP
dti-1330	229	4	aromatic	aromatic	ADJ
dti-1330	229	5	caki-1	caki-1	NUM
dti-1330	229	6	1.2	1.2	NUM
dti-1330	229	7	%	%	NOUN
dti-1330	229	8	75.9	75.9	NUM
dti-1330	229	9	%	%	NOUN
dti-1330	229	10	dutp	dutp	NOUN
dti-1330	229	11	fitc	fitc	NOUN
dti-1330	229	12	dutp	dutp	PROPN
dti-1330	229	13	fitc	fitc	PROPN
dti-1330	229	14	control	control	PROPN
dti-1330	229	15	100μm	100μm	PROPN
dti-1330	229	16	5	5	NUM
dti-1330	229	17	-	-	PUNCT
dti-1330	229	18	lox	lox	NOUN
dti-1330	229	19	inhibitor	inhibitor	PROPN
dti-1330	229	20	dutp	dutp	PROPN
dti-1330	229	21	fitc	fitc	PROPN
dti-1330	229	22	dutp	dutp	PROPN
dti-1330	229	23	fitc	fitc	PROPN
dti-1330	229	24	control	control	PROPN
dti-1330	229	25	100μm	100μm	PROPN
dti-1330	229	26	5	5	NUM
dti-1330	229	27	-	-	PUNCT
dti-1330	229	28	lox	lox	NOUN
dti-1330	229	29	inhibitor	inhibitor	NOUN
dti-1330	229	30	prtec	prtec	VERB
dti-1330	229	31	1.6	1.6	NUM
dti-1330	229	32	%	%	NOUN
dti-1330	229	33	11.5	11.5	NUM
dti-1330	229	34	%	%	NOUN
dti-1330	229	35	figure	figure	NOUN
dti-1330	229	36	5	5	NUM
dti-1330	229	37	.	.	SYM
dti-1330	229	38	5	5	NUM
dti-1330	229	39	-	-	PUNCT
dti-1330	229	40	lipoxygenase	lipoxygenase	NOUN
dti-1330	229	41	induced	induce	VERB
dti-1330	229	42	dna	dna	PROPN
dti-1330	229	43	fragmentation	fragmentation	NOUN
dti-1330	229	44	in	in	ADP
dti-1330	229	45	human	human	ADJ
dti-1330	229	46	renal	renal	ADJ
dti-1330	229	47	cell	cell	NOUN
dti-1330	229	48	carcinoma	carcinoma	NOUN
dti-1330	229	49	(	(	PUNCT
dti-1330	229	50	rcc	rcc	PROPN
dti-1330	229	51	)	)	PUNCT
dti-1330	229	52	cells	cell	NOUN
dti-1330	229	53	.	.	PUNCT
dti-1330	230	1	treatment	treatment	NOUN
dti-1330	230	2	with	with	ADP
dti-1330	230	3	100	100	NUM
dti-1330	230	4	μm	μm	NUM
dti-1330	230	5	5	5	NUM
dti-1330	230	6	-	-	PUNCT
dti-1330	230	7	lox	lox	NOUN
dti-1330	230	8	inhibitor	inhibitor	NOUN
dti-1330	230	9	induced	induce	VERB
dti-1330	230	10	dna	dna	PROPN
dti-1330	230	11	fragmentation	fragmentation	NOUN
dti-1330	230	12	in	in	ADP
dti-1330	230	13	rcc	rcc	PROPN
dti-1330	230	14	cells	cell	NOUN
dti-1330	230	15	.	.	PUNCT
dti-1330	231	1	however	however	ADV
dti-1330	231	2	,	,	PUNCT
dti-1330	231	3	treatment	treatment	NOUN
dti-1330	231	4	with	with	ADP
dti-1330	231	5	100μm	100μm	ADJ
dti-1330	231	6	5	5	NUM
dti-1330	231	7	-	-	PUNCT
dti-1330	231	8	lox	lox	NOUN
dti-1330	231	9	inhibitor	inhibitor	NOUN
dti-1330	231	10	did	do	AUX
dti-1330	231	11	not	not	PART
dti-1330	231	12	induce	induce	VERB
dti-1330	231	13	dna	dna	ADJ
dti-1330	231	14	fragmentation	fragmentation	NOUN
dti-1330	231	15	in	in	ADP
dti-1330	231	16	normal	normal	ADJ
dti-1330	231	17	proximal	proximal	ADJ
dti-1330	231	18	tubular	tubular	ADJ
dti-1330	231	19	endothelial	endothelial	ADJ
dti-1330	231	20	cells	cell	NOUN
dti-1330	231	21	(	(	PUNCT
dti-1330	231	22	prtec	prtec	NOUN
dti-1330	231	23	)	)	PUNCT
dti-1330	231	24	.	.	PUNCT
dti-1330	232	1	typical	typical	ADJ
dti-1330	232	2	fl	fl	ADP
dti-1330	232	3	ow	ow	INTJ
dti-1330	232	4	cytometry	cytometry	NOUN
dti-1330	232	5	analysis	analysis	NOUN
dti-1330	232	6	histogram	histogram	NOUN
dti-1330	232	7	in	in	ADP
dti-1330	232	8	representative	representative	ADJ
dti-1330	232	9	experiment	experiment	NOUN
dti-1330	232	10	are	be	AUX
dti-1330	232	11	presented	present	VERB
dti-1330	232	12	.	.	PUNCT
dti-1330	233	1	149	149	NUM
dti-1330	233	2	5	5	NUM
dti-1330	233	3	-	-	NOUN
dti-1330	233	4	lipoxygenase	lipoxygenase	NOUN
dti-1330	233	5	in	in	ADP
dti-1330	233	6	urological	urological	ADJ
dti-1330	233	7	tumor	tumor	NOUN
dti-1330	233	8	drug	drug	NOUN
dti-1330	233	9	target	target	NOUN
dti-1330	233	10	insights	insight	VERB
dti-1330	233	11	2008:3	2008:3	NUM
dti-1330	233	12	amines	amine	NOUN
dti-1330	233	13	frequently	frequently	ADV
dti-1330	233	14	have	have	VERB
dti-1330	233	15	a	a	DET
dti-1330	233	16	mutated	mutate	VERB
dti-1330	233	17	p53	p53	NOUN
dti-1330	233	18	gene	gene	NOUN
dti-1330	233	19	,	,	PUNCT
dti-1330	233	20	a	a	DET
dti-1330	233	21	tumor	tumor	NOUN
dti-1330	233	22	suppressor	suppressor	NOUN
dti-1330	233	23	gene	gene	NOUN
dti-1330	233	24	involved	involve	VERB
dti-1330	233	25	in	in	ADP
dti-1330	233	26	the	the	DET
dti-1330	233	27	carcinogenesis	carcinogenesis	NOUN
dti-1330	233	28	of	of	ADP
dti-1330	233	29	many	many	ADJ
dti-1330	233	30	tumors	tumor	NOUN
dti-1330	233	31	.	.	PUNCT
dti-1330	234	1	pc	pc	NOUN
dti-1330	234	2	comprises	comprise	VERB
dti-1330	234	3	32	32	NUM
dti-1330	234	4	%	%	NOUN
dti-1330	234	5	of	of	ADP
dti-1330	234	6	all	all	DET
dti-1330	234	7	cancers	cancer	NOUN
dti-1330	234	8	in	in	ADP
dti-1330	234	9	american	american	ADJ
dti-1330	234	10	men	man	NOUN
dti-1330	234	11	and	and	CCONJ
dti-1330	234	12	is	be	AUX
dti-1330	234	13	on	on	ADP
dti-1330	234	14	the	the	DET
dti-1330	234	15	rise	rise	NOUN
dti-1330	234	16	worldwide	worldwide	ADV
dti-1330	234	17	.	.	PUNCT
dti-1330	235	1	because	because	SCONJ
dti-1330	235	2	of	of	ADP
dti-1330	235	3	increased	increase	VERB
dti-1330	235	4	screening	screening	NOUN
dti-1330	235	5	,	,	PUNCT
dti-1330	235	6	pc	pc	NOUN
dti-1330	235	7	is	be	AUX
dti-1330	235	8	frequently	frequently	ADV
dti-1330	235	9	diagnosed	diagnose	VERB
dti-1330	235	10	at	at	ADP
dti-1330	235	11	a	a	DET
dti-1330	235	12	clinically	clinically	ADV
dti-1330	235	13	localized	localize	VERB
dti-1330	235	14	stage	stage	NOUN
dti-1330	235	15	,	,	PUNCT
dti-1330	235	16	making	make	VERB
dti-1330	235	17	it	it	PRON
dti-1330	235	18	amenable	amenable	ADJ
dti-1330	235	19	to	to	ADP
dti-1330	235	20	the	the	DET
dti-1330	235	21	therapy	therapy	NOUN
dti-1330	235	22	.	.	PUNCT
dti-1330	236	1	nevertheless	nevertheless	ADV
dti-1330	236	2	,	,	PUNCT
dti-1330	236	3	it	it	PRON
dti-1330	236	4	remains	remain	VERB
dti-1330	236	5	the	the	DET
dti-1330	236	6	second	second	ADJ
dti-1330	236	7	most	most	ADV
dti-1330	236	8	common	common	ADJ
dti-1330	236	9	cause	cause	NOUN
dti-1330	236	10	of	of	ADP
dti-1330	236	11	cancer	cancer	NOUN
dti-1330	236	12	death	death	NOUN
dti-1330	236	13	in	in	ADP
dti-1330	236	14	men	man	NOUN
dti-1330	236	15	.	.	PUNCT
dti-1330	237	1	these	these	DET
dti-1330	237	2	patients	patient	NOUN
dti-1330	237	3	generally	generally	ADV
dti-1330	237	4	respond	respond	VERB
dti-1330	237	5	to	to	ADP
dti-1330	237	6	androgen	androgen	NOUN
dti-1330	237	7	deprivation	deprivation	NOUN
dti-1330	237	8	therapy	therapy	NOUN
dti-1330	237	9	,	,	PUNCT
dti-1330	237	10	but	but	CCONJ
dti-1330	237	11	the	the	DET
dti-1330	237	12	vast	vast	ADJ
dti-1330	237	13	majority	majority	NOUN
dti-1330	237	14	eventually	eventually	ADV
dti-1330	237	15	experience	experience	VERB
dti-1330	237	16	disease	disease	NOUN
dti-1330	237	17	progression	progression	NOUN
dti-1330	237	18	and	and	CCONJ
dti-1330	237	19	become	become	VERB
dti-1330	237	20	refractory	refractory	NOUN
dti-1330	237	21	to	to	ADP
dti-1330	237	22	sustained	sustain	VERB
dti-1330	237	23	hormonal	hormonal	ADJ
dti-1330	237	24	manipulation	manipulation	NOUN
dti-1330	237	25	.	.	PUNCT
dti-1330	238	1	typically	typically	ADV
dti-1330	238	2	,	,	PUNCT
dti-1330	238	3	such	such	ADJ
dti-1330	238	4	patients	patient	NOUN
dti-1330	238	5	progress	progress	VERB
dti-1330	238	6	with	with	ADP
dti-1330	238	7	a	a	DET
dti-1330	238	8	rise	rise	NOUN
dti-1330	238	9	in	in	ADP
dti-1330	238	10	their	their	PRON
dti-1330	238	11	serum	serum	NOUN
dti-1330	238	12	prostatespecific	prostatespecific	NOUN
dti-1330	238	13	antigen	antigen	ADJ
dti-1330	238	14	level	level	NOUN
dti-1330	238	15	.	.	PUNCT
dti-1330	239	1	unfortunately	unfortunately	ADV
dti-1330	239	2	,	,	PUNCT
dti-1330	239	3	standard	standard	ADJ
dti-1330	239	4	therapeutic	therapeutic	ADJ
dti-1330	239	5	options	option	NOUN
dti-1330	239	6	at	at	ADP
dti-1330	239	7	this	this	DET
dti-1330	239	8	stage	stage	NOUN
dti-1330	239	9	of	of	ADP
dti-1330	239	10	disease	disease	NOUN
dti-1330	239	11	are	be	AUX
dti-1330	239	12	limited	limit	VERB
dti-1330	239	13	,	,	PUNCT
dti-1330	239	14	and	and	CCONJ
dti-1330	239	15	while	while	SCONJ
dti-1330	239	16	there	there	PRON
dti-1330	239	17	has	have	AUX
dti-1330	239	18	been	be	AUX
dti-1330	239	19	some	some	DET
dti-1330	239	20	success	success	NOUN
dti-1330	239	21	with	with	ADP
dti-1330	239	22	chemotherapy	chemotherapy	NOUN
dti-1330	239	23	for	for	ADP
dti-1330	239	24	hormone	hormone	NOUN
dti-1330	239	25	-	-	PUNCT
dti-1330	239	26	refractory	refractory	NOUN
dti-1330	239	27	pc	pc	NOUN
dti-1330	239	28	patients	patient	NOUN
dti-1330	239	29	,	,	PUNCT
dti-1330	239	30	the	the	DET
dti-1330	239	31	response	response	NOUN
dti-1330	239	32	is	be	AUX
dti-1330	239	33	generally	generally	ADV
dti-1330	239	34	short	short	ADV
dti-1330	239	35	-	-	PUNCT
dti-1330	239	36	lived	live	VERB
dti-1330	239	37	[	[	X
dti-1330	239	38	12	12	NUM
dti-1330	239	39	]	]	PUNCT
dti-1330	239	40	.	.	PUNCT
dti-1330	240	1	tc	tc	PROPN
dti-1330	240	2	is	be	AUX
dti-1330	240	3	very	very	ADV
dti-1330	240	4	rare	rare	ADJ
dti-1330	240	5	with	with	ADP
dti-1330	240	6	over	over	ADP
dti-1330	240	7	90	90	NUM
dti-1330	240	8	%	%	NOUN
dti-1330	240	9	of	of	ADP
dti-1330	240	10	all	all	DET
dti-1330	240	11	tc	tc	NOUN
dti-1330	240	12	being	be	AUX
dti-1330	240	13	germ	germ	NOUN
dti-1330	240	14	cell	cell	NOUN
dti-1330	240	15	tumors	tumor	NOUN
dti-1330	240	16	(	(	PUNCT
dti-1330	240	17	seminoma	seminoma	NOUN
dti-1330	240	18	and	and	CCONJ
dti-1330	240	19	non	non	ADJ
dti-1330	240	20	-	-	NOUN
dti-1330	240	21	seminoma	seminoma	ADJ
dti-1330	240	22	)	)	PUNCT
dti-1330	240	23	,	,	PUNCT
dti-1330	240	24	and	and	CCONJ
dti-1330	240	25	the	the	DET
dti-1330	240	26	remaining	remain	VERB
dti-1330	240	27	percentage	percentage	NOUN
dti-1330	240	28	non	non	ADJ
dti-1330	240	29	-	-	ADJ
dti-1330	240	30	germinal	germinal	ADJ
dti-1330	240	31	tumors	tumor	NOUN
dti-1330	240	32	.	.	PUNCT
dti-1330	241	1	the	the	DET
dti-1330	241	2	survival	survival	NOUN
dti-1330	241	3	rate	rate	NOUN
dti-1330	241	4	of	of	ADP
dti-1330	241	5	tc	tc	PRON
dti-1330	241	6	has	have	AUX
dti-1330	241	7	improved	improve	VERB
dti-1330	241	8	in	in	ADP
dti-1330	241	9	recent	recent	ADJ
dti-1330	241	10	years	year	NOUN
dti-1330	241	11	,	,	PUNCT
dti-1330	241	12	refl	refl	NOUN
dti-1330	241	13	ecting	ecte	VERB
dti-1330	241	14	the	the	DET
dti-1330	241	15	development	development	NOUN
dti-1330	241	16	and	and	CCONJ
dti-1330	241	17	refi	refi	NOUN
dti-1330	241	18	nement	nement	ADJ
dti-1330	241	19	of	of	ADP
dti-1330	241	20	effective	effective	ADJ
dti-1330	241	21	combination	combination	NOUN
dti-1330	241	22	chemotherapy	chemotherapy	NOUN
dti-1330	241	23	.	.	PUNCT
dti-1330	242	1	however	however	ADV
dti-1330	242	2	,	,	PUNCT
dti-1330	242	3	it	it	PRON
dti-1330	242	4	is	be	AUX
dti-1330	242	5	still	still	ADV
dti-1330	242	6	necessary	necessary	ADJ
dti-1330	242	7	to	to	PART
dti-1330	242	8	improve	improve	VERB
dti-1330	242	9	the	the	DET
dti-1330	242	10	treatment	treatment	NOUN
dti-1330	242	11	of	of	ADP
dti-1330	242	12	tc	tc	NUM
dti-1330	242	13	.	.	PUNCT
dti-1330	243	1	non	non	ADJ
dti-1330	243	2	-	-	ADJ
dti-1330	243	3	steroidal	steroidal	ADJ
dti-1330	243	4	anti	anti	ADJ
dti-1330	243	5	-	-	ADJ
dti-1330	243	6	inflammatory	inflammatory	ADJ
dti-1330	243	7	drugs	drug	NOUN
dti-1330	243	8	(	(	PUNCT
dti-1330	243	9	nsaids	nsaid	NOUN
dti-1330	243	10	)	)	PUNCT
dti-1330	243	11	have	have	VERB
dti-1330	243	12	anti	anti	ADJ
dti-1330	243	13	-	-	ADJ
dti-1330	243	14	tumor	tumor	ADJ
dti-1330	243	15	effects	effect	NOUN
dti-1330	243	16	on	on	ADP
dti-1330	243	17	human	human	ADJ
dti-1330	243	18	urological	urological	ADJ
dti-1330	243	19	tumors	tumor	NOUN
dti-1330	243	20	(	(	PUNCT
dti-1330	243	21	rcc	rcc	PROPN
dti-1330	243	22	,	,	PUNCT
dti-1330	243	23	bt	bt	NOUN
dti-1330	243	24	,	,	PUNCT
dti-1330	243	25	pc	pc	NOUN
dti-1330	243	26	and	and	CCONJ
dti-1330	243	27	tc	tc	NUM
dti-1330	243	28	)	)	PUNCT
dti-1330	243	29	and	and	CCONJ
dti-1330	243	30	have	have	AUX
dti-1330	243	31	attracted	attract	VERB
dti-1330	243	32	a	a	DET
dti-1330	243	33	great	great	ADJ
dti-1330	243	34	deal	deal	NOUN
dti-1330	243	35	of	of	ADP
dti-1330	243	36	attention	attention	NOUN
dti-1330	243	37	.	.	PUNCT
dti-1330	244	1	the	the	DET
dti-1330	244	2	typical	typical	ADJ
dti-1330	244	3	target	target	NOUN
dti-1330	244	4	of	of	ADP
dti-1330	244	5	nsaids	nsaid	NOUN
dti-1330	244	6	is	be	AUX
dti-1330	244	7	cox	cox	PROPN
dti-1330	244	8	.	.	PUNCT
dti-1330	245	1	in	in	ADP
dti-1330	245	2	recent	recent	ADJ
dti-1330	245	3	reports	report	NOUN
dti-1330	245	4	,	,	PUNCT
dti-1330	245	5	a	a	DET
dti-1330	245	6	number	number	NOUN
dti-1330	245	7	of	of	ADP
dti-1330	245	8	patients	patient	NOUN
dti-1330	245	9	have	have	AUX
dti-1330	245	10	had	have	VERB
dti-1330	245	11	significantly	significantly	ADV
dti-1330	245	12	low	low	ADJ
dti-1330	245	13	-	-	PUNCT
dti-1330	245	14	risk	risk	NOUN
dti-1330	245	15	of	of	ADP
dti-1330	245	16	colorectal	colorectal	ADJ
dti-1330	245	17	cancer	cancer	NOUN
dti-1330	245	18	while	while	SCONJ
dti-1330	245	19	they	they	PRON
dti-1330	245	20	continued	continue	VERB
dti-1330	245	21	using	use	VERB
dti-1330	245	22	nsaids	nsaid	NOUN
dti-1330	245	23	typifi	typifi	ADJ
dti-1330	245	24	ed	ed	NOUN
dti-1330	245	25	by	by	ADP
dti-1330	245	26	aspirin	aspirin	NOUN
dti-1330	245	27	.	.	PUNCT
dti-1330	246	1	consequently	consequently	ADV
dti-1330	246	2	,	,	PUNCT
dti-1330	246	3	the	the	DET
dti-1330	246	4	suppression	suppression	NOUN
dti-1330	246	5	of	of	ADP
dti-1330	246	6	carcinogenesis	carcinogenesis	NOUN
dti-1330	246	7	by	by	ADP
dti-1330	246	8	administering	administer	VERB
dti-1330	246	9	nsaids	nsaid	NOUN
dti-1330	246	10	has	have	AUX
dti-1330	246	11	come	come	VERB
dti-1330	246	12	into	into	ADP
dti-1330	246	13	focus	focus	NOUN
dti-1330	246	14	.	.	PUNCT
dti-1330	247	1	it	it	PRON
dti-1330	247	2	was	be	AUX
dti-1330	247	3	also	also	ADV
dti-1330	247	4	reported	report	VERB
dti-1330	247	5	that	that	SCONJ
dti-1330	247	6	the	the	DET
dti-1330	247	7	size	size	NOUN
dti-1330	247	8	and	and	CCONJ
dti-1330	247	9	number	number	NOUN
dti-1330	247	10	of	of	ADP
dti-1330	247	11	adenoma	adenoma	ADV
dti-1330	247	12	were	be	AUX
dti-1330	247	13	markedly	markedly	ADV
dti-1330	247	14	reduced	reduce	VERB
dti-1330	247	15	when	when	SCONJ
dti-1330	247	16	sulindac	sulindac	NOUN
dti-1330	247	17	which	which	PRON
dti-1330	247	18	is	be	AUX
dti-1330	247	19	a	a	DET
dti-1330	247	20	type	type	NOUN
dti-1330	247	21	of	of	ADP
dti-1330	247	22	nsaids	nsaid	NOUN
dti-1330	247	23	was	be	AUX
dti-1330	247	24	given	give	VERB
dti-1330	247	25	to	to	ADP
dti-1330	247	26	patients	patient	NOUN
dti-1330	247	27	with	with	ADP
dti-1330	247	28	the	the	DET
dti-1330	247	29	familial	familial	ADJ
dti-1330	247	30	adenomatous	adenomatous	ADJ
dti-1330	247	31	polyposis	polyposis	NOUN
dti-1330	247	32	,	,	PUNCT
dti-1330	247	33	a	a	DET
dti-1330	247	34	high	high	ADJ
dti-1330	247	35	risk	risk	NOUN
dti-1330	247	36	group	group	NOUN
dti-1330	247	37	for	for	ADP
dti-1330	247	38	colorectal	colorectal	ADJ
dti-1330	247	39	cancer	cancer	NOUN
dti-1330	248	1	[	[	X
dti-1330	248	2	13	13	NUM
dti-1330	248	3	]	]	PUNCT
dti-1330	248	4	.	.	PUNCT
dti-1330	249	1	a	a	DET
dti-1330	249	2	b	b	X
dti-1330	249	3	c	c	NOUN
dti-1330	249	4	d	d	NOUN
dti-1330	249	5	figure	figure	NOUN
dti-1330	249	6	6	6	NUM
dti-1330	249	7	.	.	PUNCT
dti-1330	250	1	effects	effect	NOUN
dti-1330	250	2	of	of	ADP
dti-1330	250	3	lipoxygenase	lipoxygenase	NOUN
dti-1330	250	4	(	(	PUNCT
dti-1330	250	5	lox	lox	NOUN
dti-1330	250	6	)	)	PUNCT
dti-1330	250	7	inhibitor	inhibitor	NOUN
dti-1330	250	8	in	in	ADP
dti-1330	250	9	induction	induction	NOUN
dti-1330	250	10	of	of	ADP
dti-1330	250	11	apoptosis	apoptosis	NOUN
dti-1330	250	12	on	on	ADP
dti-1330	250	13	human	human	ADJ
dti-1330	250	14	bladder	bladder	NOUN
dti-1330	250	15	tumor	tumor	NOUN
dti-1330	250	16	(	(	PUNCT
dti-1330	250	17	bt	bt	NOUN
dti-1330	250	18	)	)	PUNCT
dti-1330	250	19	cells	cell	NOUN
dti-1330	250	20	.	.	PUNCT
dti-1330	251	1	bt	bt	NOUN
dti-1330	251	2	cells	cell	NOUN
dti-1330	251	3	treated	treat	VERB
dti-1330	251	4	with	with	ADP
dti-1330	251	5	5	5	NUM
dti-1330	251	6	-	-	PUNCT
dti-1330	251	7	lox	lox	NOUN
dti-1330	251	8	inhibitors	inhibitor	NOUN
dti-1330	251	9	caffeic	caffeic	VERB
dti-1330	251	10	acid	acid	NOUN
dti-1330	251	11	(	(	PUNCT
dti-1330	251	12	b	b	NOUN
dti-1330	251	13	)	)	PUNCT
dti-1330	251	14	,	,	PUNCT
dti-1330	251	15	and	and	CCONJ
dti-1330	251	16	non	non	ADJ
dti-1330	251	17	-	-	ADJ
dti-1330	251	18	specifi	specifi	ADJ
dti-1330	251	19	c	c	PROPN
dti-1330	251	20	lox	lox	PROPN
dti-1330	251	21	inhibitor	inhibitor	PROPN
dti-1330	251	22	ndga	ndga	ADV
dti-1330	252	1	(	(	PUNCT
dti-1330	252	2	d	d	NOUN
dti-1330	252	3	)	)	PUNCT
dti-1330	252	4	showed	show	VERB
dti-1330	252	5	chromatin	chromatin	NOUN
dti-1330	252	6	condensation	condensation	NOUN
dti-1330	252	7	,	,	PUNCT
dti-1330	252	8	cellular	cellular	ADJ
dti-1330	252	9	shrinkage	shrinkage	NOUN
dti-1330	252	10	,	,	PUNCT
dti-1330	252	11	small	small	ADJ
dti-1330	252	12	membrane	membrane	NOUN
dti-1330	252	13	-	-	PUNCT
dti-1330	252	14	bound	bind	VERB
dti-1330	252	15	bodies	body	NOUN
dti-1330	252	16	(	(	PUNCT
dti-1330	252	17	apoptotic	apoptotic	ADJ
dti-1330	252	18	bodies	body	NOUN
dti-1330	252	19	)	)	PUNCT
dti-1330	252	20	,	,	PUNCT
dti-1330	252	21	and	and	CCONJ
dti-1330	252	22	cytoplasmic	cytoplasmic	ADJ
dti-1330	252	23	condensation	condensation	NOUN
dti-1330	252	24	.	.	PUNCT
dti-1330	253	1	cells	cell	NOUN
dti-1330	253	2	with	with	ADP
dti-1330	253	3	12	12	NUM
dti-1330	253	4	-	-	PUNCT
dti-1330	253	5	lox	lox	NOUN
dti-1330	253	6	inhibitor	inhibitor	PROPN
dti-1330	253	7	baicalein	baicalein	PROPN
dti-1330	253	8	showed	show	VERB
dti-1330	253	9	the	the	DET
dti-1330	253	10	same	same	ADJ
dti-1330	253	11	apoptotic	apoptotic	ADJ
dti-1330	253	12	changes	change	NOUN
dti-1330	253	13	slightly	slightly	ADV
dti-1330	253	14	(	(	PUNCT
dti-1330	253	15	c	c	NOUN
dti-1330	253	16	)	)	PUNCT
dti-1330	253	17	.	.	PUNCT
dti-1330	254	1	in	in	ADP
dti-1330	254	2	contrast	contrast	NOUN
dti-1330	254	3	,	,	PUNCT
dti-1330	254	4	untreated	untreated	ADJ
dti-1330	254	5	cells	cell	NOUN
dti-1330	254	6	(	(	PUNCT
dti-1330	254	7	a	a	PRON
dti-1330	254	8	)	)	PUNCT
dti-1330	254	9	maintained	maintain	VERB
dti-1330	254	10	normal	normal	ADJ
dti-1330	254	11	chromatin	chromatin	NOUN
dti-1330	254	12	patterns	pattern	NOUN
dti-1330	254	13	and	and	CCONJ
dti-1330	254	14	cell	cell	NOUN
dti-1330	254	15	size	size	NOUN
dti-1330	254	16	.	.	PUNCT
dti-1330	255	1	150	150	NUM
dti-1330	255	2	matsuyama	matsuyama	PROPN
dti-1330	255	3	and	and	CCONJ
dti-1330	255	4	yoshimura	yoshimura	VERB
dti-1330	255	5	drug	drug	NOUN
dti-1330	255	6	target	target	NOUN
dti-1330	255	7	insights	insight	NOUN
dti-1330	255	8	2008:3	2008:3	NUM
dti-1330	255	9	regarding	regard	VERB
dti-1330	255	10	cox-2	cox-2	NOUN
dti-1330	255	11	in	in	ADP
dti-1330	255	12	rcc	rcc	PROPN
dti-1330	255	13	,	,	PUNCT
dti-1330	255	14	bt	bt	NOUN
dti-1330	255	15	and	and	CCONJ
dti-1330	255	16	pc	pc	NOUN
dti-1330	255	17	,	,	PUNCT
dti-1330	255	18	cox-2	cox-2	NOUN
dti-1330	255	19	expression	expression	NOUN
dti-1330	255	20	in	in	ADP
dti-1330	255	21	malignant	malignant	ADJ
dti-1330	255	22	tissues	tissue	NOUN
dti-1330	255	23	was	be	AUX
dti-1330	255	24	stronger	strong	ADJ
dti-1330	255	25	than	than	ADP
dti-1330	255	26	that	that	PRON
dti-1330	255	27	in	in	ADP
dti-1330	255	28	normal	normal	ADJ
dti-1330	255	29	tissues	tissue	NOUN
dti-1330	255	30	using	use	VERB
dti-1330	255	31	immunohistochemical	immunohistochemical	ADJ
dti-1330	255	32	staining	staining	NOUN
dti-1330	255	33	and	and	CCONJ
dti-1330	255	34	rt	rt	NOUN
dti-1330	255	35	-	-	PUNCT
dti-1330	255	36	pcr	pcr	NOUN
dti-1330	256	1	[	[	X
dti-1330	256	2	9	9	NUM
dti-1330	256	3	,	,	PUNCT
dti-1330	256	4	14	14	NUM
dti-1330	256	5	,	,	PUNCT
dti-1330	256	6	15	15	NUM
dti-1330	256	7	]	]	PUNCT
dti-1330	256	8	.	.	PUNCT
dti-1330	257	1	both	both	DET
dti-1330	257	2	cox-1	cox-1	PUNCT
dti-1330	257	3	and	and	CCONJ
dti-1330	257	4	cox-2	cox-2	ADJ
dti-1330	257	5	expressions	expression	NOUN
dti-1330	257	6	in	in	ADP
dti-1330	257	7	all	all	DET
dti-1330	257	8	tissue	tissue	NOUN
dti-1330	257	9	types	type	NOUN
dti-1330	257	10	of	of	ADP
dti-1330	257	11	tc	tc	NUM
dti-1330	257	12	were	be	AUX
dti-1330	257	13	stronger	strong	ADJ
dti-1330	257	14	than	than	ADP
dti-1330	257	15	those	those	PRON
dti-1330	257	16	in	in	ADP
dti-1330	257	17	normal	normal	ADJ
dti-1330	257	18	tissues	tissue	NOUN
dti-1330	257	19	using	use	VERB
dti-1330	257	20	immunohistochemical	immunohistochemical	ADJ
dti-1330	257	21	staining	staining	NOUN
dti-1330	257	22	and	and	CCONJ
dti-1330	257	23	rt	rt	NOUN
dti-1330	257	24	-	-	PUNCT
dti-1330	257	25	pcr	pcr	NOUN
dti-1330	258	1	[	[	X
dti-1330	258	2	16	16	NUM
dti-1330	258	3	]	]	PUNCT
dti-1330	258	4	.	.	PUNCT
dti-1330	259	1	both	both	PRON
dti-1330	259	2	cox-1	cox-1	PUNCT
dti-1330	259	3	and	and	CCONJ
dti-1330	259	4	cox-2	cox-2	ADJ
dti-1330	259	5	expressions	expression	NOUN
dti-1330	259	6	appeared	appear	VERB
dti-1330	259	7	stronger	strong	ADJ
dti-1330	259	8	in	in	ADP
dti-1330	259	9	all	all	DET
dti-1330	259	10	tissue	tissue	NOUN
dti-1330	259	11	types	type	NOUN
dti-1330	259	12	of	of	ADP
dti-1330	259	13	tc	tc	PRON
dti-1330	259	14	possibly	possibly	ADV
dti-1330	259	15	due	due	ADP
dti-1330	259	16	to	to	ADP
dti-1330	259	17	the	the	DET
dti-1330	259	18	amount	amount	NOUN
dti-1330	259	19	of	of	ADP
dti-1330	259	20	pg	pg	PRON
dti-1330	259	21	increased	increase	VERB
dti-1330	259	22	in	in	ADP
dti-1330	259	23	tc	tc	NOUN
dti-1330	259	24	.	.	PUNCT
dti-1330	259	25	evidence	evidence	NOUN
dti-1330	259	26	revealed	reveal	VERB
dti-1330	259	27	the	the	DET
dti-1330	259	28	pg	pg	PROPN
dti-1330	259	29	quantity	quantity	NOUN
dti-1330	259	30	increased	increase	VERB
dti-1330	259	31	in	in	ADP
dti-1330	259	32	breast	breast	NOUN
dti-1330	259	33	cancer	cancer	NOUN
dti-1330	259	34	tissue	tissue	NOUN
dti-1330	259	35	compared	compare	VERB
dti-1330	259	36	to	to	ADP
dti-1330	259	37	normal	normal	ADJ
dti-1330	259	38	breast	breast	NOUN
dti-1330	259	39	tissue	tissue	NOUN
dti-1330	259	40	and	and	CCONJ
dti-1330	259	41	the	the	DET
dti-1330	259	42	expression	expression	NOUN
dti-1330	259	43	of	of	ADP
dti-1330	259	44	both	both	PRON
dti-1330	259	45	cox-1	cox-1	PUNCT
dti-1330	259	46	and	and	CCONJ
dti-1330	259	47	cox-2	cox-2	ADV
dti-1330	259	48	increased	increase	VERB
dti-1330	259	49	[	[	X
dti-1330	259	50	17	17	NUM
dti-1330	259	51	]	]	PUNCT
dti-1330	259	52	.	.	PUNCT
dti-1330	260	1	many	many	ADJ
dti-1330	260	2	publications	publication	NOUN
dti-1330	260	3	have	have	AUX
dti-1330	260	4	reported	report	VERB
dti-1330	260	5	cox-2	cox-2	ADJ
dti-1330	260	6	expression	expression	NOUN
dti-1330	260	7	in	in	ADP
dti-1330	260	8	malignant	malignant	ADJ
dti-1330	260	9	tissue	tissue	NOUN
dti-1330	260	10	was	be	AUX
dti-1330	260	11	stronger	strong	ADJ
dti-1330	260	12	than	than	ADP
dti-1330	260	13	in	in	ADP
dti-1330	260	14	normal	normal	ADJ
dti-1330	260	15	tissue	tissue	NOUN
dti-1330	260	16	,	,	PUNCT
dti-1330	260	17	and	and	CCONJ
dti-1330	260	18	cox-2	cox-2	NOUN
dti-1330	260	19	expression	expression	NOUN
dti-1330	260	20	in	in	ADP
dti-1330	260	21	malignant	malignant	ADJ
dti-1330	260	22	tissue	tissue	NOUN
dti-1330	260	23	was	be	AUX
dti-1330	260	24	stronger	strong	ADJ
dti-1330	260	25	than	than	ADP
dti-1330	260	26	cox-1	cox-1	PUNCT
dti-1330	260	27	expression	expression	NOUN
dti-1330	260	28	in	in	ADP
dti-1330	260	29	malignant	malignant	ADJ
dti-1330	260	30	tissue	tissue	NOUN
dti-1330	260	31	.	.	PUNCT
dti-1330	261	1	however	however	ADV
dti-1330	261	2	,	,	PUNCT
dti-1330	261	3	the	the	DET
dti-1330	261	4	correlation	correlation	NOUN
dti-1330	261	5	between	between	ADP
dti-1330	261	6	the	the	DET
dti-1330	261	7	grade	grade	NOUN
dti-1330	261	8	or	or	CCONJ
dti-1330	261	9	stage	stage	NOUN
dti-1330	261	10	,	,	PUNCT
dti-1330	261	11	and	and	CCONJ
dti-1330	261	12	cox-2	cox-2	NOUN
dti-1330	261	13	expression	expression	NOUN
dti-1330	261	14	can	can	AUX
dti-1330	261	15	be	be	AUX
dti-1330	261	16	argued	argue	VERB
dti-1330	261	17	.	.	PUNCT
dti-1330	262	1	although	although	SCONJ
dti-1330	262	2	many	many	ADJ
dti-1330	262	3	papers	paper	NOUN
dti-1330	262	4	have	have	AUX
dti-1330	262	5	reported	report	VERB
dti-1330	262	6	nsaids	nsaid	NOUN
dti-1330	262	7	produce	produce	VERB
dti-1330	262	8	anti	anti	ADJ
dti-1330	262	9	-	-	ADJ
dti-1330	262	10	tumor	tumor	ADJ
dti-1330	262	11	effects	effect	NOUN
dti-1330	262	12	,	,	PUNCT
dti-1330	262	13	our	our	PRON
dti-1330	262	14	studies	study	NOUN
dti-1330	262	15	confi	confi	VERB
dti-1330	262	16	rmed	rme	VERB
dti-1330	262	17	that	that	SCONJ
dti-1330	262	18	eight	eight	NUM
dti-1330	262	19	kinds	kind	NOUN
dti-1330	262	20	of	of	ADP
dti-1330	262	21	cox	cox	PROPN
dti-1330	262	22	inhibitors	inhibitor	NOUN
dti-1330	262	23	were	be	AUX
dti-1330	262	24	unable	unable	ADJ
dti-1330	262	25	to	to	PART
dti-1330	262	26	induce	induce	VERB
dti-1330	262	27	reduction	reduction	NOUN
dti-1330	262	28	of	of	ADP
dti-1330	262	29	the	the	DET
dti-1330	262	30	viability	viability	NOUN
dti-1330	262	31	in	in	ADP
dti-1330	262	32	human	human	ADJ
dti-1330	262	33	urological	urological	ADJ
dti-1330	262	34	tumors	tumor	NOUN
dti-1330	262	35	cells	cell	NOUN
dti-1330	262	36	in	in	ADP
dti-1330	262	37	the	the	DET
dti-1330	262	38	range	range	NOUN
dti-1330	262	39	of	of	ADP
dti-1330	262	40	10–80	10–80	NUM
dti-1330	262	41	μm	μm	NOUN
dti-1330	262	42	by	by	ADP
dti-1330	262	43	mtt	mtt	NOUN
dti-1330	262	44	assay	assay	VERB
dti-1330	263	1	[	[	X
dti-1330	263	2	18	18	NUM
dti-1330	263	3	]	]	PUNCT
dti-1330	263	4	.	.	PUNCT
dti-1330	264	1	our	our	PRON
dti-1330	264	2	results	result	NOUN
dti-1330	264	3	suggest	suggest	VERB
dti-1330	264	4	cox-2	cox-2	ADJ
dti-1330	264	5	expression	expression	NOUN
dti-1330	264	6	is	be	AUX
dti-1330	264	7	strong	strong	ADJ
dti-1330	264	8	in	in	ADP
dti-1330	264	9	treating	treat	VERB
dti-1330	264	10	urological	urological	ADJ
dti-1330	264	11	tumors	tumor	NOUN
dti-1330	264	12	,	,	PUNCT
dti-1330	264	13	but	but	CCONJ
dti-1330	264	14	the	the	DET
dti-1330	264	15	antitumor	antitumor	PROPN
dti-1330	264	16	effect	effect	NOUN
dti-1330	264	17	of	of	ADP
dti-1330	264	18	cox	cox	PROPN
dti-1330	264	19	inhibitor	inhibitor	NOUN
dti-1330	264	20	(	(	PUNCT
dti-1330	264	21	including	include	VERB
dti-1330	264	22	cox-2	cox-2	ADJ
dti-1330	264	23	inhibitor	inhibitor	NOUN
dti-1330	264	24	)	)	PUNCT
dti-1330	264	25	is	be	AUX
dti-1330	264	26	very	very	ADV
dti-1330	264	27	weak	weak	ADJ
dti-1330	264	28	in	in	ADP
dti-1330	264	29	urological	urological	ADJ
dti-1330	264	30	tumor	tumor	NOUN
dti-1330	264	31	patients	patient	NOUN
dti-1330	264	32	in	in	ADP
dti-1330	264	33	a	a	DET
dti-1330	264	34	single	single	ADJ
dti-1330	264	35	administration	administration	NOUN
dti-1330	264	36	at	at	ADP
dti-1330	264	37	a	a	DET
dti-1330	264	38	clinical	clinical	ADJ
dti-1330	264	39	dose	dose	NOUN
dti-1330	264	40	.	.	PUNCT
dti-1330	265	1	cox-2	cox-2	VERB
dti-1330	265	2	inhibitor	inhibitor	NOUN
dti-1330	265	3	is	be	AUX
dti-1330	265	4	suitable	suitable	ADJ
dti-1330	265	5	for	for	ADP
dti-1330	265	6	chemopreventive	chemopreventive	ADJ
dti-1330	265	7	therapy	therapy	NOUN
dti-1330	265	8	.	.	PUNCT
dti-1330	266	1	regarding	regard	VERB
dti-1330	266	2	5and	5and	NUM
dti-1330	266	3	12	12	NUM
dti-1330	266	4	-	-	PUNCT
dti-1330	266	5	lox	lox	NOUN
dti-1330	266	6	in	in	ADP
dti-1330	266	7	urological	urological	ADJ
dti-1330	266	8	tumors	tumor	NOUN
dti-1330	266	9	,	,	PUNCT
dti-1330	266	10	5and	5and	NUM
dti-1330	266	11	12	12	NUM
dti-1330	266	12	-	-	PUNCT
dti-1330	266	13	lox	lox	NOUN
dti-1330	266	14	expressions	expression	NOUN
dti-1330	266	15	in	in	ADP
dti-1330	266	16	malignant	malignant	ADJ
dti-1330	266	17	tissues	tissue	NOUN
dti-1330	266	18	were	be	AUX
dti-1330	266	19	stronger	strong	ADJ
dti-1330	266	20	than	than	ADP
dti-1330	266	21	those	those	PRON
dti-1330	266	22	in	in	ADP
dti-1330	266	23	normal	normal	ADJ
dti-1330	266	24	tissues	tissue	NOUN
dti-1330	266	25	using	use	VERB
dti-1330	266	26	immunohistochemical	immunohistochemical	ADJ
dti-1330	266	27	staining	staining	NOUN
dti-1330	266	28	and	and	CCONJ
dti-1330	266	29	rt	rt	NOUN
dti-1330	266	30	-	-	PUNCT
dti-1330	266	31	pcr	pcr	NOUN
dti-1330	266	32	[	[	X
dti-1330	266	33	8	8	NUM
dti-1330	266	34	,	,	PUNCT
dti-1330	266	35	19–21	19–21	NUM
dti-1330	266	36	]	]	PUNCT
dti-1330	266	37	.	.	PUNCT
dti-1330	267	1	similar	similar	ADJ
dti-1330	267	2	to	to	ADP
dti-1330	267	3	cox-2	cox-2	NUM
dti-1330	267	4	,	,	PUNCT
dti-1330	267	5	the	the	DET
dti-1330	267	6	correlation	correlation	NOUN
dti-1330	267	7	between	between	ADP
dti-1330	267	8	the	the	DET
dti-1330	267	9	grade	grade	NOUN
dti-1330	267	10	or	or	CCONJ
dti-1330	267	11	stage	stage	NOUN
dti-1330	267	12	,	,	PUNCT
dti-1330	267	13	and	and	CCONJ
dti-1330	267	14	lox	lox	NOUN
dti-1330	267	15	expression	expression	NOUN
dti-1330	267	16	can	can	AUX
dti-1330	267	17	be	be	AUX
dti-1330	267	18	argued	argue	VERB
dti-1330	267	19	.	.	PUNCT
dti-1330	268	1	furthermore	furthermore	ADV
dti-1330	268	2	,	,	PUNCT
dti-1330	268	3	lox	lox	PROPN
dti-1330	268	4	inhibitor	inhibitor	NOUN
dti-1330	268	5	(	(	PUNCT
dti-1330	268	6	particularly	particularly	ADV
dti-1330	268	7	5	5	NUM
dti-1330	268	8	-	-	PUNCT
dti-1330	268	9	lox	lox	NOUN
dti-1330	268	10	inhibitor	inhibitor	NOUN
dti-1330	268	11	)	)	PUNCT
dti-1330	268	12	could	could	AUX
dti-1330	268	13	induce	induce	VERB
dti-1330	268	14	reduction	reduction	NOUN
dti-1330	268	15	of	of	ADP
dti-1330	268	16	the	the	DET
dti-1330	268	17	viability	viability	NOUN
dti-1330	268	18	in	in	ADP
dti-1330	268	19	human	human	ADJ
dti-1330	268	20	urological	urological	ADJ
dti-1330	268	21	tumors	tumor	NOUN
dti-1330	268	22	cells	cell	NOUN
dti-1330	268	23	in	in	ADP
dti-1330	268	24	the	the	DET
dti-1330	268	25	range	range	NOUN
dti-1330	268	26	of	of	ADP
dti-1330	268	27	10–80	10–80	NUM
dti-1330	268	28	μm	μm	NOUN
dti-1330	268	29	by	by	ADP
dti-1330	268	30	mtt	mtt	NOUN
dti-1330	268	31	assay	assay	NOUN
dti-1330	268	32	.	.	PUNCT
dti-1330	269	1	the	the	DET
dti-1330	269	2	effect	effect	NOUN
dti-1330	269	3	of	of	ADP
dti-1330	269	4	5	5	NUM
dti-1330	269	5	-	-	PUNCT
dti-1330	269	6	lox	lox	NOUN
dti-1330	269	7	inhibitor	inhibitor	NOUN
dti-1330	269	8	was	be	AUX
dti-1330	269	9	stronger	strong	ADJ
dti-1330	269	10	than	than	ADP
dti-1330	269	11	that	that	PRON
dti-1330	269	12	of	of	ADP
dti-1330	269	13	12	12	NUM
dti-1330	269	14	-	-	PUNCT
dti-1330	269	15	lox	lox	NOUN
dti-1330	269	16	inhibitor	inhibitor	NOUN
dti-1330	270	1	[	[	X
dti-1330	270	2	22	22	NUM
dti-1330	270	3	]	]	PUNCT
dti-1330	270	4	.	.	PUNCT
dti-1330	271	1	furthermore	furthermore	ADV
dti-1330	271	2	,	,	PUNCT
dti-1330	271	3	urological	urological	ADJ
dti-1330	271	4	tumors	tumor	NOUN
dti-1330	271	5	cells	cell	NOUN
dti-1330	271	6	treated	treat	VERB
dti-1330	271	7	with	with	ADP
dti-1330	271	8	5	5	NUM
dti-1330	271	9	-	-	PUNCT
dti-1330	271	10	lox	lox	NOUN
dti-1330	271	11	inhibitor	inhibitor	NOUN
dti-1330	271	12	could	could	AUX
dti-1330	271	13	induce	induce	VERB
dti-1330	271	14	early	early	ADJ
dti-1330	271	15	apoptosis	apoptosis	NOUN
dti-1330	271	16	and	and	CCONJ
dti-1330	271	17	dna	dna	PROPN
dti-1330	271	18	fragmantation	fragmantation	NOUN
dti-1330	271	19	in	in	ADP
dti-1330	271	20	urological	urological	ADJ
dti-1330	271	21	tumors	tumor	NOUN
dti-1330	271	22	cells	cell	NOUN
dti-1330	271	23	using	use	VERB
dti-1330	271	24	fl	fl	PRON
dti-1330	271	25	ow	ow	INTJ
dti-1330	271	26	cytometry	cytometry	NOUN
dti-1330	271	27	and	and	CCONJ
dti-1330	271	28	hoechest	hoech	ADJ
dti-1330	271	29	staining	staining	ADJ
dti-1330	271	30	.	.	PUNCT
dti-1330	272	1	several	several	ADJ
dti-1330	272	2	papers	paper	NOUN
dti-1330	272	3	have	have	AUX
dti-1330	272	4	reported	report	VERB
dti-1330	272	5	lox	lox	NOUN
dti-1330	272	6	inhibitors	inhibitor	NOUN
dti-1330	272	7	to	to	PART
dti-1330	272	8	be	be	AUX
dti-1330	272	9	targets	target	NOUN
dti-1330	272	10	for	for	ADP
dti-1330	272	11	development	development	NOUN
dti-1330	272	12	of	of	ADP
dti-1330	272	13	new	new	ADJ
dti-1330	272	14	chemopreventive	chemopreventive	ADJ
dti-1330	272	15	or	or	CCONJ
dti-1330	272	16	chemotherapeutic	chemotherapeutic	ADJ
dti-1330	272	17	strategies	strategy	NOUN
dti-1330	272	18	for	for	ADP
dti-1330	272	19	pc	pc	NOUN
dti-1330	272	20	.	.	PUNCT
dti-1330	273	1	ghosh	ghosh	PROPN
dti-1330	273	2	j	j	PROPN
dti-1330	273	3	et	et	PROPN
dti-1330	273	4	al	al	PROPN
dti-1330	273	5	.	.	PROPN
dti-1330	273	6	reported	report	VERB
dti-1330	273	7	that	that	SCONJ
dti-1330	273	8	inhibition	inhibition	NOUN
dti-1330	273	9	of	of	ADP
dti-1330	273	10	arachidonate	arachidonate	ADJ
dti-1330	273	11	5	5	NUM
dti-1330	273	12	-	-	PUNCT
dti-1330	273	13	lox	lox	NOUN
dti-1330	273	14	triggers	trigger	VERB
dti-1330	273	15	massive	massive	ADJ
dti-1330	273	16	apoptosis	apoptosis	NOUN
dti-1330	273	17	in	in	ADP
dti-1330	273	18	both	both	DET
dti-1330	273	19	androgen	androgen	NOUN
dti-1330	273	20	-	-	PUNCT
dti-1330	273	21	sensitive	sensitive	ADJ
dti-1330	273	22	(	(	PUNCT
dti-1330	273	23	lncap	lncap	NOUN
dti-1330	273	24	)	)	PUNCT
dti-1330	273	25	and	and	CCONJ
dti-1330	273	26	androgenrefractory	androgenrefractory	ADJ
dti-1330	273	27	(	(	PUNCT
dti-1330	273	28	pc3	pc3	ADJ
dti-1330	273	29	)	)	PUNCT
dti-1330	273	30	human	human	ADJ
dti-1330	273	31	pc	pc	NOUN
dti-1330	273	32	cells	cell	NOUN
dti-1330	273	33	[	[	X
dti-1330	273	34	23	23	NUM
dti-1330	273	35	]	]	PUNCT
dti-1330	273	36	.	.	PUNCT
dti-1330	274	1	furthermore	furthermore	ADV
dti-1330	274	2	,	,	PUNCT
dti-1330	274	3	ghosh	ghosh	PROPN
dti-1330	274	4	j	j	PROPN
dti-1330	274	5	also	also	ADV
dti-1330	274	6	reported	report	VERB
dti-1330	274	7	the	the	DET
dti-1330	274	8	metabolites	metabolite	NOUN
dti-1330	274	9	of	of	ADP
dti-1330	274	10	arachidonate	arachidonate	ADJ
dti-1330	274	11	5	5	NUM
dti-1330	274	12	-	-	PUNCT
dti-1330	274	13	lox	lox	NOUN
dti-1330	274	14	promoted	promote	VERB
dti-1330	274	15	survival	survival	NOUN
dti-1330	274	16	of	of	ADP
dti-1330	274	17	pc	pc	NOUN
dti-1330	274	18	cells	cell	NOUN
dti-1330	274	19	involving	involve	VERB
dti-1330	274	20	down	down	ADP
dti-1330	274	21	-	-	PUNCT
dti-1330	274	22	regulation	regulation	NOUN
dti-1330	274	23	of	of	ADP
dti-1330	274	24	stress	stress	NOUN
dti-1330	274	25	-	-	PUNCT
dti-1330	274	26	activated	activate	VERB
dti-1330	274	27	protein	protein	NOUN
dti-1330	274	28	kinase	kinase	NOUN
dti-1330	275	1	[	[	X
dti-1330	275	2	24	24	NUM
dti-1330	275	3	]	]	PUNCT
dti-1330	275	4	.	.	PUNCT
dti-1330	276	1	pommery	pommery	PROPN
dti-1330	276	2	n	n	PROPN
dti-1330	276	3	et	et	PROPN
dti-1330	276	4	al	al	PROPN
dti-1330	276	5	.	.	PROPN
dti-1330	276	6	reported	report	VERB
dti-1330	276	7	dual	dual	ADJ
dti-1330	276	8	cox-2/5	cox-2/5	PROPN
dti-1330	276	9	-	-	PUNCT
dti-1330	276	10	lox	lox	NOUN
dti-1330	276	11	inhibitors	inhibitor	NOUN
dti-1330	276	12	induced	induce	VERB
dti-1330	276	13	agents	agent	NOUN
dti-1330	276	14	potentially	potentially	ADV
dti-1330	276	15	useful	useful	ADJ
dti-1330	276	16	in	in	ADP
dti-1330	276	17	pc	pc	NOUN
dti-1330	276	18	chemotherapy	chemotherapy	NOUN
dti-1330	276	19	through	through	ADP
dti-1330	276	20	apoptosis	apoptosis	NOUN
dti-1330	276	21	[	[	X
dti-1330	276	22	25	25	NUM
dti-1330	276	23	]	]	PUNCT
dti-1330	276	24	.	.	PUNCT
dti-1330	277	1	ghosh	ghosh	PROPN
dti-1330	277	2	j	j	PROPN
dti-1330	277	3	also	also	ADV
dti-1330	277	4	reported	report	VERB
dti-1330	277	5	the	the	DET
dti-1330	277	6	combination	combination	NOUN
dti-1330	277	7	of	of	ADP
dti-1330	277	8	selenium	selenium	NOUN
dti-1330	277	9	and	and	CCONJ
dti-1330	277	10	5	5	NUM
dti-1330	277	11	-	-	PUNCT
dti-1330	277	12	lox	lox	NOUN
dti-1330	277	13	inhibitors	inhibitor	NOUN
dti-1330	277	14	may	may	AUX
dti-1330	277	15	be	be	AUX
dti-1330	277	16	a	a	DET
dti-1330	277	17	more	more	ADV
dti-1330	277	18	effective	effective	ADJ
dti-1330	277	19	regimen	regiman	NOUN
dti-1330	277	20	for	for	ADP
dti-1330	277	21	pc	pc	NOUN
dti-1330	277	22	control	control	NOUN
dti-1330	278	1	[	[	X
dti-1330	278	2	26	26	NUM
dti-1330	278	3	]	]	PUNCT
dti-1330	278	4	.	.	PUNCT
dti-1330	279	1	research	research	NOUN
dti-1330	279	2	strongly	strongly	ADV
dti-1330	279	3	suggests	suggest	VERB
dti-1330	279	4	lox	lox	NOUN
dti-1330	279	5	expression	expression	NOUN
dti-1330	279	6	is	be	AUX
dti-1330	279	7	strong	strong	ADJ
dti-1330	279	8	in	in	ADP
dti-1330	279	9	urological	urological	ADJ
dti-1330	279	10	tumors	tumor	NOUN
dti-1330	279	11	,	,	PUNCT
dti-1330	279	12	but	but	CCONJ
dti-1330	279	13	the	the	DET
dti-1330	279	14	anti	anti	ADJ
dti-1330	279	15	-	-	ADJ
dti-1330	279	16	tumor	tumor	ADJ
dti-1330	279	17	effect	effect	NOUN
dti-1330	279	18	of	of	ADP
dti-1330	279	19	5	5	NUM
dti-1330	279	20	-	-	PUNCT
dti-1330	279	21	lox	lox	NOUN
dti-1330	279	22	inhibitor	inhibitor	NOUN
dti-1330	279	23	is	be	AUX
dti-1330	279	24	weak	weak	ADJ
dti-1330	279	25	in	in	ADP
dti-1330	279	26	urological	urological	ADJ
dti-1330	279	27	tumor	tumor	NOUN
dti-1330	279	28	patients	patient	NOUN
dti-1330	279	29	receiving	receive	VERB
dti-1330	279	30	a	a	DET
dti-1330	279	31	single	single	ADJ
dti-1330	279	32	administration	administration	NOUN
dti-1330	279	33	at	at	ADP
dti-1330	279	34	a	a	DET
dti-1330	279	35	clinical	clinical	ADJ
dti-1330	279	36	dose	dose	NOUN
dti-1330	279	37	.	.	PUNCT
dti-1330	280	1	5	5	NUM
dti-1330	280	2	-	-	PUNCT
dti-1330	280	3	lox	lox	NOUN
dti-1330	280	4	inhibitor	inhibitor	NOUN
dti-1330	280	5	is	be	AUX
dti-1330	280	6	suitable	suitable	ADJ
dti-1330	280	7	as	as	ADP
dti-1330	280	8	a	a	DET
dti-1330	280	9	chemo	chemo	NOUN
dti-1330	280	10	-	-	PUNCT
dti-1330	280	11	preventive	preventive	ADJ
dti-1330	280	12	therapy	therapy	NOUN
dti-1330	280	13	.	.	PUNCT
dti-1330	281	1	in	in	ADP
dti-1330	281	2	conclusion	conclusion	NOUN
dti-1330	281	3	,	,	PUNCT
dti-1330	281	4	it	it	PRON
dti-1330	281	5	is	be	AUX
dti-1330	281	6	clear	clear	ADJ
dti-1330	281	7	that	that	SCONJ
dti-1330	281	8	cox-2	cox-2	VERB
dti-1330	281	9	and	and	CCONJ
dti-1330	281	10	lox	lox	NOUN
dti-1330	281	11	(	(	PUNCT
dti-1330	281	12	particularly	particularly	ADV
dti-1330	281	13	5	5	NUM
dti-1330	281	14	-	-	PUNCT
dti-1330	281	15	lox	lox	NOUN
dti-1330	281	16	)	)	PUNCT
dti-1330	281	17	are	be	AUX
dti-1330	281	18	involved	involve	VERB
dti-1330	281	19	in	in	ADP
dti-1330	281	20	the	the	DET
dti-1330	281	21	initiation	initiation	NOUN
dti-1330	281	22	and	and	CCONJ
dti-1330	281	23	promotion	promotion	NOUN
dti-1330	281	24	of	of	ADP
dti-1330	281	25	urological	urological	ADJ
dti-1330	281	26	tumor	tumor	NOUN
dti-1330	281	27	tissues	tissue	NOUN
dti-1330	281	28	.	.	PUNCT
dti-1330	282	1	it	it	PRON
dti-1330	282	2	may	may	AUX
dti-1330	282	3	be	be	AUX
dti-1330	282	4	possible	possible	ADJ
dti-1330	282	5	to	to	PART
dti-1330	282	6	use	use	VERB
dti-1330	282	7	cox-2	cox-2	NOUN
dti-1330	282	8	and	and	CCONJ
dti-1330	282	9	lox	lox	NOUN
dti-1330	282	10	inhibitors	inhibitor	NOUN
dti-1330	282	11	as	as	ADP
dti-1330	282	12	anti	anti	ADJ
dti-1330	282	13	-	-	ADJ
dti-1330	282	14	tumor	tumor	ADJ
dti-1330	282	15	drugs	drug	NOUN
dti-1330	282	16	from	from	ADP
dti-1330	282	17	the	the	DET
dti-1330	282	18	viewpoint	viewpoint	NOUN
dti-1330	282	19	of	of	ADP
dti-1330	282	20	preventing	prevent	VERB
dti-1330	282	21	cancer	cancer	NOUN
dti-1330	282	22	.	.	PUNCT
dti-1330	283	1	however	however	ADV
dti-1330	283	2	,	,	PUNCT
dti-1330	283	3	it	it	PRON
dti-1330	283	4	may	may	AUX
dti-1330	283	5	be	be	AUX
dti-1330	283	6	diffi	diffi	ADJ
dti-1330	283	7	cult	cult	NOUN
dti-1330	283	8	to	to	PART
dti-1330	283	9	use	use	VERB
dti-1330	283	10	the	the	DET
dti-1330	283	11	cox-2	cox-2	ADJ
dti-1330	283	12	inhibitor	inhibitor	NOUN
dti-1330	283	13	or	or	CCONJ
dti-1330	283	14	5	5	NUM
dti-1330	283	15	-	-	PUNCT
dti-1330	283	16	lox	lox	NOUN
dti-1330	283	17	inhibitor	inhibitor	NOUN
dti-1330	283	18	at	at	ADP
dti-1330	283	19	the	the	DET
dti-1330	283	20	clinical	clinical	ADJ
dti-1330	283	21	dose	dose	NOUN
dti-1330	283	22	with	with	ADP
dti-1330	283	23	expectation	expectation	NOUN
dti-1330	283	24	of	of	ADP
dti-1330	283	25	a	a	DET
dti-1330	283	26	suppressive	suppressive	ADJ
dti-1330	283	27	effect	effect	NOUN
dti-1330	283	28	on	on	ADP
dti-1330	283	29	the	the	DET
dti-1330	283	30	cancer	cancer	NOUN
dti-1330	283	31	.	.	PUNCT
dti-1330	284	1	although	although	SCONJ
dti-1330	284	2	the	the	DET
dti-1330	284	3	clinical	clinical	ADJ
dti-1330	284	4	application	application	NOUN
dti-1330	284	5	of	of	ADP
dti-1330	284	6	5	5	NUM
dti-1330	284	7	-	-	PUNCT
dti-1330	284	8	lox	lox	NOUN
dti-1330	284	9	inhibitor	inhibitor	NOUN
dti-1330	284	10	requires	require	VERB
dti-1330	284	11	further	further	ADJ
dti-1330	284	12	research	research	NOUN
dti-1330	284	13	and	and	CCONJ
dti-1330	284	14	consideration	consideration	NOUN
dti-1330	284	15	,	,	PUNCT
dti-1330	284	16	the	the	DET
dti-1330	284	17	target	target	NOUN
dti-1330	284	18	of	of	ADP
dti-1330	284	19	5	5	NUM
dti-1330	284	20	-	-	PUNCT
dti-1330	284	21	lox	lox	NOUN
dti-1330	284	22	is	be	AUX
dti-1330	284	23	a	a	DET
dti-1330	284	24	novel	novel	ADJ
dti-1330	284	25	strategy	strategy	NOUN
dti-1330	284	26	in	in	ADP
dti-1330	284	27	the	the	DET
dti-1330	284	28	treatment	treatment	NOUN
dti-1330	284	29	of	of	ADP
dti-1330	284	30	human	human	ADJ
dti-1330	284	31	urological	urological	ADJ
dti-1330	284	32	tumors	tumor	NOUN
dti-1330	284	33	.	.	PUNCT
dti-1330	285	1	acknowledements	acknowledement	NOUN
dti-1330	285	2	this	this	DET
dti-1330	285	3	manuscript	manuscript	NOUN
dti-1330	285	4	was	be	AUX
dti-1330	285	5	edited	edit	VERB
dti-1330	285	6	by	by	ADP
dti-1330	285	7	hilah	hilah	PROPN
dti-1330	285	8	edney	edney	PROPN
dti-1330	285	9	,	,	PUNCT
dti-1330	285	10	bs	bs	PROPN
dti-1330	285	11	,	,	PUNCT
dti-1330	285	12	ms	ms	PROPN
dti-1330	285	13	.	.	PROPN
dti-1330	285	14	references	reference	NOUN
dti-1330	285	15	[	[	X
dti-1330	285	16	1	1	NUM
dti-1330	285	17	]	]	PUNCT
dti-1330	285	18	weidner	weidner	NOUN
dti-1330	285	19	,	,	PUNCT
dti-1330	285	20	n.	n.	PROPN
dti-1330	285	21	,	,	PUNCT
dti-1330	285	22	folkman	folkman	PROPN
dti-1330	285	23	,	,	PUNCT
dti-1330	285	24	j.	j.	PROPN
dti-1330	285	25	,	,	PUNCT
dti-1330	285	26	pozza	pozza	PROPN
dti-1330	285	27	,	,	PUNCT
dti-1330	285	28	f.	f.	PROPN
dti-1330	285	29	,	,	PUNCT
dti-1330	285	30	bevilaqua	bevilaqua	NOUN
dti-1330	285	31	,	,	PUNCT
dti-1330	285	32	p.	p.	PROPN
dti-1330	285	33	,	,	PUNCT
dti-1330	285	34	allred	allred	PROPN
dti-1330	285	35	,	,	PUNCT
dti-1330	285	36	e.n	e.n	PROPN
dti-1330	285	37	.	.	PROPN
dti-1330	285	38	and	and	CCONJ
dti-1330	285	39	moore	moore	PROPN
dti-1330	285	40	,	,	PUNCT
dti-1330	285	41	d.h	d.h	PROPN
dti-1330	285	42	.	.	PROPN
dti-1330	285	43	1992	1992	NUM
dti-1330	285	44	.	.	PUNCT
dti-1330	286	1	tumor	tumor	PROPN
dti-1330	286	2	angiogenesis	angiogenesis	PROPN
dti-1330	286	3	:	:	PUNCT
dti-1330	286	4	a	a	DET
dti-1330	286	5	new	new	ADJ
dti-1330	286	6	signifi	signifi	NOUN
dti-1330	287	1	ca	can	AUX
dti-1330	287	2	nt	not	PART
dti-1330	287	3	and	and	CCONJ
dti-1330	287	4	independent	independent	ADJ
dti-1330	287	5	prognostic	prognostic	ADJ
dti-1330	287	6	indicator	indicator	NOUN
dti-1330	287	7	in	in	ADP
dti-1330	287	8	early	early	ADJ
dti-1330	287	9	stage	stage	NOUN
dti-1330	287	10	brest	brest	NOUN
dti-1330	287	11	carcinoma	carcinoma	NOUN
dti-1330	287	12	.	.	PUNCT
dti-1330	288	1	j.	j.	PROPN
dti-1330	288	2	nalt	nalt	PROPN
dti-1330	288	3	.	.	PUNCT
dti-1330	289	1	cancer	cancer	NOUN
dti-1330	289	2	inst	inst	PROPN
dti-1330	289	3	.	.	PROPN
dti-1330	289	4	,	,	PUNCT
dti-1330	289	5	84:1875–87	84:1875–87	NUM
dti-1330	289	6	.	.	PUNCT
dti-1330	290	1	[	[	X
dti-1330	290	2	2	2	NUM
dti-1330	290	3	]	]	X
dti-1330	290	4	lafyatis	lafyatis	PROPN
dti-1330	290	5	,	,	PUNCT
dti-1330	290	6	r.	r.	PROPN
dti-1330	290	7	,	,	PUNCT
dti-1330	290	8	thompson	thompson	PROPN
dti-1330	290	9	,	,	PUNCT
dti-1330	290	10	n.l	n.l	PROPN
dti-1330	290	11	.	.	PROPN
dti-1330	290	12	,	,	PUNCT
dti-1330	290	13	remmers	remmer	NOUN
dti-1330	290	14	,	,	PUNCT
dti-1330	290	15	e.f	e.f	PROPN
dti-1330	290	16	.	.	PROPN
dti-1330	290	17	,	,	PUNCT
dti-1330	290	18	flanders	flanders	PROPN
dti-1330	290	19	,	,	PUNCT
dti-1330	290	20	k.c	k.c	PROPN
dti-1330	290	21	.	.	PROPN
dti-1330	290	22	,	,	PUNCT
dti-1330	290	23	roche	roche	PROPN
dti-1330	290	24	,	,	PUNCT
dti-1330	290	25	n.s	n.s	PROPN
dti-1330	290	26	.	.	PROPN
dti-1330	290	27	and	and	CCONJ
dti-1330	290	28	kim	kim	PROPN
dti-1330	290	29	,	,	PUNCT
dti-1330	290	30	s.j	s.j	PROPN
dti-1330	290	31	.	.	PROPN
dti-1330	290	32	1989	1989	NUM
dti-1330	290	33	.	.	PUNCT
dti-1330	291	1	transforming	transform	VERB
dti-1330	291	2	growth	growth	NOUN
dti-1330	291	3	factor	factor	NOUN
dti-1330	291	4	-	-	PUNCT
dti-1330	291	5	beta	beta	NOUN
dti-1330	291	6	production	production	NOUN
dti-1330	291	7	by	by	ADP
dti-1330	291	8	synovial	synovial	ADJ
dti-1330	291	9	tissues	tissue	NOUN
dti-1330	291	10	from	from	ADP
dti-1330	291	11	rheumatoid	rheumatoid	NOUN
dti-1330	291	12	patients	patient	NOUN
dti-1330	291	13	and	and	CCONJ
dti-1330	291	14	streptococcal	streptococcal	ADJ
dti-1330	291	15	cell	cell	NOUN
dti-1330	291	16	wall	wall	NOUN
dti-1330	291	17	arthritic	arthritic	ADJ
dti-1330	291	18	rats	rat	NOUN
dti-1330	291	19	.	.	PUNCT
dti-1330	292	1	studies	study	NOUN
dti-1330	292	2	on	on	ADP
dti-1330	292	3	secretion	secretion	NOUN
dti-1330	292	4	by	by	ADP
dti-1330	292	5	synovial	synovial	ADJ
dti-1330	292	6	fi	fi	NOUN
dti-1330	292	7	broblast	broblast	ADJ
dti-1330	292	8	-	-	PUNCT
dti-1330	292	9	like	like	ADJ
dti-1330	292	10	cells	cell	NOUN
dti-1330	292	11	and	and	CCONJ
dti-1330	292	12	immunohistologic	immunohistologic	ADJ
dti-1330	292	13	localization	localization	NOUN
dti-1330	292	14	.	.	PUNCT
dti-1330	293	1	j.	j.	PROPN
dti-1330	293	2	immunol	immunol	PROPN
dti-1330	293	3	.	.	PROPN
dti-1330	293	4	,	,	PUNCT
dti-1330	293	5	143:1142–8	143:1142–8	NUM
dti-1330	293	6	.	.	PUNCT
dti-1330	294	1	[	[	X
dti-1330	294	2	3	3	NUM
dti-1330	294	3	]	]	X
dti-1330	294	4	xie	xie	PROPN
dti-1330	294	5	,	,	PUNCT
dti-1330	294	6	w.	w.	PROPN
dti-1330	294	7	,	,	PUNCT
dti-1330	294	8	chipman	chipman	PROPN
dti-1330	294	9	,	,	PUNCT
dti-1330	294	10	j.g	j.g	PROPN
dti-1330	294	11	.	.	PROPN
dti-1330	294	12	,	,	PUNCT
dti-1330	294	13	robertson	robertson	PROPN
dti-1330	294	14	,	,	PUNCT
dti-1330	294	15	d.l	d.l	PROPN
dti-1330	294	16	.	.	PROPN
dti-1330	294	17	,	,	PUNCT
dti-1330	294	18	erikson	erikson	PROPN
dti-1330	294	19	,	,	PUNCT
dti-1330	294	20	r.l	r.l	PROPN
dti-1330	294	21	.	.	PROPN
dti-1330	294	22	and	and	CCONJ
dti-1330	294	23	simmons	simmon	NOUN
dti-1330	294	24	,	,	PUNCT
dti-1330	294	25	d.l	d.l	PROPN
dti-1330	294	26	.	.	PROPN
dti-1330	294	27	1991	1991	NUM
dti-1330	294	28	.	.	PUNCT
dti-1330	295	1	expression	expression	NOUN
dti-1330	295	2	of	of	ADP
dti-1330	295	3	a	a	DET
dti-1330	295	4	mitogen	mitogen	NOUN
dti-1330	295	5	-	-	PUNCT
dti-1330	295	6	responsive	responsive	ADJ
dti-1330	295	7	gene	gene	NOUN
dti-1330	295	8	encoding	encode	VERB
dti-1330	295	9	prostaglandin	prostaglandin	ADJ
dti-1330	295	10	synthase	synthase	NOUN
dti-1330	295	11	is	be	AUX
dti-1330	295	12	regulated	regulate	VERB
dti-1330	295	13	by	by	ADP
dti-1330	295	14	mrna	mrna	PROPN
dti-1330	295	15	splicing	splicing	PROPN
dti-1330	295	16	.	.	PUNCT
dti-1330	296	1	proc	proc	PROPN
dti-1330	296	2	.	.	PUNCT
dti-1330	297	1	natl	natl	PROPN
dti-1330	297	2	.	.	PUNCT
dti-1330	298	1	acad	acad	PROPN
dti-1330	298	2	.	.	PUNCT
dti-1330	299	1	sci	sci	PROPN
dti-1330	299	2	.	.	PUNCT
dti-1330	299	3	u.s.a	u.s.a	PROPN
dti-1330	299	4	.	.	PROPN
dti-1330	299	5	,	,	PUNCT
dti-1330	299	6	88:2692–6	88:2692–6	NUM
dti-1330	299	7	.	.	PUNCT
dti-1330	300	1	[	[	X
dti-1330	300	2	4	4	NUM
dti-1330	300	3	]	]	X
dti-1330	300	4	matsuyama	matsuyama	PROPN
dti-1330	300	5	,	,	PUNCT
dti-1330	300	6	m.	m.	NOUN
dti-1330	300	7	and	and	CCONJ
dti-1330	300	8	yoshimura	yoshimura	PROPN
dti-1330	300	9	,	,	PUNCT
dti-1330	300	10	r.	r.	PROPN
dti-1330	300	11	2004	2004	NUM
dti-1330	300	12	.	.	PUNCT
dti-1330	301	1	relationship	relationship	NOUN
dti-1330	301	2	between	between	ADP
dti-1330	301	3	cyclooxygenase	cyclooxygenase	NOUN
dti-1330	301	4	(	(	PUNCT
dti-1330	301	5	cox)-2	cox)-2	NOUN
dti-1330	301	6	and	and	CCONJ
dti-1330	301	7	malignant	malignant	ADJ
dti-1330	301	8	tumors	tumor	NOUN
dti-1330	301	9	.	.	PUNCT
dti-1330	302	1	recent	recent	ADJ
dti-1330	302	2	res	re	NOUN
dti-1330	302	3	.	.	PUNCT
dti-1330	302	4	devel	devel	NOUN
dti-1330	302	5	.	.	PUNCT
dti-1330	303	1	cancer	cancer	NOUN
dti-1330	303	2	.	.	PUNCT
dti-1330	303	3	,	,	PUNCT
dti-1330	304	1	6:243–51	6:243–51	X
dti-1330	304	2	.	.	PUNCT
dti-1330	305	1	151	151	NUM
dti-1330	305	2	5	5	NUM
dti-1330	305	3	-	-	NOUN
dti-1330	305	4	lipoxygenase	lipoxygenase	NOUN
dti-1330	305	5	in	in	ADP
dti-1330	305	6	urological	urological	ADJ
dti-1330	305	7	tumor	tumor	NOUN
dti-1330	305	8	drug	drug	NOUN
dti-1330	305	9	target	target	NOUN
dti-1330	305	10	insights	insight	VERB
dti-1330	305	11	2008:3	2008:3	NUM
dti-1330	306	1	[	[	X
dti-1330	306	2	5	5	NUM
dti-1330	306	3	]	]	X
dti-1330	306	4	sigal	sigal	ADJ
dti-1330	306	5	,	,	PUNCT
dti-1330	306	6	e.	e.	PROPN
dti-1330	306	7	1991	1991	NUM
dti-1330	306	8	.	.	PUNCT
dti-1330	307	1	the	the	DET
dti-1330	307	2	molecular	molecular	ADJ
dti-1330	307	3	biology	biology	NOUN
dti-1330	307	4	of	of	ADP
dti-1330	307	5	mammalian	mammalian	ADJ
dti-1330	307	6	arachidonic	arachidonic	ADJ
dti-1330	307	7	acid	acid	NOUN
dti-1330	307	8	metabolism	metabolism	NOUN
dti-1330	307	9	.	.	PUNCT
dti-1330	308	1	am	be	AUX
dti-1330	308	2	.	.	PUNCT
dti-1330	309	1	j.	j.	PROPN
dti-1330	309	2	physiol	physiol	PROPN
dti-1330	309	3	.	.	PUNCT
dti-1330	309	4	,	,	PUNCT
dti-1330	310	1	260:13–28	260:13–28	X
dti-1330	310	2	.	.	PUNCT
dti-1330	311	1	[	[	X
dti-1330	311	2	6	6	NUM
dti-1330	311	3	]	]	SYM
dti-1330	311	4	funk	funk	NOUN
dti-1330	311	5	,	,	PUNCT
dti-1330	311	6	c.d	c.d	PROPN
dti-1330	311	7	.	.	PROPN
dti-1330	311	8	1996	1996	NUM
dti-1330	311	9	.	.	PUNCT
dti-1330	312	1	the	the	DET
dti-1330	312	2	molecular	molecular	ADJ
dti-1330	312	3	biology	biology	NOUN
dti-1330	312	4	of	of	ADP
dti-1330	312	5	mammalian	mammalian	ADJ
dti-1330	312	6	lipoxygenases	lipoxygenase	NOUN
dti-1330	312	7	and	and	CCONJ
dti-1330	312	8	the	the	DET
dti-1330	312	9	quest	quest	NOUN
dti-1330	312	10	for	for	ADP
dti-1330	312	11	eicosanoid	eicosanoid	ADJ
dti-1330	312	12	functions	function	NOUN
dti-1330	312	13	using	use	VERB
dti-1330	312	14	lipoxygenase	lipoxygenase	NOUN
dti-1330	312	15	-	-	PUNCT
dti-1330	312	16	defi	defi	NOUN
dti-1330	312	17	cient	cient	NOUN
dti-1330	312	18	mice	mouse	NOUN
dti-1330	312	19	.	.	PUNCT
dti-1330	313	1	biochim	biochim	NOUN
dti-1330	313	2	.	.	PUNCT
dti-1330	314	1	biophys	biophy	NOUN
dti-1330	314	2	.	.	PUNCT
dti-1330	315	1	acta	acta	PROPN
dti-1330	315	2	.	.	PROPN
dti-1330	315	3	,	,	PUNCT
dti-1330	316	1	11:65–84	11:65–84	PROPN
dti-1330	316	2	.	.	PUNCT
dti-1330	317	1	[	[	X
dti-1330	317	2	7	7	NUM
dti-1330	317	3	]	]	X
dti-1330	317	4	matsuyama	matsuyama	PROPN
dti-1330	317	5	,	,	PUNCT
dti-1330	317	6	m.	m.	NOUN
dti-1330	317	7	,	,	PUNCT
dti-1330	317	8	hayama	hayama	NOUN
dti-1330	317	9	,	,	PUNCT
dti-1330	317	10	t.	t.	NOUN
dti-1330	317	11	,	,	PUNCT
dti-1330	317	12	funao	funao	INTJ
dti-1330	317	13	,	,	PUNCT
dti-1330	317	14	k.	k.	PROPN
dti-1330	317	15	,	,	PUNCT
dti-1330	317	16	kawahito	kawahito	PROPN
dti-1330	317	17	,	,	PUNCT
dti-1330	317	18	y.	y.	PROPN
dti-1330	317	19	,	,	PUNCT
dti-1330	317	20	sano	sano	PROPN
dti-1330	317	21	,	,	PUNCT
dti-1330	317	22	h.	h.	PROPN
dti-1330	317	23	,	,	PUNCT
dti-1330	317	24	takemoto	takemoto	NOUN
dti-1330	317	25	,	,	PUNCT
dti-1330	317	26	y.	y.	NOUN
dti-1330	317	27	,	,	PUNCT
dti-1330	317	28	nakatani	nakatani	ADJ
dti-1330	317	29	,	,	PUNCT
dti-1330	317	30	t.	t.	NOUN
dti-1330	317	31	and	and	CCONJ
dti-1330	317	32	yoshimura	yoshimura	PROPN
dti-1330	317	33	,	,	PUNCT
dti-1330	317	34	r.	r.	PROPN
dti-1330	317	35	2007	2007	NUM
dti-1330	317	36	.	.	PUNCT
dti-1330	318	1	overexpression	overexpression	NOUN
dti-1330	318	2	of	of	ADP
dti-1330	318	3	cysteinyllt1	cysteinyllt1	NOUN
dti-1330	318	4	receptor	receptor	NOUN
dti-1330	318	5	in	in	ADP
dti-1330	318	6	prostate	prostate	NOUN
dti-1330	318	7	cancer	cancer	NOUN
dti-1330	318	8	and	and	CCONJ
dti-1330	318	9	cyslt1r	cyslt1r	NOUN
dti-1330	318	10	antagonist	antagonist	NOUN
dti-1330	318	11	inhibits	inhibit	VERB
dti-1330	318	12	prostate	prostate	NOUN
dti-1330	318	13	cancer	cancer	NOUN
dti-1330	318	14	cell	cell	NOUN
dti-1330	318	15	growth	growth	NOUN
dti-1330	318	16	through	through	ADP
dti-1330	318	17	apoptosis	apoptosis	NOUN
dti-1330	318	18	.	.	PUNCT
dti-1330	319	1	oncol	oncol	PROPN
dti-1330	319	2	.	.	PUNCT
dti-1330	320	1	rep	rep	PROPN
dti-1330	320	2	.	.	PROPN
dti-1330	320	3	,	,	PUNCT
dti-1330	320	4	18:99–104	18:99–104	NUM
dti-1330	320	5	.	.	PUNCT
dti-1330	321	1	[	[	X
dti-1330	321	2	8	8	NUM
dti-1330	321	3	]	]	PUNCT
dti-1330	321	4	yoshimura	yoshimura	NOUN
dti-1330	321	5	,	,	PUNCT
dti-1330	321	6	r.	r.	PROPN
dti-1330	321	7	,	,	PUNCT
dti-1330	321	8	matsuyama	matsuyama	PROPN
dti-1330	321	9	,	,	PUNCT
dti-1330	321	10	m.	m.	NOUN
dti-1330	321	11	,	,	PUNCT
dti-1330	321	12	tsuchida	tsuchida	PROPN
dti-1330	321	13	,	,	PUNCT
dti-1330	321	14	k.	k.	PROPN
dti-1330	321	15	,	,	PUNCT
dti-1330	321	16	kawahito	kawahito	PROPN
dti-1330	321	17	,	,	PUNCT
dti-1330	321	18	y.	y.	PROPN
dti-1330	321	19	,	,	PUNCT
dti-1330	321	20	sano	sano	PROPN
dti-1330	321	21	,	,	PUNCT
dti-1330	321	22	h.	h.	PROPN
dti-1330	321	23	and	and	CCONJ
dti-1330	321	24	nakatani	nakatani	PROPN
dti-1330	321	25	,	,	PUNCT
dti-1330	321	26	t.	t.	NOUN
dti-1330	321	27	2003	2003	NUM
dti-1330	321	28	.	.	PUNCT
dti-1330	322	1	expression	expression	NOUN
dti-1330	322	2	of	of	ADP
dti-1330	322	3	lipoxygenase	lipoxygenase	NOUN
dti-1330	322	4	in	in	ADP
dti-1330	322	5	human	human	ADJ
dti-1330	322	6	bladder	bladder	NOUN
dti-1330	322	7	carcinoma	carcinoma	NOUN
dti-1330	322	8	and	and	CCONJ
dti-1330	322	9	growth	growth	NOUN
dti-1330	322	10	inhibition	inhibition	NOUN
dti-1330	322	11	by	by	ADP
dti-1330	322	12	its	its	PRON
dti-1330	322	13	inhibitors	inhibitor	NOUN
dti-1330	322	14	.	.	PUNCT
dti-1330	323	1	j.	j.	PROPN
dti-1330	323	2	urol	urol	PROPN
dti-1330	323	3	.	.	PROPN
dti-1330	323	4	,	,	PUNCT
dti-1330	323	5	170:1994–9	170:1994–9	NUM
dti-1330	323	6	.	.	PUNCT
dti-1330	324	1	[	[	X
dti-1330	324	2	9	9	NUM
dti-1330	324	3	]	]	PUNCT
dti-1330	324	4	yoshimura	yoshimura	NOUN
dti-1330	324	5	,	,	PUNCT
dti-1330	324	6	r.	r.	PROPN
dti-1330	324	7	,	,	PUNCT
dti-1330	324	8	sano	sano	PROPN
dti-1330	324	9	,	,	PUNCT
dti-1330	324	10	h.	h.	PROPN
dti-1330	324	11	,	,	PUNCT
dti-1330	324	12	masuda	masuda	PROPN
dti-1330	324	13	,	,	PUNCT
dti-1330	324	14	c.	c.	PROPN
dti-1330	324	15	,	,	PUNCT
dti-1330	324	16	kawamura	kawamura	PROPN
dti-1330	324	17	,	,	PUNCT
dti-1330	324	18	m.	m.	NOUN
dti-1330	324	19	,	,	PUNCT
dti-1330	324	20	tsubouchi	tsubouchi	PROPN
dti-1330	324	21	,	,	PUNCT
dti-1330	324	22	y.	y.	PROPN
dti-1330	324	23	,	,	PUNCT
dti-1330	324	24	chargui	chargui	PROPN
dti-1330	324	25	,	,	PUNCT
dti-1330	324	26	j.	j.	PROPN
dti-1330	324	27	,	,	PUNCT
dti-1330	324	28	yoshimura	yoshimura	PROPN
dti-1330	324	29	,	,	PUNCT
dti-1330	324	30	n.	n.	NOUN
dti-1330	324	31	,	,	PUNCT
dti-1330	324	32	hla	hla	PROPN
dti-1330	324	33	,	,	PUNCT
dti-1330	324	34	t.	t.	PROPN
dti-1330	324	35	and	and	CCONJ
dti-1330	324	36	wada	wada	PROPN
dti-1330	324	37	,	,	PUNCT
dti-1330	324	38	s.	s.	PROPN
dti-1330	324	39	2000	2000	NUM
dti-1330	324	40	.	.	PUNCT
dti-1330	325	1	expression	expression	NOUN
dti-1330	325	2	of	of	ADP
dti-1330	325	3	cyclooxygenase-2	cyclooxygenase-2	NUM
dti-1330	325	4	in	in	ADP
dti-1330	325	5	prostate	prostate	NOUN
dti-1330	325	6	carcinoma	carcinoma	NOUN
dti-1330	325	7	.	.	PUNCT
dti-1330	326	1	cancer	cancer	NOUN
dti-1330	326	2	,	,	PUNCT
dti-1330	326	3	89:589–96	89:589–96	NOUN
dti-1330	326	4	.	.	PUNCT
dti-1330	327	1	[	[	X
dti-1330	327	2	10	10	NUM
dti-1330	327	3	]	]	X
dti-1330	327	4	fitzgerald	fitzgerald	PROPN
dti-1330	327	5	,	,	PUNCT
dti-1330	327	6	s.m	s.m	PROPN
dti-1330	327	7	.	.	PROPN
dti-1330	327	8	and	and	CCONJ
dti-1330	327	9	flinn	flinn	PROPN
dti-1330	327	10	,	,	PUNCT
dti-1330	327	11	s.	s.	PROPN
dti-1330	327	12	2000	2000	NUM
dti-1330	327	13	.	.	PUNCT
dti-1330	328	1	evaluating	evaluate	VERB
dti-1330	328	2	research	research	NOUN
dti-1330	328	3	studies	study	NOUN
dti-1330	328	4	using	use	VERB
dti-1330	328	5	the	the	DET
dti-1330	328	6	analysis	analysis	NOUN
dti-1330	328	7	of	of	ADP
dti-1330	328	8	variance	variance	NOUN
dti-1330	328	9	(	(	PUNCT
dti-1330	328	10	anova	anova	PROPN
dti-1330	328	11	):	):	PUNCT
dti-1330	328	12	issues	issue	NOUN
dti-1330	328	13	and	and	CCONJ
dti-1330	328	14	interpretations	interpretation	NOUN
dti-1330	328	15	.	.	PUNCT
dti-1330	329	1	j.	j.	PROPN
dti-1330	329	2	hand	hand	PROPN
dti-1330	329	3	.	.	PUNCT
dti-1330	330	1	ther	ther	PROPN
dti-1330	330	2	.	.	PUNCT
dti-1330	330	3	,	,	PUNCT
dti-1330	331	1	13:56–60	13:56–60	NUM
dti-1330	331	2	.	.	PUNCT
dti-1330	332	1	[	[	X
dti-1330	332	2	11	11	NUM
dti-1330	332	3	]	]	SYM
dti-1330	332	4	kawahito	kawahito	PROPN
dti-1330	332	5	,	,	PUNCT
dti-1330	332	6	y.	y.	PROPN
dti-1330	332	7	,	,	PUNCT
dti-1330	332	8	sano	sano	PROPN
dti-1330	332	9	,	,	PUNCT
dti-1330	332	10	h.	h.	PROPN
dti-1330	332	11	,	,	PUNCT
dti-1330	332	12	mukai	mukai	PROPN
dti-1330	332	13	,	,	PUNCT
dti-1330	332	14	s.	s.	PROPN
dti-1330	332	15	,	,	PUNCT
dti-1330	332	16	asai	asai	PROPN
dti-1330	332	17	,	,	PUNCT
dti-1330	332	18	k.	k.	PROPN
dti-1330	332	19	,	,	PUNCT
dti-1330	332	20	kimura	kimura	PROPN
dti-1330	332	21	,	,	PUNCT
dti-1330	332	22	s.	s.	PROPN
dti-1330	332	23	,	,	PUNCT
dti-1330	332	24	yamamura	yamamura	NOUN
dti-1330	332	25	,	,	PUNCT
dti-1330	332	26	s.	s.	PROPN
dti-1330	332	27	,	,	PUNCT
dti-1330	332	28	kato	kato	PROPN
dti-1330	332	29	,	,	PUNCT
dti-1330	332	30	h.	h.	PROPN
dti-1330	332	31	,	,	PUNCT
dti-1330	332	32	chrousos	chrouso	NOUN
dti-1330	332	33	,	,	PUNCT
dti-1330	332	34	g.p	g.p	PROPN
dti-1330	332	35	.	.	PROPN
dti-1330	332	36	,	,	PUNCT
dti-1330	332	37	wilder	wilder	PROPN
dti-1330	332	38	,	,	PUNCT
dti-1330	332	39	r.l	r.l	PROPN
dti-1330	332	40	.	.	PROPN
dti-1330	332	41	and	and	CCONJ
dti-1330	332	42	kondo	kondo	PROPN
dti-1330	332	43	,	,	PUNCT
dti-1330	332	44	m.	m.	NOUN
dti-1330	332	45	1995	1995	NUM
dti-1330	332	46	.	.	PUNCT
dti-1330	333	1	corticotoropin	corticotoropin	NOUN
dti-1330	333	2	-	-	PUNCT
dti-1330	333	3	releasing	release	VERB
dti-1330	333	4	hormone	hormone	NOUN
dti-1330	333	5	in	in	ADP
dti-1330	333	6	colonic	colonic	ADJ
dti-1330	333	7	mucosa	mucosa	NOUN
dti-1330	333	8	in	in	ADP
dti-1330	333	9	patients	patient	NOUN
dti-1330	333	10	with	with	ADP
dti-1330	333	11	ulcerative	ulcerative	ADJ
dti-1330	333	12	colitis	colitis	NOUN
dti-1330	333	13	.	.	PUNCT
dti-1330	334	1	gut	gut	NOUN
dti-1330	334	2	,	,	PUNCT
dti-1330	334	3	37:544–51	37:544–51	NUM
dti-1330	334	4	.	.	PUNCT
dti-1330	335	1	[	[	X
dti-1330	335	2	12	12	NUM
dti-1330	335	3	]	]	X
dti-1330	335	4	oh	oh	INTJ
dti-1330	335	5	,	,	PUNCT
dti-1330	335	6	w.k	w.k	PROPN
dti-1330	335	7	.	.	PROPN
dti-1330	335	8	and	and	CCONJ
dti-1330	335	9	kantoff	kantoff	PROPN
dti-1330	335	10	,	,	PUNCT
dti-1330	335	11	p.w	p.w	PROPN
dti-1330	335	12	.	.	PROPN
dti-1330	335	13	1998	1998	NUM
dti-1330	335	14	.	.	PUNCT
dti-1330	336	1	management	management	NOUN
dti-1330	336	2	of	of	ADP
dti-1330	336	3	hormone	hormone	NOUN
dti-1330	336	4	refractory	refractory	NOUN
dti-1330	336	5	prostate	prostate	NOUN
dti-1330	336	6	cancer	cancer	NOUN
dti-1330	336	7	:	:	PUNCT
dti-1330	336	8	current	current	ADJ
dti-1330	336	9	standards	standard	NOUN
dti-1330	336	10	and	and	CCONJ
dti-1330	336	11	future	future	ADJ
dti-1330	336	12	prospects	prospect	NOUN
dti-1330	336	13	.	.	PUNCT
dti-1330	337	1	j.	j.	PROPN
dti-1330	337	2	urol	urol	PROPN
dti-1330	337	3	,	,	PUNCT
dti-1330	337	4	160:1220–9	160:1220–9	X
dti-1330	337	5	.	.	PUNCT
dti-1330	338	1	[	[	X
dti-1330	338	2	13	13	NUM
dti-1330	338	3	]	]	SYM
dti-1330	338	4	sano	sano	PROPN
dti-1330	338	5	,	,	PUNCT
dti-1330	338	6	h.	h.	PROPN
dti-1330	338	7	,	,	PUNCT
dti-1330	338	8	kawahito	kawahito	PROPN
dti-1330	338	9	,	,	PUNCT
dti-1330	338	10	y.	y.	PROPN
dti-1330	338	11	,	,	PUNCT
dti-1330	338	12	wilder	wild	ADJ
dti-1330	338	13	,	,	PUNCT
dti-1330	338	14	r.l	r.l	PROPN
dti-1330	338	15	.	.	PROPN
dti-1330	338	16	,	,	PUNCT
dti-1330	338	17	hashiramoto	hashiramoto	PROPN
dti-1330	338	18	,	,	PUNCT
dti-1330	338	19	a.	a.	PROPN
dti-1330	338	20	,	,	PUNCT
dti-1330	338	21	mukai	mukai	PROPN
dti-1330	338	22	,	,	PUNCT
dti-1330	338	23	s.	s.	PROPN
dti-1330	338	24	,	,	PUNCT
dti-1330	338	25	asai	asai	PROPN
dti-1330	338	26	,	,	PUNCT
dti-1330	338	27	k.	k.	PROPN
dti-1330	338	28	,	,	PUNCT
dti-1330	338	29	kimura	kimura	PROPN
dti-1330	338	30	,	,	PUNCT
dti-1330	338	31	s.	s.	PROPN
dti-1330	338	32	,	,	PUNCT
dti-1330	338	33	kato	kato	PROPN
dti-1330	338	34	,	,	PUNCT
dti-1330	338	35	h.	h.	PROPN
dti-1330	338	36	,	,	PUNCT
dti-1330	338	37	kondo	kondo	PROPN
dti-1330	338	38	,	,	PUNCT
dti-1330	338	39	m.	m.	NOUN
dti-1330	338	40	and	and	CCONJ
dti-1330	338	41	hla	hla	PROPN
dti-1330	338	42	,	,	PUNCT
dti-1330	338	43	t.	t.	NOUN
dti-1330	338	44	1995	1995	NUM
dti-1330	338	45	.	.	PUNCT
dti-1330	339	1	expression	expression	NOUN
dti-1330	339	2	of	of	ADP
dti-1330	339	3	cyclooxygenase-1	cyclooxygenase-1	PROPN
dti-1330	339	4	and	and	CCONJ
dti-1330	339	5	-2	-2	INTJ
dti-1330	339	6	in	in	ADP
dti-1330	339	7	human	human	ADJ
dti-1330	339	8	colorectal	colorectal	ADJ
dti-1330	339	9	cancer	cancer	NOUN
dti-1330	339	10	.	.	PUNCT
dti-1330	340	1	cancer	cancer	NOUN
dti-1330	340	2	res	re	NOUN
dti-1330	340	3	.	.	PROPN
dti-1330	340	4	,	,	PUNCT
dti-1330	340	5	55:3785–9	55:3785–9	NUM
dti-1330	340	6	.	.	PUNCT
dti-1330	341	1	[	[	X
dti-1330	341	2	14	14	NUM
dti-1330	341	3	]	]	PUNCT
dti-1330	341	4	yoshimura	yoshimura	NOUN
dti-1330	341	5	,	,	PUNCT
dti-1330	341	6	r.	r.	PROPN
dti-1330	341	7	,	,	PUNCT
dti-1330	341	8	matsuyama	matsuyama	PROPN
dti-1330	341	9	,	,	PUNCT
dti-1330	341	10	m.	m.	NOUN
dti-1330	341	11	,	,	PUNCT
dti-1330	341	12	kawahito	kawahito	PROPN
dti-1330	341	13	,	,	PUNCT
dti-1330	341	14	y.	y.	PROPN
dti-1330	341	15	,	,	PUNCT
dti-1330	341	16	tsuchida	tsuchida	PROPN
dti-1330	341	17	,	,	PUNCT
dti-1330	341	18	k.	k.	PROPN
dti-1330	341	19	,	,	PUNCT
dti-1330	341	20	kuratsukuri	kuratsukuri	PROPN
dti-1330	341	21	,	,	PUNCT
dti-1330	341	22	k.	k.	PROPN
dti-1330	341	23	,	,	PUNCT
dti-1330	341	24	takemoto	takemoto	NOUN
dti-1330	341	25	,	,	PUNCT
dti-1330	341	26	y.	y.	PROPN
dti-1330	341	27	,	,	PUNCT
dti-1330	341	28	mitsuhashi	mitsuhashi	PROPN
dti-1330	341	29	,	,	PUNCT
dti-1330	341	30	m.	m.	NOUN
dti-1330	341	31	,	,	PUNCT
dti-1330	341	32	sano	sano	PROPN
dti-1330	341	33	,	,	PUNCT
dti-1330	341	34	y.	y.	PROPN
dti-1330	341	35	and	and	CCONJ
dti-1330	341	36	nakatani	nakatani	ADJ
dti-1330	341	37	,	,	PUNCT
dti-1330	341	38	t.	t.	NOUN
dti-1330	341	39	2004	2004	NUM
dti-1330	341	40	.	.	PUNCT
dti-1330	342	1	stydy	stydy	NOUN
dti-1330	342	2	of	of	ADP
dti-1330	342	3	cyclooxygenase-2	cyclooxygenase-2	NUM
dti-1330	342	4	in	in	ADP
dti-1330	342	5	renal	renal	ADJ
dti-1330	342	6	cell	cell	NOUN
dti-1330	342	7	carcinoma	carcinoma	NOUN
dti-1330	342	8	.	.	PUNCT
dti-1330	343	1	int	int	NOUN
dti-1330	343	2	.	.	PUNCT
dti-1330	344	1	j.	j.	PROPN
dti-1330	344	2	mol	mol	PROPN
dti-1330	344	3	.	.	PROPN
dti-1330	344	4	med	med	PROPN
dti-1330	344	5	.	.	PROPN
dti-1330	344	6	,	,	PUNCT
dti-1330	344	7	13:229–33	13:229–33	PROPN
dti-1330	344	8	.	.	PUNCT
dti-1330	345	1	[	[	X
dti-1330	345	2	15	15	NUM
dti-1330	345	3	]	]	PUNCT
dti-1330	345	4	yoshimura	yoshimura	NOUN
dti-1330	345	5	,	,	PUNCT
dti-1330	345	6	r.	r.	PROPN
dti-1330	345	7	,	,	PUNCT
dti-1330	345	8	sano	sano	PROPN
dti-1330	345	9	,	,	PUNCT
dti-1330	345	10	h.	h.	PROPN
dti-1330	345	11	,	,	PUNCT
dti-1330	345	12	mitsuhashi	mitsuhashi	PROPN
dti-1330	345	13	,	,	PUNCT
dti-1330	345	14	m.	m.	NOUN
dti-1330	345	15	,	,	PUNCT
dti-1330	345	16	kohno	kohno	NOUN
dti-1330	345	17	,	,	PUNCT
dti-1330	345	18	m.	m.	NOUN
dti-1330	345	19	,	,	PUNCT
dti-1330	345	20	chargui	chargui	PROPN
dti-1330	345	21	,	,	PUNCT
dti-1330	345	22	j.	j.	PROPN
dti-1330	345	23	and	and	CCONJ
dti-1330	345	24	wada	wada	PROPN
dti-1330	345	25	,	,	PUNCT
dti-1330	345	26	s.	s.	PROPN
dti-1330	345	27	2001	2001	NUM
dti-1330	345	28	.	.	PUNCT
dti-1330	346	1	expression	expression	NOUN
dti-1330	346	2	of	of	ADP
dti-1330	346	3	cyclooxygenase-2	cyclooxygenase-2	NUM
dti-1330	346	4	in	in	ADP
dti-1330	346	5	patients	patient	NOUN
dti-1330	346	6	with	with	ADP
dti-1330	346	7	bladder	bladder	NOUN
dti-1330	346	8	carcinoma	carcinoma	NOUN
dti-1330	346	9	.	.	PUNCT
dti-1330	347	1	j.	j.	PROPN
dti-1330	347	2	urol	urol	PROPN
dti-1330	347	3	.	.	PROPN
dti-1330	347	4	,	,	PUNCT
dti-1330	347	5	165:1468–72	165:1468–72	NUM
dti-1330	347	6	.	.	PUNCT
dti-1330	348	1	[	[	X
dti-1330	348	2	16	16	NUM
dti-1330	348	3	]	]	PUNCT
dti-1330	348	4	hase	hase	PROPN
dti-1330	348	5	,	,	PUNCT
dti-1330	348	6	t.	t.	PROPN
dti-1330	348	7	,	,	PUNCT
dti-1330	348	8	yoshimura	yoshimura	PROPN
dti-1330	348	9	,	,	PUNCT
dti-1330	348	10	r.	r.	PROPN
dti-1330	348	11	,	,	PUNCT
dti-1330	348	12	matsuyama	matsuyama	PROPN
dti-1330	348	13	,	,	PUNCT
dti-1330	348	14	m.	m.	NOUN
dti-1330	348	15	,	,	PUNCT
dti-1330	348	16	kawahito	kawahito	PROPN
dti-1330	348	17	,	,	PUNCT
dti-1330	348	18	y.	y.	PROPN
dti-1330	348	19	,	,	PUNCT
dti-1330	348	20	wada	wada	PROPN
dti-1330	348	21	,	,	PUNCT
dti-1330	348	22	s.	s.	PROPN
dti-1330	348	23	,	,	PUNCT
dti-1330	348	24	tsuchida	tsuchida	PROPN
dti-1330	348	25	,	,	PUNCT
dti-1330	348	26	k.	k.	PROPN
dti-1330	348	27	,	,	PUNCT
dti-1330	348	28	sano	sano	PROPN
dti-1330	348	29	,	,	PUNCT
dti-1330	348	30	h.	h.	PROPN
dti-1330	348	31	and	and	CCONJ
dti-1330	348	32	nakatani	nakatani	PROPN
dti-1330	348	33	,	,	PUNCT
dti-1330	348	34	t.	t.	NOUN
dti-1330	348	35	2003	2003	NUM
dti-1330	348	36	.	.	PUNCT
dti-1330	349	1	cyclooxygenase-1	cyclooxygenase-1	NOUN
dti-1330	349	2	and	and	CCONJ
dti-1330	349	3	-2	-2	INTJ
dti-1330	349	4	in	in	ADP
dti-1330	349	5	human	human	ADJ
dti-1330	349	6	testicular	testicular	NOUN
dti-1330	349	7	tumours	tumour	NOUN
dti-1330	349	8	.	.	PUNCT
dti-1330	350	1	eur	eur	PROPN
dti-1330	350	2	.	.	PUNCT
dti-1330	351	1	j.	j.	PROPN
dti-1330	351	2	cancer	cancer	PROPN
dti-1330	351	3	,	,	PUNCT
dti-1330	351	4	39:2043–9	39:2043–9	NUM
dti-1330	351	5	.	.	PUNCT
dti-1330	352	1	[	[	X
dti-1330	352	2	17	17	NUM
dti-1330	352	3	]	]	X
dti-1330	352	4	hwang	hwang	PROPN
dti-1330	352	5	,	,	PUNCT
dti-1330	352	6	d.	d.	PROPN
dti-1330	352	7	,	,	PUNCT
dti-1330	352	8	scollard	scollard	NOUN
dti-1330	352	9	,	,	PUNCT
dti-1330	352	10	d.	d.	PROPN
dti-1330	352	11	,	,	PUNCT
dti-1330	352	12	byrne	byrne	PROPN
dti-1330	352	13	,	,	PUNCT
dti-1330	352	14	j.	j.	PROPN
dti-1330	352	15	and	and	CCONJ
dti-1330	352	16	levine	levine	PROPN
dti-1330	352	17	,	,	PUNCT
dti-1330	352	18	e.	e.	PROPN
dti-1330	352	19	1998	1998	NUM
dti-1330	352	20	.	.	PUNCT
dti-1330	353	1	expression	expression	NOUN
dti-1330	353	2	of	of	ADP
dti-1330	353	3	cyclooxygenase-1	cyclooxygenase-1	PROPN
dti-1330	353	4	and	and	CCONJ
dti-1330	353	5	cyclooxygenase-2	cyclooxygenase-2	NUM
dti-1330	353	6	in	in	ADP
dti-1330	353	7	human	human	ADJ
dti-1330	353	8	breast	breast	NOUN
dti-1330	353	9	cancer	cancer	NOUN
dti-1330	353	10	.	.	PUNCT
dti-1330	354	1	j.	j.	PROPN
dti-1330	354	2	natl	natl	PROPN
dti-1330	354	3	.	.	PUNCT
dti-1330	354	4	cancer	cancer	NOUN
dti-1330	354	5	inst	inst	PROPN
dti-1330	354	6	.	.	PROPN
dti-1330	354	7	,	,	PUNCT
dti-1330	354	8	90:455–60	90:455–60	NOUN
dti-1330	354	9	.	.	PUNCT
dti-1330	355	1	[	[	X
dti-1330	355	2	18	18	NUM
dti-1330	355	3	]	]	PUNCT
dti-1330	355	4	yoshimura	yoshimura	NOUN
dti-1330	355	5	,	,	PUNCT
dti-1330	355	6	r.	r.	PROPN
dti-1330	355	7	,	,	PUNCT
dti-1330	355	8	matsuyama	matsuyama	PROPN
dti-1330	355	9	,	,	PUNCT
dti-1330	355	10	m.	m.	NOUN
dti-1330	355	11	,	,	PUNCT
dti-1330	355	12	kawahito	kawahito	PROPN
dti-1330	355	13	,	,	PUNCT
dti-1330	355	14	y.	y.	PROPN
dti-1330	355	15	,	,	PUNCT
dti-1330	355	16	takemoto	takemoto	NOUN
dti-1330	355	17	,	,	PUNCT
dti-1330	355	18	y.	y.	PROPN
dti-1330	355	19	,	,	PUNCT
dti-1330	355	20	tsuchida	tsuchida	PROPN
dti-1330	355	21	,	,	PUNCT
dti-1330	355	22	k.	k.	PROPN
dti-1330	355	23	,	,	PUNCT
dti-1330	355	24	kuratsukuri	kuratsukuri	PROPN
dti-1330	355	25	,	,	PUNCT
dti-1330	355	26	k.	k.	PROPN
dti-1330	355	27	,	,	PUNCT
dti-1330	355	28	segawa	segawa	PROPN
dti-1330	355	29	,	,	PUNCT
dti-1330	355	30	y.	y.	PROPN
dti-1330	355	31	,	,	PUNCT
dti-1330	355	32	sinnka	sinnka	PROPN
dti-1330	355	33	,	,	PUNCT
dti-1330	355	34	t.	t.	PROPN
dti-1330	355	35	,	,	PUNCT
dti-1330	355	36	sano	sano	PROPN
dti-1330	355	37	,	,	PUNCT
dti-1330	355	38	y.	y.	PROPN
dti-1330	355	39	and	and	CCONJ
dti-1330	355	40	nakatani	nakatani	ADJ
dti-1330	355	41	,	,	PUNCT
dti-1330	355	42	t.	t.	PROPN
dti-1330	355	43	2004	2004	NUM
dti-1330	355	44	.	.	PUNCT
dti-1330	356	1	the	the	DET
dti-1330	356	2	effect	effect	NOUN
dti-1330	356	3	of	of	ADP
dti-1330	356	4	cyclooxygenase-2	cyclooxygenase-2	NUM
dti-1330	356	5	inhibitors	inhibitor	NOUN
dti-1330	356	6	on	on	ADP
dti-1330	356	7	urological	urological	ADJ
dti-1330	356	8	cancer	cancer	NOUN
dti-1330	356	9	cells	cell	NOUN
dti-1330	356	10	.	.	PUNCT
dti-1330	357	1	int	int	NOUN
dti-1330	357	2	.	.	PUNCT
dti-1330	358	1	j.	j.	PROPN
dti-1330	358	2	mol	mol	PROPN
dti-1330	358	3	.	.	PROPN
dti-1330	358	4	med	med	PROPN
dti-1330	358	5	.	.	PROPN
dti-1330	358	6	,	,	PUNCT
dti-1330	358	7	13:789–93	13:789–93	PROPN
dti-1330	358	8	.	.	PUNCT
dti-1330	359	1	[	[	X
dti-1330	359	2	19	19	NUM
dti-1330	359	3	]	]	X
dti-1330	359	4	matsuyama	matsuyama	PROPN
dti-1330	359	5	,	,	PUNCT
dti-1330	359	6	m.	m.	NOUN
dti-1330	359	7	,	,	PUNCT
dti-1330	359	8	yoshimura	yoshimura	NOUN
dti-1330	359	9	,	,	PUNCT
dti-1330	359	10	r.	r.	PROPN
dti-1330	359	11	,	,	PUNCT
dti-1330	359	12	mitsuhashi	mitsuhashi	PROPN
dti-1330	359	13	,	,	PUNCT
dti-1330	359	14	m.	m.	NOUN
dti-1330	359	15	,	,	PUNCT
dti-1330	359	16	tsuchida	tsuchida	PROPN
dti-1330	359	17	,	,	PUNCT
dti-1330	359	18	k.	k.	PROPN
dti-1330	359	19	,	,	PUNCT
dti-1330	359	20	takemoto	takemoto	NOUN
dti-1330	359	21	,	,	PUNCT
dti-1330	359	22	y.	y.	PROPN
dti-1330	359	23	,	,	PUNCT
dti-1330	359	24	kawahito	kawahito	PROPN
dti-1330	359	25	,	,	PUNCT
dti-1330	359	26	y.	y.	PROPN
dti-1330	359	27	,	,	PUNCT
dti-1330	359	28	sano	sano	PROPN
dti-1330	359	29	,	,	PUNCT
dti-1330	359	30	h.	h.	PROPN
dti-1330	359	31	and	and	CCONJ
dti-1330	359	32	nakatani	nakatani	ADJ
dti-1330	359	33	,	,	PUNCT
dti-1330	359	34	t.	t.	NOUN
dti-1330	359	35	2005	2005	NUM
dti-1330	359	36	.	.	PUNCT
dti-1330	360	1	5	5	NUM
dti-1330	360	2	-	-	PUNCT
dti-1330	360	3	lipoxygenase	lipoxygenase	NOUN
dti-1330	360	4	inhibitors	inhibitor	NOUN
dti-1330	360	5	attenuate	attenuate	VERB
dti-1330	360	6	growth	growth	NOUN
dti-1330	360	7	of	of	ADP
dti-1330	360	8	human	human	ADJ
dti-1330	360	9	renal	renal	ADJ
dti-1330	360	10	cell	cell	NOUN
dti-1330	360	11	carcinoma	carcinoma	NOUN
dti-1330	360	12	and	and	CCONJ
dti-1330	360	13	induce	induce	VERB
dti-1330	360	14	apoptosis	apoptosis	NOUN
dti-1330	360	15	through	through	ADP
dti-1330	360	16	arachidonic	arachidonic	ADJ
dti-1330	360	17	acid	acid	NOUN
dti-1330	360	18	pathway	pathway	NOUN
dti-1330	360	19	.	.	PUNCT
dti-1330	361	1	oncol	oncol	PROPN
dti-1330	361	2	.	.	PUNCT
dti-1330	362	1	rep	rep	PROPN
dti-1330	362	2	.	.	PROPN
dti-1330	362	3	,	,	PUNCT
dti-1330	362	4	14:73–9	14:73–9	NUM
dti-1330	362	5	.	.	PUNCT
dti-1330	363	1	[	[	X
dti-1330	363	2	20	20	NUM
dti-1330	363	3	]	]	PUNCT
dti-1330	363	4	matsuyama	matsuyama	PROPN
dti-1330	363	5	,	,	PUNCT
dti-1330	363	6	m.	m.	NOUN
dti-1330	363	7	,	,	PUNCT
dti-1330	363	8	yoshimura	yoshimura	NOUN
dti-1330	363	9	,	,	PUNCT
dti-1330	363	10	r.	r.	PROPN
dti-1330	363	11	,	,	PUNCT
dti-1330	363	12	mitsuhashi	mitsuhashi	PROPN
dti-1330	363	13	,	,	PUNCT
dti-1330	363	14	m.	m.	NOUN
dti-1330	363	15	,	,	PUNCT
dti-1330	363	16	hase	hase	PROPN
dti-1330	363	17	,	,	PUNCT
dti-1330	363	18	t.	t.	PROPN
dti-1330	363	19	,	,	PUNCT
dti-1330	363	20	tsuchida	tsuchida	PROPN
dti-1330	363	21	,	,	PUNCT
dti-1330	363	22	k.	k.	PROPN
dti-1330	363	23	,	,	PUNCT
dti-1330	363	24	takemoto	takemoto	NOUN
dti-1330	363	25	,	,	PUNCT
dti-1330	363	26	y.	y.	PROPN
dti-1330	363	27	,	,	PUNCT
dti-1330	363	28	kawahito	kawahito	PROPN
dti-1330	363	29	,	,	PUNCT
dti-1330	363	30	y.	y.	PROPN
dti-1330	363	31	,	,	PUNCT
dti-1330	363	32	sano	sano	PROPN
dti-1330	363	33	,	,	PUNCT
dti-1330	363	34	h.	h.	PROPN
dti-1330	363	35	and	and	CCONJ
dti-1330	363	36	nakatani	nakatani	ADJ
dti-1330	363	37	,	,	PUNCT
dti-1330	363	38	t.	t.	NOUN
dti-1330	363	39	2004	2004	NUM
dti-1330	363	40	.	.	PUNCT
dti-1330	364	1	expression	expression	NOUN
dti-1330	364	2	of	of	ADP
dti-1330	364	3	lipoxygenase	lipoxygenase	NOUN
dti-1330	364	4	in	in	ADP
dti-1330	364	5	human	human	ADJ
dti-1330	364	6	prostate	prostate	NOUN
dti-1330	364	7	cancer	cancer	NOUN
dti-1330	364	8	and	and	CCONJ
dti-1330	364	9	growth	growth	NOUN
dti-1330	364	10	reduction	reduction	NOUN
dti-1330	364	11	by	by	ADP
dti-1330	364	12	its	its	PRON
dti-1330	364	13	inhibitors	inhibitor	NOUN
dti-1330	364	14	.	.	PUNCT
dti-1330	365	1	int	int	NOUN
dti-1330	365	2	.	.	PUNCT
dti-1330	366	1	j.	j.	PROPN
dti-1330	366	2	oncol	oncol	PROPN
dti-1330	366	3	.	.	PROPN
dti-1330	366	4	,	,	PUNCT
dti-1330	366	5	24:821–7	24:821–7	NUM
dti-1330	366	6	.	.	PUNCT
dti-1330	367	1	[	[	X
dti-1330	367	2	21	21	NUM
dti-1330	367	3	]	]	PUNCT
dti-1330	367	4	yoshimura	yoshimura	NOUN
dti-1330	367	5	,	,	PUNCT
dti-1330	367	6	r.	r.	PROPN
dti-1330	367	7	,	,	PUNCT
dti-1330	367	8	matsuyama	matsuyama	PROPN
dti-1330	367	9	,	,	PUNCT
dti-1330	367	10	m.	m.	NOUN
dti-1330	367	11	,	,	PUNCT
dti-1330	367	12	mitsuhashi	mitsuhashi	PROPN
dti-1330	367	13	,	,	PUNCT
dti-1330	367	14	m.	m.	NOUN
dti-1330	367	15	,	,	PUNCT
dti-1330	367	16	takemoto	takemoto	NOUN
dti-1330	367	17	,	,	PUNCT
dti-1330	367	18	y.	y.	PROPN
dti-1330	367	19	,	,	PUNCT
dti-1330	367	20	tsuchida	tsuchida	PROPN
dti-1330	367	21	,	,	PUNCT
dti-1330	367	22	k.	k.	PROPN
dti-1330	367	23	,	,	PUNCT
dti-1330	367	24	kawahito	kawahito	PROPN
dti-1330	367	25	,	,	PUNCT
dti-1330	367	26	y.	y.	PROPN
dti-1330	367	27	,	,	PUNCT
dti-1330	367	28	sano	sano	PROPN
dti-1330	367	29	,	,	PUNCT
dti-1330	367	30	h.	h.	PROPN
dti-1330	367	31	and	and	CCONJ
dti-1330	367	32	nakatani	nakatani	ADJ
dti-1330	367	33	,	,	PUNCT
dti-1330	367	34	t.	t.	PROPN
dti-1330	367	35	2004	2004	NUM
dti-1330	367	36	.	.	PUNCT
dti-1330	368	1	relationship	relationship	NOUN
dti-1330	368	2	between	between	ADP
dti-1330	368	3	lipoxygenase	lipoxygenase	NOUN
dti-1330	368	4	and	and	CCONJ
dti-1330	368	5	human	human	ADJ
dti-1330	368	6	testicular	testicular	NOUN
dti-1330	368	7	cancer	cancer	NOUN
dti-1330	368	8	.	.	PUNCT
dti-1330	369	1	int	int	NOUN
dti-1330	369	2	.	.	PUNCT
dti-1330	370	1	j.	j.	PROPN
dti-1330	370	2	mol	mol	PROPN
dti-1330	370	3	.	.	PROPN
dti-1330	370	4	med	med	PROPN
dti-1330	370	5	.	.	PROPN
dti-1330	370	6	,	,	PUNCT
dti-1330	370	7	13:389–93	13:389–93	NUM
dti-1330	370	8	.	.	PUNCT
dti-1330	371	1	[	[	X
dti-1330	371	2	22	22	NUM
dti-1330	371	3	]	]	X
dti-1330	371	4	matsuyama	matsuyama	PROPN
dti-1330	371	5	,	,	PUNCT
dti-1330	371	6	m.	m.	NOUN
dti-1330	371	7	,	,	PUNCT
dti-1330	371	8	yoshimuira	yoshimuira	PROPN
dti-1330	371	9	,	,	PUNCT
dti-1330	371	10	r.	r.	PROPN
dti-1330	371	11	,	,	PUNCT
dti-1330	371	12	tsuchida	tsuchida	PROPN
dti-1330	371	13	,	,	PUNCT
dti-1330	371	14	k.	k.	PROPN
dti-1330	371	15	,	,	PUNCT
dti-1330	371	16	takemoto	takemoto	NOUN
dti-1330	371	17	,	,	PUNCT
dti-1330	371	18	y.	y.	PROPN
dti-1330	371	19	,	,	PUNCT
dti-1330	371	20	segawa	segawa	PROPN
dti-1330	371	21	,	,	PUNCT
dti-1330	371	22	y.	y.	PROPN
dti-1330	371	23	,	,	PUNCT
dti-1330	371	24	shinnka	shinnka	PROPN
dti-1330	371	25	,	,	PUNCT
dti-1330	371	26	t.	t.	PROPN
dti-1330	371	27	,	,	PUNCT
dti-1330	371	28	kawahito	kawahito	PROPN
dti-1330	371	29	,	,	PUNCT
dti-1330	371	30	y.	y.	PROPN
dti-1330	371	31	,	,	PUNCT
dti-1330	371	32	sano	sano	PROPN
dti-1330	371	33	,	,	PUNCT
dti-1330	371	34	h.	h.	PROPN
dti-1330	371	35	and	and	CCONJ
dti-1330	371	36	nakatani	nakatani	ADJ
dti-1330	371	37	,	,	PUNCT
dti-1330	371	38	t.	t.	PROPN
dti-1330	371	39	2004	2004	NUM
dti-1330	371	40	.	.	PUNCT
dti-1330	372	1	lipoxygenase	lipoxygenase	NOUN
dti-1330	372	2	inhibitors	inhibitor	NOUN
dti-1330	372	3	prevent	prevent	VERB
dti-1330	372	4	urological	urological	ADJ
dti-1330	372	5	cancer	cancer	NOUN
dti-1330	372	6	cell	cell	NOUN
dti-1330	372	7	growth	growth	NOUN
dti-1330	372	8	.	.	PUNCT
dti-1330	373	1	int	int	NOUN
dti-1330	373	2	.	.	PUNCT
dti-1330	374	1	j.	j.	PROPN
dti-1330	374	2	mol	mol	PROPN
dti-1330	374	3	.	.	PROPN
dti-1330	374	4	med	med	PROPN
dti-1330	374	5	.	.	PROPN
dti-1330	374	6	,	,	PUNCT
dti-1330	374	7	13:665–8	13:665–8	NUM
dti-1330	374	8	.	.	PUNCT
dti-1330	375	1	[	[	X
dti-1330	375	2	23	23	NUM
dti-1330	375	3	]	]	X
dti-1330	375	4	ghosh	ghosh	PROPN
dti-1330	375	5	,	,	PUNCT
dti-1330	375	6	j.	j.	PROPN
dti-1330	375	7	and	and	CCONJ
dti-1330	375	8	myers	myers	PROPN
dti-1330	375	9	,	,	PUNCT
dti-1330	375	10	c.e	c.e	PROPN
dti-1330	375	11	.	.	PROPN
dti-1330	375	12	1998	1998	NUM
dti-1330	375	13	.	.	PUNCT
dti-1330	376	1	inhibition	inhibition	NOUN
dti-1330	376	2	of	of	ADP
dti-1330	376	3	arachidonate	arachidonate	ADJ
dti-1330	376	4	5	5	NUM
dti-1330	376	5	-	-	PUNCT
dti-1330	376	6	lipoxygenase	lipoxygenase	NOUN
dti-1330	376	7	triggers	trigger	NOUN
dti-1330	376	8	massive	massive	ADJ
dti-1330	376	9	apoptosis	apoptosis	NOUN
dti-1330	376	10	in	in	ADP
dti-1330	376	11	human	human	ADJ
dti-1330	376	12	prostate	prostate	NOUN
dti-1330	376	13	cancer	cancer	NOUN
dti-1330	376	14	cells	cell	NOUN
dti-1330	376	15	.	.	PUNCT
dti-1330	377	1	proc	proc	NOUN
dti-1330	377	2	.	.	PUNCT
dti-1330	378	1	natl	natl	PROPN
dti-1330	378	2	.	.	PUNCT
dti-1330	379	1	acad	acad	PROPN
dti-1330	379	2	.	.	PUNCT
dti-1330	380	1	sci	sci	PROPN
dti-1330	380	2	.	.	PUNCT
dti-1330	380	3	u.s.a	u.s.a	PROPN
dti-1330	380	4	.	.	PROPN
dti-1330	380	5	,	,	PUNCT
dti-1330	380	6	95:13182–7	95:13182–7	X
dti-1330	380	7	.	.	PUNCT
dti-1330	381	1	[	[	X
dti-1330	381	2	24	24	NUM
dti-1330	381	3	]	]	X
dti-1330	381	4	ghosh	ghosh	PROPN
dti-1330	381	5	,	,	PUNCT
dti-1330	381	6	j.	j.	PROPN
dti-1330	381	7	2003	2003	NUM
dti-1330	381	8	.	.	PUNCT
dti-1330	381	9	inhibition	inhibition	NOUN
dti-1330	381	10	of	of	ADP
dti-1330	381	11	arachidonate	arachidonate	ADJ
dti-1330	381	12	5	5	NUM
dti-1330	381	13	-	-	PUNCT
dti-1330	381	14	lipoxygenase	lipoxygenase	NOUN
dti-1330	381	15	triggers	trigger	NOUN
dti-1330	381	16	prostate	prostate	NOUN
dti-1330	381	17	cancer	cancer	NOUN
dti-1330	381	18	cell	cell	NOUN
dti-1330	381	19	death	death	NOUN
dti-1330	381	20	through	through	ADP
dti-1330	381	21	rapid	rapid	ADJ
dti-1330	381	22	activation	activation	NOUN
dti-1330	381	23	of	of	ADP
dti-1330	381	24	c	c	PROPN
dti-1330	381	25	-	-	PUNCT
dti-1330	381	26	jun	jun	PROPN
dti-1330	381	27	n	n	CCONJ
dti-1330	381	28	-	-	PUNCT
dti-1330	381	29	terminal	terminal	ADJ
dti-1330	381	30	kinase	kinase	NOUN
dti-1330	381	31	.	.	PUNCT
dti-1330	382	1	biochem	biochem	PROPN
dti-1330	382	2	.	.	PUNCT
dti-1330	383	1	biophys	biophy	NOUN
dti-1330	383	2	.	.	PUNCT
dti-1330	384	1	res	re	NOUN
dti-1330	384	2	.	.	PUNCT
dti-1330	385	1	commun	commun	PROPN
dti-1330	385	2	.	.	PROPN
dti-1330	385	3	,	,	PUNCT
dti-1330	385	4	307:342–9	307:342–9	NUM
dti-1330	385	5	.	.	PUNCT
dti-1330	386	1	[	[	X
dti-1330	386	2	25	25	NUM
dti-1330	386	3	]	]	PUNCT
dti-1330	386	4	pommery	pommery	NOUN
dti-1330	386	5	,	,	PUNCT
dti-1330	386	6	n.	n.	NOUN
dti-1330	386	7	,	,	PUNCT
dti-1330	386	8	taverne	taverne	NOUN
dti-1330	386	9	,	,	PUNCT
dti-1330	386	10	t.	t.	NOUN
dti-1330	386	11	,	,	PUNCT
dti-1330	386	12	telliez	telliez	NOUN
dti-1330	386	13	,	,	PUNCT
dti-1330	386	14	a.	a.	NOUN
dti-1330	386	15	,	,	PUNCT
dti-1330	386	16	goossens	goossens	PROPN
dti-1330	386	17	,	,	PUNCT
dti-1330	386	18	l.	l.	PROPN
dti-1330	386	19	,	,	PUNCT
dti-1330	386	20	charlier	charlier	NOUN
dti-1330	386	21	,	,	PUNCT
dti-1330	386	22	c.	c.	PROPN
dti-1330	386	23	,	,	PUNCT
dti-1330	386	24	pommery	pommery	NOUN
dti-1330	386	25	,	,	PUNCT
dti-1330	386	26	j.	j.	PROPN
dti-1330	386	27	,	,	PUNCT
dti-1330	386	28	goossens	goossens	PROPN
dti-1330	386	29	,	,	PUNCT
dti-1330	386	30	j.f	j.f	PROPN
dti-1330	386	31	.	.	PROPN
dti-1330	386	32	,	,	PUNCT
dti-1330	386	33	houssin	houssin	PROPN
dti-1330	386	34	,	,	PUNCT
dti-1330	386	35	r.	r.	PROPN
dti-1330	386	36	,	,	PUNCT
dti-1330	386	37	durant	durant	PROPN
dti-1330	386	38	,	,	PUNCT
dti-1330	386	39	f.	f.	PROPN
dti-1330	386	40	and	and	CCONJ
dti-1330	386	41	henichart	henichart	PROPN
dti-1330	386	42	,	,	PUNCT
dti-1330	386	43	j.p	j.p	PROPN
dti-1330	386	44	.	.	PROPN
dti-1330	386	45	2004	2004	NUM
dti-1330	386	46	.	.	PUNCT
dti-1330	387	1	new	new	ADJ
dti-1330	387	2	cox-2/5	cox-2/5	PROPN
dti-1330	387	3	-	-	PUNCT
dti-1330	387	4	lox	lox	NOUN
dti-1330	387	5	inhibitors	inhibitor	NOUN
dti-1330	387	6	:	:	PUNCT
dti-1330	387	7	apoptosis	apoptosis	NOUN
dti-1330	387	8	-	-	PUNCT
dti-1330	387	9	inducing	induce	VERB
dti-1330	387	10	agents	agent	NOUN
dti-1330	387	11	potentially	potentially	ADV
dti-1330	387	12	useful	useful	ADJ
dti-1330	387	13	in	in	ADP
dti-1330	387	14	prostate	prostate	NOUN
dti-1330	387	15	cancer	cancer	NOUN
dti-1330	387	16	chemotherapy	chemotherapy	NOUN
dti-1330	387	17	.	.	PUNCT
dti-1330	388	1	j.	j.	PROPN
dti-1330	388	2	med	med	PROPN
dti-1330	388	3	.	.	PROPN
dti-1330	388	4	chem	chem	PROPN
dti-1330	388	5	.	.	PUNCT
dti-1330	388	6	,	,	PUNCT
dti-1330	389	1	47:6195–206	47:6195–206	X
dti-1330	389	2	.	.	PUNCT
dti-1330	390	1	[	[	X
dti-1330	390	2	26	26	NUM
dti-1330	390	3	]	]	X
dti-1330	390	4	ghosh	ghosh	PROPN
dti-1330	390	5	,	,	PUNCT
dti-1330	390	6	j.	j.	PROPN
dti-1330	390	7	2004	2004	PROPN
dti-1330	390	8	.	.	PUNCT
dti-1330	391	1	rapid	rapid	ADJ
dti-1330	391	2	induction	induction	NOUN
dti-1330	391	3	of	of	ADP
dti-1330	391	4	apoptosis	apoptosis	NOUN
dti-1330	391	5	in	in	ADP
dti-1330	391	6	prostate	prostate	NOUN
dti-1330	391	7	cancer	cancer	NOUN
dti-1330	391	8	cells	cell	NOUN
dti-1330	391	9	by	by	ADP
dti-1330	391	10	selenium	selenium	NOUN
dti-1330	391	11	:	:	PUNCT
dti-1330	391	12	reversal	reversal	NOUN
dti-1330	391	13	by	by	ADP
dti-1330	391	14	metabolites	metabolite	NOUN
dti-1330	391	15	of	of	ADP
dti-1330	391	16	arachidonate	arachidonate	ADJ
dti-1330	391	17	5	5	NUM
dti-1330	391	18	-	-	PUNCT
dti-1330	391	19	lipoxygenase	lipoxygenase	NOUN
dti-1330	391	20	.	.	PUNCT
dti-1330	392	1	biochem	biochem	PROPN
dti-1330	392	2	.	.	PUNCT
dti-1330	393	1	biophys	biophy	NOUN
dti-1330	393	2	.	.	PUNCT
dti-1330	394	1	res	re	NOUN
dti-1330	394	2	.	.	PUNCT
dti-1330	395	1	commun	commun	PROPN
dti-1330	395	2	.	.	PROPN
dti-1330	395	3	,	,	PUNCT
dti-1330	395	4	315:624–35	315:624–35	NUM
dti-1330	395	5	.	.	PUNCT
dti-1330	396	1	<	<	X
dti-1330	396	2	<	<	X
dti-1330	396	3	/ascii85encodepages	/ascii85encodepage	NOUN
dti-1330	396	4	false	false	ADJ
dti-1330	396	5	/allowtransparency	/allowtransparency	NOUN
dti-1330	396	6	false	false	ADJ
dti-1330	396	7	/autopositionepsfiles	/autopositionepsfile	NOUN
dti-1330	396	8	true	true	ADJ
dti-1330	396	9	/autorotatepages	/autorotatepage	NOUN
dti-1330	396	10	/none	/none	PUNCT
dti-1330	396	11	/binding	/binding	PUNCT
dti-1330	396	12	/left	/left	ADJ
dti-1330	397	1	/calgrayprofile	/calgrayprofile	VERB
dti-1330	397	2	(	(	PUNCT
dti-1330	397	3	dot	dot	NOUN
dti-1330	397	4	gain	gain	NOUN
dti-1330	397	5	20	20	NUM
dti-1330	397	6	%	%	NOUN
dti-1330	397	7	)	)	PUNCT
dti-1330	397	8	/calrgbprofile	/calrgbprofile	PUNCT
dti-1330	398	1	(	(	PUNCT
dti-1330	398	2	srgb	srgb	PROPN
dti-1330	398	3	iec61966	iec61966	NOUN
dti-1330	398	4	-	-	PUNCT
dti-1330	398	5	2.1	2.1	NUM
dti-1330	398	6	)	)	PUNCT
dti-1330	398	7	/calcmykprofile	/calcmykprofile	PUNCT
dti-1330	399	1	(	(	PUNCT
dti-1330	399	2	u.s	u.s	PROPN
dti-1330	399	3	.	.	PROPN
dti-1330	399	4	web	web	NOUN
dti-1330	399	5	coated	coat	VERB
dti-1330	399	6	\050swop\051	\050swop\051	ADJ
dti-1330	399	7	v2	v2	NOUN
dti-1330	399	8	)	)	PUNCT
dti-1330	399	9	/srgbprofile	/srgbprofile	PUNCT
dti-1330	399	10	(	(	PUNCT
dti-1330	399	11	srgb	srgb	PROPN
dti-1330	399	12	iec61966	iec61966	NOUN
dti-1330	399	13	-	-	PUNCT
dti-1330	399	14	2.1	2.1	NUM
dti-1330	399	15	)	)	PUNCT
dti-1330	399	16	/cannotembedfontpolicy	/cannotembedfontpolicy	PUNCT
dti-1330	400	1	/error	/error	INTJ
dti-1330	400	2	/compatibilitylevel	/compatibilitylevel	NOUN
dti-1330	401	1	1.4	1.4	NUM
dti-1330	401	2	/compressobjects	/compressobject	NOUN
dti-1330	401	3	/tags	/tag	VERB
dti-1330	401	4	/compresspages	/compresspage	NOUN
dti-1330	401	5	true	true	ADJ
dti-1330	401	6	/convertimagestoindexed	/convertimagestoindexed	ADJ
dti-1330	401	7	true	true	ADJ
dti-1330	401	8	/passthroughjpegimages	/passthroughjpegimage	NOUN
dti-1330	401	9	true	true	ADJ
dti-1330	401	10	/createjdffile	/createjdffile	ADJ
dti-1330	401	11	false	false	ADJ
dti-1330	401	12	/createjobticket	/createjobticket	NOUN
dti-1330	401	13	false	false	ADJ
dti-1330	401	14	/defaultrenderingintent	/defaultrenderingintent	NOUN
dti-1330	401	15	/default	/default	PUNCT
dti-1330	401	16	/detectblends	/detectblend	NOUN
dti-1330	401	17	true	true	ADJ
dti-1330	401	18	/detectcurves	/detectcurve	VERB
dti-1330	401	19	0.1000	0.1000	NUM
dti-1330	401	20	/colorconversionstrategy	/colorconversionstrategy	NOUN
dti-1330	401	21	/leavecolorunchanged	/leavecolorunchange	VERB
dti-1330	401	22	/dothumbnails	/dothumbnail	VERB
dti-1330	402	1	false	false	ADJ
dti-1330	402	2	/embedallfonts	/embedallfont	NOUN
dti-1330	402	3	true	true	ADJ
dti-1330	402	4	/embedopentype	/embedopentype	PUNCT
dti-1330	402	5	false	false	ADJ
dti-1330	402	6	/parseiccprofilesincomments	/parseiccprofilesincomment	NOUN
dti-1330	402	7	true	true	ADJ
dti-1330	402	8	/embedjoboptions	/embedjoboption	NOUN
dti-1330	402	9	true	true	ADJ
dti-1330	402	10	/dscreportinglevel	/dscreportinglevel	NOUN
dti-1330	402	11	0	0	NUM
dti-1330	402	12	/emitdscwarnings	/emitdscwarning	NOUN
dti-1330	402	13	false	false	ADJ
dti-1330	402	14	/endpage	/endpage	NOUN
dti-1330	402	15	-1	-1	NOUN
dti-1330	402	16	/imagememory	/imagememory	NUM
dti-1330	402	17	1048576	1048576	NUM
dti-1330	402	18	/lockdistillerparams	/lockdistillerparams	NOUN
dti-1330	402	19	false	false	ADJ
dti-1330	402	20	/maxsubsetpct	/maxsubsetpct	ADJ
dti-1330	402	21	100	100	NUM
dti-1330	402	22	/optimize	/optimize	NOUN
dti-1330	402	23	true	true	ADJ
dti-1330	402	24	/opm	/opm	NOUN
dti-1330	402	25	1	1	NUM
dti-1330	402	26	/parsedsccomments	/parsedsccomment	NOUN
dti-1330	402	27	true	true	ADJ
dti-1330	402	28	/parsedsccommentsfordocinfo	/parsedsccommentsfordocinfo	VERB
dti-1330	402	29	true	true	ADJ
dti-1330	402	30	/preservecopypage	/preservecopypage	NOUN
dti-1330	402	31	true	true	ADJ
dti-1330	402	32	/preservedicmykvalues	/preservedicmykvalue	NOUN
dti-1330	402	33	true	true	ADJ
dti-1330	402	34	/preserveepsinfo	/preserveepsinfo	NOUN
dti-1330	402	35	true	true	ADJ
dti-1330	402	36	/preserveflatness	/preserveflatness	NOUN
dti-1330	402	37	true	true	ADJ
dti-1330	402	38	/preservehalftoneinfo	/preservehalftoneinfo	PUNCT
dti-1330	402	39	false	false	ADJ
dti-1330	402	40	/preserveopicomments	/preserveopicomment	NOUN
dti-1330	402	41	false	false	ADJ
dti-1330	402	42	/preserveoverprintsettings	/preserveoverprintsetting	NOUN
dti-1330	402	43	true	true	ADJ
dti-1330	402	44	/startpage	/startpage	NOUN
dti-1330	402	45	1	1	NUM
dti-1330	402	46	/subsetfonts	/subsetfont	NOUN
dti-1330	402	47	true	true	ADJ
dti-1330	402	48	/transferfunctioninfo	/transferfunctioninfo	PUNCT
dti-1330	402	49	/apply	/apply	PUNCT
dti-1330	402	50	/ucrandbginfo	/ucrandbginfo	PUNCT
dti-1330	403	1	/preserve	/preserve	NOUN
dti-1330	403	2	/useprologue	/useprologue	NOUN
dti-1330	403	3	false	false	ADJ
dti-1330	403	4	/colorsettingsfile	/colorsettingsfile	NOUN
dti-1330	403	5	(	(	PUNCT
dti-1330	403	6	)	)	PUNCT
dti-1330	403	7	/alwaysembed	/alwaysembe	VERB
dti-1330	403	8	[	[	PUNCT
dti-1330	403	9	true	true	ADJ
dti-1330	403	10	]	]	PUNCT
dti-1330	403	11	/neverembed	/neverembed	PUNCT
dti-1330	404	1	[	[	PUNCT
dti-1330	404	2	true	true	ADJ
dti-1330	404	3	]	]	PUNCT
dti-1330	404	4	/antialiascolorimages	/antialiascolorimages	X
dti-1330	404	5	false	false	ADJ
dti-1330	404	6	/cropcolorimages	/cropcolorimages	PUNCT
dti-1330	404	7	true	true	ADJ
dti-1330	404	8	/colorimageminresolution	/colorimageminresolution	NOUN
dti-1330	404	9	150	150	NUM
dti-1330	404	10	/colorimageminresolutionpolicy	/colorimageminresolutionpolicy	NOUN
dti-1330	404	11	/ok	/ok	PUNCT
dti-1330	405	1	/downsamplecolorimages	/downsamplecolorimage	VERB
dti-1330	406	1	true	true	ADJ
dti-1330	406	2	/colorimagedownsampletype	/colorimagedownsampletype	PUNCT
dti-1330	406	3	/bicubic	/bicubic	NOUN
dti-1330	406	4	/colorimageresolution	/colorimageresolution	NOUN
dti-1330	407	1	300	300	NUM
dti-1330	407	2	/colorimagedepth	/colorimagedepth	PRON
dti-1330	407	3	-1	-1	INTJ
dti-1330	407	4	/colorimagemindownsampledepth	/colorimagemindownsampledepth	SYM
dti-1330	407	5	1	1	NUM
dti-1330	407	6	/colorimagedownsamplethreshold	/colorimagedownsamplethreshold	SYM
dti-1330	407	7	1.50000	1.50000	NUM
dti-1330	407	8	/encodecolorimages	/encodecolorimage	NOUN
dti-1330	407	9	true	true	ADJ
dti-1330	407	10	/colorimagefilter	/colorimagefilter	PUNCT
dti-1330	407	11	/dctencode	/dctencode	PUNCT
dti-1330	408	1	/autofiltercolorimages	/autofiltercolorimage	NOUN
dti-1330	408	2	true	true	ADJ
dti-1330	408	3	/colorimageautofilterstrategy	/colorimageautofilterstrategy	PUNCT
dti-1330	408	4	/jpeg	/jpeg	PUNCT
dti-1330	408	5	/coloracsimagedict	/coloracsimagedict	PUNCT
dti-1330	409	1	<	<	X
dti-1330	409	2	<	<	X
dti-1330	409	3	/qfactor	/qfactor	NOUN
dti-1330	409	4	0.15	0.15	NUM
dti-1330	409	5	/hsamples	/hsample	NOUN
dti-1330	410	1	[	[	X
dti-1330	410	2	1	1	NUM
dti-1330	410	3	1	1	NUM
dti-1330	410	4	1	1	NUM
dti-1330	410	5	1	1	NUM
dti-1330	410	6	]	]	PUNCT
dti-1330	410	7	/vsamples	/vsample	NOUN
dti-1330	411	1	[	[	X
dti-1330	411	2	1	1	NUM
dti-1330	411	3	1	1	NUM
dti-1330	411	4	1	1	NUM
dti-1330	411	5	1	1	NUM
dti-1330	411	6	]	]	PUNCT
dti-1330	411	7	>	>	PUNCT
dti-1330	411	8	>	>	X
dti-1330	411	9	/colorimagedict	/colorimagedict	PUNCT
dti-1330	412	1	<	<	X
dti-1330	412	2	<	<	X
dti-1330	412	3	/qfactor	/qfactor	NOUN
dti-1330	412	4	0.15	0.15	NUM
dti-1330	412	5	/hsamples	/hsample	NOUN
dti-1330	413	1	[	[	X
dti-1330	413	2	1	1	NUM
dti-1330	413	3	1	1	NUM
dti-1330	413	4	1	1	NUM
dti-1330	413	5	1	1	NUM
dti-1330	413	6	]	]	PUNCT
dti-1330	413	7	/vsamples	/vsample	NOUN
dti-1330	414	1	[	[	X
dti-1330	414	2	1	1	NUM
dti-1330	414	3	1	1	NUM
dti-1330	414	4	1	1	NUM
dti-1330	414	5	1	1	NUM
dti-1330	414	6	]	]	PUNCT
dti-1330	414	7	>	>	PUNCT
dti-1330	414	8	>	>	X
dti-1330	414	9	/jpeg2000coloracsimagedict	/jpeg2000coloracsimagedict	PUNCT
dti-1330	415	1	<	<	X
dti-1330	415	2	<	<	X
dti-1330	415	3	/tilewidth	/tilewidth	PUNCT
dti-1330	415	4	256	256	NUM
dti-1330	415	5	/tileheight	/tileheight	NUM
dti-1330	415	6	256	256	NUM
dti-1330	415	7	/quality	/quality	NOUN
dti-1330	415	8	30	30	NUM
dti-1330	415	9	>	>	PUNCT
dti-1330	415	10	>	>	X
dti-1330	415	11	/jpeg2000colorimagedict	/jpeg2000colorimagedict	PUNCT
dti-1330	415	12	<	<	X
dti-1330	415	13	<	<	X
dti-1330	415	14	/tilewidth	/tilewidth	PUNCT
dti-1330	415	15	256	256	NUM
dti-1330	415	16	/tileheight	/tileheight	NUM
dti-1330	415	17	256	256	NUM
dti-1330	415	18	/quality	/quality	NOUN
dti-1330	415	19	30	30	NUM
dti-1330	415	20	>	>	PUNCT
dti-1330	415	21	>	>	X
dti-1330	415	22	/antialiasgrayimages	/antialiasgrayimages	X
dti-1330	415	23	false	false	ADJ
dti-1330	415	24	/cropgrayimages	/cropgrayimage	NOUN
dti-1330	415	25	true	true	ADJ
dti-1330	415	26	/grayimageminresolution	/grayimageminresolution	ADV
dti-1330	415	27	150	150	NUM
dti-1330	415	28	/grayimageminresolutionpolicy	/grayimageminresolutionpolicy	NOUN
dti-1330	416	1	/ok	/ok	ADJ
dti-1330	416	2	/downsamplegrayimages	/downsamplegrayimages	PUNCT
dti-1330	417	1	true	true	ADJ
dti-1330	417	2	/grayimagedownsampletype	/grayimagedownsampletype	INTJ
dti-1330	417	3	/bicubic	/bicubic	NOUN
dti-1330	417	4	/grayimageresolution	/grayimageresolution	NOUN
dti-1330	417	5	300	300	NUM
dti-1330	417	6	/grayimagedepth	/grayimagedepth	PUNCT
dti-1330	417	7	-1	-1	PUNCT
dti-1330	417	8	/grayimagemindownsampledepth	/grayimagemindownsampledepth	PUNCT
dti-1330	418	1	2	2	NUM
dti-1330	418	2	/grayimagedownsamplethreshold	/grayimagedownsamplethreshold	NUM
dti-1330	418	3	1.50000	1.50000	NUM
dti-1330	418	4	/encodegrayimages	/encodegrayimage	NOUN
dti-1330	418	5	true	true	ADJ
dti-1330	418	6	/grayimagefilter	/grayimagefilter	NOUN
dti-1330	418	7	/dctencode	/dctencode	PUNCT
dti-1330	419	1	/autofiltergrayimages	/autofiltergrayimages	VERB
dti-1330	419	2	true	true	ADJ
dti-1330	419	3	/grayimageautofilterstrategy	/grayimageautofilterstrategy	INTJ
dti-1330	419	4	/jpeg	/jpeg	PUNCT
dti-1330	419	5	/grayacsimagedict	/grayacsimagedict	PUNCT
dti-1330	420	1	<	<	X
dti-1330	420	2	<	<	X
dti-1330	420	3	/qfactor	/qfactor	NOUN
dti-1330	420	4	0.15	0.15	NUM
dti-1330	420	5	/hsamples	/hsample	NOUN
dti-1330	421	1	[	[	X
dti-1330	421	2	1	1	NUM
dti-1330	421	3	1	1	NUM
dti-1330	421	4	1	1	NUM
dti-1330	421	5	1	1	NUM
dti-1330	421	6	]	]	PUNCT
dti-1330	421	7	/vsamples	/vsample	NOUN
dti-1330	422	1	[	[	X
dti-1330	422	2	1	1	NUM
dti-1330	422	3	1	1	NUM
dti-1330	422	4	1	1	NUM
dti-1330	422	5	1	1	NUM
dti-1330	422	6	]	]	PUNCT
dti-1330	422	7	>	>	PUNCT
dti-1330	422	8	>	>	X
dti-1330	422	9	/grayimagedict	/grayimagedict	PUNCT
dti-1330	423	1	<	<	X
dti-1330	423	2	<	<	X
dti-1330	423	3	/qfactor	/qfactor	NOUN
dti-1330	423	4	0.15	0.15	NUM
dti-1330	423	5	/hsamples	/hsample	NOUN
dti-1330	424	1	[	[	X
dti-1330	424	2	1	1	NUM
dti-1330	424	3	1	1	NUM
dti-1330	424	4	1	1	NUM
dti-1330	424	5	1	1	NUM
dti-1330	424	6	]	]	PUNCT
dti-1330	424	7	/vsamples	/vsample	NOUN
dti-1330	425	1	[	[	X
dti-1330	425	2	1	1	NUM
dti-1330	425	3	1	1	NUM
dti-1330	425	4	1	1	NUM
dti-1330	425	5	1	1	NUM
dti-1330	425	6	]	]	PUNCT
dti-1330	425	7	>	>	X
dti-1330	425	8	>	>	X
dti-1330	425	9	/jpeg2000grayacsimagedict	/jpeg2000grayacsimagedict	PUNCT
dti-1330	426	1	<	<	X
dti-1330	426	2	<	<	X
dti-1330	426	3	/tilewidth	/tilewidth	PUNCT
dti-1330	426	4	256	256	NUM
dti-1330	426	5	/tileheight	/tileheight	NUM
dti-1330	426	6	256	256	NUM
dti-1330	426	7	/quality	/quality	NOUN
dti-1330	426	8	30	30	NUM
dti-1330	426	9	>	>	PUNCT
dti-1330	426	10	>	>	X
dti-1330	426	11	/jpeg2000grayimagedict	/jpeg2000grayimagedict	PUNCT
dti-1330	426	12	<	<	X
dti-1330	426	13	<	<	X
dti-1330	426	14	/tilewidth	/tilewidth	PUNCT
dti-1330	426	15	256	256	NUM
dti-1330	426	16	/tileheight	/tileheight	NUM
dti-1330	426	17	256	256	NUM
dti-1330	426	18	/quality	/quality	NOUN
dti-1330	426	19	30	30	NUM
dti-1330	426	20	>	>	PUNCT
dti-1330	426	21	>	>	X
dti-1330	426	22	/antialiasmonoimages	/antialiasmonoimage	NOUN
dti-1330	426	23	false	false	ADJ
dti-1330	426	24	/cropmonoimages	/cropmonoimage	NOUN
dti-1330	426	25	true	true	ADJ
dti-1330	426	26	/monoimageminresolution	/monoimageminresolution	NUM
dti-1330	426	27	1200	1200	NUM
dti-1330	426	28	/monoimageminresolutionpolicy	/monoimageminresolutionpolicy	PUNCT
dti-1330	427	1	/ok	/ok	PROPN
dti-1330	427	2	/downsamplemonoimages	/downsamplemonoimage	VERB
dti-1330	428	1	true	true	ADJ
dti-1330	428	2	/monoimagedownsampletype	/monoimagedownsampletype	PUNCT
dti-1330	428	3	/bicubic	/bicubic	NOUN
dti-1330	428	4	/monoimageresolution	/monoimageresolution	NOUN
dti-1330	428	5	1200	1200	NUM
dti-1330	428	6	/monoimagedepth	/monoimagedepth	PRON
dti-1330	428	7	-1	-1	PUNCT
dti-1330	429	1	/monoimagedownsamplethreshold	/monoimagedownsamplethreshold	PUNCT
dti-1330	429	2	1.50000	1.50000	NUM
dti-1330	429	3	/encodemonoimages	/encodemonoimage	NOUN
dti-1330	429	4	true	true	ADJ
dti-1330	429	5	/monoimagefilter	/monoimagefilter	ADP
dti-1330	429	6	/ccittfaxencode	/ccittfaxencode	INTJ
dti-1330	429	7	/monoimagedict	/monoimagedict	PUNCT
dti-1330	430	1	<	<	X
dti-1330	430	2	<	<	X
dti-1330	430	3	/k	/k	PUNCT
dti-1330	430	4	-1	-1	INTJ
dti-1330	430	5	>	>	PUNCT
dti-1330	430	6	>	>	X
dti-1330	430	7	/allowpsxobjects	/allowpsxobjects	PROPN
dti-1330	430	8	false	false	ADJ
dti-1330	430	9	/checkcompliance	/checkcompliance	NOUN
dti-1330	430	10	[	[	PUNCT
dti-1330	430	11	/none	/none	X
dti-1330	430	12	]	]	PUNCT
dti-1330	430	13	/pdfx1acheck	/pdfx1acheck	PUNCT
dti-1330	430	14	false	false	ADJ
dti-1330	430	15	/pdfx3check	/pdfx3check	PUNCT
dti-1330	430	16	false	false	ADJ
dti-1330	430	17	/pdfxcompliantpdfonly	/pdfxcompliantpdfonly	ADV
dti-1330	430	18	false	false	ADJ
dti-1330	430	19	/pdfxnotrimboxerror	/pdfxnotrimboxerror	NOUN
dti-1330	430	20	true	true	ADJ
dti-1330	430	21	/pdfxtrimboxtomediaboxoffset	/pdfxtrimboxtomediaboxoffset	NOUN
dti-1330	430	22	[	[	PUNCT
dti-1330	430	23	0.00000	0.00000	NUM
dti-1330	430	24	0.00000	0.00000	NUM
dti-1330	430	25	0.00000	0.00000	NUM
dti-1330	430	26	0.00000	0.00000	NUM
dti-1330	430	27	]	]	PUNCT
dti-1330	430	28	/pdfxsetbleedboxtomediabox	/pdfxsetbleedboxtomediabox	PUNCT
dti-1330	431	1	true	true	ADJ
dti-1330	431	2	/pdfxbleedboxtotrimboxoffset	/pdfxbleedboxtotrimboxoffset	PUNCT
dti-1330	431	3	[	[	PUNCT
dti-1330	431	4	0.00000	0.00000	NUM
dti-1330	431	5	0.00000	0.00000	NUM
dti-1330	431	6	0.00000	0.00000	NUM
dti-1330	431	7	0.00000	0.00000	NUM
dti-1330	431	8	]	]	PUNCT
dti-1330	431	9	/pdfxoutputintentprofile	/pdfxoutputintentprofile	PUNCT
dti-1330	432	1	(	(	PUNCT
dti-1330	432	2	)	)	PUNCT
dti-1330	432	3	/pdfxoutputconditionidentifier	/pdfxoutputconditionidentifi	ADJ
dti-1330	432	4	(	(	PUNCT
dti-1330	432	5	)	)	PUNCT
dti-1330	432	6	/pdfxoutputcondition	/pdfxoutputcondition	PRON
dti-1330	432	7	(	(	PUNCT
dti-1330	432	8	)	)	PUNCT
dti-1330	432	9	/pdfxregistryname	/pdfxregistryname	PUNCT
dti-1330	432	10	(	(	PUNCT
dti-1330	432	11	http://www.color.org	http://www.color.org	PROPN
dti-1330	432	12	)	)	PUNCT
dti-1330	432	13	/pdfxtrapped	/pdfxtrapped	PUNCT
dti-1330	432	14	/unknown	/unknown	VERB
dti-1330	432	15	/description	/description	X
dti-1330	433	1	<	<	X
dti-1330	433	2	<	<	X
dti-1330	433	3	/jpn	/jpn	PROPN
dti-1330	433	4	<	<	X
dti-1330	433	5	feff3053306e8a2d5b9a306f30019ad889e350cf5ea6753b50cf3092542b308030d730ea30d730ec30b9537052377528306e00200050004400460020658766f830924f5c62103059308b3068304d306b4f7f75283057307e305930023053306e8a2d5b9a30674f5c62103057305f00200050004400460020658766f8306f0020004100630072006f0062006100740020304a30883073002000520065006100640065007200200035002e003000204ee5964d30678868793a3067304d307e305930023053306e8a2d5b9a306b306f30d530a930f330c8306e57cb30818fbc307f304c5fc59808306730593002	feff3053306e8a2d5b9a306f30019ad889e350cf5ea6753b50cf3092542b308030d730ea30d730ec30b9537052377528306e00200050004400460020658766f830924f5c62103059308b3068304d306b4f7f75283057307e305930023053306e8a2d5b9a30674f5c62103057305f00200050004400460020658766f8306f0020004100630072006f0062006100740020304a30883073002000520065006100640065007200200035002e003000204ee5964d30678868793a3067304d307e305930023053306e8a2d5b9a306b306f30d530a930f330c8306e57cb30818fbc307f304c5fc59808306730593002	X
dti-1330	433	6	>	>	X
dti-1330	433	7	/fra	/fra	PUNCT
dti-1330	434	1	<	<	X
dti-1330	434	2	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	X
dti-1330	434	3	>	>	X
dti-1330	434	4	/deu	/deu	PUNCT
dti-1330	435	1	<	<	X
dti-1330	435	2	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	X
dti-1330	435	3	>	>	X
dti-1330	435	4	/ptb	/ptb	PROPN
dti-1330	436	1	<	<	X
dti-1330	437	1	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	X
dti-1330	437	2	>	>	X
dti-1330	437	3	/dan	/dan	PUNCT
dti-1330	438	1	<	<	X
dti-1330	438	2	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	NOUN
dti-1330	438	3	>	>	X
dti-1330	438	4	/nld	/nld	PUNCT
dti-1330	439	1	<	<	X
dti-1330	439	2	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	X
dti-1330	439	3	>	>	X
dti-1330	439	4	/esp	/esp	PUNCT
dti-1330	440	1	<	<	X
dti-1330	440	2	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	X
dti-1330	440	3	>	>	X
dti-1330	440	4	/suo	/suo	PUNCT
dti-1330	441	1	<	<	X
dti-1330	441	2	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	PROPN
dti-1330	441	3	>	>	X
dti-1330	441	4	/ita	/ita	PUNCT
dti-1330	442	1	<	<	X
dti-1330	442	2	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	NOUN
dti-1330	442	3	>	>	X
dti-1330	442	4	/nor	/nor	X
dti-1330	442	5	<	<	X
dti-1330	442	6	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	X
dti-1330	442	7	>	>	X
dti-1330	442	8	/sve	/sve	NOUN
dti-1330	443	1	<	<	X
dti-1330	443	2	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	X
dti-1330	443	3	>	>	X
dti-1330	443	4	/enu	/enu	PROPN
dti-1330	443	5	<	<	X
dti-1330	443	6	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	X
dti-1330	443	7	>	>	X
dti-1330	443	8	>	>	X
dti-1330	443	9	>	>	X
dti-1330	443	10	>	>	X
dti-1330	443	11	>	>	X
dti-1330	443	12	setdistillerparams	setdistillerparam	NOUN
dti-1330	444	1	<	<	X
dti-1330	444	2	<	<	X
dti-1330	444	3	/hwresolution	/hwresolution	NOUN
dti-1330	445	1	[	[	X
dti-1330	445	2	2400	2400	NUM
dti-1330	445	3	2400	2400	NUM
dti-1330	445	4	]	]	PUNCT
dti-1330	445	5	/pagesize	/pagesize	X
dti-1330	446	1	[	[	X
dti-1330	446	2	612.000	612.000	NUM
dti-1330	446	3	792.000	792.000	NUM
dti-1330	446	4	]	]	PUNCT
dti-1330	446	5	>	>	PUNCT
dti-1330	446	6	>	>	X
dti-1330	446	7	setpagedevice	setpagedevice	PROPN